Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Frontal bossing	13/216	6.853082426572506E-6	0.02081114502157119	0	0	4.943690492416129	58.78449431863668	CDKN1C;RERE;HDAC4;BRAF;PIK3R1;GNS;EDA2R;HDAC6;MTOR;TBX15;SON;NSD1;PAFAH1B1
Concave bridge of nose	14/275	2.0392025793781526E-5	0.02081114502157119	0	0	4.144955300127714	44.767036889737	CDKN1C;RERE;HDAC4;MEF2C;INSR;BRAF;ABCC9;GNS;ARID1B;SHROOM4;MTOR;MECP2;SON;PEX6
Depressed nasal root/bridge	14/275	2.0392025793781526E-5	0.02081114502157119	0	0	4.144955300127714	44.767036889737	CDKN1C;RERE;HDAC4;MEF2C;INSR;BRAF;ABCC9;GNS;ARID1B;SHROOM4;MTOR;MECP2;SON;PEX6
Depressed nasal bridge	14/277	2.2098375387917376E-5	0.02081114502157119	0	0	4.113012251795522	44.09151792576593	CDKN1C;RERE;HDAC4;MEF2C;INSR;BRAF;ABCC9;GNS;ARID1B;SHROOM4;MTOR;MECP2;SON;PEX6
Mental impairment	11/182	3.3741276540763705E-5	0.025420677745811374	0	0	4.935053319573443	50.81520099293789	MEF2C;DSTYK;COL3A1;ATXN1;NFIA;MAOA;INSR;PEX6;BRAF;TTC19;MTOR
Hypoplastic feet	8/103	7.044462146475419E-5	0.04257666910819963	0	0	6.410118319053447	61.285113522664346	RERE;MECP2;HDAC4;BBS1;COL3A1;SON;SHROOM4;HDAC6
Autistic behavior	6/54	7.911778172482012E-5	0.04257666910819963	0	0	9.464423076923078	89.38743378109675	RERE;MECP2;MEF2C;MAOA;RSRC2;ARID1B
Big calvaria	11/213	1.3884862196676624E-4	0.051292559093870746	0	0	4.1710735779460295	37.04800219610109	MECP2;TBX15;NFIA;NSD1;PEX6;IDS;BRAF;ABCC9;HDAC6;MTOR;FOXP1
Increased size of skull	11/213	1.3884862196676624E-4	0.051292559093870746	0	0	4.1710735779460295	37.04800219610109	MECP2;TBX15;NFIA;NSD1;PEX6;IDS;BRAF;ABCC9;HDAC6;MTOR;FOXP1
Increased head circumference	11/215	1.5071692228979446E-4	0.051292559093870746	0	0	4.129757785467128	36.342311087500775	MECP2;TBX15;NFIA;NSD1;PEX6;IDS;BRAF;ABCC9;HDAC6;MTOR;FOXP1
Low set ears	13/293	1.6114747258287859E-4	0.051292559093870746	0	0	3.570045172219085	31.177885059041124	CDKN1C;RERE;MEF2C;INSR;BRAF;GNS;ARID1B;HDAC6;MECP2;TBX15;SON;NFIA;PAFAH1B1
Diastolic blood pressure	8/117	1.722385022621225E-4	0.051292559093870746	0	0	5.5828177227793185	48.384217797196754	ATXN2;PDE1A;INSR;EBF1;SIK3;MAP4;ATP2B1;CPEB4
Thickened facial skin with coarse facial features	9/151	1.9413846536716115E-4	0.051292559093870746	0	0	4.831698361374473	41.296230747887364	CDKN1C;HPGD;INSR;NSD1;IDS;BRAF;ABCC9;GNS;ARID1B
Coarse facial features	9/152	2.040002706275897E-4	0.051292559093870746	0	0	4.797665369649805	40.76763007726119	CDKN1C;HPGD;INSR;NSD1;IDS;BRAF;ABCC9;GNS;ARID1B
clinical depression	3/10	2.60491924531315E-4	0.051292559093870746	0	0	32.146116241173274	265.299926689255	ATXN1;MAOA;FKBP5
Papilledema	3/10	2.60491924531315E-4	0.051292559093870746	0	0	32.146116241173274	265.299926689255	IL11RA;IDS;BRAF
Small midface	9/158	2.723257716690775E-4	0.051292559093870746	0	0	4.603060611600031	37.78427605005978	RERE;CDKN1C;MECP2;HDAC4;FOXC1;NSD1;BRAF;PIK3R1;MTOR
Decreased projection of midface	9/158	2.723257716690775E-4	0.051292559093870746	0	0	4.603060611600031	37.78427605005978	RERE;CDKN1C;MECP2;HDAC4;FOXC1;NSD1;BRAF;PIK3R1;MTOR
Hypotrophic midface	9/158	2.723257716690775E-4	0.051292559093870746	0	0	4.603060611600031	37.78427605005978	RERE;CDKN1C;MECP2;HDAC4;FOXC1;NSD1;BRAF;PIK3R1;MTOR
Midface retrusion	9/158	2.723257716690775E-4	0.051292559093870746	0	0	4.603060611600031	37.78427605005978	RERE;CDKN1C;MECP2;HDAC4;FOXC1;NSD1;BRAF;PIK3R1;MTOR
Restless Legs Syndrome	6/68	2.871114954725692E-4	0.05150233349738896	0	0	7.322084367245657	59.71628364862867	ATXN2;ATXN1;MAOB;MAOA;BTBD9;MAP2K5
Spinocerebellar Ataxia Type 5	5/46	3.5184590343556387E-4	0.060245614465534954	0	0	9.201476497523595	73.17306030017292	BBS1;FOXC1;ATXN2;ATXN1;ANGPTL1
Orbital separation excessive	14/368	4.3963946980299037E-4	0.06784071455053543	0	0	3.041431261770245	23.508911900747474	MEF2C;FOXC1;INSR;BRAF;ABCC9;ARID1B;SHROOM4;MTOR;FOXP1;TBX15;COL3A1;NSD1;PEX6;PAFAH1B1
Body mass index	14/370	4.639300988766419E-4	0.06784071455053543	0	0	3.024032459425718	23.211797789466356	ADH1B;EYA2;INSR;FAM13A;RAB27B;ATP2B1;FHIT;SMG6;TBX15;GON4L;SIK3;ATP13A2;MAP2K5;CPEB4
Finding of body mass index	14/370	4.639300988766419E-4	0.06784071455053543	0	0	3.024032459425718	23.211797789466356	ADH1B;EYA2;INSR;FAM13A;RAB27B;ATP2B1;FHIT;SMG6;TBX15;GON4L;SIK3;ATP13A2;MAP2K5;CPEB4
Gambling, Pathological	3/12	4.6823960135755806E-4	0.06784071455053543	0	0	25.0	191.66326060862912	MAOB;MAOA;LMO3
Bulging forehead	7/105	5.109786509256391E-4	0.0687448777870315	0	0	5.415333701047987	41.0438037597171	CDKN1C;NSD1;BRAF;ABCC9;PIK3R1;GNS;FOXP1
Prominent forehead	7/105	5.109786509256391E-4	0.0687448777870315	0	0	5.415333701047987	41.0438037597171	CDKN1C;NSD1;BRAF;ABCC9;PIK3R1;GNS;FOXP1
Small nose	9/176	5.992897693478965E-4	0.07112235831143901	0	0	4.103147790023066	30.444393682013285	CDKN1C;MEF2C;NFIA;PEX6;BRAF;HDAC6;MTOR;FOXP1;PAFAH1B1
Thick lower lip vermilion	6/78	6.032672715159098E-4	0.07112235831143901	0	0	6.301923076923077	46.71710246360414	INSR;IDS;ABCC9;BRAF;ARID1B;GNS
Full lower lip	6/78	6.032672715159098E-4	0.07112235831143901	0	0	6.301923076923077	46.71710246360414	INSR;IDS;ABCC9;BRAF;ARID1B;GNS
Hydrocephalus	11/253	6.041718784088262E-4	0.07112235831143901	0	0	3.4745098039215687	25.75185695912743	CDKN1C;TBX15;FOXC1;NFIA;NSD1;MBOAT7;OGDH;IDS;BRAF;HDAC6;PAFAH1B1
Short nose	9/179	6.765790929489163E-4	0.07385951967412033	0	0	4.030121309224079	29.41368401577025	CDKN1C;MEF2C;NFIA;PEX6;BRAF;HDAC6;MTOR;FOXP1;PAFAH1B1
Autism Spectrum Disorders	18/572	6.870861657231909E-4	0.07385951967412033	0	0	2.5128100617212064	18.300923456984908	MEF2A;RERE;MEF2C;FOXC1;MAOB;MAOA;SFSWAP;HGF;FHIT;ARID1B;ARHGAP24;MTOR;FOXP1;MECP2;SLC16A7;DIP2A;PAFAH1B1;FKBP5
Impaired cognition	20/671	6.90415503906077E-4	0.07385951967412033	0	0	2.3832003296991497	17.345449063546877	MEF2A;BBS1;MEF2C;MAOA;INSR;HGF;BRAF;TTC19;HDAC6;MTOR;FOXP1;DSTYK;COL3A1;ATXN1;NFIA;NFIC;ZNF407;PEX6;PMP22;ATP13A2
Antisocial Personality Disorder	4/31	7.254585155143223E-4	0.07385951967412033	0	0	11.143341815097541	80.55194928059622	MAOB;ADH1B;MAOA;SRSF5
Large hand	4/31	7.254585155143223E-4	0.07385951967412033	0	0	11.143341815097541	80.55194928059622	NSD1;INSR;PEX6;ABCC9
ovarian neoplasm	25/938	7.82287309442284E-4	0.07630690792783863	0	0	2.138429235614658	15.296801219659777	CDKN1C;CHIC1;POP4;PIK3R1;WASL;FHIT;HDAC6;AKAP13;HPGDS;PRKCI;IGFBP5;IL11RA;EYA2;INSR;NR1H2;HGF;BRAF;IL16;ARHGAP24;DCN;MTOR;FOXP1;TGFBR3;DLC1;SIK3
Delayed bone age	9/183	7.921142604683601E-4	0.07630690792783863	0	0	3.9366697973970215	28.110991011559346	CDKN1C;GHR;MECP2;INSR;NSD1;BRAF;ABCC9;PIK3R1;ARID1B
Brugada Syndrome (disorder)	5/55	8.102671401947293E-4	0.07630690792783863	0	0	7.54176245210728	53.683370469595545	SEMA3A;AKAP9;IDS;ABCC9;SRSF5
Late tooth eruption	6/84	8.935648704758371E-4	0.08209899675810924	0	0	5.815384615384615	40.825695901891976	GHR;IL11RA;IDS;PIK3R1;ARID1B;EDA2R
Postnatal growth retardation	6/86	0.0010110085408195036	0.08962999772435142	0	0	5.669423076923077	39.10091614540961	CDKN1C;MECP2;INSR;COG1;BRAF;ARID1B
Systolic Pressure	7/118	0.0010231191670154263	0.08962999772435142	0	0	4.777940102264426	32.895636518083	INSR;SIK3;EBF2;ATP2B1;FHIT;ARHGAP24;HIPK2
Presenile dementia	13/362	0.0011835069672583491	0.10132433512868638	0	0	2.854060726865012	19.234295087697948	NAA50;MEF2C;MAOB;MAOA;INSR;NR1H2;LMO3;TOM1L2;ATXN2;ATXN1;ATP13A2;SRSF5;PAFAH1B1
Profound Mental Retardation	9/196	0.0012832730471114993	0.10522971932962993	0	0	3.660563057907988	24.373278543811974	MECP2;HDAC4;MEF2C;TMEM135;GON4L;NSD1;PEX6;IDS;SHROOM4
Mammary Neoplasms	49/2387	0.0012849925906989585	0.10522971932962993	0	0	1.6801236237203014	11.184586872156613	ITSN2;CDKN1C;NUMA1;WASL;LSP1;MECP2;GHR;AKAP13;VPS39;RBM5;MEF2A;PRKCI;EGFL7;IGFBP5;IL11RA;HGF;DCN;FOXP1;CEACAM1;AKAP9;UTS2;SRSF5;FKBP5;HPGD;ADH1B;SEMA3A;PIK3R1;FHIT;HDAC6;CALD1;SAFB2;RAI2;SASH1;GSN;INSR;MIB2;RAB27B;BRAF;ATP2B1;PUM1;ARHGAP24;MTOR;HIPK2;AIMP2;SON;DLC1;NFIC;PMP22;OGT
Hernia, Inguinal	7/124	0.0013659272177103414	0.10592092441338709	0	0	4.531531531531532	29.889627618834655	COL3A1;NFIA;INSR;NSD1;IDS;PIK3R1;ARID1B
Heart failure	22/815	0.0013731216145933165	0.10592092441338709	0	0	2.153587745229777	14.193583087414494	MEF2A;HDAC4;MEF2C;FOXC1;GSN;NPR1;HGF;IL16;ABCC9;ATP2B1;FSTL1;DCN;MTOR;MECP2;AIMP2;ATXN1;SGCD;GOLGB1;SIK3;IDS;UTS2;OGT
Alcohol problem	3/17	0.0013777874425951598	0.10592092441338709	0	0	16.067354698533407	105.84010591710908	ADH1B;MAOA;LMO3
Slowed saccades	3/18	0.0016371829532615236	0.12092682715561097	0	0	14.995437262357415	96.19240443286807	ATXN2;ATXN1;ATP13A2
Oppositional Defiant Disorder	3/18	0.0016371829532615236	0.12092682715561097	0	0	14.995437262357415	96.19240443286807	MAOB;MAOA;LMO3
Glomerular filtration rate finding	5/65	0.001727590845327222	0.12295554321026742	0	0	6.281609195402299	39.95748830830956	SLC7A6;ATXN2;SORT1;PIP5K1B;DNAJC16
Congestive heart failure	23/884	0.0017299293310709246	0.12295554321026742	0	0	2.074719318621758	13.194540002561709	MEF2A;HDAC4;MEF2C;FOXC1;GSN;PPP1R12A;NPR1;HGF;IL16;ABCC9;ATP11A;FSTL1;DCN;MTOR;MECP2;AIMP2;COL3A1;ATXN1;SGCD;GOLGB1;IDS;UTS2;OGT
Werner Syndrome	6/96	0.0017857815016559537	0.12457479475440698	0	0	5.036923076923077	31.873141224388615	MECP2;AIMP2;COL3A1;INSR;DCN;MTOR
Rhizomelia	4/40	0.0019188174484482926	0.13142155142372214	0	0	8.353689567430026	52.26106783220467	TBX15;COG1;HDAC6;MTOR
Cerebral atrophy	12/338	0.0019921754457820754	0.13400937329037638	0	0	2.8126177479348824	17.490342355259738	MECP2;RERE;CEACAM1;ATXN1;ADH1B;ROGDI;BRAF;ABCC9;ATP13A2;PTPN23;TTC19;PAFAH1B1
Nephrolithiasis	6/99	0.002088506941468651	0.1380246605002177	0	0	4.873697270471464	30.077076478194293	CDKN1C;MECP2;USP8;PDE1A;NSD1;HIPK2
High forehead	7/134	0.0021299663003634434	0.13833763885291536	0	0	4.172589912747393	25.668309068259752	GHR;MEF2C;PEX6;NSD1;BRAF;MTOR;PAFAH1B1
Dementia	14/436	0.002213937648044711	0.1408095327267573	0	0	2.5423907319641916	15.541590326407901	NAA50;MEF2C;MAOA;NR1H2;LMO3;ROGDI;MECP2;TOM1L2;HPGDS;ATXN2;ATXN1;ATP13A2;SRSF5;PAFAH1B1
Squamous cell carcinoma of penis	3/20	0.0022427852305828082	0.1408095327267573	0	0	13.229926191008722	80.70303634853826	BRAF;FHIT;MTOR
Mental Retardation, Psychosocial	7/138	0.0025144952496453784	0.14353679427538724	0	0	4.044357334433671	24.208241717295547	MECP2;HDAC4;MEF2C;TMEM135;GON4L;PEX6;NSD1
Saccular Aneurysm	2/6	0.0025517686912307955	0.14353679427538724	0	0	37.36742424242424	223.119715164246	TGFBR3;COL3A1
Visual Pathway Glioma	2/6	0.0025517686912307955	0.14353679427538724	0	0	37.36742424242424	223.119715164246	BRAF;MTOR
Dilated fourth ventricle	2/6	0.0025517686912307955	0.14353679427538724	0	0	37.36742424242424	223.119715164246	ATXN2;ATXN1
Ossifying fibromyxoid tumor	2/6	0.0025517686912307955	0.14353679427538724	0	0	37.36742424242424	223.119715164246	PHF1;CREB3L2
Small chin	3/21	0.0025910544228102818	0.14353679427538724	0	0	12.494296577946768	74.41216184749106	MEF2C;NFIA;MTOR
Abnormal hair quantity	3/21	0.0025910544228102818	0.14353679427538724	0	0	12.494296577946768	74.41216184749106	HPGD;PEX6;BRAF
Olivopontocerebellar Atrophies	3/21	0.0025910544228102818	0.14353679427538724	0	0	12.494296577946768	74.41216184749106	ATXN2;ATXN1;TTC19
Macrostomia	6/104	0.0026771716253728593	0.1461580509098487	0	0	4.623861852433281	27.387107883372217	MECP2;INSR;ABCC9;GNS;ARID1B;MTOR
Acid reflux	7/140	0.002725737301375402	0.14668360591830198	0	0	3.983133509449299	23.52046837067667	RERE;MECP2;FAM13A;BRAF;ATP11A;KIAA0319L;SHROOM4
Short lower third of face	3/22	0.002970916631495668	0.14950073801413774	0	0	11.836101660996597	68.87291137947287	MEF2C;NFIA;MTOR
Downward slant of palpebral fissure	9/222	0.0029923431241290913	0.14950073801413774	0	0	3.209459089165342	18.65240871848501	MECP2;RERE;SON;NSD1;BRAF;ARID1B;MTOR;PAFAH1B1;FOXP1
Malnutrition	9/225	0.003270470507133332	0.14950073801413774	0	0	3.164396887159533	18.109278282313312	MECP2;GHR;HPGDS;MAOB;MAOA;INSR;NR1H2;SAA1;MTOR
Clubbed Fingers	3/23	0.0033832645439353087	0.14950073801413774	0	0	11.243726235741445	63.96459377833129	HPGD;FAM13A;ATP11A
Enlarged kidney	3/23	0.0033832645439353087	0.14950073801413774	0	0	11.243726235741445	63.96459377833129	CDKN1C;NSD1;SAA1
Global developmental delay	26/1102	0.003383668509618785	0.14950073801413774	0	0	1.8785161090458489	10.68649267320726	RERE;HDAC4;CEP104;MAOB;DGKB;DHTKD1;MECP2;NSD1;BBS1;MEF2C;INSR;MBOAT7;COG1;BRAF;ARID1B;TTC19;SHROOM4;FOXP1;COL3A1;SON;NFIA;PEX6;OGDH;STT3A;PMP22;PAFAH1B1
Systemic arterial pressure	5/76	0.0034340939476512405	0.14950073801413774	0	0	5.305434137391398	30.103044748928745	ATXN2;LSP1;MAP4;ATP2B1;FHIT
Blood Pressure	5/76	0.0034340939476512405	0.14950073801413774	0	0	5.305434137391398	30.103044748928745	ATXN2;LSP1;MAP4;ATP2B1;FHIT
Blood pressure finding	5/76	0.0034340939476512405	0.14950073801413774	0	0	5.305434137391398	30.103044748928745	ATXN2;LSP1;MAP4;ATP2B1;FHIT
Familial dilated cardiomyopathy	5/76	0.0034340939476512405	0.14950073801413774	0	0	5.305434137391398	30.103044748928745	MEF2A;SGCD;CALD1;LAMA4;ABCC9
Weight Gain	6/110	0.003538453006420044	0.14950073801413774	0	0	4.355769230769231	24.58424749988011	GSN;IGFBP5;NSD1;MAP4;FAM126B;FSTL1
Alcohol-Related Disorders	2/7	0.003541176645642669	0.14950073801413774	0	0	29.89242424242424	168.69180477245845	ADH1B;NPR1
Chromosome 17 trisomy	2/7	0.003541176645642669	0.14950073801413774	0	0	29.89242424242424	168.69180477245845	PMP22;BRAF
Desmoplastic infantile astrocytoma	2/7	0.003541176645642669	0.14950073801413774	0	0	29.89242424242424	168.69180477245845	BRAF;HDAC6
Heparan sulfate excretion in urine	2/7	0.003541176645642669	0.14950073801413774	0	0	29.89242424242424	168.69180477245845	IDS;GNS
Impaired horizontal smooth pursuit	2/7	0.003541176645642669	0.14950073801413774	0	0	29.89242424242424	168.69180477245845	ATXN2;ATXN1
Diabetic Nephropathy	16/561	0.003594664485589247	0.14950073801413774	0	0	2.2533871559633027	12.682749341084689	HDAC4;FOXC1;CALCRL;ADH1B;INSR;HGF;SEMA3A;PIK3R1;ACACB;DCN;GHR;HPGDS;CALD1;SAA1;UTS2;SASH1
Hydronephrosis	6/111	0.0036999160020995425	0.14950073801413774	0	0	4.314065934065934	24.15637562186777	CDKN1C;TBX15;NFIA;PEX6;BRAF;ARID1B
Corneal Neovascularization	4/48	0.0037604204516521874	0.14950073801413774	0	0	6.8320610687022905	38.144930782425405	CEACAM1;INSR;DCN;ANGPTL1
Cryptorchidism	13/414	0.003799690450922612	0.14950073801413774	0	0	2.477294905029915	13.805557426355591	CDKN1C;RERE;NUMA1;SEMA3A;BRAF;ATP2B1;ARID1B;MECP2;TGFBR3;COL3A1;NSD1;PEX6;STT3A
Childhood Solid Neoplasm	3/24	0.0038289382980989527	0.14950073801413774	0	0	10.70776751765345	59.590522153015485	INSR;BRAF;HDAC6
Elastosis perforans serpiginosa	3/24	0.0038289382980989527	0.14950073801413774	0	0	10.70776751765345	59.590522153015485	MAOB;INSR;MTOR
Inattention	3/24	0.0038289382980989527	0.14950073801413774	0	0	10.70776751765345	59.590522153015485	MAOA;LMO3;MAP2K5
Norrie disease	3/24	0.0038289382980989527	0.14950073801413774	0	0	10.70776751765345	59.590522153015485	MAOB;MAOA;FZD4
Stereotyped Behavior	5/78	0.0038410220529284597	0.14950073801413774	0	0	5.15955492573348	28.697531116465925	RERE;MECP2;MEF2C;LMO3;FOXP1
Dyskinetic syndrome	5/78	0.0038410220529284597	0.14950073801413774	0	0	5.15955492573348	28.697531116465925	MEF2C;ATXN2;MAOB;MAOA;MTOR
Low-set, posteriorly rotated ears	7/149	0.003849634082126722	0.14950073801413774	0	0	3.728968405024743	20.732233438733328	RERE;INSR;PEX6;NSD1;COG1;BRAF;ARID1B
Malignant neoplasm of prostate	60/3239	0.004033754336767412	0.15420199353330147	0	0	1.516780327207982	8.362097522002177	ITSN2;CDKN1C;RERE;PRDM2;IKZF5;GHR;AKAP13;HPGDS;SLC16A7;PRKCI;PPP1R12A;IGFBP5;IL11RA;HGF;IL16;FRS3;DCN;FOXP1;TGFBR3;SLC7A6;CEACAM1;SRSF5;FKBP5;HDAC4;IGSF8;FOXC1;COL15A1;HPGD;MAOA;NPR1;SEMA3A;TSHZ2;FOXK1;PIK3R1;RCHY1;FSTL1;FHIT;HDAC6;ABR;CALD1;NSD1;MAP2K5;GSN;FZD4;SORT1;INSR;NR1H2;RAB27B;BRAF;HOOK3;TPD52L1;ARHGAP24;MTOR;HIPK2;AIMP2;TBX15;DLC1;NFIC;HOXD3;OGT
Antisocial behavior	4/49	0.004052561019324886	0.15420199353330147	0	0	6.679898218829517	36.795593079677495	MAOB;ADH1B;MAOA;LMO3
Obesity	40/1961	0.004186552520901527	0.15728805657017522	0	0	1.6411990436396973	8.987005196893591	HDAC4;ZNF197;CALCRL;MAOA;ADH1B;NPR1;PIK3R1;ACACB;GHR;HPGDS;ATXN2;ATXN1;CALD1;NSD1;SLC16A7;MAP2K5;BBS1;PRKCI;FZD4;SORT1;INSR;NR1H2;LMO3;HGF;SYVN1;BRAF;ATP2B1;SORBS3;CRLS1;PDGFRL;ARHGAP24;DCN;MTOR;AIMP2;TBX15;CEACAM1;SIK3;SAA1;UTS2;OSBPL1A
Joint hyperflexibility	6/114	0.004217173802385903	0.15728805657017522	0	0	4.193589743589744	22.933023314863608	HDAC4;COL3A1;BRAF;ABCC9;PIK3R1;ARID1B
Depressed nasal ridge	5/80	0.004281360912784898	0.15758227828391064	0	0	5.021455938697318	27.38443137416005	RERE;NSD1;ARID1B;EDA2R;HDAC6
Excessive wrinkled skin	3/25	0.004308727014399468	0.15758227828391064	0	0	10.220532319391635	55.67239216201582	COL3A1;BRAF;PIK3R1
Lymphedema	4/50	0.004359667683779656	0.15791219389228814	0	0	6.534351145038168	35.516547205567086	HGF;ABCC9;BRAF;PAFAH1B1
Mean Corpuscular Volume (result)	8/194	0.00454052864742008	0.16015133746168514	0	0	3.258814703675919	17.580366238732413	AKAP13;MEF2C;ATXN2;EPB41L2;PIK3R1;ATP11A;CPEB4;FOXP1
Retinal Neovascularization	2/8	0.004680245133125118	0.16015133746168514	0	0	24.90909090909091	133.62244662591715	FZD4;HGF
Rett Syndrome, Atypical	2/8	0.004680245133125118	0.16015133746168514	0	0	24.90909090909091	133.62244662591715	MECP2;MEF2C
Adrenocortical cytomegaly	2/8	0.004680245133125118	0.16015133746168514	0	0	24.90909090909091	133.62244662591715	CDKN1C;NSD1
Overgrowth of external genitalia	2/8	0.004680245133125118	0.16015133746168514	0	0	24.90909090909091	133.62244662591715	CDKN1C;NSD1
Pancreatic hyperplasia	2/8	0.004680245133125118	0.16015133746168514	0	0	24.90909090909091	133.62244662591715	CDKN1C;NSD1
Endometrial Neoplasms	9/238	0.0047190863971985795	0.16015133746168514	0	0	2.9827706319134113	15.976137265522887	CDKN1C;CEACAM1;BRAF;ABCC9;PIK3R1;FSTL1;FHIT;DCN;MTOR
Anteverted nostril	10/283	0.0047699616687585525	0.16043255005547738	0	0	2.7845982142857144	14.88483866069705	RERE;HDAC4;MEF2C;NFIA;NSD1;PEX6;BRAF;ABCC9;GNS;PAFAH1B1
Malignant Uterine Corpus Neoplasm	3/26	0.004823370296240119	0.16079323810563298	0	0	9.775665399239545	52.146159532430104	BRAF;PIK3R1;MTOR
Generalized hirsutism	4/52	0.005020157204073779	0.1658853700679467	0	0	6.261450381679389	33.149959376220615	USP8;INSR;ABCC9;ARID1B
Prostatic Neoplasms	33/1554	0.00514494969961084	0.16853065668203507	0	0	1.695939253879168	8.937158391723734	ITSN2;IGSF8;FOXC1;COL15A1;HPGD;MAOA;PIK3R1;RCHY1;FHIT;HDAC6;MECP2;GHR;ADAMTS15;ABR;AKAP13;HPGDS;MAP2K5;IGFBP5;IL11RA;INSR;HGF;BRAF;IL16;TPD52L1;DCN;MTOR;FOXP1;TGFBR3;CEACAM1;DLC1;NFIC;HOXD3;FKBP5
Vitiligo	9/243	0.005393222513283555	0.17184263379522277	0	0	2.9182879377431905	15.24108619794704	RERE;AIMP2;DSTYK;HPGDS;ATXN2;NR1H2;HGF;BRAF;FOXP1
Malignant neoplasm of urinary bladder	26/1144	0.005494318649204613	0.17184263379522277	0	0	1.8038759689922481	9.387443948661984	CDKN1C;HDAC4;NUMA1;ADH1B;PRDM2;PIK3R1;FHIT;HPGDS;CALD1;MAP4;GSN;URGCP;IGFBP5;FZD4;NR1H2;HGF;PRRC2C;RAB27B;BRAF;SYN3;PODN;ARHGAP24;DCN;MTOR;HIPK2;CEACAM1
Intellectual Disability	48/2503	0.0055952709393318496	0.17184263379522277	0	0	1.549715054466638	8.036564265255684	CDKN1C;RERE;HDAC4;CEP104;FOXC1;MAOB;HPGD;MAOA;ROGDI;PIK3R1;PTPN23;GNS;HDAC6;DHTKD1;MECP2;ATXN1;NSD1;ZNF407;WWC3;IDS;NAA50;BBS1;MEF2C;PPP1R12A;IL11RA;INSR;MBOAT7;COG1;BRAF;ABCC9;ARID1B;TTC19;SHROOM4;MTOR;FOXP1;TBX15;COL3A1;TMEM135;DLG2;SON;GON4L;NFIA;PEX6;STT3A;PMP22;ATP13A2;OGT;PAFAH1B1
Fanconi Anemia	10/290	0.0056435766691696	0.17184263379522277	0	0	2.7140066964285716	14.051056574366452	HPGDS;ATXN1;INSR;PHF1;SAA1;FSTL1;FHIT;ARHGAP24;MTOR;PAFAH1B1
Degenerative polyarthritis	23/976	0.0058232707894112	0.17184263379522277	0	0	1.8652943487967388	9.598605475233278	HDAC4;COL15A1;ACAA2;CALCRL;HPGD;FZD4;HGF;SEMA3A;IL16;PIK3R1;FSTL1;FOXP1;MECP2;GHR;TGFBR3;ADAMTS15;AIMP2;COL3A1;HPGDS;CLEC3B;CILP;SIK3;SAA1
nervous system disorder	13/436	0.005823857461549036	0.17184263379522277	0	0	2.3457797213578897	12.070895562423901	MEF2A;MEF2C;MAOB;TTC19;HDAC6;MTOR;MECP2;ATXN2;ATXN1;PEX6;OGDH;PMP22;PAFAH1B1
Gastroesophageal reflux disease	9/246	0.005832102102941482	0.17184263379522277	0	0	2.880904299857164	14.820460058038941	MECP2;RERE;COL3A1;FAM13A;BRAF;ATP11A;KIAA0319L;SHROOM4;FOXP1
Pilocytic Astrocytoma	6/122	0.005856693425397559	0.17184263379522277	0	0	3.9027851458885943	20.06097950006401	HGF;PMP22;BRAF;ARHGAP24;MTOR;HIPK2
Benign Meningioma	3/28	0.005959940123334458	0.17184263379522277	0	0	8.992699619771862	46.066855979224975	HGF;LMO3;PRDM2
Hyperinsulinemic hypoglycemia	3/28	0.005959940123334458	0.17184263379522277	0	0	8.992699619771862	46.066855979224975	CDKN1C;INSR;MTOR
Bruxism	2/9	0.00596484844612917	0.17184263379522277	0	0	21.3495670995671	109.34974206016729	MECP2;SHROOM4
Chronic acquired lymphedema	2/9	0.00596484844612917	0.17184263379522277	0	0	21.3495670995671	109.34974206016729	CALCRL;HGF
Long clavicle	2/9	0.00596484844612917	0.17184263379522277	0	0	21.3495670995671	109.34974206016729	TBX15;HPGD
Ovarian cancer stage III	2/9	0.00596484844612917	0.17184263379522277	0	0	21.3495670995671	109.34974206016729	HGF;ARHGAP24
Premature tooth eruption	2/9	0.00596484844612917	0.17184263379522277	0	0	21.3495670995671	109.34974206016729	INSR;NSD1
Hodgkin Disease	16/592	0.005975945056324445	0.17184263379522277	0	0	2.1286666666666667	10.898801059747486	MEF2A;FOXC1;COL15A1;IL11RA;HGF;EBF1;PIK3R1;FHIT;ARHGAP24;HDAC6;MTOR;FOXP1;HPGDS;DLC1;SRSF5;PAFAH1B1
Heartburn	7/162	0.00605401295656986	0.17276868793483835	0	0	3.413949433304272	17.435155585105843	RERE;MECP2;FAM13A;BRAF;ATP11A;KIAA0319L;SHROOM4
Dilated ventricles (finding)	8/204	0.006110193623299836	0.1730608975862442	0	0	3.090966619205822	15.75711979199468	MECP2;RERE;MEF2C;SON;NFIA;NSD1;ROGDI;PAFAH1B1
Blepharophimosis	5/88	0.006405776022052649	0.1800787930975547	0	0	4.535613719244795	22.907367419464396	RERE;MECP2;TBX15;ABCC9;ARID1B
Myotonic Dystrophy	6/125	0.006577455315072618	0.1821438960739693	0	0	3.8038138332255977	19.11076899446775	MEF2A;MEF2C;INSR;PMP22;WASL;ATP2B1
Brain Aneurysm	3/29	0.006583111288235174	0.1821438960739693	0	0	8.64638783269962	43.432948703873194	COL3A1;CCDC80;FHIT
Patent ductus arteriosus	9/251	0.006624293539191344	0.1821438960739693	0	0	2.8206579412805093	14.15127346546112	FOXC1;HPGDS;HPGD;NSD1;DLC1;HGF;BRAF;ABCC9;ARID1B
Charcot-Marie-Tooth Disease	10/298	0.006790064897974767	0.1846910133985709	0	0	2.6375325520833335	13.1673399907424	SGCD;SORT1;LAMA4;SYVN1;PMP22;BRAF;ABCC9;LRIG3;HDAC6;DHTKD1
Neurodevelopmental Disorders	8/208	0.006842062552930627	0.1846910133985709	0	0	3.028527131782946	15.096196375231045	MECP2;MEF2C;DLG2;NR1H2;ARID1B;SHROOM4;MTOR;FOXP1
Hyperactive behavior	18/709	0.006864014302044048	0.1846910133985709	0	0	2.0002217450165727	9.964030280893539	RERE;USP8;MEF2C;MAOA;LMO3;HGF;BRAF;GNS;SHROOM4;MTOR;FOXP1;MECP2;AIMP2;ATXN2;NFIA;NFIC;PMP22;MAP2K5
Precancerous Conditions	13/446	0.006991859039224002	0.18661915367827622	0	0	2.290417986471807	11.36736462511727	CCDC134;IGFBP5;HPGD;NR1H2;HGF;SEMA3A;BRAF;FHIT;ARHGAP24;DCN;TGFBR3;HPGDS;PMP22
Skin carcinoma	5/90	0.007034754399340383	0.18661915367827622	0	0	4.428442641424386	21.951314117185408	HPGDS;NR1H2;BRAF;FHIT;SASH1
Rhabdomyosarcoma	12/397	0.007142616760193644	0.1868569384635844	0	0	2.374353205849269	11.733284435096412	CDKN1C;AIMP2;PRKCI;MEF2C;INSR;HGF;UTS2;BRAF;ATP2B1;ARHGAP24;HDAC6;MTOR
Pheochromocytoma, Extra-Adrenal	3/30	0.007243629019286195	0.1868569384635844	0	0	8.32572877059569	41.02613544280235	MAOB;MAOA;UTS2
Congenital Epicanthus	9/255	0.00731555933261134	0.1868569384635844	0	0	2.774224162475088	13.642945823242824	MECP2;RERE;COL3A1;PEX6;BRAF;ABCC9;ARID1B;SHROOM4;PAFAH1B1
Embryonal Rhabdomyosarcoma	5/91	0.007364881365569806	0.1868569384635844	0	0	4.376726365499421	21.494244711443358	CDKN1C;MEF2A;AIMP2;HGF;MTOR
Spinocerebellar tract degeneration	2/10	0.007390943411487676	0.1868569384635844	0	0	18.679924242424242	91.67172619510711	ATXN2;ATXN1
Deep plantar creases	2/10	0.007390943411487676	0.1868569384635844	0	0	18.679924242424242	91.67172619510711	ABCC9;MTOR
Miller-McKusick-Malvaux-Syndrome (3M Syndrome)	2/10	0.007390943411487676	0.1868569384635844	0	0	18.679924242424242	91.67172619510711	IGFBP5;INSR
Stereotypic Movement Disorder	5/92	0.007705659811148367	0.19351480339063934	0	0	4.326198969480777	21.05041972321926	RERE;MECP2;MEF2C;LMO3;FOXP1
Adenoma of large intestine	9/258	0.007869242305624627	0.19619427069212952	0	0	2.7403778538277623	13.276564806847219	HPGDS;HPGD;INSR;SEMA3A;PMP22;BRAF;OSBPL1A;FHIT;MTOR
Diagnosis, Psychiatric	3/31	0.007942006618421668	0.19619427069212952	0	0	8.027973927213472	38.81998492690587	MAOA;LMO3;BRAF
Malignant neoplasm of thyroid	14/505	0.007968601915555035	0.19619427069212952	0	0	2.1773025571396243	10.521262051408307	SORT1;HGF;BRAF;FHIT;ARHGAP24;MTOR;HIPK2;TBX15;CEACAM1;HPGDS;CCDC80;CREB3L2;AKAP9;METTL7A
Speech Disorders	5/93	0.008057257457136483	0.19708888857813722	0	0	4.276819923371647	20.61932742952296	MECP2;BBS1;PIK3R1;ARID1B;FOXP1
Androgenetic Alopecia	4/60	0.008326939197062656	0.20237148358280663	0	0	5.364776444929117	25.68794088541528	GHR;TBX15;EBF1;EDA2R
Alzheimer's Disease	39/1982	0.008411305883137741	0.20311146962679405	0	0	1.5731361421662764	7.516725354411055	HDAC4;MAOB;MAOA;PHF1;HDAC6;IL1RL1;HPGDS;ARHGAP20;ATXN2;ATXN1;SLC16A7;MEF2A;MEF2C;GSN;IGFBP5;FZD4;SORT1;INSR;NR1H2;LMO3;HGF;SYVN1;PRRC2C;ABCC9;HOOK3;ARHGAP24;DCN;MTOR;CLK1;AIMP2;COL3A1;NFIA;NFIC;AKAP9;OGDH;PKP4;SRSF5;OGT;FKBP5
Systemic Scleroderma	15/562	0.008538451816235743	0.20443549965611524	0	0	2.0962220587485523	9.984673707431158	EGFL7;IGFBP5;HGF;IL16;RNPC3;CSAD;MECP2;AIMP2;COL3A1;HPGDS;NFIC;PMP22;UTS2;KIAA0319L;CD22
Gait, Shuffling	2/11	0.00895456794352509	0.20443549965611524	0	0	16.603535353535353	78.29549005267604	MECP2;TTC19
Small face	2/11	0.00895456794352509	0.20443549965611524	0	0	16.603535353535353	78.29549005267604	GHR;INSR
Thick nasal alae	2/11	0.00895456794352509	0.20443549965611524	0	0	16.603535353535353	78.29549005267604	INSR;ABCC9
Abnormality of brainstem morphology	2/11	0.00895456794352509	0.20443549965611524	0	0	16.603535353535353	78.29549005267604	TGFBR3;COL3A1
Asymmetric overgrowth	2/11	0.00895456794352509	0.20443549965611524	0	0	16.603535353535353	78.29549005267604	CDKN1C;NSD1
Decreased vibratory sense	2/11	0.00895456794352509	0.20443549965611524	0	0	16.603535353535353	78.29549005267604	ATXN2;ATXN1
Hypopigmentation-immunodeficiency disease	2/11	0.00895456794352509	0.20443549965611524	0	0	16.603535353535353	78.29549005267604	RAB27B;VPS39
Posterior helix pit	2/11	0.00895456794352509	0.20443549965611524	0	0	16.603535353535353	78.29549005267604	CDKN1C;NSD1
B-Cell Lymphomas	18/730	0.009124813174277682	0.20586088351190207	0	0	1.9390857194635738	9.107416082033367	CDKN1C;HDAC4;IL11RA;INSR;HGF;BRAF;PRDM2;PIK3R1;FHIT;ARHGAP24;HDAC6;MTOR;FOXP1;TBRG1;AIMP2;MAP4;CD22;PAFAH1B1
Cardiac fibrosis	5/96	0.009178617088910351	0.20586088351190207	0	0	4.135194307608101	19.39769502035169	NPR1;HGF;UTS2;IL16;DCN
Heroin Dependence	4/62	0.009332018040459194	0.20586088351190207	0	0	5.179257699394578	24.209424938024245	ADH1B;MAOA;LMO3;FKBP5
Autistic Disorder	17/677	0.009411813284891482	0.20586088351190207	0	0	1.9730923694779117	9.20603394869988	MEF2A;RERE;MEF2C;MBD6;MAOB;MAOA;SEMA3A;CELF6;SYN3;ARID1B;MTOR;FOXP1;MECP2;GHR;NSD1;ZNF407;PAFAH1B1
Attention deficit hyperactivity disorder	12/412	0.009432036229900057	0.20586088351190207	0	0	2.2835433070866142	10.649631386320532	MECP2;RERE;MEF2C;ATXN1;MAOB;MAOA;NSD1;LMO3;IL16;SYN3;BTBD9;DHTKD1
Delayed speech and language development	8/220	0.00943816589934347	0.20586088351190207	0	0	2.8553459119496853	13.314459736122618	MECP2;BBS1;MEF2C;NSD1;PIK3R1;ARID1B;FOXP1;DHTKD1
Dysdiadochokinesis	3/33	0.009454189765744374	0.20586088351190207	0	0	7.4920152091254755	34.92251007314368	ATXN2;ATXN1;TTC19
Mean blood pressure	3/33	0.009454189765744374	0.20586088351190207	0	0	7.4920152091254755	34.92251007314368	ATXN2;MAP4;ATP2B1
Body Height	10/314	0.009618741431496368	0.20824022397957942	0	0	2.496659128289474	11.594589479932045	CNOT4;GHR;INSR;NSD1;STAT2;NFIC;SCMH1;ATP13A2;SYN3;ARHGAP24
Mental and motor retardation	23/1021	0.00974977127201732	0.20987079075250997	0	0	1.7769200953347024	8.228048853451103	RERE;HDAC4;BBS1;CEP104;INSR;MBOAT7;COG1;BRAF;RSRC2;PTPN23;SYN3;ARID1B;SHROOM4;DHTKD1;MECP2;COL3A1;SON;NFIA;NSD1;PEX6;OGDH;STT3A;PAFAH1B1
Prominent eyes	6/137	0.010112739611234031	0.2134334034503689	0	0	3.4532589547856722	15.864131098652752	CDKN1C;FOXC1;COL3A1;INSR;NSD1;BRAF
Protruding eyes	6/137	0.010112739611234031	0.2134334034503689	0	0	3.4532589547856722	15.864131098652752	CDKN1C;FOXC1;COL3A1;INSR;NSD1;BRAF
MYELODYSPLASTIC SYNDROME	17/683	0.010210160888231175	0.2134334034503689	0	0	1.9547016896414486	8.96107947741733	CDKN1C;ZNF197;NR1H2;PRDM2;FHIT;TM9SF4;ARHGAP24;HIPK2;FOXP1;MECP2;AIMP2;AKAP13;HPGDS;NSD1;SAA1;CD22;PAFAH1B1
Psychotic Disorders	10/317	0.010236817762934978	0.2134334034503689	0	0	2.471880089576547	11.32557237595447	MEF2A;MECP2;GHR;HPGDS;MAOB;MAOA;ADH1B;TTC19;PAFAH1B1;FKBP5
Diffuse Large B-Cell Lymphoma	15/575	0.010383133161826846	0.2134334034503689	0	0	2.046172453044963	9.346041232952585	CDKN1C;HDAC4;HGF;BRAF;FHIT;ARHGAP24;HDAC6;MTOR;FOXP1;COL3A1;CALD1;DLC1;MAP4;EIF4G3;CD22
Mental Depression	15/575	0.010383133161826846	0.2134334034503689	0	0	2.046172453044963	9.346041232952585	HDAC4;PRKCI;MAOB;MAOA;ADH1B;SORT1;DGKB;LMO3;ABCC9;HDAC6;MECP2;TGFBR3;SRSF5;MAP2K5;FKBP5
Hirsutism	4/64	0.010412927967126633	0.2134334034503689	0	0	5.006106870229008	22.851411929572716	USP8;BBS1;GNS;SHROOM4
Depressive disorder	18/741	0.010528368618976564	0.2134334034503689	0	0	1.9084794538883683	8.690608330065691	USP8;PRKCI;MAOB;MAOA;ADH1B;SORT1;DGKB;LMO3;ABCC9;TTC19;HDAC6;MECP2;TGFBR3;AIMP2;ATXN2;SRSF5;MAP2K5;FKBP5
Trichoepithelioma	2/12	0.01065183962003434	0.2134334034503689	0	0	14.942424242424243	67.86882961601465	BRAF;MTOR
Adenocarcinoma of the gastroesophageal junction	2/12	0.01065183962003434	0.2134334034503689	0	0	14.942424242424243	67.86882961601465	HGF;BRAF
Gangliosidosis GM1	2/12	0.01065183962003434	0.2134334034503689	0	0	14.942424242424243	67.86882961601465	NFIA;NFIC
Large head (disorder)	2/12	0.01065183962003434	0.2134334034503689	0	0	14.942424242424243	67.86882961601465	NFIA;NSD1
Plaque build-up in arteries	2/12	0.01065183962003434	0.2134334034503689	0	0	14.942424242424243	67.86882961601465	TGFBR3;COL3A1
Prominent globes	6/139	0.010811783522276325	0.21378534854770598	0	0	3.4009832272990166	15.3966546740333	CDKN1C;FOXC1;COL3A1;INSR;NSD1;BRAF
Oral Cavity Carcinoma	5/100	0.01083509578923735	0.21378534854770598	0	0	3.960274248840492	17.920101587456422	CDKN1C;ADH1B;BRAF;FHIT;ARHGAP24
Generalized hypotonia	16/633	0.010940023279737926	0.21378534854770598	0	0	1.9829627228525122	8.953725824545067	RERE;MEF2C;MBOAT7;BRAF;SYN3;MTOR;FOXP1;DHTKD1;ATXN2;ATXN1;SON;NFIA;PEX6;OGDH;STT3A;PMP22
Small hand	4/65	0.010982459633126447	0.21378534854770598	0	0	4.923789262920786	22.213457912207332	HDAC4;COL3A1;SON;SHROOM4
Melanocytic nevus of skin	4/65	0.010982459633126447	0.21378534854770598	0	0	4.923789262920786	22.213457912207332	MAOA;HGF;BRAF;ARHGAP24
Uterine Corpus Cancer	15/579	0.011009917074131924	0.21378534854770598	0	0	2.031236755107231	9.158762963990979	FOXC1;IGFBP5;YTHDC1;INSR;NR1H2;BRAF;PRDM2;PIK3R1;FSTL1;FHIT;ARHGAP24;DCN;MTOR;MECP2;HPGDS
Sleep disturbances	5/101	0.01127906844030163	0.21464940986193923	0	0	3.9188218390804597	17.5751581320036	MECP2;ATXN2;MAOA;GNS;FKBP5
Electroencephalogram abnormal	6/141	0.011544402695378705	0.21464940986193923	0	0	3.35025641025641	14.947351813252139	RERE;MECP2;PEX6;ROGDI;BRAF;PAFAH1B1
Malignant neoplasm of liver	19/805	0.011561751108147411	0.21464940986193923	0	0	1.8543746330005872	8.270609047250106	CCDC134;FOXC1;URGCP;HGF;BRAF;PRDM2;PIK3R1;FHIT;DCN;HDAC6;MTOR;AIMP2;HERC3;HPGDS;CALD1;NSD1;DLC1;OGT;CPEB4
Round face	4/66	0.011571702008510406	0.21464940986193923	0	0	4.844127062299926	21.600895759317066	HDAC4;USP8;PEX6;NSD1
Hypertrophic disorder of skin, unspecified	4/66	0.011571702008510406	0.21464940986193923	0	0	4.844127062299926	21.600895759317066	HDAC4;AKAP13;AIMP2;BRAF
Round, full face	4/66	0.011571702008510406	0.21464940986193923	0	0	4.844127062299926	21.600895759317066	HDAC4;USP8;PEX6;NSD1
Thyroid Neoplasm	13/476	0.011640977928998745	0.21464940986193923	0	0	2.1386813956069286	9.524026946474736	CDKN1C;IGFBP5;HPGD;SORT1;BRAF;PRDM2;FHIT;ARHGAP24;DCN;CEACAM1;CREB3L2;AKAP9;METTL7A
Endometriosis	18/749	0.011653562626449515	0.21464940986193923	0	0	1.886798905608755	8.40029918317389	MAOB;HPGD;MAOA;INSR;HGF;BRAF;IL16;FMO2;ABCC9;DCN;MTOR;AIMP2;AKAP13;HPGDS;CALD1;UTS2;METTL7A;FKBP5
Bladder Neoplasm	26/1217	0.011738518351495263	0.21464940986193923	0	0	1.6866708648194795	7.497049050005551	CDKN1C;HDAC4;NUMA1;ADH1B;PRDM2;PIK3R1;FHIT;HPGDS;CALD1;MAP4;GSN;URGCP;IGFBP5;FZD4;NR1H2;HGF;PRRC2C;RAB27B;BRAF;SYN3;PODN;ARHGAP24;DCN;MTOR;HIPK2;CEACAM1
Short stature	18/750	0.011800690271507264	0.21464940986193923	0	0	1.8841221575885774	8.364743552576877	CDKN1C;RERE;HDAC4;BBS1;INSR;BRAF;ARID1B;SHROOM4;HDAC6;MECP2;GHR;TBX15;COL3A1;SON;NSD1;PEX6;OGDH;IDS
Exophthalmos	6/142	0.011923553038960791	0.21464940986193923	0	0	3.325452488687783	14.729225810981422	CDKN1C;FOXC1;COL3A1;INSR;NSD1;BRAF
EAR, PATELLA, SHORT STATURE SYNDROME	3/36	0.012016942633390716	0.21464940986193923	0	0	6.809885931558935	30.109486655073866	MAOB;INSR;MTOR
Ovarian Mucinous Adenocarcinoma	3/36	0.012016942633390716	0.21464940986193923	0	0	6.809885931558935	30.109486655073866	MAST2;ULK1;MTOR
High, narrow palate	4/67	0.01218089022118615	0.21464940986193923	0	0	4.766993820428935	21.012369759338274	BBS1;NSD1;INSR;BRAF
Fine hair	4/67	0.01218089022118615	0.21464940986193923	0	0	4.766993820428935	21.012369759338274	MECP2;COL3A1;NSD1;BRAF
Sunken eyes	5/103	0.012203896174543621	0.21464940986193923	0	0	3.8384549221987645	16.912232462663606	RERE;HDAC4;TBX15;SON;PIK3R1
Carcinoma of bladder	25/1162	0.012332819749831808	0.21464940986193923	0	0	1.6967012995544073	7.457835797121039	CDKN1C;HDAC4;NUMA1;ADH1B;PIK3R1;FHIT;HPGDS;CALD1;MAP4;GSN;URGCP;IGFBP5;FZD4;NR1H2;HGF;PRRC2C;RAB27B;BRAF;SYN3;PODN;ARHGAP24;DCN;MTOR;HIPK2;CEACAM1
Rieger syndrome	2/13	0.012478954276550222	0.21464940986193923	0	0	13.583333333333334	59.54541741446951	FOXC1;PIK3R1
Schizophrenia and related disorders	2/13	0.012478954276550222	0.21464940986193923	0	0	13.583333333333334	59.54541741446951	DLG2;SYN3
Secondary Open Angle Glaucoma	2/13	0.012478954276550222	0.21464940986193923	0	0	13.583333333333334	59.54541741446951	FOXC1;ATXN2
Other specified congenital malformation syndromes, not elsewhere classified in ICD10CM	2/13	0.012478954276550222	0.21464940986193923	0	0	13.583333333333334	59.54541741446951	BBS1;BRAF
Akinetic-Rigid Variant of Huntington Disease	2/13	0.012478954276550222	0.21464940986193923	0	0	13.583333333333334	59.54541741446951	MAOB;MAOA
Diverticulosis	2/13	0.012478954276550222	0.21464940986193923	0	0	13.583333333333334	59.54541741446951	COL3A1;HPGD
Dysmetric saccades	2/13	0.012478954276550222	0.21464940986193923	0	0	13.583333333333334	59.54541741446951	ATXN2;ATXN1
Juvenile Huntington Disease	2/13	0.012478954276550222	0.21464940986193923	0	0	13.583333333333334	59.54541741446951	MAOB;MAOA
Enophthalmos	5/104	0.012685044852966041	0.21682914556922314	0	0	3.7994891443167305	16.59362881397576	RERE;HDAC4;TBX15;SON;PIK3R1
Hypoplasia of corpus callosum	7/187	0.01276188514290628	0.21682914556922314	0	0	2.936036036036036	12.804911278697585	RERE;MEF2C;SON;NFIA;NSD1;ARID1B;PAFAH1B1
Spinocerebellar Ataxia Type 4	3/37	0.012951037364766448	0.21682914556922314	0	0	6.609259673451129	28.72767187090778	FOXC1;ATXN2;ATXN1
Influenza due to Influenza A virus subtype H1N1	3/37	0.012951037364766448	0.21682914556922314	0	0	6.609259673451129	28.72767187090778	DLG2;NUMA1;BRAF
Juvenile Pilocytic Astrocytoma	3/37	0.012951037364766448	0.21682914556922314	0	0	6.609259673451129	28.72767187090778	ABR;HGF;BRAF
Pelvic Organ Prolapse	3/37	0.012951037364766448	0.21682914556922314	0	0	6.609259673451129	28.72767187090778	COL3A1;CALD1;DCN
Feeding difficulties in infancy	8/233	0.013012035071969215	0.21688644299162846	0	0	2.688578811369509	11.673488115492674	MECP2;RERE;CEP104;INSR;NSD1;PEX6;BRAF;ARID1B
Creatinine measurement, serum (procedure)	4/69	0.013460006171425325	0.22010542314047382	0	0	4.6198473282442745	19.902452417857162	SLC7A6;SORT1;PIP5K1B;DNAJC16
Mucoepidermoid Carcinoma	4/69	0.013460006171425325	0.22010542314047382	0	0	4.6198473282442745	19.902452417857162	NUMA1;BRAF;FHIT;MTOR
Lymphoma, Non-Hodgkin	14/539	0.013517173615498458	0.22010542314047382	0	0	2.0326984126984127	8.748315806272409	INSR;HGF;BRAF;IL16;LSP1;ARHGAP24;HDAC6;FOXP1;TGFBR3;AIMP2;HPGDS;DLC1;CD22;PAFAH1B1
Muscular Dystrophy, Duchenne	7/190	0.013826647092550439	0.22010542314047382	0	0	2.8874612317235266	12.361676596807673	CDKN1C;HPGDS;SGCD;MAOA;INSR;PMP22;DCN
Seizures	25/1174	0.013867664296564846	0.22010542314047382	0	0	1.6778977931378178	7.178374718441294	RERE;HDAC4;ROGDI;PTPN23;GNS;MECP2;ATXN2;NSD1;IDS;MEF2C;INSR;NR1H2;LMO3;HGF;BRAF;RSRC2;SYN3;ARID1B;MTOR;TGFBR3;COL3A1;NFIA;PEX6;STT3A;PAFAH1B1
Bladder neck obstruction	3/38	0.01392549984120925	0.22010542314047382	0	0	6.420097772949484	27.43971358771341	MECP2;COL3A1;HGF
Gross motor development delay	3/38	0.01392549984120925	0.22010542314047382	0	0	6.420097772949484	27.43971358771341	MECP2;NSD1;FOXP1
Depressive Symptoms	6/147	0.013951631253057487	0.22010542314047382	0	0	3.2067103109656303	13.699575808237489	AIMP2;MAOA;LMO3;IDS;ABCC9;FKBP5
Mild Mental Retardation	6/147	0.013951631253057487	0.22010542314047382	0	0	3.2067103109656303	13.699575808237489	MECP2;PMP22;ABCC9;ARID1B;HDAC6;DHTKD1
Deglutition Disorders	7/191	0.014195301281811503	0.22010542314047382	0	0	2.8716216216216215	12.218302787375125	RERE;MECP2;ATXN2;ATXN1;BRAF;GNS;KIAA0319L
Microstomia	5/107	0.014205142413547742	0.22010542314047382	0	0	3.687176019833221	15.68580442998891	RERE;MECP2;SON;NFIA;PAFAH1B1
Schizophrenia	37/1923	0.014234111644351127	0.22010542314047382	0	0	1.5290233251677494	6.501581436260721	ITSN2;CDKN1C;RERE;HDAC4;MAOB;MAOA;SFSWAP;SEMA3A;HP1BP3;FSTL1;FHIT;MECP2;GHR;HPGDS;ATXN2;ATXN1;SGCD;VPS39;MEF2A;GSN;SORT1;INSR;LMO3;SYN3;BTBD9;LEMD2;MTOR;FOXP1;COL3A1;DLG2;DLC1;AKAP9;STT3A;PMP22;PKP4;PAFAH1B1;FKBP5
Renal cortical cysts	2/14	0.014432184633845775	0.22010542314047382	0	0	12.450757575757576	52.76997763279668	CDKN1C;NSD1
Huntington Disease, Late Onset	2/14	0.014432184633845775	0.22010542314047382	0	0	12.450757575757576	52.76997763279668	MAOB;MAOA
Congenital hemihypertrophy	2/14	0.014432184633845775	0.22010542314047382	0	0	12.450757575757576	52.76997763279668	CDKN1C;NSD1
Deep palmar crease	2/14	0.014432184633845775	0.22010542314047382	0	0	12.450757575757576	52.76997763279668	BRAF;MTOR
Familial Exudative Vitreoretinopathy	2/14	0.014432184633845775	0.22010542314047382	0	0	12.450757575757576	52.76997763279668	MAOA;FZD4
Fulminant Hepatic Failure with Cerebral Edema	2/14	0.014432184633845775	0.22010542314047382	0	0	12.450757575757576	52.76997763279668	MAOB;MAOA
Hepatic Stupor	2/14	0.014432184633845775	0.22010542314047382	0	0	12.450757575757576	52.76997763279668	MAOB;MAOA
Miller Dieker syndrome	2/14	0.014432184633845775	0.22010542314047382	0	0	12.450757575757576	52.76997763279668	ABR;PAFAH1B1
Paramyotonia Congenita (disorder)	2/14	0.014432184633845775	0.22010542314047382	0	0	12.450757575757576	52.76997763279668	IDS;BRAF
Vesico-Ureteral Reflux	5/108	0.01473785359613392	0.22208992830614868	0	0	3.6511922032511253	15.398304396372557	RERE;CDKN1C;DSTYK;NFIA;NSD1
Physical aggression	5/108	0.01473785359613392	0.22208992830614868	0	0	3.6511922032511253	15.398304396372557	MAOA;ATP13A2;ARID1B;TTC19;FOXP1
Breast Carcinoma	82/4963	0.014862077300927668	0.22208992830614868	0	0	1.3561302477218673	5.707874178233258	ITSN2;CDKN1C;NUMA1;MAST2;PRDM2;WASL;LSP1;PTPN23;EDA2R;MECP2;GHR;AKAP13;HPGDS;DIP2A;VPS39;RBM5;MEF2A;EGFL7;IGFBP5;HGF;EBF1;VWA5A;EBF2;IL16;ATP11A;FAM126B;FRS3;ARID1B;DCN;SHROOM4;FOXP1;TGFBR3;SLC25A16;CEACAM1;AKAP9;UTS2;ULK1;SRSF5;ANGPTL1;PAFAH1B1;HDAC4;FOXC1;COL15A1;HPGD;MAOA;ADH1B;WBP2;TSHZ2;ANKRD12;PIK3R1;FSTL1;FHIT;HDAC6;ADAMTS15;ATXN1;CALD1;MAP2K5;RAI2;SASH1;CCDC134;GSN;SORT1;EYA2;INSR;STAT2;NR1H2;SYVN1;RAB27B;BRAF;ATP2B1;TPD52L1;ARHGAP24;MTOR;HIPK2;AIMP2;DLC1;NFIC;PMP22;TACC1;HOXD3;OGT;CPEB4
Subependymal Giant Cell Astrocytoma	3/39	0.014940547508832574	0.22208992830614868	0	0	6.241444866920152	26.237014818343223	HGF;BRAF;MTOR
Benign Ovarian Neoplasm	3/39	0.014940547508832574	0.22208992830614868	0	0	6.241444866920152	26.237014818343223	IL11RA;IL16;FHIT
Osteoporosis	12/441	0.015440841861143943	0.22208992830614868	0	0	2.125984251968504	8.866925882049902	GHR;USP8;HPGDS;TMEM135;GSN;HPGD;NSD1;HGF;IL16;PRDM2;ABCC9;OSBPL1A
Amyotrophic Lateral Sclerosis	16/660	0.015691083736940423	0.22208992830614868	0	0	1.8971428571428572	7.881988556620881	HDAC4;MAOB;SORT1;HGF;SEMA3A;ARHGAP24;HDAC6;MTOR;MECP2;HPGDS;ATXN2;ATXN1;OSBP;AAK1;VPS54;MAP2K5
Aggressive reaction	5/110	0.015843098320806454	0.22208992830614868	0	0	3.58128078817734	14.844485186460327	MAOA;ATP13A2;ARID1B;TTC19;FOXP1
Bone Density	5/110	0.015843098320806454	0.22208992830614868	0	0	3.58128078817734	14.844485186460327	RERE;TOM1L2;MEF2C;TMEM135;SMG6
Degenerative Diseases, Spinal Cord	3/40	0.01599636596277121	0.22208992830614868	0	0	6.072448874730243	25.11196688004519	ATXN1;MGST1;TTC19
Congenital chromosomal disease	13/497	0.016118273326232873	0.22208992830614868	0	0	2.0436579231045635	8.435814570320222	CDKN1C;HDAC4;FOXC1;EYA2;NR1H2;SYVN1;BRAF;FHIT;MTOR;FOXP1;MECP2;HPGDS;PAFAH1B1
Multiple Myeloma	27/1312	0.016146445444420156	0.22208992830614868	0	0	1.6219429204044087	6.692226263900467	HDAC4;ZNF197;SEMA3A;PRDM2;PIK3R1;FHIT;HDAC6;MECP2;IL1RL1;HPGDS;ATXN1;CRNDE;SLC16A7;IL11RA;HGF;MIB2;BRAF;IL16;ARHGAP24;DCN;MTOR;AIMP2;CEACAM1;DLC1;CD22;ANGPTL1;PAFAH1B1
Congenital Abnormality	15/607	0.016272331852369294	0.22208992830614868	0	0	1.9323382147087327	7.957927302435148	CDKN1C;HDAC4;MEF2C;FOXC1;EGFL7;ADH1B;INSR;SEMA3A;BRAF;MTOR;MECP2;COL3A1;NFIA;PMP22;PAFAH1B1
Asthma	27/1313	0.01629098239236237	0.22208992830614868	0	0	1.620593842930302	6.672217490375403	ITSN2;CDKN1C;SFSWAP;FAM13A;FSTL1;HDAC6;AKAP13;IL1RL1;HPGDS;ATXN2;IDS;SLC16A7;PIP5K1B;BBS1;GSN;PPP1R12A;STAT2;IL16;DCN;MTOR;TGFBR3;AIMP2;COL3A1;NFIA;UTS2;PAFAH1B1;FKBP5
Umbilical hernia	5/111	0.016415890979259943	0.22208992830614868	0	0	3.5473143931179063	14.57770783543529	HDAC4;INSR;IDS;ABCC9;ARID1B
Physical Activity Measurement	5/111	0.016415890979259943	0.22208992830614868	0	0	3.5473143931179063	14.57770783543529	TBX15;EYA2;ATP13A2;FHIT;MAP2K5
Reticular pattern on pulmonary HRCT	2/15	0.01650787892904742	0.22208992830614868	0	0	11.492424242424242	47.163960979657126	FAM13A;ATP11A
Stage III Colorectal Cancer AJCC v7	2/15	0.01650787892904742	0.22208992830614868	0	0	11.492424242424242	47.163960979657126	PPP1R12A;BRAF
Symmetric Diabetic Proximal Motor Neuropathy	2/15	0.01650787892904742	0.22208992830614868	0	0	11.492424242424242	47.163960979657126	HGF;INSR
Thyroid stimulating hormone measurement	2/15	0.01650787892904742	0.22208992830614868	0	0	11.492424242424242	47.163960979657126	NFIA;INSR
Acro-Osteolysis	2/15	0.01650787892904742	0.22208992830614868	0	0	11.492424242424242	47.163960979657126	COL3A1;HPGD
Asymmetric Diabetic Proximal Motor Neuropathy	2/15	0.01650787892904742	0.22208992830614868	0	0	11.492424242424242	47.163960979657126	HGF;INSR
Developmental reading disorder	2/15	0.01650787892904742	0.22208992830614868	0	0	11.492424242424242	47.163960979657126	DIP2A;KIAA0319L
Diabetic Amyotrophy	2/15	0.01650787892904742	0.22208992830614868	0	0	11.492424242424242	47.163960979657126	HGF;INSR
Diabetic Asymmetric Polyneuropathy	2/15	0.01650787892904742	0.22208992830614868	0	0	11.492424242424242	47.163960979657126	HGF;INSR
Diabetic Autonomic Neuropathy	2/15	0.01650787892904742	0.22208992830614868	0	0	11.492424242424242	47.163960979657126	HGF;INSR
Diabetic Mononeuropathy	2/15	0.01650787892904742	0.22208992830614868	0	0	11.492424242424242	47.163960979657126	HGF;INSR
Ground-glass opacification on pulmonary HRCT	2/15	0.01650787892904742	0.22208992830614868	0	0	11.492424242424242	47.163960979657126	FAM13A;ATP11A
Hepatic Coma	2/15	0.01650787892904742	0.22208992830614868	0	0	11.492424242424242	47.163960979657126	MAOB;MAOA
Honeycomb lung	2/15	0.01650787892904742	0.22208992830614868	0	0	11.492424242424242	47.163960979657126	FAM13A;ATP11A
Limb-girdle muscular dystrophy type 2A	2/15	0.01650787892904742	0.22208992830614868	0	0	11.492424242424242	47.163960979657126	SGCD;BRAF
Partial or complete agenesis of corpus callosum	2/15	0.01650787892904742	0.22208992830614868	0	0	11.492424242424242	47.163960979657126	NSD1;ARID1B
Poor coordination	2/15	0.01650787892904742	0.22208992830614868	0	0	11.492424242424242	47.163960979657126	BBS1;NSD1
Thyroid carcinoma	17/721	0.016598266524547444	0.22251128113156662	0	0	1.8455070281124497	7.5637312261612655	HPGD;SORT1;HGF;MIB2;BRAF;PRDM2;FHIT;ARHGAP24;MTOR;HIPK2;TBX15;CEACAM1;HPGDS;CCDC80;CREB3L2;AKAP9;METTL7A
Aggressive behavior	5/112	0.01700229885118832	0.22402444021897588	0	0	3.5139828839474343	14.317395467632844	MAOA;ATP13A2;ARID1B;TTC19;FOXP1
Neonatal Hypotonia	5/112	0.01700229885118832	0.22402444021897588	0	0	3.5139828839474343	14.317395467632844	MECP2;PEX6;NSD1;BRAF;ARID1B
Alcohol withdrawal syndrome	3/41	0.017093109979164117	0.22402444021897588	0	0	5.912347408445067	24.057813539558293	ADH1B;LMO3;FKBP5
Retrusion of lower jaw	11/395	0.017127432647482097	0.22402444021897588	0	0	2.1737132352941178	8.840652262129671	MECP2;RERE;GHR;TBX15;DSTYK;COL3A1;NSD1;PEX6;BRAF;ABCC9;PIK3R1
Decreased projection of lower jaw	11/395	0.017127432647482097	0.22402444021897588	0	0	2.1737132352941178	8.840652262129671	MECP2;RERE;GHR;TBX15;DSTYK;COL3A1;NSD1;PEX6;BRAF;ABCC9;PIK3R1
Decreased projection of mandible	11/395	0.017127432647482097	0.22402444021897588	0	0	2.1737132352941178	8.840652262129671	MECP2;RERE;GHR;TBX15;DSTYK;COL3A1;NSD1;PEX6;BRAF;ABCC9;PIK3R1
Hypoplastic mandible condyle	11/395	0.017127432647482097	0.22402444021897588	0	0	2.1737132352941178	8.840652262129671	MECP2;RERE;GHR;TBX15;DSTYK;COL3A1;NSD1;PEX6;BRAF;ABCC9;PIK3R1
Solid Neoplasm	19/840	0.017351910921779387	0.22539533945635498	0	0	1.772041600299822	7.18394992623796	EGFL7;NR1H2;HGF;BRAF;IL16;PRDM2;FOXK1;FHIT;ARHGAP24;MTOR;FOXP1;SLC25A16;HPGDS;CLEC3B;DLC1;CRNDE;OSBP;RBM5;PAFAH1B1
Endometrial Carcinoma	19/840	0.017351910921779387	0.22539533945635498	0	0	1.772041600299822	7.18394992623796	CDKN1C;FOXC1;IGFBP5;YTHDC1;INSR;NR1H2;HGF;BRAF;PRDM2;ABCC9;PIK3R1;FSTL1;FHIT;ARHGAP24;DCN;MTOR;MECP2;CEACAM1;HPGDS
Glioma	41/2211	0.01766622643299821	0.22846292248875277	0	0	1.4749083461341526	5.95287842139037	CDKN1C;RERE;HDAC4;IGSF8;SEMA3A;LAMA4;PRDM2;PIK3R1;WASL;FSTL1;HDAC6;HPGDS;HMBOX1;MAN2A2;CALD1;NSD1;CRNDE;LRIG3;PRKCI;EGFL7;GSN;SCARA5;FZD4;SORT1;INSR;LMO3;HGF;BRAF;ARHGAP24;DCN;MTOR;HIPK2;FOXP1;ST7L;CLK1;AIMP2;NFIC;PMP22;ULK1;ANGPTL1;FKBP5
Aplasia/Hypoplasia of the mandible	11/397	0.017709363781979244	0.22846292248875277	0	0	2.1622269633241897	8.721692201228132	MECP2;RERE;GHR;TBX15;DSTYK;COL3A1;NSD1;PEX6;BRAF;ABCC9;PIK3R1
Degenerative Diseases, Central Nervous System	3/42	0.018230904561028403	0.23113218474990244	0	0	5.760456273764259	23.06853674645757	ATXN1;MGST1;TTC19
Ptosis	3/42	0.018230904561028403	0.23113218474990244	0	0	5.760456273764259	23.06853674645757	COL3A1;CALD1;DCN
Prostate carcinoma	55/3145	0.01833411382369993	0.23113218474990244	0	0	1.4040399392628722	5.614744219600642	CDKN1C;RERE;PRDM2;IKZF5;GHR;AKAP13;HPGDS;SLC16A7;PRKCI;PPP1R12A;IGFBP5;IL11RA;HGF;EBF2;IL16;FRS3;DCN;FOXP1;TGFBR3;SLC7A6;CEACAM1;SRSF5;FKBP5;HDAC4;IGSF8;FOXC1;HPGD;MAOA;NPR1;SEMA3A;FOXK1;PIK3R1;RCHY1;FSTL1;FHIT;HDAC6;CALD1;NSD1;MAP2K5;GSN;FZD4;SORT1;INSR;NR1H2;RAB27B;BRAF;HOOK3;ARHGAP24;MTOR;HIPK2;AIMP2;TBX15;DLC1;HOXD3;OGT
Micrognathism	11/400	0.018609763822694265	0.23113218474990244	0	0	2.1452190130550934	8.54670035207852	MECP2;RERE;GHR;TBX15;DSTYK;COL3A1;NSD1;PEX6;BRAF;ABCC9;PIK3R1
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)	8/249	0.01866369774292336	0.23113218474990244	0	0	2.508025346585609	9.984887656331468	ATXN1;INSR;PHF1;FSTL1;FHIT;ARHGAP24;MTOR;PAFAH1B1
Amyloidosis, Familial	2/16	0.018702459594335294	0.23113218474990244	0	0	10.670995670995671	42.46096137853554	GSN;PMP22
Stage III Colorectal Cancer	2/16	0.018702459594335294	0.23113218474990244	0	0	10.670995670995671	42.46096137853554	PPP1R12A;BRAF
Nystagmus, End-Position	2/16	0.018702459594335294	0.23113218474990244	0	0	10.670995670995671	42.46096137853554	ATXN2;ATXN1
Subcapsular cataract	2/16	0.018702459594335294	0.23113218474990244	0	0	10.670995670995671	42.46096137853554	FOXC1;FZD4
Thyroxine measurement	2/16	0.018702459594335294	0.23113218474990244	0	0	10.670995670995671	42.46096137853554	NFIA;INSR
Partial agenesis of corpus callosum	2/16	0.018702459594335294	0.23113218474990244	0	0	10.670995670995671	42.46096137853554	NSD1;ARID1B
Hyperkyphosis	6/157	0.01870693631105199	0.23113218474990244	0	0	2.992817116658176	11.908003000853572	MECP2;USP8;SON;IDS;ARID1B;SHROOM4
Renal fibrosis	7/202	0.01872573244630563	0.23113218474990244	0	0	2.708108108108108	10.77246580447313	AIMP2;FOXC1;HPGDS;HGF;SYVN1;DCN;HIPK2
Tumor Progression	39/2090	0.01877527171050442	0.23113218474990244	0	0	1.4812522955386542	5.888295765589056	CDKN1C;FOXC1;HPGD;PHF1;SEMA3A;LAMA4;HP1BP3;PRDM2;FSTL1;FHIT;HDAC6;HPGDS;CALD1;NSD1;CRNDE;EGFL7;URGCP;FZD4;IL11RA;INSR;NR1H2;HGF;RAB27B;BRAF;IL16;RSRC2;ARHGAP24;DCN;MTOR;HIPK2;FOXP1;TGFBR3;AIMP2;CEACAM1;CCDC80;DLC1;SAA1;ANGPTL1;CPEB4
Carcinoma of urinary bladder, superficial	3/43	0.019409845923049132	0.2359354958443527	0	0	5.61615969581749	22.13876010517927	CEACAM1;NR1H2;SYN3
Radial deviation of finger	3/43	0.019409845923049132	0.2359354958443527	0	0	5.61615969581749	22.13876010517927	BBS1;BRAF;PIK3R1
Amphetamine Addiction	4/77	0.019415981871980178	0.2359354958443527	0	0	4.111889574401339	16.207665496215352	LMO3;PRDM2;FHIT;MAP2K5
Decreased width of tooth	4/77	0.019415981871980178	0.2359354958443527	0	0	4.111889574401339	16.207665496215352	GHR;FOXC1;PIK3R1;EDA2R
Ischemic cardiomyopathy	5/116	0.019486499751264798	0.23603101145663827	0	0	3.386662524593559	13.336790047054077	ATXN2;ATXN1;HGF;ATP2B1;SMG6
Short neck	7/204	0.01964697497816235	0.23645416850714882	0	0	2.680340238715873	10.533286566658637	MECP2;TBX15;IDS;BRAF;ABCC9;GNS;PAFAH1B1
Brachydactyly	7/204	0.01964697497816235	0.23645416850714882	0	0	2.680340238715873	10.533286566658637	RERE;GHR;HDAC4;BBS1;TBX15;INSR;BRAF
Strabismus	11/404	0.019862725782833924	0.2382894523055267	0	0	2.122945666816345	8.319633809633492	RERE;BBS1;TBX15;SON;NSD1;PEX6;BRAF;RSRC2;ARID1B;SHROOM4;FOXP1
Congenital anomaly of brain	3/44	0.020630002460968435	0.24058903764741885	0	0	5.47890197533154	21.263666959256337	COL3A1;MTOR;PAFAH1B1
Linear atrophy	3/44	0.020630002460968435	0.24058903764741885	0	0	5.47890197533154	21.263666959256337	CEP104;USP8;COL3A1
Muscle hypotonia	12/460	0.020721252061474293	0.24058903764741885	0	0	2.0338160854893137	7.884282154140845	CDKN1C;MECP2;RERE;HDAC4;CEP104;MEF2C;NSD1;PEX6;COG1;BRAF;ARID1B;PAFAH1B1
Burkitt Lymphoma	11/407	0.020842668785393634	0.24058903764741885	0	0	2.1065359477124184	8.153880359389097	TBRG1;AIMP2;HPGDS;CALD1;INSR;COG1;PIK3R1;FHIT;CD22;ARHGAP24;FOXP1
Retinal Diseases	10/355	0.02094163354193356	0.24058903764741885	0	0	2.1953125	8.48711339485521	MEF2A;BBS1;MEF2C;ATXN1;SCARA5;FZD4;ADH1B;INSR;HGF;BRAF
child abuse behavior	2/17	0.0210124219235468	0.24058903764741885	0	0	9.959090909090909	38.468397807581326	MAOA;FKBP5
Childhood Astrocytoma	2/17	0.0210124219235468	0.24058903764741885	0	0	9.959090909090909	38.468397807581326	EYA2;BRAF
Completed Suicide	2/17	0.0210124219235468	0.24058903764741885	0	0	9.959090909090909	38.468397807581326	MAOA;FKBP5
Curly hair (finding)	2/17	0.0210124219235468	0.24058903764741885	0	0	9.959090909090909	38.468397807581326	BRAF;MTOR
de novo myelodysplastic syndromes	2/17	0.0210124219235468	0.24058903764741885	0	0	9.959090909090909	38.468397807581326	HPGDS;PAFAH1B1
Dysesthesia	2/17	0.0210124219235468	0.24058903764741885	0	0	9.959090909090909	38.468397807581326	PMP22;ARID1B
Endomyocardial Fibrosis	2/17	0.0210124219235468	0.24058903764741885	0	0	9.959090909090909	38.468397807581326	COL3A1;UTS2
Hypertrophy of kidney	2/17	0.0210124219235468	0.24058903764741885	0	0	9.959090909090909	38.468397807581326	HGF;DCN
Long foot	2/17	0.0210124219235468	0.24058903764741885	0	0	9.959090909090909	38.468397807581326	INSR;NSD1
Rales	2/17	0.0210124219235468	0.24058903764741885	0	0	9.959090909090909	38.468397807581326	FAM13A;ATP11A
Spinocerebellar Ataxia Type 1	4/79	0.021121925323578438	0.2411099778603636	0	0	4.001832061068702	15.436841724938839	FOXC1;ATXN2;ATXN1;PUM1
Addictive Behavior	7/208	0.02158370885978895	0.2440029915136209	0	0	2.626462283178701	10.074627279219346	MAOA;ADH1B;LMO3;BRAF;HDAC6;MTOR;FOXP1
Rough hair texture	3/45	0.021891415724044537	0.2440029915136209	0	0	5.348180336773493	20.43893058321172	INSR;BRAF;GNS
Liposarcoma, Dedifferentiated	3/45	0.021891415724044537	0.2440029915136209	0	0	5.348180336773493	20.43893058321172	HGF;BRAF;FOXP1
Coarse hair	3/45	0.021891415724044537	0.2440029915136209	0	0	5.348180336773493	20.43893058321172	INSR;BRAF;GNS
Lipoatrophy	3/45	0.021891415724044537	0.2440029915136209	0	0	5.348180336773493	20.43893058321172	COL3A1;INSR;PIK3R1
Abnormality of the fingernails	4/80	0.022008272382257926	0.2440029915136209	0	0	3.9489754921655282	15.070620804723404	MECP2;HPGD;PEX6;NSD1
Dandy-Walker Syndrome	4/80	0.022008272382257926	0.2440029915136209	0	0	3.9489754921655282	15.070620804723404	CDKN1C;FOXC1;NSD1;ARID1B
Microdontia (disorder)	4/80	0.022008272382257926	0.2440029915136209	0	0	3.9489754921655282	15.070620804723404	GHR;FOXC1;PIK3R1;EDA2R
Urothelial Carcinoma	8/257	0.02206744680024858	0.2440029915136209	0	0	2.4264499859904736	9.253635239840774	HPGDS;GSN;IGFBP5;NUMA1;PIK3R1;FHIT;DCN;MTOR
Smoking Behaviors	7/209	0.02208787366767845	0.2440029915136209	0	0	2.6133261974846134	9.963898108676243	TBX15;EYA2;FAM13A;USP34;FHIT;MAP2K5;CPEB4
Trisomy	7/209	0.02208787366767845	0.2440029915136209	0	0	2.6133261974846134	9.963898108676243	IL1RL1;ARHGAP20;PMP22;RNPC3;CD22;PAFAH1B1;FOXP1
Malignant neoplasm of endometrium	14/577	0.022839566404454562	0.24883659856002552	0	0	1.8917505427274521	7.149418817855259	FOXC1;IGFBP5;YTHDC1;INSR;NR1H2;BRAF;PRDM2;PIK3R1;FSTL1;FHIT;ARHGAP24;DCN;MTOR;MECP2
Muscle degeneration	8/259	0.02298270077150257	0.24883659856002552	0	0	2.4068686494332745	9.08114787435786	MECP2;USP8;ATXN2;INSR;HGF;OGDH;TTC19;DHTKD1
Sparse or absent eyebrows	3/46	0.023194101324465047	0.24883659856002552	0	0	5.223538774427447	19.6606544742761	COL3A1;BRAF;EDA2R
Sparse/absent eyebrows	3/46	0.023194101324465047	0.24883659856002552	0	0	5.223538774427447	19.6606544742761	COL3A1;BRAF;EDA2R
Absence of eyebrow	3/46	0.023194101324465047	0.24883659856002552	0	0	5.223538774427447	19.6606544742761	COL3A1;BRAF;EDA2R
Aplasia/Hypoplasia of the eyebrow	3/46	0.023194101324465047	0.24883659856002552	0	0	5.223538774427447	19.6606544742761	COL3A1;BRAF;EDA2R
Ketosis	3/46	0.023194101324465047	0.24883659856002552	0	0	5.223538774427447	19.6606544742761	ACAA2;ADH1B;INSR
Papillary renal cell carcinoma, sporadic	2/18	0.02343433279612842	0.24883659856002552	0	0	9.336174242424242	35.04382594171533	BRAF;MTOR
Atrophy/Degeneration affecting the brainstem	2/18	0.02343433279612842	0.24883659856002552	0	0	9.336174242424242	35.04382594171533	ATXN2;ATXN1
Diabetic Neuralgia	2/18	0.02343433279612842	0.24883659856002552	0	0	9.336174242424242	35.04382594171533	HGF;INSR
Nail-Patella Syndrome	2/18	0.02343433279612842	0.24883659856002552	0	0	9.336174242424242	35.04382594171533	GSN;LDB1
Overgrowth Syndrome	2/18	0.02343433279612842	0.24883659856002552	0	0	9.336174242424242	35.04382594171533	CDKN1C;NSD1
Periventricular Nodular Heterotopia	2/18	0.02343433279612842	0.24883659856002552	0	0	9.336174242424242	35.04382594171533	KIAA0319L;PAFAH1B1
Hearing Loss, Partial	8/260	0.023450223649803308	0.24883659856002552	0	0	2.3971945367294203	8.99637203872863	MECP2;TBX15;FOXC1;PMP22;IDS;BRAF;GNS;ARID1B
Waist-Hip Ratio	5/122	0.023640884264819317	0.2501550871504898	0	0	3.212005108556833	12.028245044012657	TBX15;EYA2;MBOAT7;FAM13A;CPEB4
Absent speech	4/82	0.023848348464806175	0.2509405828685052	0	0	3.8473282442748094	14.373773409505871	RERE;MECP2;ARID1B;GNS
Decreased size of teeth	4/82	0.023848348464806175	0.2509405828685052	0	0	3.8473282442748094	14.373773409505871	GHR;FOXC1;PIK3R1;EDA2R
Transitional cell carcinoma of bladder	6/167	0.024466783089695694	0.2560176997191213	0	0	2.8054945054945053	10.409615872876731	HPGDS;IGFBP5;DLC1;BRAF;FHIT;MTOR
Follicular thyroid carcinoma	6/167	0.024466783089695694	0.2560176997191213	0	0	2.8054945054945053	10.409615872876731	HGF;STT3A;BRAF;FHIT;MTOR;HIPK2
Abnormality of the cornea	3/47	0.024538049850328827	0.25605217115287726	0	0	5.104562737642586	18.925321074511665	GSN;PIK3R1;DCN
Parkinsonian Disorders	7/214	0.024731451760114535	0.25735739994572226	0	0	2.5495495495495497	9.432516189342083	MECP2;ATXN2;MAOB;MAOA;PHF1;ATP13A2;MTOR
Kyphosis deformity of spine	6/168	0.025101059947463963	0.2594416773194216	0	0	2.788034188034188	10.273474408466287	MECP2;USP8;SON;IDS;ARID1B;SHROOM4
Skeletal muscle atrophy	7/215	0.025285105836538802	0.2594416773194216	0	0	2.5371621621621623	9.330514725658364	MECP2;USP8;ATXN2;INSR;OGDH;TTC19;DHTKD1
Neurogenic muscle atrophy, especially in the lower limbs	7/215	0.025285105836538802	0.2594416773194216	0	0	2.5371621621621623	9.330514725658364	MECP2;USP8;ATXN2;INSR;OGDH;TTC19;DHTKD1
Arthropathy	5/125	0.02591670803583946	0.2594416773194216	0	0	3.1312260536398466	11.437953637104618	GHR;AIMP2;HPGD;SYVN1;DCN
Epilepsies, Partial	3/48	0.025923227749689488	0.2594416773194216	0	0	4.990874524714829	18.2297475833438	MECP2;SYN3;MTOR
Sleep Disorders	3/48	0.025923227749689488	0.2594416773194216	0	0	4.990874524714829	18.2297475833438	MECP2;ATXN2;FKBP5
Spinocerebellar Ataxia Type 6 (disorder)	3/48	0.025923227749689488	0.2594416773194216	0	0	4.990874524714829	18.2297475833438	FOXC1;ATXN2;ATXN1
Underdeveloped brows	3/48	0.025923227749689488	0.2594416773194216	0	0	4.990874524714829	18.2297475833438	GHR;PEX6;BRAF
Underdeveloped supraorbital ridges	3/48	0.025923227749689488	0.2594416773194216	0	0	4.990874524714829	18.2297475833438	GHR;PEX6;BRAF
Cutis marmorata	3/48	0.025923227749689488	0.2594416773194216	0	0	4.990874524714829	18.2297475833438	NFIA;RNPC3;ARID1B
Infantile Spasm	3/48	0.025923227749689488	0.2594416773194216	0	0	4.990874524714829	18.2297475833438	ATXN2;MTOR;PAFAH1B1
Neuroblastic tumors	3/48	0.025923227749689488	0.2594416773194216	0	0	4.990874524714829	18.2297475833438	TGFBR3;BRAF;ARHGAP24
Psychotic symptom	3/48	0.025923227749689488	0.2594416773194216	0	0	4.990874524714829	18.2297475833438	GYPC;LMO3;FKBP5
Endogenous Hyperinsulinism	2/19	0.025964829399899636	0.2594416773194216	0	0	8.786541889483066	32.07977314642938	COL3A1;INSR
Exogenous Hyperinsulinism	2/19	0.025964829399899636	0.2594416773194216	0	0	8.786541889483066	32.07977314642938	COL3A1;INSR
Congenital anomaly of face	5/126	0.026705357475000035	0.2661351365299606	0	0	3.1051898293277604	11.249764531925074	GHR;HDAC4;TBX15;INSR;PAFAH1B1
Trichohepatoenteric Syndrome	8/267	0.02691165232231458	0.26704955956955767	0	0	2.331567447846518	8.42907311144637	GHR;COL3A1;HPGD;INSR;NSD1;BTBD9;PAFAH1B1;FOXP1
Medulloblastoma	14/590	0.02693889902745737	0.26704955956955767	0	0	1.8478009259259258	6.67829249808203	MEF2A;GSN;HGF;PRDM2;FHIT;ARHGAP24;MTOR;SLC25A16;ABR;AIMP2;HPGDS;DLC1;MAP2K5;PAFAH1B1
Defective or absent horizontal voluntary eye movements	3/49	0.027349578190390335	0.27040908410288816	0	0	4.88212927756654	17.57104774900409	CEP104;ATXN2;BRAF
Malignant Neoplasms	28/1438	0.027480329765487813	0.2709905817450068	0	0	1.5289111389236545	5.495342084766898	CDKN1C;FOXC1;PRDM2;PIK3R1;PTPN23;FSTL1;FHIT;MECP2;GHR;HPGDS;CRNDE;MAP2K5;GSN;URGCP;NR1H2;HGF;BRAF;ATP2B1;ARID1B;MTOR;HIPK2;CEACAM1;DLC1;SIK3;MPHOSPH8;CPEB4;PAFAH1B1;FKBP5
Cardiomyopathies	12/480	0.027622844386277167	0.27168473838931095	0	0	1.9448818897637796	6.980399227585325	MEF2A;CDKN1C;RERE;MEF2C;COL3A1;GSN;SGCD;NSD1;HGF;UTS2;ABCC9;DCN
Neuroblastoma	32/1698	0.02855757644613302	0.27302801816053035	0	0	1.4830958024235334	5.27364100152108	CDKN1C;MAOB;MAOA;MGST1;PRDM2;PIK3R1;HDAC6;MECP2;HPGDS;ATXN2;NSD1;NAA50;PRKCI;URGCP;IGFBP5;LMO3;HGF;EBF1;BRAF;ARID1B;ARHGAP24;MTOR;HIPK2;FOXP1;TGFBR3;AIMP2;NFIA;NFIC;SAA1;UTS2;ULK1;OSBPL1A
5,10-Methylenetetrahydrofolate reductase deficiency	2/20	0.02860061796912081	0.27302801816053035	0	0	8.297979797979798	29.493733260353054	HPGDS;AKAP9
Sprengel deformity	2/20	0.02860061796912081	0.27302801816053035	0	0	8.297979797979798	29.493733260353054	COL3A1;BRAF
Stenosis of external auditory canal	2/20	0.02860061796912081	0.27302801816053035	0	0	8.297979797979798	29.493733260353054	MECP2;TBX15
Abnormality of the heart valves	2/20	0.02860061796912081	0.27302801816053035	0	0	8.297979797979798	29.493733260353054	IDS;BRAF
Chronic myocardial ischemia	2/20	0.02860061796912081	0.27302801816053035	0	0	8.297979797979798	29.493733260353054	HGF;ABCC9
Compensatory Hyperinsulinemia	2/20	0.02860061796912081	0.27302801816053035	0	0	8.297979797979798	29.493733260353054	COL3A1;INSR
Coronary Artery Vasospasm	2/20	0.02860061796912081	0.27302801816053035	0	0	8.297979797979798	29.493733260353054	SGCD;ABCC9
High Grade Intraepithelial Neoplasia	2/20	0.02860061796912081	0.27302801816053035	0	0	8.297979797979798	29.493733260353054	ADH1B;BRAF
Hypoplasia of iris	2/20	0.02860061796912081	0.27302801816053035	0	0	8.297979797979798	29.493733260353054	FOXC1;PIK3R1
Motion Sickness	2/20	0.02860061796912081	0.27302801816053035	0	0	8.297979797979798	29.493733260353054	HOXD3;MAP2K5
Advanced bone age	3/50	0.028817021895385514	0.27302801816053035	0	0	4.77801148774371	16.94659872229953	CDKN1C;NSD1;INSR
Hypertrichosis	3/50	0.028817021895385514	0.27302801816053035	0	0	4.77801148774371	16.94659872229953	INSR;IDS;ARID1B
Everted lower lip vermilion	4/87	0.028846602396573155	0.27302801816053035	0	0	3.614641773199669	12.816663277603318	MECP2;FOXC1;ABCC9;EDA2R
Protruding lower lip	4/87	0.028846602396573155	0.27302801816053035	0	0	3.614641773199669	12.816663277603318	MECP2;FOXC1;ABCC9;EDA2R
Pervasive Development Disorder	5/129	0.02916258485462465	0.2753269602691004	0	0	3.0296007910023484	10.709241106319546	MECP2;MAOA;FOXP1;FKBP5;PAFAH1B1
Chordoma	4/88	0.029915214786204625	0.2810677740695523	0	0	3.5714285714285716	12.53352882958129	HDAC4;BRAF;FHIT;MTOR
High density lipoprotein measurement	9/324	0.029919877197210107	0.2810677740695523	0	0	2.1588660366870482	7.575962276746366	HPGDS;SGCD;HGF;FAM13A;SIK3;ATP2B1;SYN3;CD22;RBM5
Deafness	8/273	0.030149085068161708	0.2825164264969282	0	0	2.2780751791721516	7.976909647207014	MECP2;TBX15;FOXC1;PMP22;IDS;BRAF;GNS;ARID1B
Blood basophil count (lab test)	7/224	0.03065385273333011	0.28588628255007814	0	0	2.430813301781044	8.471376878492867	RERE;DSTYK;RAB5B;ATXN2;ATXN1;MAST2;SIK3
Cirrhosis	11/433	0.030882833931979388	0.28588628255007814	0	0	1.974091627172196	6.865011785340308	GHR;COL3A1;HPGDS;ADH1B;DGKB;NPR1;HGF;MBOAT7;ARHGAP24;DCN;CPEB4
Bronchioloalveolar Adenocarcinoma	4/89	0.03100698605564177	0.28588628255007814	0	0	3.5292321508756173	12.25893872692698	HGF;BRAF;FHIT;MTOR
Pulmonary Emphysema	7/225	0.031294155843282954	0.28588628255007814	0	0	2.4195388048599056	8.382066140449782	TGFBR3;HDAC4;HPGDS;IGFBP5;HGF;FAM13A;IL16
Sandhoff Disease	2/21	0.03133847258305797	0.28588628255007814	0	0	7.860845295055821	27.221390192212386	NFIA;NFIC
Syphilis	2/21	0.03133847258305797	0.28588628255007814	0	0	7.860845295055821	27.221390192212386	RERE;GYPC
Urinary bladder sphincter dysfunction	2/21	0.03133847258305797	0.28588628255007814	0	0	7.860845295055821	27.221390192212386	ATXN2;ATXN1
Amyloid nephropathy	2/21	0.03133847258305797	0.28588628255007814	0	0	7.860845295055821	27.221390192212386	GSN;SAA1
Diastasis recti	2/21	0.03133847258305797	0.28588628255007814	0	0	7.860845295055821	27.221390192212386	CDKN1C;NSD1
Glucose measurement	2/21	0.03133847258305797	0.28588628255007814	0	0	7.860845295055821	27.221390192212386	SIK3;ATP2B1
Chronic Kidney Diseases	10/380	0.031435338829881386	0.28588628255007814	0	0	2.0443412162162162	7.073057897939555	GHR;HPGDS;ATXN2;INSR;HGF;SAA1;UTS2;PIP5K1B;DNAJC16;MTOR
Behavioral Symptoms	3/52	0.03187476471224657	0.28588628255007814	0	0	4.582525025219213	15.791109296614858	MAOA;PEX6;NSD1
Congenital neurologic anomalies	3/52	0.03187476471224657	0.28588628255007814	0	0	4.582525025219213	15.791109296614858	NFIA;NR1H2;PMP22
Drug usage	3/52	0.03187476471224657	0.28588628255007814	0	0	4.582525025219213	15.791109296614858	INSR;IL16;BRAF
Friedreich Ataxia	3/52	0.03187476471224657	0.28588628255007814	0	0	4.582525025219213	15.791109296614858	ATXN2;ATXN1;PIP5K1B
Invasive Lobular Breast Carcinoma	3/52	0.03187476471224657	0.28588628255007814	0	0	4.582525025219213	15.791109296614858	EGFL7;FMO2;FOXP1
Malignant ascites	3/52	0.03187476471224657	0.28588628255007814	0	0	4.582525025219213	15.791109296614858	HGF;FHIT;MTOR
Non-arthropod borne lymphocytic choriomeningitis	3/52	0.03187476471224657	0.28588628255007814	0	0	4.582525025219213	15.791109296614858	GYPC;STAT2;MTOR
Nasopharyngeal carcinoma	17/782	0.03286239594378293	0.2899506895259486	0	0	1.692904953145917	5.781992024775171	CDKN1C;FOXC1;STAT2;NR1H2;HGF;VWA5A;IL16;PRDM2;CSAD;FHIT;ARHGAP24;AIMP2;COL3A1;HPGDS;DLC1;SAA1;ULK1
Liver and Intrahepatic Biliary Tract Carcinoma	14/607	0.033091369215103854	0.2899506895259486	0	0	1.793235900318531	6.112213685616764	FOXC1;HGF;PRDM2;FHIT;DCN;HDAC6;MTOR;AIMP2;HPGDS;CALD1;NSD1;DLC1;OGT;CPEB4
Central neuroblastoma	31/1655	0.03321330729919628	0.2899506895259486	0	0	1.471046011948433	5.008624318178315	CDKN1C;MAOB;MAOA;MGST1;PRDM2;PIK3R1;HDAC6;MECP2;HPGDS;ATXN2;NSD1;NAA50;PRKCI;URGCP;IGFBP5;LMO3;HGF;EBF1;BRAF;ARID1B;ARHGAP24;MTOR;HIPK2;FOXP1;TGFBR3;AIMP2;NFIA;NFIC;SAA1;ULK1;OSBPL1A
Neurogenic Muscular Atrophy	7/228	0.03326880047456264	0.2899506895259486	0	0	2.3863275039745626	8.120995232187267	MECP2;USP8;ATXN2;INSR;OGDH;TTC19;DHTKD1
Cerebellar vermis hypoplasia	3/53	0.03346480034558463	0.2899506895259486	0	0	4.490646387832699	15.255898415285056	RERE;CEP104;FOXC1
Thyroid Gland Follicular Adenoma	5/134	0.03356662868392623	0.2899506895259486	0	0	2.9114318809587454	9.882048760648589	CCDC80;HPGD;PRDM2;BRAF;DCN
Large auricle	5/134	0.03356662868392623	0.2899506895259486	0	0	2.9114318809587454	9.882048760648589	MECP2;INSR;NSD1;BRAF;PIK3R1
Large pinnae	5/134	0.03356662868392623	0.2899506895259486	0	0	2.9114318809587454	9.882048760648589	MECP2;INSR;NSD1;BRAF;PIK3R1
Macrotia	5/134	0.03356662868392623	0.2899506895259486	0	0	2.9114318809587454	9.882048760648589	MECP2;INSR;NSD1;BRAF;PIK3R1
Cognitive delay	20/966	0.03392631132402589	0.2899506895259486	0	0	1.614671960673095	5.46334659673355	RERE;HDAC4;BBS1;CEP104;INSR;MBOAT7;COG1;BRAF;ARID1B;SHROOM4;DHTKD1;MECP2;COL3A1;SON;NFIA;NSD1;PEX6;OGDH;STT3A;PAFAH1B1
Endometrioma	7/229	0.033945071592507425	0.2899506895259486	0	0	2.3754565376186996	8.03619702718383	MAOB;MAOA;FMO2;ABCC9;METTL7A;MTOR;FKBP5
Relative macrocephaly	2/22	0.03417523391280095	0.2899506895259486	0	0	7.467424242424243	25.21192135526794	CDKN1C;BRAF
Self-harm	2/22	0.03417523391280095	0.2899506895259486	0	0	7.467424242424243	25.21192135526794	RERE;MAOA
Self-Injurious Behavior	2/22	0.03417523391280095	0.2899506895259486	0	0	7.467424242424243	25.21192135526794	RERE;MAOA
Squamous cell carcinoma of tonsil	2/22	0.03417523391280095	0.2899506895259486	0	0	7.467424242424243	25.21192135526794	HGF;HIPK2
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	2/22	0.03417523391280095	0.2899506895259486	0	0	7.467424242424243	25.21192135526794	CDKN1C;GHR
Abnormality of the immune system	2/22	0.03417523391280095	0.2899506895259486	0	0	7.467424242424243	25.21192135526794	PMP22;PIK3R1
Adenoid cystic carcinoma of salivary gland	2/22	0.03417523391280095	0.2899506895259486	0	0	7.467424242424243	25.21192135526794	FHIT;MTOR
Conduct Disorder	2/22	0.03417523391280095	0.2899506895259486	0	0	7.467424242424243	25.21192135526794	MAOA;LMO3
Diabetic Polyneuropathies	2/22	0.03417523391280095	0.2899506895259486	0	0	7.467424242424243	25.21192135526794	HGF;INSR
Fibromyxosarcoma	2/22	0.03417523391280095	0.2899506895259486	0	0	7.467424242424243	25.21192135526794	CREB3L2;DCN
Hypoplastic iliac wing	2/22	0.03417523391280095	0.2899506895259486	0	0	7.467424242424243	25.21192135526794	TBX15;HDAC6
Mucopolysaccharidosis Type IIIA	2/22	0.03417523391280095	0.2899506895259486	0	0	7.467424242424243	25.21192135526794	IDS;GNS
Protein Misfolding Disorders	2/22	0.03417523391280095	0.2899506895259486	0	0	7.467424242424243	25.21192135526794	CEACAM1;PMP22
Byzanthine arch palate	8/280	0.03425351899862658	0.2899618113883738	0	0	2.2186502507979937	7.485650456764763	MECP2;SON;HPGD;INSR;NSD1;PEX6;BRAF;ARID1B
Adrenal Cortical Adenoma	4/92	0.03442180715871551	0.2901009784905119	0	0	3.4083969465648853	11.48311081248744	CDKN1C;USP8;UTS2;MTOR
Neurilemmoma	5/135	0.03449432861745811	0.2901009784905119	0	0	2.888888888888889	9.726774362811305	PMP22;BRAF;SRSF5;ARHGAP24;MTOR
Acute lymphocytic leukemia	19/907	0.03450099239812831	0.2901009784905119	0	0	1.6325363825363826	5.496369929523768	CDKN1C;HDAC4;MEF2C;MAOA;PDE1A;INSR;EBF1;IL16;PRDM2;ATP11A;FHIT;ARHGAP24;MTOR;FOXP1;CEACAM1;HPGDS;CD22;PAFAH1B1;FKBP5
Mental deficiency	21/1032	0.03539532680860458	0.2969581204632816	0	0	1.5873675286138194	5.303673462151017	RERE;HDAC4;BBS1;CEP104;MEF2C;MAOA;BRAF;GNS;ARID1B;MTOR;FOXP1;MECP2;COL3A1;TMEM135;SON;GON4L;NFIA;NSD1;PEX6;STT3A;PAFAH1B1
PARKINSON DISEASE, LATE-ONSET	4/93	0.035606732354626906	0.2974070083811077	0	0	3.3699288103610945	11.239455813338443	ATXN2;MAOB;BRAF;ATP13A2
Joint laxity	4/93	0.035606732354626906	0.2974070083811077	0	0	3.3699288103610945	11.239455813338443	COL3A1;NSD1;PIK3R1;ARID1B
Nystagmus	12/500	0.036065276215045135	0.30017804489677613	0	0	1.8632373822124693	6.190466001695678	BBS1;CEP104;FOXC1;ATXN2;ATXN1;NSD1;PEX6;BRAF;ATP13A2;ARID1B;TTC19;FOXP1
Anaplasia	8/283	0.03612339782016085	0.30017804489677613	0	0	2.194108527131783	7.286227377534581	FOXC1;LDB1;MAOA;CALD1;HGF;BRAF;RAI2;DCN
Malignant neoplasm of esophagus	15/673	0.03618786251212325	0.30017804489677613	0	0	1.7325227963525835	5.7502977461184495	CDKN1C;PRKCI;GSN;ADH1B;NR1H2;HGF;RSRC2;PRDM2;FOXK1;FHIT;ARHGAP24;MTOR;AIMP2;AKAP13;HPGDS
Hamman-Rich syndrome	7/233	0.036741540067226755	0.30017804489677613	0	0	2.3329347046161204	7.707659983107282	MECP2;COL3A1;HGF;FAM13A;ATP11A;FHIT;DCN
Neuropathy	8/284	0.03676171715678844	0.30017804489677613	0	0	2.186046511627907	7.221163659872746	HPGDS;GSN;ADH1B;SORT1;INSR;HGF;PMP22;HDAC6
Spinocerebellar Ataxia Type 2	3/55	0.036766395581544	0.30017804489677613	0	0	4.317490494296578	14.261409456312757	FOXC1;ATXN2;ATXN1
Common Migraine	3/55	0.036766395581544	0.30017804489677613	0	0	4.317490494296578	14.261409456312757	DLG2;MAOA;UTS2
Dysmorphic features	3/55	0.036766395581544	0.30017804489677613	0	0	4.317490494296578	14.261409456312757	MECP2;IL1RL1;MEF2C
Insulin Sensitivity	3/55	0.036766395581544	0.30017804489677613	0	0	4.317490494296578	14.261409456312757	INSR;PIK3R1;ACACB
Lymphocytic Choriomeningitis	3/55	0.036766395581544	0.30017804489677613	0	0	4.317490494296578	14.261409456312757	GYPC;STAT2;MTOR
Macroglossia	4/94	0.0368150402820044	0.30017804489677613	0	0	3.3323155216284985	11.002802052924078	CDKN1C;NSD1;IDS;ABCC9
Congenital dislocation of radial head	2/23	0.03710780806873346	0.3012610193856012	0	0	7.111471861471862	23.424675371454104	TBX15;ARID1B
fibroma	2/23	0.03710780806873346	0.3012610193856012	0	0	7.111471861471862	23.424675371454104	BRAF;MTOR
Rheumatism	4/95	0.03804675475896188	0.3068996256467011	0	0	3.295528898582334	10.772884547684043	AIMP2;GOLGB1;RNPC3;FSTL1
Sciatic Neuropathy	4/95	0.03804675475896188	0.3068996256467011	0	0	3.295528898582334	10.772884547684043	PMP22;ABCC9;RCHY1;MTOR
Polyneuropathy	4/95	0.03804675475896188	0.3068996256467011	0	0	3.295528898582334	10.772884547684043	NAA50;GSN;ADH1B;PMP22
Plaque, Amyloid	7/235	0.03819515217563701	0.307438329584668	0	0	2.3122332859174963	7.5495496085293805	GSN;MAOB;NFIA;NFIC;SAA1;HOOK3;DCN
Channelopathies	3/56	0.038477578182643024	0.30773893208920655	0	0	4.2358131860248225	13.798922172513326	ATXN1;IDS;ABCC9
HER2 gene amplification	3/56	0.038477578182643024	0.30773893208920655	0	0	4.2358131860248225	13.798922172513326	SLC25A16;AIMP2;BRAF
Oculomotor apraxia	3/56	0.038477578182643024	0.30773893208920655	0	0	4.2358131860248225	13.798922172513326	CEP104;ATXN2;BRAF
Genetic Diseases, Inborn	12/507	0.03941249060293076	0.3125153530332229	0	0	1.8362204724409448	5.937735631970421	MECP2;AIMP2;MEF2C;SON;NSD1;PEX6;PMP22;BRAF;PIK3R1;ARID1B;PAFAH1B1;FOXP1
Cognition Disorders	7/237	0.03968607800394842	0.3125153530332229	0	0	2.291891891891892	7.395373238401031	MAOA;BRAF;SHROOM4;HDAC6;MTOR;PAFAH1B1;FOXP1
Congenital deafness	8/289	0.0400674337902488	0.3125153530332229	0	0	2.1465971475075176	6.906013881266555	MECP2;TBX15;FOXC1;PMP22;IDS;BRAF;GNS;ARID1B
Child Development Disorders, Specific	2/24	0.04013316542579769	0.3125153530332229	0	0	6.787878787878788	21.826778695455054	MECP2;PMP22
bilateral breast cancer	2/24	0.04013316542579769	0.3125153530332229	0	0	6.787878787878788	21.826778695455054	FHIT;CRLS1
Child Development Deviations	2/24	0.04013316542579769	0.3125153530332229	0	0	6.787878787878788	21.826778695455054	MECP2;PMP22
Fetal overgrowth	2/24	0.04013316542579769	0.3125153530332229	0	0	6.787878787878788	21.826778695455054	CDKN1C;NSD1
Generalized overgrowth	2/24	0.04013316542579769	0.3125153530332229	0	0	6.787878787878788	21.826778695455054	CDKN1C;NSD1
Intestinal Pseudo-Obstruction	2/24	0.04013316542579769	0.3125153530332229	0	0	6.787878787878788	21.826778695455054	HGF;IDS
Overgrowth	2/24	0.04013316542579769	0.3125153530332229	0	0	6.787878787878788	21.826778695455054	CDKN1C;NSD1
Poor eye contact	2/24	0.04013316542579769	0.3125153530332229	0	0	6.787878787878788	21.826778695455054	MECP2;MEF2C
Postural instability	2/24	0.04013316542579769	0.3125153530332229	0	0	6.787878787878788	21.826778695455054	ATXN2;ATP13A2
Familial Alzheimer Disease (FAD)	6/188	0.04015328666527207	0.3125153530332229	0	0	2.479120879120879	7.970500017612411	MEF2A;MAOB;NFIA;INSR;NFIC;OGDH
Secondary malignant neoplasm of lung	15/683	0.040308463484510844	0.31307625143536566	0	0	1.7056922012548608	5.4773082555878965	IGSF8;PRKCI;FOXC1;COL15A1;IGFBP5;SCARA5;HPGD;MAOA;EYA2;INSR;HGF;BRAF;DCN;DLC1;SASH1
Adult Hepatocellular Carcinoma	4/97	0.0405804646732989	0.31389447725732433	0	0	3.224328983009111	10.332260639873317	MECP2;FHIT;PDGFRL;FOXP1
Gilles de la Tourette syndrome	4/97	0.0405804646732989	0.31389447725732433	0	0	3.224328983009111	10.332260639873317	MAOA;LMO3;BTBD9;MAP2K5
Neoplasms	24/1236	0.040716009409528985	0.31429755624117967	0	0	1.5155879224286064	4.851599895544211	MEF2A;CDKN1C;USP8;EGFL7;GSN;FZD4;INSR;HGF;SEMA3A;BRAF;PRDM2;FOXK1;PIK3R1;ARID1B;HDAC6;MTOR;CEACAM1;HMBOX1;DLC1;CRNDE;AKAP9;OGDH;PKP4;ANGPTL1
Esophageal carcinoma	15/685	0.04117142480669209	0.3171631027542109	0	0	1.7004221918296962	5.424365217562889	CDKN1C;PRKCI;GSN;ADH1B;NR1H2;HGF;RSRC2;PRDM2;FOXK1;FHIT;ARHGAP24;MTOR;SMG6;HPGDS;DLC1
Neurodegenerative Disorders	16/745	0.04138532416295042	0.3181602369833351	0	0	1.668477366255144	5.31381501815964	GSN;MAOB;SORT1;NR1H2;HGF;MGST1;TTC19;HDAC6;MTOR;CLK1;ATXN2;ATXN1;OGDH;IDS;ATP13A2;OGT
Cholangiocarcinoma	11/455	0.04175319708178949	0.32033460979042977	0	0	1.87413884472708	5.952226089608519	HDAC4;AIMP2;PRKCI;HPGD;MAOA;DLC1;HGF;BRAF;FHIT;ARHGAP24;HDAC6
Long philtrum	6/190	0.04191532832492554	0.3209248817073059	0	0	2.451923076923077	7.777754234534465	RERE;MECP2;NSD1;BRAF;ABCC9;MTOR
Heart valve disease	3/58	0.04201964137058377	0.32107097168963294	0	0	4.0813688212927755	12.936380563569678	IDS;BRAF;LSP1
Vascular Diseases	10/401	0.04275264438153756	0.3260105493628582	0	0	1.9324448529411764	6.091692730426222	ATXN1;MAOB;IGFBP5;MAOA;SORT1;HGF;FSTL1;MAP2K5;ARHGAP24;MTOR
Insulin-resistant diabetes mellitus	2/25	0.04324833944161719	0.3283958582722947	0	0	6.492424242424242	20.391382952476295	INSR;PIK3R1
Port-Wine Stain	2/25	0.04324833944161719	0.3283958582722947	0	0	6.492424242424242	20.391382952476295	CDKN1C;NSD1
hearing impairment	8/294	0.043566058674748435	0.3283958582722947	0	0	2.108527131782946	6.60702106585348	MECP2;TBX15;FOXC1;PMP22;IDS;BRAF;GNS;ARID1B
Fibromatosis, Aggressive	3/59	0.043850044255631604	0.3283958582722947	0	0	4.008283541553504	12.533820668703028	ATXN1;CREB3L2;BRAF
Sleep Apnea Syndromes	3/59	0.043850044255631604	0.3283958582722947	0	0	4.008283541553504	12.533820668703028	GSN;PMP22;IDS
Squamous cell carcinoma of mouth	3/59	0.043850044255631604	0.3283958582722947	0	0	4.008283541553504	12.533820668703028	CALD1;FHIT;ARHGAP24
SVEINSSON CHORIORETINAL ATROPHY	3/59	0.043850044255631604	0.3283958582722947	0	0	4.008283541553504	12.533820668703028	IDS;RNPC3;PAFAH1B1
Tooth problem	3/59	0.043850044255631604	0.3283958582722947	0	0	4.008283541553504	12.533820668703028	MECP2;SON;ARID1B
Angina Pectoris	3/59	0.043850044255631604	0.3283958582722947	0	0	4.008283541553504	12.533820668703028	ATXN2;ATP2B1;SMG6
Nerve Degeneration	5/145	0.04464600451276631	0.3330520099320663	0	0	2.6811713191023534	8.33573605341224	ATXN2;IDS;VPS54;ATP13A2;TTC19
Developmental delay (disorder)	6/193	0.04464859703097782	0.3330520099320663	0	0	2.4122171945701356	7.499420176675089	MECP2;HDAC4;MEF2C;MAOB;PMP22;PAFAH1B1
Eclampsia	6/194	0.04558386978929502	0.3391061106687691	0	0	2.3992635024549918	7.409408805835608	CDKN1C;ERVFRD-1;EGFL7;IGFBP5;MAOA;INSR
Ventricular arrhythmia	3/60	0.04571968388839857	0.3391061106687691	0	0	3.937762657594557	12.148889127623873	SEMA3A;IDS;ABCC9
Xeroderma Pigmentosum	4/101	0.04592906587759689	0.3391061106687691	0	0	3.0907373888407963	9.521502139301797	HPGDS;HGF;NR1H2;BRAF
Neuromuscular Diseases	4/101	0.04592906587759689	0.3391061106687691	0	0	3.0907373888407963	9.521502139301797	MEF2A;MEF2C;COL15A1;ATXN1
Esophageal Neoplasms	14/637	0.0463429200627343	0.3391061106687691	0	0	1.7042090244337436	5.234796276334022	CDKN1C;PRKCI;GSN;ADH1B;NR1H2;HGF;RSRC2;PRDM2;FOXK1;FHIT;ARHGAP24;MTOR;AKAP13;HPGDS
Malaria, Vivax	2/26	0.04645042556545922	0.3391061106687691	0	0	6.221590909090909	19.09636232332055	HPGDS;GYPC
Yellow Fever	2/26	0.04645042556545922	0.3391061106687691	0	0	6.221590909090909	19.09636232332055	GYPC;STAT2
Hereditary nonpolyposis colorectal carcinoma	2/26	0.04645042556545922	0.3391061106687691	0	0	6.221590909090909	19.09636232332055	DLC1;BRAF
Hyperprolactinemia	2/26	0.04645042556545922	0.3391061106687691	0	0	6.221590909090909	19.09636232332055	INSR;BRAF
MOHR-TRANEBJAERG SYNDROME	2/26	0.04645042556545922	0.3391061106687691	0	0	6.221590909090909	19.09636232332055	BRAF;FHIT
Pfaundler-Hurler Syndrome	2/26	0.04645042556545922	0.3391061106687691	0	0	6.221590909090909	19.09636232332055	IDS;GNS
Glaucoma, Primary Open Angle	5/147	0.046869122899159135	0.34028246234944853	0	0	2.6431385246343964	8.089051045860945	TGFBR3;HPGDS;ATXN2;COL15A1;FOXC1
Monosomy	5/147	0.046869122899159135	0.34028246234944853	0	0	2.6431385246343964	8.089051045860945	MECP2;FOXC1;SYVN1;CD22;PAFAH1B1
Anxiety	11/464	0.04688255852385553	0.34028246234944853	0	0	1.8360472665887546	5.6185057915978405	MECP2;USP8;ATXN2;MAOA;ADH1B;NR1H2;PMP22;FHIT;TTC19;MAP2K5;FKBP5
Inflammatory Breast Carcinoma	4/102	0.047324731963057504	0.34109457337412546	0	0	3.05904346471413	9.332291948220483	STAT2;PUM1;ARHGAP24;HDAC6
Kidney Diseases	14/639	0.04734199244151864	0.34109457337412546	0	0	1.6985777777777777	5.181269613040205	CDKN1C;FOXC1;NPR1;INSR;HGF;ACACB;ARHGAP24;DCN;MTOR;HIPK2;GHR;CALD1;SAA1;UTS2
Carcinoma, Papillary	6/196	0.04749086286134387	0.34109457337412546	0	0	2.3737651821862347	7.233379865736588	CCDC80;IGFBP5;HGF;AKAP9;BRAF;HDAC6
Ganglioglioma	3/61	0.04762828393809132	0.34109457337412546	0	0	3.869673528254884	11.780557383893125	HGF;BRAF;MTOR
Hemiparesis	3/61	0.04762828393809132	0.34109457337412546	0	0	3.869673528254884	11.780557383893125	TGFBR3;COL3A1;MTOR
Leukoplakia	3/61	0.04762828393809132	0.34109457337412546	0	0	3.869673528254884	11.780557383893125	HPGDS;FHIT;ARHGAP24
Profound intellectual disabilities	3/61	0.04762828393809132	0.34109457337412546	0	0	3.869673528254884	11.780557383893125	MECP2;IDS;SHROOM4
Adenocarcinoma of pancreas	9/354	0.04794255476667444	0.34269374536254765	0	0	1.9680933852140077	5.978579145715893	MECP2;AIMP2;IL1RL1;CEACAM1;CALCRL;EYA2;BRAF;LSP1;FKBP5
Hydrops Fetalis	4/103	0.0487437572176149	0.34760240666601927	0	0	3.0279898218829517	9.14809667864452	CALCRL;NPR1;PEX6;BRAF
Multiple polyps	3/62	0.049575554188959134	0.34760240666601927	0	0	3.803892504994522	11.427872305226096	PRDM2;BRAF;MTOR
Phyllodes Tumor	3/62	0.049575554188959134	0.34760240666601927	0	0	3.803892504994522	11.427872305226096	FHIT;DCN;MTOR
Respiratory Distress Syndrome	2/27	0.04973658008839511	0.34760240666601927	0	0	5.972424242424243	17.923332341340387	HPGDS;BRAF
Encephalopathy, Toxic	2/27	0.04973658008839511	0.34760240666601927	0	0	5.972424242424243	17.923332341340387	SRSF5;MTOR
Toxic Encephalitis	2/27	0.04973658008839511	0.34760240666601927	0	0	5.972424242424243	17.923332341340387	SRSF5;MTOR
Visual field defects	2/27	0.04973658008839511	0.34760240666601927	0	0	5.972424242424243	17.923332341340387	TGFBR3;COL3A1
Bulbar palsy	2/27	0.04973658008839511	0.34760240666601927	0	0	5.972424242424243	17.923332341340387	ATXN1;GSN
Childhood Cerebral Astrocytoma	2/27	0.04973658008839511	0.34760240666601927	0	0	5.972424242424243	17.923332341340387	HGF;BRAF
Generalized hyperpigmentation	2/27	0.04973658008839511	0.34760240666601927	0	0	5.972424242424243	17.923332341340387	INSR;BRAF
Generalized vitiligo	2/27	0.04973658008839511	0.34760240666601927	0	0	5.972424242424243	17.923332341340387	RERE;FOXP1
Intracranial Astrocytoma	2/27	0.04973658008839511	0.34760240666601927	0	0	5.972424242424243	17.923332341340387	HGF;BRAF
Fetal Growth Retardation	8/304	0.05115520667971716	0.3537905411583987	0	0	2.0362455478734547	6.053536061831452	CDKN1C;RERE;INSR;BRAF;PIK3R1;ARID1B;HDAC6;MTOR
Speech impairment	6/200	0.0514513313136005	0.3537905411583987	0	0	2.3243457573354482	6.896610322406802	MECP2;BBS1;MEF2C;PIK3R1;FOXP1;DHTKD1
Bulbo-Spinal Atrophy, X-Linked	3/63	0.051561191159002095	0.3537905411583987	0	0	3.740304182509506	11.08994953236532	ATXN2;ATXN1;INSR
Large, late-closing fontanelle	3/63	0.051561191159002095	0.3537905411583987	0	0	3.740304182509506	11.08994953236532	CDKN1C;HPGD;NSD1
Abnormality of the dentition	3/63	0.051561191159002095	0.3537905411583987	0	0	3.740304182509506	11.08994953236532	MECP2;SON;ARID1B
Wide bregma sutures	3/63	0.051561191159002095	0.3537905411583987	0	0	3.740304182509506	11.08994953236532	CDKN1C;HPGD;NSD1
gliosarcoma	3/63	0.051561191159002095	0.3537905411583987	0	0	3.740304182509506	11.08994953236532	HGF;BRAF;TACC1
Large bregma sutures	3/63	0.051561191159002095	0.3537905411583987	0	0	3.740304182509506	11.08994953236532	CDKN1C;HPGD;NSD1
Large fontanelle	3/63	0.051561191159002095	0.3537905411583987	0	0	3.740304182509506	11.08994953236532	CDKN1C;HPGD;NSD1
Neuro-degenerative disease	3/63	0.051561191159002095	0.3537905411583987	0	0	3.740304182509506	11.08994953236532	ATXN2;IDS;TTC19
Eosinophil count procedure	6/201	0.052472090700969046	0.358499712999653	0	0	2.312307692307692	6.815466471105365	RERE;IL1RL1;RAB5B;ATXN2;ATXN1;SIK3
Eosinophil count result	6/201	0.052472090700969046	0.358499712999653	0	0	2.312307692307692	6.815466471105365	RERE;IL1RL1;RAB5B;ATXN2;ATXN1;SIK3
GASTRIC CANCER, INTESTINAL	2/28	0.05310401907454376	0.358499712999653	0	0	5.742424242424242	16.856901666119466	HPGDS;ARHGAP24
Hyperglycemia, Postprandial	2/28	0.05310401907454376	0.358499712999653	0	0	5.742424242424242	16.856901666119466	COL3A1;INSR
Pain, Postoperative	2/28	0.05310401907454376	0.358499712999653	0	0	5.742424242424242	16.856901666119466	MAOB;MAOA
Cerebral Astrocytoma	2/28	0.05310401907454376	0.358499712999653	0	0	5.742424242424242	16.856901666119466	HGF;BRAF
Depressed philtrum	2/28	0.05310401907454376	0.358499712999653	0	0	5.742424242424242	16.856901666119466	NSD1;BRAF
Malignant Bone Neoplasm	2/28	0.05310401907454376	0.358499712999653	0	0	5.742424242424242	16.856901666119466	MTOR;FOXP1
Reactive airway disease	2/28	0.05310401907454376	0.358499712999653	0	0	5.742424242424242	16.856901666119466	BBS1;IDS
Reticulocyte count (procedure)	6/202	0.05350514337708623	0.35981147598541774	0	0	2.300392464678179	6.735497358910868	AIMP2;ATXN2;ATXN1;MAST2;USP34;ATP11A
Retinopathy of Prematurity	3/64	0.05358487869068738	0.35981147598541774	0	0	3.678800723056785	10.765967512026805	ZNF197;FZD4;HGF
Extrapyramidal sign	3/64	0.05358487869068738	0.35981147598541774	0	0	3.678800723056785	10.765967512026805	ATXN1;MAOB;MAOA
Melanocytic nevus	6/203	0.054550504668064305	0.36564368520391144	0	0	2.28859820382663	6.656681537923825	CDKN1C;COL3A1;MAOA;HGF;BRAF;ARHGAP24
White Blood Cell Count procedure	4/107	0.05465267323063379	0.3656778331435124	0	0	2.9098050841176906	8.458096733604878	RERE;ATXN1;FKBP5;SMG6
Developmental regression	5/154	0.055160541269963385	0.36776948489195055	0	0	2.518064234102188	7.296109785676185	MECP2;SON;MAOA;PEX6;ROGDI
Invasive Carcinoma	5/154	0.055160541269963385	0.36776948489195055	0	0	2.518064234102188	7.296109785676185	GSN;HGF;MAST2;BRAF;FHIT
Stress, Psychological	3/65	0.05564628849521476	0.36833682127458656	0	0	3.619281246167055	10.455162134959886	MECP2;MAOA;FKBP5
FRIEDREICH ATAXIA 1	3/65	0.05564628849521476	0.36833682127458656	0	0	3.619281246167055	10.455162134959886	ATXN1;PHF1;PIP5K1B
Carcinoma, Lewis Lung	4/108	0.05618786015357825	0.36833682127458656	0	0	2.881679389312977	8.296512177379656	AIMP2;IL1RL1;HGF;BRAF
Malignant neoplasm of breast	79/5054	0.05632630603381976	0.36833682127458656	0	0	1.2532835299492113	3.6051873880930874	ITSN2;CDKN1C;NUMA1;PRDM2;WASL;LSP1;PTPN23;EDA2R;MECP2;GHR;AKAP13;HPGDS;DIP2A;VPS39;RBM5;MEF2A;EGFL7;IGFBP5;HGF;EBF1;IL16;FRS3;ARID1B;DCN;FOXP1;TGFBR3;SLC25A16;CEACAM1;AKAP9;SIK3;UTS2;ULK1;SRSF5;ANGPTL1;PAFAH1B1;HDAC4;FOXC1;COL15A1;HPGD;MAOA;ADH1B;WBP2;SEMA3A;TSHZ2;ANKRD12;PIK3R1;RCHY1;FSTL1;FHIT;HDAC6;ATXN1;CALD1;MAP2K5;RAI2;SASH1;GSN;SORT1;EYA2;INSR;STAT2;NR1H2;SYVN1;RAB27B;BRAF;HOOK3;ATP2B1;TPD52L1;ARHGAP24;MTOR;HIPK2;AIMP2;GOLGB1;DLC1;NFIC;PMP22;TACC1;HOXD3;OGT;CPEB4
Salivary duct carcinoma	2/29	0.05655001727726344	0.36833682127458656	0	0	5.529461279461279	15.88409508840907	NUMA1;BRAF
Smith-Magenis syndrome	2/29	0.05655001727726344	0.36833682127458656	0	0	5.529461279461279	15.88409508840907	HDAC4;PMP22
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	2/29	0.05655001727726344	0.36833682127458656	0	0	5.529461279461279	15.88409508840907	NR1H2;ARHGAP24
Treatment related leukaemia	2/29	0.05655001727726344	0.36833682127458656	0	0	5.529461279461279	15.88409508840907	PRDM2;FHIT
Bulbar weakness	2/29	0.05655001727726344	0.36833682127458656	0	0	5.529461279461279	15.88409508840907	ATXN1;GSN
Deep philtrum	2/29	0.05655001727726344	0.36833682127458656	0	0	5.529461279461279	15.88409508840907	NSD1;BRAF
Infection of bone	2/29	0.05655001727726344	0.36833682127458656	0	0	5.529461279461279	15.88409508840907	HPGD;PIK3R1
LEOPARD Syndrome	2/29	0.05655001727726344	0.36833682127458656	0	0	5.529461279461279	15.88409508840907	BRAF;MTOR
Neonatal hypoglycemia	2/29	0.05655001727726344	0.36833682127458656	0	0	5.529461279461279	15.88409508840907	CDKN1C;NSD1
Diffuse Astrocytoma	3/66	0.05774508073947563	0.36833682127458656	0	0	3.5616512764801738	10.156821903543955	IGFBP5;HGF;BRAF
Language Delay	6/206	0.057760569107815254	0.36833682127458656	0	0	2.253923076923077	6.426946549311187	MECP2;BBS1;MEF2C;PIK3R1;FOXP1;DHTKD1
Myocardial Infarction	19/966	0.05799388640914439	0.36833682127458656	0	0	1.5260336284623508	4.345255135072693	MEF2A;CDKN1C;MEF2C;GSN;ADH1B;SORT1;NPR1;HGF;ABCC9;ATP2B1;FSTL1;DCN;MTOR;SMG6;CEACAM1;COL3A1;HPGDS;ATXN2;UTS2
Alcoholic Intoxication, Chronic	10/424	0.058034925086421225	0.36833682127458656	0	0	1.8229166666666667	5.1893156382755254	PHF3;AIMP2;MAOB;MAOA;ADH1B;LMO3;SEMA3A;PIK3R1;SRSF5;FKBP5
Curvature of little finger	5/157	0.058957462799884425	0.36833682127458656	0	0	2.4679874974793305	6.986722217542328	RERE;MECP2;HDAC4;TBX15;BRAF
Mental Retardation	22/1158	0.05907682260834384	0.36833682127458656	0	0	1.4761169475871623	4.175811742382806	RERE;HDAC4;BBS1;CEP104;FOXC1;PPP1R12A;MAOB;MAOA;BRAF;GNS;ARID1B;SHROOM4;MTOR;FOXP1;MECP2;COL3A1;SON;NFIA;NSD1;PEX6;STT3A;PAFAH1B1
Abortion, Tubal	4/110	0.05932735910849115	0.36833682127458656	0	0	2.827020020164194	7.985440230374298	CEACAM1;ECM2;LAMA4;IL16
Primary malignant neoplasm	20/1032	0.05947469540554853	0.36833682127458656	0	0	1.5040650406504066	4.244778891671724	CDKN1C;FOXC1;URGCP;NR1H2;HGF;BRAF;PRDM2;PIK3R1;PTPN23;ARID1B;MTOR;HIPK2;MECP2;GHR;CEACAM1;HPGDS;CRNDE;MPHOSPH8;MAP2K5;FKBP5
Lymphoma, T-Cell, Cutaneous	7/260	0.05959040249095343	0.36833682127458656	0	0	2.081081081081081	5.869191290350883	CDKN1C;STAT2;BRAF;IL16;CD22;ARHGAP24;HDAC6
West Syndrome	3/67	0.05988090455805543	0.36833682127458656	0	0	3.5058222433460076	9.870283576797776	ATXN2;MTOR;PAFAH1B1
Metastatic Renal Cell Cancer	3/67	0.05988090455805543	0.36833682127458656	0	0	3.5058222433460076	9.870283576797776	DLC1;ULK1;MTOR
neurofibroma	3/67	0.05988090455805543	0.36833682127458656	0	0	3.5058222433460076	9.870283576797776	HGF;BRAF;ARID1B
Carcinoma, Signet Ring Cell	2/30	0.06007190706628915	0.36833682127458656	0	0	5.331709956709957	14.993903963046998	MECP2;BRAF
TUBEROUS SCLEROSIS 2 (disorder)	2/30	0.06007190706628915	0.36833682127458656	0	0	5.331709956709957	14.993903963046998	BRAF;MTOR
Broad foot	2/30	0.06007190706628915	0.36833682127458656	0	0	5.331709956709957	14.993903963046998	BBS1;NSD1
Gonadoblastoma	2/30	0.06007190706628915	0.36833682127458656	0	0	5.331709956709957	14.993903963046998	CDKN1C;NSD1
High grade serous carcinoma	2/30	0.06007190706628915	0.36833682127458656	0	0	5.331709956709957	14.993903963046998	BRAF;FHIT
Noncancerous mole	2/30	0.06007190706628915	0.36833682127458656	0	0	5.331709956709957	14.993903963046998	COL3A1;BRAF
Overlap syndrome	2/30	0.06007190706628915	0.36833682127458656	0	0	5.331709956709957	14.993903963046998	RNPC3;PAFAH1B1
Protoplasmic astrocytoma	2/30	0.06007190706628915	0.36833682127458656	0	0	5.331709956709957	14.993903963046998	HGF;BRAF
Pain	11/485	0.06048378548982921	0.36833682127458656	0	0	1.7527922561429634	4.917248266444446	MECP2;ATXN2;MAOA;FZD4;CILP;NPR1;LMO3;HGF;IL16;MTOR;FKBP5
Endothelial dysfunction	7/262	0.06156617345174253	0.36833682127458656	0	0	2.0645468998410177	5.755219076699723	AIMP2;COL15A1;MAOB;MAOA;HGF;UTS2;OGT
Cardiomegaly	5/159	0.061569813547523215	0.36833682127458656	0	0	2.435686918445539	6.789680831538777	CDKN1C;HDAC4;NPR1;NSD1;ABCC9
Clinodactyly of the 5th finger	5/159	0.061569813547523215	0.36833682127458656	0	0	2.435686918445539	6.789680831538777	RERE;MECP2;HDAC4;TBX15;BRAF
Cardiovascular Diseases	16/787	0.06172268262343297	0.36833682127458656	0	0	1.574101167315175	4.384035123817698	MEF2A;BBS1;MAOA;ADH1B;SORT1;NPR1;INSR;HGF;ABCC9;IL1RL1;CEACAM1;HPGDS;SAA1;UTS2;MAP4;PAFAH1B1
Thin skin	3/68	0.062053398593448716	0.36833682127458656	0	0	3.4517110266159694	9.594928232918134	USP8;COL3A1;PIK3R1
Low posterior hairline	3/68	0.062053398593448716	0.36833682127458656	0	0	3.4517110266159694	9.594928232918134	TBX15;ABCC9;BRAF
Migraine with Aura	3/68	0.062053398593448716	0.36833682127458656	0	0	3.4517110266159694	9.594928232918134	MAOA;INSR;CSAD
Cleft Palate	4/112	0.06255853765605562	0.36833682127458656	0	0	2.774385072094996	7.689631482174756	CDKN1C;NFIA;FZD4;GOLGB1
Coronary heart disease	18/913	0.06274470263591944	0.36833682127458656	0	0	1.527761758875473	4.229885144804202	MEF2A;MEF2C;ADH1B;SORT1;INSR;IL16;ABCC9;ATP2B1;FHIT;SMG6;FOXP1;IL1RL1;COL3A1;HPGDS;ATXN2;DLC1;SIK3;UTS2
Slow-growing hair	2/31	0.06366707741132564	0.36833682127458656	0	0	5.147596656217346	14.176932574386663	BRAF;ARID1B
Major depression, single episode	2/31	0.06366707741132564	0.36833682127458656	0	0	5.147596656217346	14.176932574386663	MAOA;FKBP5
Congenital long QT syndrome	2/31	0.06366707741132564	0.36833682127458656	0	0	5.147596656217346	14.176932574386663	AKAP9;SRSF5
Embryotoxon	2/31	0.06366707741132564	0.36833682127458656	0	0	5.147596656217346	14.176932574386663	FOXC1;PEX6
Lymphatic obstruction	2/31	0.06366707741132564	0.36833682127458656	0	0	5.147596656217346	14.176932574386663	BRAF;ABCC9
Onset of lymphedema around puberty	2/31	0.06366707741132564	0.36833682127458656	0	0	5.147596656217346	14.176932574386663	BRAF;ABCC9
Pulmonary Fibrosis	10/432	0.06409508362514935	0.36833682127458656	0	0	1.7876184834123223	4.911280884376058	MECP2;COL3A1;IGFBP5;HGF;FAM13A;ATP11A;CSAD;FSTL1;DCN;MTOR
Lipodystrophy	4/113	0.06420830403801692	0.36833682127458656	0	0	2.748791932208138	7.54714560983748	USP8;INSR;EBF1;PIK3R1
Eosinophilic disorder	5/161	0.06424688925553687	0.36833682127458656	0	0	2.4042145593869733	6.599621792446572	IL1RL1;HPGDS;NUMA1;GOLGB1;FKBP5
Underdeveloped nasal alae	3/69	0.06426219148839593	0.36833682127458656	0	0	3.3992395437262357	9.330177708133315	MECP2;HDAC4;PIK3R1
Coronary Artery Disease	19/981	0.06542526084643989	0.36833682127458656	0	0	1.501039501039501	4.093104825558902	MEF2A;RERE;CALCRL;ADH1B;SORT1;NPR1;INSR;IL16;ATP2B1;PAFAH2;SMG6;AKAP13;IL1RL1;COL3A1;HPGDS;ATXN2;SAA1;UTS2;FKBP5
Speech Delay	6/213	0.06568330335965536	0.36833682127458656	0	0	2.1769230769230767	5.927566748136667	MECP2;BBS1;MEF2C;PIK3R1;FOXP1;DHTKD1
Lymphoid leukemia	6/213	0.06568330335965536	0.36833682127458656	0	0	2.1769230769230767	5.927566748136667	CEACAM1;HPGDS;IL16;ATP11A;CD22;ARHGAP24
Obsessive-Compulsive Disorder	4/114	0.06588073661558856	0.36833682127458656	0	0	2.7236641221374045	7.408119083257065	MECP2;MAOA;BTBD9;TTC19
Deformity of face	3/70	0.06650690242377871	0.36833682127458656	0	0	3.3483343737585836	9.07549136600121	GHR;TBX15;INSR
Distortion of face	3/70	0.06650690242377871	0.36833682127458656	0	0	3.3483343737585836	9.07549136600121	GHR;TBX15;INSR
Funny looking face	3/70	0.06650690242377871	0.36833682127458656	0	0	3.3483343737585836	9.07549136600121	GHR;TBX15;INSR
Aortic Valve Insufficiency	6/214	0.06686460762298556	0.36833682127458656	0	0	2.166346153846154	5.860151538143699	FOXC1;COL3A1;HPGDS;FSTL1;HDAC6;FKBP5
Blast Phase	6/214	0.06686460762298556	0.36833682127458656	0	0	2.166346153846154	5.860151538143699	CDKN1C;EBF2;PRDM2;FHIT;ARHGAP24;PAFAH1B1
Intelligence	6/214	0.06686460762298556	0.36833682127458656	0	0	2.166346153846154	5.860151538143699	CCDC134;MEF2C;PDE1A;SCMH1;DCAF5;FOXP1
Grade I Astrocytoma	2/32	0.06733297285530632	0.36833682127458656	0	0	4.975757575757576	13.425117507998763	HGF;BRAF
Neurotoxicity Syndromes	2/32	0.06733297285530632	0.36833682127458656	0	0	4.975757575757576	13.425117507998763	SRSF5;MTOR
Posterior embryotoxon	2/32	0.06733297285530632	0.36833682127458656	0	0	4.975757575757576	13.425117507998763	FOXC1;PEX6
Prominent metopic ridge	2/32	0.06733297285530632	0.36833682127458656	0	0	4.975757575757576	13.425117507998763	CDKN1C;NSD1
Idiopathic Pulmonary Fibrosis	9/379	0.06757617347374514	0.36833682127458656	0	0	1.8327479230202965	4.938338951376203	MECP2;COL3A1;IGFBP5;HGF;FAM13A;ATP11A;FHIT;DCN;HIPK2
Essential Tremor	3/71	0.06878714155018502	0.36833682127458656	0	0	3.2989264146723327	8.830363169900501	HPGDS;ATXN2;SORT1
Heart Diseases	8/325	0.06973853129873736	0.36833682127458656	0	0	1.8992981683906782	5.057835386298615	MEF2A;GHR;HPGDS;SGCD;HGF;BRAF;ABCC9;MTOR
Precursor Cell Lymphoblastic Leukemia Lymphoma	13/618	0.07044000703404936	0.36833682127458656	0	0	1.6246496586417536	4.310185626695259	CDKN1C;MEF2C;GYPC;PDE1A;EBF1;BRAF;IL16;ATP11A;FHIT;ARHGAP24;CEACAM1;HPGDS;CD22
Refractory anaemia with excess blasts	2/33	0.07106709245000838	0.36833682127458656	0	0	4.815004887585533	12.731503130134351	NSD1;PAFAH1B1
Scapular weakness	2/33	0.07106709245000838	0.36833682127458656	0	0	4.815004887585533	12.731503130134351	SGCD;BRAF
Muscular Dystrophy, Emery-Dreifuss	2/33	0.07106709245000838	0.36833682127458656	0	0	4.815004887585533	12.731503130134351	YTHDC1;GOLGB1
Ventricular hypertrophy	2/33	0.07106709245000838	0.36833682127458656	0	0	4.815004887585533	12.731503130134351	SGCD;BRAF
Angiomyolipoma	2/33	0.07106709245000838	0.36833682127458656	0	0	4.815004887585533	12.731503130134351	BRAF;MTOR
Aplasia/Hypoplasia of the corpus callosum	2/33	0.07106709245000838	0.36833682127458656	0	0	4.815004887585533	12.731503130134351	NSD1;BRAF
Ataxic	2/33	0.07106709245000838	0.36833682127458656	0	0	4.815004887585533	12.731503130134351	ATXN2;ATXN1
Autosomal Dominant Parkinsonism	2/33	0.07106709245000838	0.36833682127458656	0	0	4.815004887585533	12.731503130134351	ATXN2;ATP13A2
Craniopharyngioma	2/33	0.07106709245000838	0.36833682127458656	0	0	4.815004887585533	12.731503130134351	GHR;BRAF
Fibrillary Astrocytoma	2/33	0.07106709245000838	0.36833682127458656	0	0	4.815004887585533	12.731503130134351	HGF;BRAF
Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	2/33	0.07106709245000838	0.36833682127458656	0	0	4.815004887585533	12.731503130134351	HPGDS;FOXP1
Infantile Severe Myoclonic Epilepsy	2/33	0.07106709245000838	0.36833682127458656	0	0	4.815004887585533	12.731503130134351	PMP22;MTOR
Mixed oligoastrocytoma	2/33	0.07106709245000838	0.36833682127458656	0	0	4.815004887585533	12.731503130134351	HGF;BRAF
secondary acute myeloid leukemia	3/72	0.07110251049383849	0.36833682127458656	0	0	3.2509505703422055	8.5943190175208	SEMA3A;FOXP1;PAFAH1B1
Spinocerebellar Ataxia Type 7	3/72	0.07110251049383849	0.36833682127458656	0	0	3.2509505703422055	8.5943190175208	FOXC1;ATXN2;ATXN1
Eating Disorders	3/72	0.07110251049383849	0.36833682127458656	0	0	3.2509505703422055	8.5943190175208	HDAC4;LMO3;UTS2
Familial primary gastric lymphoma	3/72	0.07110251049383849	0.36833682127458656	0	0	3.2509505703422055	8.5943190175208	HPGDS;CALD1;FOXP1
Hyperuricemia	3/72	0.07110251049383849	0.36833682127458656	0	0	3.2509505703422055	8.5943190175208	ADH1B;MAOA;SAA1
Mesothelioma	9/383	0.07112587014320741	0.36833682127458656	0	0	1.812771801327535	4.791707230185333	CDKN1C;SLC25A16;GSN;PPP1R12A;HGF;BRAF;FHIT;MAP2K5;MTOR
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)	5/166	0.07122158212090812	0.36833682127458656	0	0	2.3289545703338805	6.153003388570978	AIMP2;HPGDS;HGF;NR1H2;BRAF
Anaplastic astrocytoma	5/166	0.07122158212090812	0.36833682127458656	0	0	2.3289545703338805	6.153003388570978	ABR;IGFBP5;HGF;BRAF;PAFAH1B1
Progressive Neoplastic Disease	5/167	0.07266463253800813	0.36833682127458656	0	0	2.3144600539236553	6.068283967634463	HDAC4;ATXN1;HGF;BRAF;FHIT
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1	3/73	0.0734526027895043	0.36833682127458656	0	0	3.20434546442151	8.366914317577193	AIMP2;FOXC1;PIK3R1
Autoimmune Diseases	20/1060	0.07360999964941257	0.36833682127458656	0	0	1.4613821138211383	3.812708520178487	GSN;HGF;SEMA3A;IL16;PIK3R1;ATP11A;RNPC3;MTOR;MECP2;ABR;AIMP2;IL1RL1;CEACAM1;HPGDS;ATXN2;CILP;SAA1;UTS2;KIAA0319L;CD22
Mental disorders	8/329	0.07369234280834469	0.36833682127458656	0	0	1.8752445120625951	4.890368368500098	MECP2;ATXN1;MAOB;MAOA;ADH1B;LMO3;CD22;FKBP5
Prader-Willi Syndrome	4/119	0.07457938846120313	0.36833682127458656	0	0	2.6045801526717556	6.761206448065206	CDKN1C;GHR;MECP2;BRAF
Premature Birth	4/119	0.07457938846120313	0.36833682127458656	0	0	2.6045801526717556	6.761206448065206	COL3A1;FZD4;PEX6;BRAF
Malignant Glioma	11/504	0.07483712472838766	0.36833682127458656	0	0	1.6835779342162829	4.364576795408757	CDKN1C;AIMP2;HPGDS;EGFL7;HGF;CREB3L2;BRAF;PIK3R1;ANGPTL1;DCN;MTOR
Sarcoma, Spindle Cell	2/34	0.07486698887728016	0.36833682127458656	0	0	4.664299242424242	12.090060570365456	SYVN1;BRAF
Winged scapula	2/34	0.07486698887728016	0.36833682127458656	0	0	4.664299242424242	12.090060570365456	SGCD;BRAF
Coxa valga	2/34	0.07486698887728016	0.36833682127458656	0	0	4.664299242424242	12.090060570365456	ABCC9;ARID1B
Coxa valga deformity	2/34	0.07486698887728016	0.36833682127458656	0	0	4.664299242424242	12.090060570365456	ABCC9;ARID1B
Generalized Anxiety Disorder	2/34	0.07486698887728016	0.36833682127458656	0	0	4.664299242424242	12.090060570365456	MAOA;PDE1A
Metastatic Carcinoma	2/34	0.07486698887728016	0.36833682127458656	0	0	4.664299242424242	12.090060570365456	GSN;BRAF
Infant, Small for Gestational Age	7/275	0.07537952111156423	0.36833682127458656	0	0	1.963089955627269	5.075018716528992	CDKN1C;RERE;INSR;BRAF;PIK3R1;ARID1B;HDAC6
Fibrosis	5/169	0.0755985611674828	0.36833682127458656	0	0	2.2860013082889448	5.9031823907779835	COL3A1;NPR1;HGF;FHIT;DCN
Movement Disorders	5/169	0.0755985611674828	0.36833682127458656	0	0	2.2860013082889448	5.9031823907779835	MECP2;PEX6;OGDH;UTS2;PAFAH1B1
Progressive cGVHD	5/169	0.0755985611674828	0.36833682127458656	0	0	2.2860013082889448	5.9031823907779835	HDAC4;ATXN1;HGF;BRAF;FHIT
Adenoma	19/1000	0.07574842411891491	0.36833682127458656	0	0	1.4704775346977181	3.794328529378258	CDKN1C;USP8;GSN;HPGD;SORT1;INSR;HGF;MIB2;BRAF;FHIT;ARHGAP24;MTOR;GHR;TBRG1;CEACAM1;HPGDS;UTS2;MAP2K5;SASH1
Thick eyebrow	3/74	0.07583700434747846	0.36833682127458656	0	0	3.159053178385905	8.147731778910817	ABCC9;ARID1B;GNS
Hamartoma	3/74	0.07583700434747846	0.36833682127458656	0	0	3.159053178385905	8.147731778910817	LAMA4;BRAF;MTOR
Carcinogenesis	64/4065	0.07595493646187303	0.36833682127458656	0	0	1.2458667511339987	3.2113648953011324	CDKN1C;RERE;LDB1;PHF1;HP1BP3;PRDM2;PTPN23;CSAD;EDA2R;MECP2;AKAP13;HPGDS;MEF2A;USP8;PRKCI;IGFBP5;SCARA5;IL11RA;LMO3;HGF;EBF1;VWA5A;DCN;FOXP1;TGFBR3;CEACAM1;CCDC80;SIK3;UTS2;PAFAH1B1;HDAC4;HPGD;MAOA;ADH1B;SEMA3A;MGST1;PIK3R1;RCHY1;FSTL1;FHIT;HDAC6;TBRG1;ATXN1;CALD1;NSD1;CRNDE;SAFB2;MAP2K5;SASH1;GSN;URGCP;FZD4;EYA2;INSR;NR1H2;BRAF;ARHGAP24;MTOR;HIPK2;AIMP2;TBX15;DLC1;NFIC;PMP22
Achondrogenesis, type IB (disorder)	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	DCN
Reduced factor XIII activity	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	BRAF
Bulbocavernosus Reflex, Decreased	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
DIABETES MELLITUS, INSULIN-DEPENDENT, 4	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	BBS1
Secondary glaucoma	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	FOXC1
EHLERS-DANLOS SYNDROME, PROGEROID FORM	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	DCN
Familial Amyloid Polyneuropathy, Type V	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	GSN
Serrated polyp	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	BRAF
Gastritis, Hypertrophic	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	HGF
Hereditary, Type VII, Motor and Sensory Neuropathy	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Skeletal malformation	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	TBX15
Speech and language disorder	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	FOXP1
Neoplasms, Fibrous Tissue	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	CREB3L2
Osteoarthropathy, Primary Hypertrophic	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	HPGD
Ovarian Small Cell Carcinoma, Hypercalcemic Type	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	HGF
Struma Ovarii	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	BRAF
Reflex, Abnormal	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Reflex, Acoustic, Abnormal	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Reflex, Anal, Absent	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Reflex, Anal, Decreased	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Reflex, Ankle, Abnormal	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Reflex, Ankle, Decreased	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Reflex, Biceps, Abnormal	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Reflex, Biceps, Absent	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Reflex, Biceps, Decreased	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Reflex, Corneal, Absent	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Reflex, Gag, Absent	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Reflex, Gag, Decreased	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Reflex, Knee, Abnormal	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Reflex, Knee, Decreased	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Reflex, Moro, Asymmetric	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Reflex, Pendular	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Reflex, Triceps, Abnormal	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Reflex, Triceps, Absent	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Reflex, Triceps, Decreased	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Serous cystadenoma, borderline malignancy	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	BRAF
Sterility, Reproductive	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	TTC19
Thinning of Descemet membrane	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	FOXC1
Uveitis, Intermediate	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	TGFBR3
Abnormal Deep Tendon Reflex	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Abnormal joint morphology	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	GHR
Uterus absent (finding)	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	ARID1B
Abnormality of upper lip	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PAFAH1B1
Vitreoretinopathy	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	FZD4
Yellow-brown discoloration of the teeth	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	ROGDI
Alcoholic Neuropathy	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	ADH1B
Anomalous pulmonary artery	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	BRAF
Axenfeld anomaly (disorder)	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	FOXC1
Benign neoplasm of prostate	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	FKBP5
Benign Struma Ovarii	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	BRAF
Bile duct adenoma	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	BRAF
Broad columella	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	HDAC4
Bulbocavernousus Reflex Absent	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Bulla of lung	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	GYPC
C1q DEFICIENCY	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	RNPC3
Calcium Pyrophosphate Dihydrate Deposition	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	CILP
Central opacification of the cornea	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	FOXC1
Childhood Ganglioglioma	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	BRAF
Cigarette-paper scars	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	COL3A1
Communication delay	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	NSD1
Congenital anomaly of skeletal bone	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	TBX15
Cri-du-Chat Syndrome	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	IL1RL1
Critical illness myopathy	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	SAA1
Decreased serum insulin-like growth factor 1	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	GHR
Deep-set nails	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	NSD1
Dyschromatosis universalis hereditaria	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	SASH1
edema disease	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	IL1RL1
Eisenmenger Complex	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	TGFBR3
Enlarged cisterna magna	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	NSD1
Epicanthus inversus	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PEX6
Equilibration disorder	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	ATXN2
Erlenmeyer flask deformity of the femurs	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	ABCC9
Expressed Emotion	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	LMO3
Exudative vitreoretinopathy	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	FZD4
Familial Neuroblastoma	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	MGST1
Fetal hydantoin syndrome	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	MECP2
Fibrocalculous pancreatic diabetes	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	INSR
Focal white matter lesions	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	MTOR
Granuloma Annulare	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	BRAF
hazardous drinking	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	ADH1B
hepatitis immune	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	HPGDS
Hoffman's Reflex	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Hyperplasia of columella	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	HDAC4
Hyporeflexia	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Insulin resistance - type A	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	INSR
Intestinal-Type Sinonasal Adenocarcinoma	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	BRAF
Juvenile cataract	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	LEMD2
Lentigo maligna melanoma	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	BRAF
Malignant melanoma of conjunctiva	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	BRAF
Mesenchymal Glioblastoma	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	HDAC4
Neck Pain	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	FKBP5
Numerous nevi	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	BRAF
Obesity Adverse Event	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	RSRC2
Palmo-Mental Reflex	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	PMP22
Papillary and follicular adenocarcinoma	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	BRAF
Pectus excavatum of inferior sternum	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	BRAF
Pilomyxoid astrocytoma	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	BRAF
Pygmy (disorder)	1/6	0.07720228187817363	0.36833682127458656	0	0	14.889811320754717	38.137664807523706	GHR
MYOTONIC DYSTROPHY 1	3/75	0.078255293881903	0.36833682127458656	0	0	3.115019011406844	7.936379393898385	IGFBP5;HGF;INSR
COLORBLINDNESS, PARTIAL, DEUTAN SERIES	2/35	0.0787302673618927	0.36833682127458656	0	0	4.5227272727272725	11.495540762855125	GOLGB1;MTOR
Gait, Drop Foot	2/35	0.0787302673618927	0.36833682127458656	0	0	4.5227272727272725	11.495540762855125	PMP22;TTC19
Tooth agenesis	2/35	0.0787302673618927	0.36833682127458656	0	0	4.5227272727272725	11.495540762855125	GHR;FOXP1
Abnormality of the metacarpal bones	2/35	0.0787302673618927	0.36833682127458656	0	0	4.5227272727272725	11.495540762855125	MECP2;ABCC9
Excessive daytime somnolence	2/35	0.0787302673618927	0.36833682127458656	0	0	4.5227272727272725	11.495540762855125	MAOA;BRAF
Neoplasm of uncertain or unknown behavior of ovary	2/35	0.0787302673618927	0.36833682127458656	0	0	4.5227272727272725	11.495540762855125	BRAF;PIK3R1
Essential Hypertension	7/278	0.07880650986128152	0.36833682127458656	0	0	1.941059140321133	4.931764786786829	HPGDS;CALCRL;NPR1;INSR;HGF;UTS2;ATP2B1
Intrauterine retardation	7/278	0.07880650986128152	0.36833682127458656	0	0	1.941059140321133	4.931764786786829	CDKN1C;RERE;INSR;BRAF;PIK3R1;ARID1B;HDAC6
Atherosclerosis	21/1134	0.07893300818239324	0.36833682127458656	0	0	1.4340392760877936	3.6412491223038126	CDKN1C;MEF2C;COL15A1;MAOA;SORT1;PDE1A;INSR;HGF;ARHGAP24;DCN;TGFBR3;ABR;AIMP2;IL1RL1;COL3A1;HPGDS;OSBP;SAA1;UTS2;SASH1;SNTB2
Adenomatous Polyposis Coli	9/392	0.07953095458047957	0.36833682127458656	0	0	1.7693511190580204	4.4793051593322994	GHR;HPGDS;GSN;HPGD;BRAF;FHIT;MTOR;PAFAH1B1;HIPK2
Congenital heart disease	4/122	0.08006373938605257	0.36833682127458656	0	0	2.5379738646655454	6.408211982415268	HPGDS;MEF2C;DLC1;BRAF
Lung diseases	9/393	0.08050069281582709	0.36833682127458656	0	0	1.7646522373540856	4.44602276231905	IL1RL1;COL3A1;HPGDS;GSN;INSR;HGF;FAM13A;IL16;MTOR
Tumor Angiogenesis	11/511	0.08062808486934793	0.36833682127458656	0	0	1.6594039215686274	4.178226812007976	ABR;CEACAM1;CLEC3B;FZD4;HGF;SEMA3A;LAMA4;BRAF;ARHGAP24;DCN;MTOR
Exanthema	6/225	0.08067315116280364	0.36833682127458656	0	0	2.0563751317175973	5.176614824114247	MECP2;HPGDS;DLG2;BRAF;PIK3R1;FHIT
Varicosity	3/76	0.08070704331056726	0.36833682127458656	0	0	3.0721912599614565	7.732488596209779	COL3A1;EBF1;ARHGAP24
Acromegaly	3/76	0.08070704331056726	0.36833682127458656	0	0	3.0721912599614565	7.732488596209779	GHR;INSR;BRAF
Amphetamine-Related Disorders	3/76	0.08070704331056726	0.36833682127458656	0	0	3.0721912599614565	7.732488596209779	PRDM2;FHIT;MAP2K5
Amphetamine Abuse	3/76	0.08070704331056726	0.36833682127458656	0	0	3.0721912599614565	7.732488596209779	PRDM2;FHIT;MAP2K5
Nonverbal	3/76	0.08070704331056726	0.36833682127458656	0	0	3.0721912599614565	7.732488596209779	RERE;MECP2;GNS
Pheochromocytoma	7/280	0.08114093772864805	0.36833682127458656	0	0	1.9266409266409266	4.838889052162078	CALCRL;MAOB;MAOA;INSR;UTS2;PRDM2;MTOR
Malignant tumor of colon	34/2001	0.0816898512006895	0.36833682127458656	0	0	1.323733849902705	3.3157223092560537	CDKN1C;MAOB;HPGD;PRDM2;PIK3R1;FSTL1;FHIT;HDAC6;GHR;ADAMTS15;HPGDS;CLEC3B;CALD1;MAP2K5;SASH1;GSN;IGFBP5;STAT2;NR1H2;HGF;BRAF;ARHGAP24;DCN;MTOR;HIPK2;TGFBR3;AIMP2;CEACAM1;DLC1;SAA1;PMP22;UTS2;ULK1;MPHOSPH8
Dull intelligence	18/947	0.08213745827198647	0.36833682127458656	0	0	1.4691916385985624	3.6720404516799454	RERE;HDAC4;BBS1;CEP104;MAOA;BRAF;GNS;ARID1B;MTOR;FOXP1;MECP2;COL3A1;SON;NFIA;NSD1;PEX6;STT3A;PAFAH1B1
Low intelligence	18/947	0.08213745827198647	0.36833682127458656	0	0	1.4691916385985624	3.6720404516799454	RERE;HDAC4;BBS1;CEP104;MAOA;BRAF;GNS;ARID1B;MTOR;FOXP1;MECP2;COL3A1;SON;NFIA;NSD1;PEX6;STT3A;PAFAH1B1
Malignant tumor of cervix	17/884	0.08246672128655881	0.36833682127458656	0	0	1.4857075360264589	3.707375818781378	GSN;URGCP;FZD4;NR1H2;HGF;BRAF;IL16;ACACB;FHIT;ARHGAP24;HDAC6;MTOR;ST7L;HPGDS;ATXN1;XPNPEP2;CRNDE
Redundant skin	2/36	0.08265458479276294	0.36833682127458656	0	0	4.389483065953654	10.943354318667156	HPGD;NSD1
Seckel syndrome	2/36	0.08265458479276294	0.36833682127458656	0	0	4.389483065953654	10.943354318667156	AIMP2;NR1H2
Thickened nuchal skin fold	2/36	0.08265458479276294	0.36833682127458656	0	0	4.389483065953654	10.943354318667156	INSR;BRAF
Barrett's Adenocarcinoma	2/36	0.08265458479276294	0.36833682127458656	0	0	4.389483065953654	10.943354318667156	AIMP2;BRAF
Hepatic Encephalopathy	2/36	0.08265458479276294	0.36833682127458656	0	0	4.389483065953654	10.943354318667156	MAOB;MAOA
Hereditary Motor and Sensory-Neuropathy Type II	2/36	0.08265458479276294	0.36833682127458656	0	0	4.389483065953654	10.943354318667156	PMP22;DHTKD1
Learning Disorders	2/36	0.08265458479276294	0.36833682127458656	0	0	4.389483065953654	10.943354318667156	MECP2;KIAA0319L
Distal amyotrophy	3/77	0.0831918181767547	0.36833682127458656	0	0	3.0305210153118898	7.535712573837268	ATXN2;ATXN1;PMP22
Azoospermia	5/174	0.08321033595457436	0.36833682127458656	0	0	2.2178013557323903	5.514305159909708	RERE;HPGDS;MAST2;WASL;RBM5
Dysarthria	7/282	0.08351510810213511	0.36833682127458656	0	0	1.9124324324324324	4.748049028188954	RERE;ATXN2;ATXN1;BRAF;ATP13A2;GNS;TTC19
Experimental Organism Basal Cell Carcinoma	7/282	0.08351510810213511	0.36833682127458656	0	0	1.9124324324324324	4.748049028188954	SLC25A16;AIMP2;HPGDS;HGF;BRAF;DCN;MTOR
Uterine Cervical Neoplasm	4/124	0.08382838367973638	0.36833682127458656	0	0	2.495419847328244	6.186104930160686	GHR;GSN;FHIT;MTOR
Drug Dependence	5/175	0.08477977420793736	0.36833682127458656	0	0	2.20464277665089	5.4403931798682486	MAOA;ADH1B;INSR;BRAF;FHIT
leukemia	33/1941	0.08501515586668541	0.36833682127458656	0	0	1.3232245525953519	3.2616502516484553	CDKN1C;RERE;FOXC1;LDB1;NUMA1;PRDM2;PIK3R1;RNPC3;FHIT;HDAC6;AKAP13;IL1RL1;HPGDS;ATXN1;NSD1;IDS;MEF2C;GSN;NR1H2;HGF;EBF1;BRAF;IL16;ARHGAP24;MTOR;HIPK2;SLC25A16;AIMP2;SON;HOXD3;CD22;ANGPTL1;PAFAH1B1
Klinefelter Syndrome	3/78	0.08570917804931497	0.36833682127458656	0	0	2.989961977186312	7.345724724151839	BBS1;SLC10A7;PMP22
Tetralogy of Fallot	4/125	0.08574282058949605	0.36833682127458656	0	0	2.474670367800139	6.078787520830289	ATXN2;FOXC1;BRAF;ARID1B
Thin upper lip vermilion	4/125	0.08574282058949605	0.36833682127458656	0	0	2.474670367800139	6.078787520830289	SON;NFIA;ARID1B;MTOR
Peripheral Arterial Diseases	4/125	0.08574282058949605	0.36833682127458656	0	0	2.474670367800139	6.078787520830289	VIT;CNOT4;ATXN2;HGF
Drug abuse	6/229	0.08606222028683044	0.36833682127458656	0	0	2.01907554329079	4.952155799407688	MAOA;ADH1B;INSR;IL16;FHIT;FKBP5
Pancreatic Ductal Adenocarcinoma	14/701	0.08612443705304293	0.36833682127458656	0	0	1.5402717127607957	3.776687841926259	RERE;FOXC1;IGFBP5;NR1H2;HGF;BRAF;PIK3R1;ACACB;FHIT;MTOR;GHR;AIMP2;DLC1;CPEB4
Carcinoma, Transitional Cell	9/399	0.08646980659151744	0.36833682127458656	0	0	1.7369649805447471	4.252020763766951	HPGDS;GSN;IGFBP5;NUMA1;PRRC2C;PIK3R1;FHIT;DCN;MTOR
X-linked Adrenal Hypoplasia	2/37	0.08663764871884673	0.36833682127458656	0	0	4.263852813852814	10.429472735527005	CDKN1C;PMP22
Brittle hair	2/37	0.08663764871884673	0.36833682127458656	0	0	4.263852813852814	10.429472735527005	NR1H2;BRAF
Increased calcium level in kidney	2/37	0.08663764871884673	0.36833682127458656	0	0	4.263852813852814	10.429472735527005	CDKN1C;NSD1
Malignant neoplasm of oropharynx	2/37	0.08663764871884673	0.36833682127458656	0	0	4.263852813852814	10.429472735527005	ADH1B;ARHGAP24
Carcinoma of larynx	5/177	0.0879652916188209	0.36833682127458656	0	0	2.1787846386884078	5.2962179274646095	HPGDS;ADH1B;INSR;NR1H2;OGT
Conduction disorder of the heart	3/79	0.08825867690628736	0.36833682127458656	0	0	2.9504702821693014	7.16221723714365	SGCD;LAMA4;ABCC9
Reduced systolic function	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	SGCD
Ceroid Lipofuscinosis, Neuronal, Parry Type	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	ATP13A2
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	COG1
Ruddy face	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	USP8
Histiocytosis, Non-Langerhans-Cell	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	BRAF
Short sternum	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	ARID1B
Soluble Transferrin Receptor Measurement	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	SIK3
Southeast Asian ovalocytosis	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	GYPC
Spinocerebellar Ataxia 10	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	ATXN2
Myoclonus, Eyelid	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	MECP2
SPLIT-HAND/FOOT MALFORMATION 4	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	CDKN1C
Reflex, Corneal, Decreased	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	PMP22
Thick rib	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	GNS
Torre-Muir syndrome	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	FHIT
Transitional cell carcinoma in situ	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	CEACAM1
Abnormal isoelectric focusing of serum transferrin	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	COG1
Abnormality of oral mucosa	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	SAA1
Unilateral Hypotonia	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	MECP2
Acral Lentiginous Malignant Melanoma	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	BRAF
Viral gastroenteritis due to Rotavirus	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	HPGDS
ACTIVATED PI3K-DELTA SYNDROME	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	PIK3R1
Vitreous Hemorrhage	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	FZD4
Acute glomerulonephritis	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	DCN
Weaver syndrome	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	NSD1
Acute peritonitis	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	COL3A1
Adamantinous Craniopharyngioma	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	BRAF
Adult Angiosarcoma	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	BRAF
Anus Neoplasms	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	FHIT
Arthrogryposis renal dysfunction cholestasis syndrome	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	VPS39
asthma with copd	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	FAM13A
Baby eczema	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	BRAF
Borderline mental retardation (I.Q. 70-85)	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	MAOA
Broad eyebrow	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	RERE
Chromosome 2q37 deletion syndrome	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	HDAC4
Chronic nasopharyngitis	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	DLC1
Cohen syndrome	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	BBS1
Composite Lymphoma	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	FOXP1
Congenital melanocytic nevus	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	BRAF
Deficiency of acetyl-CoA acetyltransferase	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	ACAA2
Ehlers-Danlos syndrome type 1	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	COL3A1
Elephantiasis	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	HGF
Excessive sputum secretion	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	COL3A1
Facial erythema	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	USP8
Fenestration (morphologic abnormality)	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	MEF2C
Fetus or newborn affected by alcohol transmitted via placenta or breast milk	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	ADH1B
Fibrosis of bile duct	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	HGF
Floppy Muscles	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	MECP2
Foot acroosteolysis	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	COL3A1
Generalized amyloid deposition	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	GSN
Hypertrophic nerve changes	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	PMP22
Hypoplastic sternum	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	ARID1B
Immunoglobulin deficiency	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	RAI2
impaired motor coordination	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	ATP13A2
Lupus-like syndrome	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	RNPC3
Mild depression	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	MTOR
Molluscoid pseudotumors	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	COL3A1
MPS III C	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	GNS
Mucopolysaccharidosis III	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	GNS
Muscle Tone Atonic	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	MECP2
Myxoinflammatory fibroblastic sarcoma	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	TGFBR3
Nance-Horan syndrome	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	RAI2
Narrow foramen obturatorium	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	KIAA0319L
Neuropathy ataxia and retinis pigmentosa	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	ATP11A
Overriding aorta	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	MEF2C
Pancreatic Pseudocyst	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	ADH1B
Paraneoplastic Encephalomyelitis	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	RBM5
Parkinsonism with favorable response to dopaminergic medication	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	ATP13A2
PAROXYSMAL EXTREME PAIN DISORDER	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	IDS
POLYCYSTIC LIVER DISEASE 1	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	HDAC6
Pupillary abnormality	1/7	0.08947915236317884	0.36833682127458656	0	0	12.407547169811322	29.948712208251436	PIK3R1
Renal glomerular disease	4/127	0.08963520327213288	0.36833682127458656	0	0	2.4341835784770063	5.871268177446544	CDKN1C;DCN;MTOR;PAFAH1B1
Gastritis, Atrophic	4/127	0.08963520327213288	0.36833682127458656	0	0	2.4341835784770063	5.871268177446544	HPGD;NR1H2;MGST1;FHIT
Interstitial lung fibrosis	4/127	0.08963520327213288	0.36833682127458656	0	0	2.4341835784770063	5.871268177446544	NPR1;HGF;DCN;MTOR
Spastic gait	2/38	0.090677216520654	0.36833682127458656	0	0	4.14520202020202	9.950346663649716	MECP2;TTC19
End Stage Liver Disease	2/38	0.090677216520654	0.36833682127458656	0	0	4.14520202020202	9.950346663649716	GHR;MAOA
Keratosis	2/38	0.090677216520654	0.36833682127458656	0	0	4.14520202020202	9.950346663649716	HPGDS;BRAF
Pituitary dwarfism	2/38	0.090677216520654	0.36833682127458656	0	0	4.14520202020202	9.950346663649716	GHR;RNPC3
Prominent back of the head	2/38	0.090677216520654	0.36833682127458656	0	0	4.14520202020202	9.950346663649716	CDKN1C;NSD1
Prominent occiput	2/38	0.090677216520654	0.36833682127458656	0	0	4.14520202020202	9.950346663649716	CDKN1C;NSD1
Desmoplastic	3/80	0.09083986350634335	0.36833682127458656	0	0	2.9120043454644216	6.984899794573199	GHR;HGF;BRAF
Paroxysmal kinesigenic choreoathetosis	3/80	0.09083986350634335	0.36833682127458656	0	0	2.9120043454644216	6.984899794573199	AIMP2;GSN;MTOR
Amyloidosis	16/833	0.09086765734818777	0.36833682127458656	0	0	1.4818702570379436	3.55404522898672	GSN;MAOB;SORT1;INSR;NR1H2;SYVN1;HOOK3;DCN;HDAC6;MECP2;AIMP2;ATXN1;NFIA;NFIC;SAA1;FKBP5
Scleroderma	5/179	0.0912125895551389	0.36833682127458656	0	0	2.1535209406790856	5.156740160311496	AIMP2;COL3A1;HGF;IL16;CSAD
Colon Carcinoma	35/2091	0.09150880671990584	0.36833682127458656	0	0	1.302765004126872	3.1153280917783674	CDKN1C;HPGD;PRDM2;PIK3R1;FSTL1;FHIT;HDAC6;GHR;ADAMTS15;HPGDS;CLEC3B;CALD1;MAP2K5;SASH1;GSN;IGFBP5;STAT2;NR1H2;HGF;BRAF;PDGFRL;ARHGAP24;DCN;MTOR;HIPK2;TGFBR3;AIMP2;CEACAM1;DLC1;SAA1;PMP22;UTS2;ULK1;SRSF5;MPHOSPH8
Promyelocytic leukemia	6/233	0.09164521500894773	0.36833682127458656	0	0	1.9830904778041343	4.73925013876334	AIMP2;HPGDS;HMBOX1;HOXD3;MTOR;HIPK2
Penile hypospadias	5/180	0.09285924496246466	0.36833682127458656	0	0	2.1411056376573616	5.088702450845536	RERE;CDKN1C;MECP2;PEX6;ARID1B
Epstein-Barr Virus Infections	6/234	0.09307104511368608	0.36833682127458656	0	0	1.9742914979757085	4.687742237602591	AIMP2;HPGDS;PIK3R1;FHIT;ARHGAP24;DCN
Connective Tissue Diseases	3/81	0.09345228174532143	0.36833682127458656	0	0	2.8745247148288975	6.813498374307926	COL3A1;RNPC3;CD22
Insulin Resistance	3/81	0.09345228174532143	0.36833682127458656	0	0	2.8745247148288975	6.813498374307926	INSR;PIK3R1;ACACB
Malignant neoplasm of larynx	4/129	0.09361125902520641	0.36833682127458656	0	0	2.3949923664122137	5.672789969583208	HPGDS;ADH1B;NR1H2;OGT
cervical cancer	18/965	0.09385428977579846	0.36833682127458656	0	0	1.4398865687910891	3.4067886241445393	GSN;URGCP;FZD4;NR1H2;HGF;BRAF;IL16;ACACB;FHIT;ARHGAP24;HDAC6;MTOR;ST7L;HPGDS;HMBOX1;ATXN1;XPNPEP2;CRNDE
Hepatoblastoma	6/235	0.09450884218262577	0.36833682127458656	0	0	1.965569365132684	4.636899763332221	CDKN1C;IL1RL1;INSR;NSD1;HGF;CRNDE
Microcephaly	6/235	0.09450884218262577	0.36833682127458656	0	0	1.965569365132684	4.636899763332221	MECP2;FZD4;PEX6;PIK3R1;PTPN23;PAFAH1B1
Sense of smell impaired	2/39	0.09477109436688844	0.36833682127458656	0	0	4.032964782964783	9.502837927577062	SEMA3A;ATP13A2
Sialorrhea	2/39	0.09477109436688844	0.36833682127458656	0	0	4.032964782964783	9.502837927577062	MECP2;GNS
Obesity, Abdominal	2/39	0.09477109436688844	0.36833682127458656	0	0	4.032964782964783	9.502837927577062	GHR;USP8
Alcohol consumption	2/39	0.09477109436688844	0.36833682127458656	0	0	4.032964782964783	9.502837927577062	SGCD;ADH1B
Anosmia	2/39	0.09477109436688844	0.36833682127458656	0	0	4.032964782964783	9.502837927577062	SEMA3A;ATP13A2
Drooling	2/39	0.09477109436688844	0.36833682127458656	0	0	4.032964782964783	9.502837927577062	MECP2;GNS
Neuronal Ceroid-Lipofuscinoses	2/39	0.09477109436688844	0.36833682127458656	0	0	4.032964782964783	9.502837927577062	CALD1;ATP13A2
Hepatocarcinogenesis	11/527	0.09489266723419999	0.36833682127458656	0	0	1.6066119471044231	3.7835853454237753	HDAC4;CEACAM1;HPGDS;URGCP;HPGD;DLC1;HGF;LAMA4;ARHGAP24;DCN;MTOR
Tauopathies	4/130	0.09563027355005745	0.36833682127458656	0	0	2.375863322428208	5.576782817530099	AIMP2;OGT;HDAC6;FKBP5
Salivary Gland Neoplasms	3/82	0.09609547101947209	0.36833682127458656	0	0	2.8379939356018675	6.647754149502204	SON;HGF;BRAF
Cerebellar Dysmetria	3/82	0.09609547101947209	0.36833682127458656	0	0	2.8379939356018675	6.647754149502204	ATXN2;ATXN1;TTC19
Nephrotic Syndrome	5/182	0.09619822686963393	0.36833682127458656	0	0	2.1166958893434638	4.9559139679325375	GSN;SAA1;BRAF;WASL;FKBP5
Primary Myelofibrosis	5/182	0.09619822686963393	0.36833682127458656	0	0	2.1166958893434638	4.9559139679325375	HPGD;HDAC6;MTOR;FKBP5;PAFAH1B1
Epileptic encephalopathy	10/468	0.09629426883189776	0.36833682127458656	0	0	1.6440365720524017	3.8476151972203922	MECP2;MEF2C;NSD1;MBOAT7;ROGDI;BRAF;PTPN23;ARID1B;MTOR;PAFAH1B1
Lymphoma, Large-Cell, Follicular	3/83	0.09876896657711075	0.36833682127458656	0	0	2.8023764258555133	6.48742247461567	AIMP2;HPGDS;EBF1
Bulbous nasal tip	3/83	0.09876896657711075	0.36833682127458656	0	0	2.8023764258555133	6.48742247461567	ABCC9;BRAF;ARID1B
Bulbous nose	3/83	0.09876896657711075	0.36833682127458656	0	0	2.8023764258555133	6.48742247461567	ABCC9;BRAF;ARID1B
Potato nose	3/83	0.09876896657711075	0.36833682127458656	0	0	2.8023764258555133	6.48742247461567	ABCC9;BRAF;ARID1B
Abnormal coordination	2/40	0.09891713642860518	0.36833682127458656	0	0	3.926634768740032	9.084162674523707	TTC19;MAP2K5
Adrenal cortical hypofunction	2/40	0.09891713642860518	0.36833682127458656	0	0	3.926634768740032	9.084162674523707	CDKN1C;PEX6
Congenital omphalocele	2/40	0.09891713642860518	0.36833682127458656	0	0	3.926634768740032	9.084162674523707	CDKN1C;NSD1
Hypokalemia	2/40	0.09891713642860518	0.36833682127458656	0	0	3.926634768740032	9.084162674523707	USP8;COL3A1
Islet Cell Tumor	2/40	0.09891713642860518	0.36833682127458656	0	0	3.926634768740032	9.084162674523707	SEMA3A;MTOR
Psychiatric symptom	2/40	0.09891713642860518	0.36833682127458656	0	0	3.926634768740032	9.084162674523707	MAOA;FKBP5
Ulcer	5/184	0.09959762273106798	0.36833682127458656	0	0	2.092831610265631	4.827360934459743	EGFL7;NPR1;HGF;BRAF;FOXP1
Muscle Spasticity	8/353	0.10021504072402715	0.36833682127458656	0	0	1.7426356589147287	4.008823537824459	MECP2;ATXN2;ATXN1;SGCD;NSD1;PEX6;ROGDI;ATP13A2
Cervix carcinoma	20/1105	0.10081693344239229	0.36833682127458656	0	0	1.3973998726162378	3.206262666197658	GSN;URGCP;IGFBP5;FZD4;NR1H2;HGF;VWA5A;BRAF;IL16;ACACB;FHIT;ARHGAP24;HDAC6;MTOR;ST7L;HPGDS;HMBOX1;ATXN1;XPNPEP2;CRNDE
Adrenocortical carcinoma	5/185	0.10131978771009674	0.36833682127458656	0	0	2.0810983397190292	4.764619601847447	CDKN1C;AIMP2;NSD1;UTS2;BRAF
Hypersensitivity	5/185	0.10131978771009674	0.36833682127458656	0	0	2.0810983397190292	4.764619601847447	RERE;IL1RL1;ATXN2;IL16;ARID1B
Skin Ulcer	3/84	0.10147229981807977	0.36833682127458656	0	0	2.7676383607942543	6.332271951563625	HGF;KIAA0319L;OGT
Soft Tissue Neoplasms	3/84	0.10147229981807977	0.36833682127458656	0	0	2.7676383607942543	6.332271951563625	HGF;CREB3L2;FOXP1
Amyloidosis, Primary Cutaneous	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	GSN
Anticipation, Genetic	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	ATXN2
AXENFELD-RIEGER SYNDROME, TYPE 3	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	FOXC1
Charcot-Marie-Tooth disease, X-linked, 1	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	PMP22
Ritual compulsion	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	MAOA
Dementia, familial British	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	GSN
Ehlers-Danlos Syndrome, Type IV	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	COL3A1
Serrated adenocarcinoma	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	BRAF
Severe failure to thrive	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	INSR
Hypergonadotropic Ovarian Failure, X-Linked	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	XPNPEP2
Simple Endometrial Hyperplasia	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	CDKN1C
Skin nodule	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	BRAF
Spinal Cord Ischemia	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	HGF
Myelodysplastic syndrome, no ICD-O subtype	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	PAFAH1B1
Sprains and Strains	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	MTOR
Squamous cell carcinoma of lip	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	BRAF
Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	HDAC4
PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	HDAC4
Pulmonary Hypertension, Primary, Fenfluramine-Associated	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	HDAC4
Testicular dysgenesis syndrome	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	TGFBR3
Thick upper lip vermilion	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	ABCC9
Tubular adenoma	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	BRAF
Abnormality of nail color	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	PEX6
Abnormality of the antitragus	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	MECP2
Abnormality of the elbow	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	GHR
Ureterocele	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	PEX6
Absence of scalp hair	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	COL3A1
Very Low Birth Weight	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	GHR
Wernicke-Korsakoff Syndrome	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	ADH1B
Alcohol Related Birth Defect	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	ADH1B
Amyloid Neuropathies	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	GSN
Anterior synechiae	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	FOXC1
Aplasia/Hypoplasia involving the nose	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	GHR
Aplasia/Hypoplasia of the distal phalanx of the 5th finger	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	ARID1B
Breast size	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	TBX15
cardiac symptom	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	SGCD
Cerebellar vermis atrophy	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	SYN3
Cerebral cortex myoclonus	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	MECP2
Choroidal and/or chorioretinal disorder	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	FZD4
Chromosome 1p36 Deletion Syndrome	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	RERE
Complex Endometrial Hyperplasia	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	CDKN1C
Congenital anomaly of anterior segment of eye	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	FOXC1
Congenital hypoplasia of nose	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	GHR
Dental White Spot	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	AIMP2
Dermal translucency	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	COL3A1
Developmental Psychomotor Disorders	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	MECP2
Drooping upper lip	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	EDA2R
EARLY REPOLARIZATION ASSOCIATED WITH VENTRICULAR FIBRILLATION	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	ABCC9
Endometrial Stromal Tumors	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	PHF1
Erdheim-Chester Disease	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	BRAF
Esophageal dysplasia	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	ADH1B
Everted upper lip vermilion	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	EDA2R
Expressive language delay	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	NSD1
Exudative vitreoretinopathy 1	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	FZD4
Familial Nonmedullary Thyroid Gland Carcinoma	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	BRAF
Familial renal cell carcinoma	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	FHIT
Flexion contracture - wrist	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	TBX15
Glaucoma of childhood	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	FOXC1
Gonadotropin-Resistant Ovary Syndrome	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	XPNPEP2
Hereditary Clear Cell Renal Cell Carcinoma	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	FHIT
Hereditary Renal Cell Carcinoma	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	FHIT
Hypoplastic fifth fingernail	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	ARID1B
Hypotrophic nose	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	GHR
Impulsive aggression	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	MAOA
Infantile fibrosarcoma	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	BRAF
Intramucosal Adenocarcinoma	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	BRAF
Klippel-Trenaunay-Weber Syndrome	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	ROGDI
Krukenberg Tumor	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	FHIT
KUFOR-RAKEB SYNDROME	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	ATP13A2
Leukonychia	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	PEX6
Loss of scalp hair	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	COL3A1
Lubs X-linked mental retardation syndrome	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	MECP2
Macrocytosis	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	ADH1B
Motor deterioration	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	MECP2
Motor disturbances	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	MAOB
Mowat-Wilson syndrome	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	MEF2C
Neonatal disorder	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	FKBP5
Neonatal encephalopathy	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	MECP2
Non-small cell lung cancer stage II	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	FHIT
Optic nerve dysplasia	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	BRAF
Panniculitis	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	BRAF
Pharyngeal Neoplasms	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	ADH1B
Polysyndactyly	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	FZD4
Premenstrual Dysphoric Disorder	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	MAOA
Progressive spasticity	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	MECP2
Protruding upper lip	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	EDA2R
Psychomotor Disorders	1/8	0.10159329899237998	0.36833682127458656	0	0	10.634501347708895	24.318740541198824	MECP2
Sarcoma	13/658	0.10181378981720184	0.36878129446288394	0	0	1.5207096240463278	3.4742279946981163	MEF2A;CDKN1C;HDAC4;PHF1;NR1H2;HGF;BRAF;MTOR;FOXP1;TGFBR3;SLC25A16;ATXN2;CREB3L2
Adenocarcinoma of large intestine	7/297	0.10257760652073956	0.36993103805818356	0	0	1.8121155638397017	4.126432916277109	INSR;DLC1;BRAF;PIK3R1;FHIT;PDGFRL;FKBP5
Eosinophilia	5/186	0.10305682624125984	0.36993103805818356	0	0	2.069494718570733	4.702874455563987	IL1RL1;HPGDS;NUMA1;GOLGB1;FKBP5
Anemia, Macrocytic	2/41	0.103113243950383	0.36993103805818356	0	0	3.8257575757575757	8.691843610876065	ADH1B;PAFAH1B1
Unable to walk	2/41	0.103113243950383	0.36993103805818356	0	0	3.8257575757575757	8.691843610876065	MEF2C;MBOAT7
Breaking out	2/41	0.103113243950383	0.36993103805818356	0	0	3.8257575757575757	8.691843610876065	USP8;HPGD
Choreatic disease	2/41	0.103113243950383	0.36993103805818356	0	0	3.8257575757575757	8.691843610876065	MECP2;ATXN1
Growth Hormone-Secreting Pituitary Adenoma	2/41	0.103113243950383	0.36993103805818356	0	0	3.8257575757575757	8.691843610876065	GHR;MTOR
Laryngeal neoplasm	2/41	0.103113243950383	0.36993103805818356	0	0	3.8257575757575757	8.691843610876065	ADH1B;MGST1
Lytic lesion	2/41	0.103113243950383	0.36993103805818356	0	0	3.8257575757575757	8.691843610876065	HPGD;BRAF
Malignant Meningioma	2/41	0.103113243950383	0.36993103805818356	0	0	3.8257575757575757	8.691843610876065	PRKCI;PRDM2
Down Syndrome	10/475	0.10349942760189823	0.3709632195778788	0	0	1.6186995967741935	3.671516938119547	CDKN1C;MECP2;GHR;HPGDS;GSN;NFIA;MAOA;NFIC;ARHGAP24;MTOR
Diabetes Mellitus	26/1507	0.1038828208244262	0.37198344681141965	0	0	1.3351845599819943	3.02351440466716	CDKN1C;MAOA;ADH1B;SEMA3A;PIK3R1;ACACB;GHR;HPGDS;MEF2A;BBS1;USP8;IGFBP5;SORT1;INSR;HGF;EBF2;ATP2B1;DCN;MTOR;AIMP2;PEX6;SIK3;PMP22;UTS2;OGT;FKBP5
Malformations of Cortical Development, Group II	3/85	0.10420499864086306	0.3720760472797452	0	0	2.7337475656125383	6.182083566059002	PEX6;KIAA0319L;PAFAH1B1
Downturned corners of mouth	3/85	0.10420499864086306	0.3720760472797452	0	0	2.7337475656125383	6.182083566059002	HDAC4;MEF2C;PIK3R1
Hyperopia	3/85	0.10420499864086306	0.3720760472797452	0	0	2.7337475656125383	6.182083566059002	SON;HGF;NSD1
Childhood Glioblastoma	5/187	0.10480865746235711	0.3725880314141629	0	0	2.0580186097427475	4.642105675020281	HDAC4;STAT2;BRAF;FSTL1;HDAC6
Epilepsy	21/1177	0.1051167724801828	0.3725880314141629	0	0	1.377508650519031	3.103090908829365	MEF2A;RERE;HDAC4;MEF2C;INSR;NR1H2;ROGDI;BRAF;WASL;GNS;ARID1B;MTOR;MECP2;TGFBR3;COL3A1;NFIA;NSD1;PEX6;STT3A;IDS;PAFAH1B1
Adenocarcinoma Of Esophagus	7/299	0.10528482344134846	0.3725880314141629	0	0	1.7995186967789707	4.05087133982487	NR1H2;HGF;FHIT;ARHGAP24;MTOR;FOXP1;FKBP5
Metastatic melanoma	9/417	0.10592195653198823	0.3725880314141629	0	0	1.6587891966124972	3.724069189756386	IGSF8;PRKCI;RAB5B;HGF;VWA5A;BRAF;TM9SF4;ARHGAP24;MTOR
Dystonia Disorders	4/135	0.10602861593058668	0.3725880314141629	0	0	2.284598799603753	5.126745391151838	ATXN2;ATXN1;GSN;PAFAH1B1
Motor Neuron Disease	4/135	0.10602861593058668	0.3725880314141629	0	0	2.284598799603753	5.126745391151838	ATXN2;SEMA3A;VPS54;HDAC6
Malignant Peripheral Nerve Sheath Tumor	5/188	0.10657519852644404	0.3725880314141629	0	0	2.0466679228691667	4.582293927442241	HGF;PMP22;BRAF;PDGFRL;MTOR
Muscular hypotonia of the trunk	3/86	0.10696658776305248	0.3725880314141629	0	0	2.7006734160978514	6.036649890151567	MECP2;MBOAT7;PAFAH1B1
Arrhythmogenic Right Ventricular Dysplasia	2/42	0.10735736440672582	0.3725880314141629	0	0	3.7299242424242425	8.323669678801366	MEF2C;SYN3
Defective tooth enamel	2/42	0.10735736440672582	0.3725880314141629	0	0	3.7299242424242425	8.323669678801366	PEX6;PIK3R1
Dystrophic tooth enamel	2/42	0.10735736440672582	0.3725880314141629	0	0	3.7299242424242425	8.323669678801366	PEX6;PIK3R1
Epiretinal Membrane	2/42	0.10735736440672582	0.3725880314141629	0	0	3.7299242424242425	8.323669678801366	MECP2;HGF
Hyperextensible skin	2/42	0.10735736440672582	0.3725880314141629	0	0	3.7299242424242425	8.323669678801366	COL3A1;BRAF
Postnatal microcephaly	2/42	0.10735736440672582	0.3725880314141629	0	0	3.7299242424242425	8.323669678801366	MECP2;PAFAH1B1
Hyperreflexia	7/301	0.10803041252358217	0.3725880314141629	0	0	1.7870932156646442	3.9768944736621115	MECP2;DSTYK;ATXN1;NSD1;PEX6;PMP22;ATP13A2
Poor school performance	18/985	0.10807515633550054	0.3725880314141629	0	0	1.4086049304466757	3.1340451167833816	RERE;HDAC4;BBS1;CEP104;MAOA;BRAF;GNS;ARID1B;MTOR;FOXP1;MECP2;COL3A1;SON;NFIA;NSD1;PEX6;STT3A;PAFAH1B1
Amyotrophic Lateral Sclerosis, Sporadic	4/136	0.10816773290505559	0.3725880314141629	0	0	2.267175572519084	5.042362104840698	ATXN2;ATXN1;HGF;VPS54
Adult Glioblastoma	5/189	0.10835636468210393	0.3725880314141629	0	0	2.03544061302682	4.523420352545295	HDAC4;STAT2;IL16;FSTL1;HDAC6
Dysmorphic facies	3/87	0.109756589005866	0.3725880314141629	0	0	2.6683867463335145	5.895774345364743	GHR;TBX15;INSR
Hemangiosarcoma	3/87	0.109756589005866	0.3725880314141629	0	0	2.6683867463335145	5.895774345364743	HGF;BRAF;MTOR
Cerebellar atrophy	5/190	0.11015206922153745	0.3725880314141629	0	0	2.0243346795070933	4.465466550256612	ATXN2;ATXN1;STT3A;ATP13A2;TTC19
Malignant neoplasm of kidney	9/421	0.1105567113505307	0.3725880314141629	0	0	1.6423444524196291	3.6168147458843323	HPGDS;HGF;SYVN1;BRAF;PIK3R1;RCHY1;FHIT;ARHGAP24;MTOR
Transient Cerebral Ischemia	2/43	0.11164749063359239	0.3725880314141629	0	0	3.6387657058388765	7.977661868166088	TGFBR3;COL3A1
Flushing	2/43	0.11164749063359239	0.3725880314141629	0	0	3.6387657058388765	7.977661868166088	HPGDS;ADH1B
Gemistocytic astrocytoma	2/43	0.11164749063359239	0.3725880314141629	0	0	3.6387657058388765	7.977661868166088	HGF;BRAF
Spontaneous abortion	4/138	0.11250398314566325	0.3725880314141629	0	0	2.233109262846075	4.878822648241307	CEACAM1;ECM2;LAMA4;IL16
Alcohol Use Disorder	3/88	0.11257452159089079	0.3725880314141629	0	0	2.6368597629165733	5.7592705199973615	PRKCI;ADH1B;PIK3R1
Recurrent hypoglycemia	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	INSR
Renal medullary carcinoma	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	MTOR
Rhegmatogenous retinal detachment	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	FZD4
Clinically Isolated Syndrome, CNS Demyelinating	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	PMP22
Saddle nose	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	FOXC1
Dementia, familial Danish	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	GSN
Sclerosing Epithelioid Fibrosarcoma	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	CREB3L2
Secondary Adrenal Insufficiency	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	BRAF
Early Childhood Epilepsy, Myoclonic	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	PMP22
Gait, Scissors	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	TTC19
Severe major depression with psychotic features	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	MAOA
Skin Wrinkling	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	PIK3R1
Snoring	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	GSN
Peroxisome Biogenesis Disorder, Complementation Group C	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	PEX6
Subcortical Band Heterotopia	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	PAFAH1B1
Polyposis, Gastric	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	HPGD
Supranuclear gaze palsy	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	ATP13A2
Symptomatic Myoclonic Epilepsy	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	PMP22
RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	FZD4
Talipes Calcaneovalgus	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	PMP22
SHORT STATURE, IDIOPATHIC, X-LINKED	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	GHR
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 (disorder)	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	BRAF
Thin eyebrow	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	PEX6
Ventricular tachycardia, polymorphic	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	ATXN2
Ulnar claw	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	PMP22
Abnormality of the knee	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	HPGD
von Willebrand's factor (lab test)	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	SCARA5
Acute inflammatory demyelinating polyneuropathy	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	PMP22
Adult Soft Tissue Sarcoma	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	FOXP1
AL-RAQAD SYNDROME	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	FOXC1
Asthenia	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	MTOR
Attention deficit-hyperactivity	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	LMO3
Axonal degeneration	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	TTC19
Benign Infantile Myoclonic Epilepsy	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	PMP22
Birth length less than 3rd percentile	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	PIK3R1
Blushing	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	USP8
Bone Sarcoma	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	FOXP1
Butterfly vertebrae	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	COG1
Central hypoventilation	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	MECP2
Colorectal cancer recurrent	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	BRAF
Congenital hypomyelinating neuropathy	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	PMP22
Congenital lactic acidosis	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	OGDH
Demyelination	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	PMP22
Dilatation of the cerebral artery	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	COL3A1
Dysembryoplastic neuroepithelial tumor	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	BRAF
Dysglycemia	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	INSR
Endometrial Diseases	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	CALD1
Factor XII Deficiency	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	BRAF
Familial Colorectal Cancer Type X	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	BRAF
Female Pseudohermaphroditism	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	INSR
Fibular aplasia	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	TBX15
heroin abuse	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	HPGDS
High weight	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	BRAF
Histiocytic syndrome	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	BRAF
Horizontal eyebrow	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	RERE
Hypopharyngeal Cancer	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	HGF
Hypoplastic pubic bone	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	TBX15
Idiopathic Myoclonic Epilepsy	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	PMP22
Inherited Peripheral Neuropathy	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	PMP22
LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	GHR
Malignant epithelioma	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	HPGD
Megalencephaly cutis marmorata telangiectatica congenita	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	MTOR
Oropharyngeal Neoplasms	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	BRAF
Ovarian Teratoma	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	BRAF
Peripheral Nervous System Neoplasms	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	HGF
Psychomotor Impairment	1/9	0.11354687020532493	0.3725880314141629	0	0	9.304716981132076	20.242780016871993	MECP2
Myocardial Diseases, Secondary	3/89	0.11541990243061037	0.37384264626547886	0	0	2.6060659651604916	5.626961536513599	SGCD;HGF;UTS2
Hypotension	3/89	0.11541990243061037	0.37384264626547886	0	0	2.6060659651604916	5.626961536513599	MAOB;MAOA;SAA1
Nasopharyngeal Neoplasms	3/89	0.11541990243061037	0.37384264626547886	0	0	2.6060659651604916	5.626961536513599	ADH1B;HGF;LSP1
Cerebellar degeneration	5/193	0.11562551866662048	0.37384264626547886	0	0	1.991725768321513	4.2969463789708024	ATXN2;ATXN1;STT3A;ATP13A2;TTC19
Arthritis, Adjuvant-Induced	2/44	0.11598165998532645	0.37384264626547886	0	0	3.551948051948052	7.652044107537512	IL1RL1;SAA1
Arthritis, Collagen-Induced	2/44	0.11598165998532645	0.37384264626547886	0	0	3.551948051948052	7.652044107537512	IL1RL1;SAA1
Arthritis, Experimental	2/44	0.11598165998532645	0.37384264626547886	0	0	3.551948051948052	7.652044107537512	IL1RL1;SAA1
Ataxia, Truncal	2/44	0.11598165998532645	0.37384264626547886	0	0	3.551948051948052	7.652044107537512	MECP2;ATXN1
Liposarcoma, Myxoid	2/44	0.11598165998532645	0.37384264626547886	0	0	3.551948051948052	7.652044107537512	CREB3L2;MTOR
Amelogenesis Imperfecta	2/44	0.11598165998532645	0.37384264626547886	0	0	3.551948051948052	7.652044107537512	PEX6;ROGDI
Apraxias	2/44	0.11598165998532645	0.37384264626547886	0	0	3.551948051948052	7.652044107537512	MECP2;TTC19
HELLP Syndrome	2/44	0.11598165998532645	0.37384264626547886	0	0	3.551948051948052	7.652044107537512	CDKN1C;HPGDS
Mitochondrial Encephalomyopathies	2/44	0.11598165998532645	0.37384264626547886	0	0	3.551948051948052	7.652044107537512	RERE;TTC19
Mixed anxiety and depressive disorder	2/44	0.11598165998532645	0.37384264626547886	0	0	3.551948051948052	7.652044107537512	GSN;MAOA
Neoplasm of uncertain or unknown behavior of breast	2/44	0.11598165998532645	0.37384264626547886	0	0	3.551948051948052	7.652044107537512	BRAF;ARID1B
Malignant neoplasm of skin	7/307	0.11649513097934648	0.37384264626547886	0	0	1.750810810810811	3.7640783186480347	AIMP2;HPGDS;STAT2;NR1H2;PMP22;BRAF;SASH1
Substance Dependence	4/140	0.11691634774478075	0.37384264626547886	0	0	2.200044903457566	4.721948844310389	MAOA;INSR;FHIT;FKBP5
Hip circumference	3/90	0.11829224639585925	0.37384264626547886	0	0	2.5759800708011014	5.498679465203404	INSR;EBF1;ATP13A2
Parkinson Disease	19/1064	0.1183196930983264	0.37384264626547886	0	0	1.3757085020242914	2.936264151776049	MEF2C;MAOB;MAOA;INSR;PHF1;LMO3;HGF;PRDM2;SYN3;MTOR;AIMP2;HPGDS;ATXN2;DLG2;OGDH;PMP22;SLC16A7;ULK1;ATP13A2
Dystonia	6/251	0.11910826448486465	0.37384264626547886	0	0	1.8356985871271585	3.9058570289722088	MECP2;ATXN2;GSN;ATXN1;TTC19;PAFAH1B1
Pectus excavatum	4/141	0.11915059779145694	0.37384264626547886	0	0	2.1838747422967626	4.645903186251498	MECP2;COL3A1;HPGD;BRAF
Gait abnormality	5/195	0.11934550529904288	0.37384264626547886	0	0	1.9705585803589434	4.18888058834619	MECP2;RERE;CEP104;PMP22;ATP13A2
Hypospadias	5/195	0.11934550529904288	0.37384264626547886	0	0	1.9705585803589434	4.18888058834619	CDKN1C;MECP2;RERE;PEX6;ARID1B
Peripheral Neuropathy	7/309	0.11939185802071006	0.37384264626547886	0	0	1.7390370502953285	3.6960524321280857	ATXN2;GSN;INSR;PMP22;EBF2;MAP4;HDAC6
Young onset Parkinson disease	2/45	0.12035795355597584	0.37384264626547886	0	0	3.4691684284707542	7.345218380347374	MAOB;ATP13A2
Atypical Teratoid Rhabdoid Tumor	2/45	0.12035795355597584	0.37384264626547886	0	0	3.4691684284707542	7.345218380347374	INSR;BRAF
Bronchogenic Carcinoma	2/45	0.12035795355597584	0.37384264626547886	0	0	3.4691684284707542	7.345218380347374	HPGDS;ARHGAP24
Diminished sweating	2/45	0.12035795355597584	0.37384264626547886	0	0	3.4691684284707542	7.345218380347374	ROGDI;EDA2R
Endometrial Stromal Sarcoma	2/45	0.12035795355597584	0.37384264626547886	0	0	3.4691684284707542	7.345218380347374	CALD1;PHF1
Enteritis	2/45	0.12035795355597584	0.37384264626547886	0	0	3.4691684284707542	7.345218380347374	AIMP2;COL3A1
Impulsive character (finding)	2/45	0.12035795355597584	0.37384264626547886	0	0	3.4691684284707542	7.345218380347374	MAOA;LMO3
Inherited neuropathies	2/45	0.12035795355597584	0.37384264626547886	0	0	3.4691684284707542	7.345218380347374	PMP22;LRIG3
Turridolichocephaly	3/91	0.12119106662564044	0.37384264626547886	0	0	2.546577946768061	5.374264778854641	PEX6;NSD1;BRAF
Waist Circumference	3/91	0.12119106662564044	0.37384264626547886	0	0	2.546577946768061	5.374264778854641	TBX15;MAP2K5;CPEB4
Narrow cranium shape	3/91	0.12119106662564044	0.37384264626547886	0	0	2.546577946768061	5.374264778854641	PEX6;NSD1;BRAF
Narrow head shape	3/91	0.12119106662564044	0.37384264626547886	0	0	2.546577946768061	5.374264778854641	PEX6;NSD1;BRAF
Narrow skull shape	3/91	0.12119106662564044	0.37384264626547886	0	0	2.546577946768061	5.374264778854641	PEX6;NSD1;BRAF
Spinal Muscular Atrophy	5/196	0.1212265176788667	0.37384264626547886	0	0	1.9601412208380975	4.136083084940125	HDAC4;AIMP2;ATXN2;VPS54;RNPC3
Clear-cell metastatic renal cell carcinoma	4/142	0.12140330128522826	0.37384264626547886	0	0	2.16793893129771	4.571396693630436	HPGDS;INSR;FHIT;MTOR
Diabetes Mellitus, Non-Insulin-Dependent	28/1672	0.12206444385715383	0.37384264626547886	0	0	1.2945470158866466	2.7226992392897045	CDKN1C;MAOA;ADH1B;DGKB;NPR1;PIK3R1;ACACB;FHIT;HPGDS;ATXN1;SGCD;MEF2A;PRKCI;IGFBP5;SORT1;INSR;NR1H2;HGF;BRAF;DCN;MTOR;FOXP1;TGFBR3;AIMP2;COL3A1;UTS2;OGT;FKBP5
Acute leukemia	10/492	0.12226375123298931	0.37384264626547886	0	0	1.5602308091286308	3.278941551609127	HPGDS;LDB1;INSR;EBF1;IL16;FHIT;CD22;ANGPTL1;ARHGAP24;PAFAH1B1
Alzheimer Disease, Late Onset	6/253	0.12238892826954126	0.37384264626547886	0	0	1.8206477732793522	3.824364171371488	HPGDS;ATXN1;MAOB;INSR;PHF1;PIK3R1
Substance Use Disorders	4/143	0.12367426141507444	0.37384264626547886	0	0	2.1522324125432477	4.498389776413369	MAOA;INSR;FHIT;FKBP5
Cardiomyopathies, Primary	3/92	0.12411587470508552	0.37384264626547886	0	0	2.5178365446234032	5.253565848788453	SGCD;HGF;UTS2
Secondary malignant neoplasm of lymph node	22/1271	0.12433553505006052	0.37384264626547886	0	0	1.3344117917284648	2.7819435925757676	CDKN1C;PRKCI;FOXC1;GSN;IGFBP5;HPGD;VWA5A;RAB27B;BRAF;FSTL1;FHIT;ARHGAP24;MTOR;FOXP1;GHR;CEACAM1;CALD1;DLC1;PMP22;SRSF5;OGT;RBM5
Abnormal behavior	8/372	0.12456205261381385	0.37384264626547886	0	0	1.6500553709856036	3.4369849349801243	MECP2;HDAC4;MAOB;MAOA;NSD1;LMO3;PEX6;FKBP5
Dysautonomia, Familial	2/46	0.12477449531771621	0.37384264626547886	0	0	3.390151515151515	7.055743376872092	CEACAM1;MAOA
Single tumor	2/46	0.12477449531771621	0.37384264626547886	0	0	3.390151515151515	7.055743376872092	BRAF;HIPK2
Telangiectasia of the skin	2/46	0.12477449531771621	0.37384264626547886	0	0	3.390151515151515	7.055743376872092	COL3A1;KIAA0319L
Abnormality of dental enamel	2/46	0.12477449531771621	0.37384264626547886	0	0	3.390151515151515	7.055743376872092	PEX6;PIK3R1
Bilateral single transverse palmar creases	2/46	0.12477449531771621	0.37384264626547886	0	0	3.390151515151515	7.055743376872092	HDAC4;PEX6
Decreased fertility	2/46	0.12477449531771621	0.37384264626547886	0	0	3.390151515151515	7.055743376872092	SEMA3A;BRAF
Hereditary Diseases	2/46	0.12477449531771621	0.37384264626547886	0	0	3.390151515151515	7.055743376872092	MECP2;ACAA2
Hypohidrosis	2/46	0.12477449531771621	0.37384264626547886	0	0	3.390151515151515	7.055743376872092	ROGDI;EDA2R
Congenital clubfoot	5/198	0.12503008529605067	0.37384264626547886	0	0	1.9396303575328053	4.032881162299189	TBX15;COL3A1;HPGD;COG1;SHROOM4
Agammaglobulinemia, non-Bruton type	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	PIK3R1
Ambiguous genitalia, female	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	TBX15
Ambiguous genitalia, male	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	TBX15
Refractory anemia with excess blasts II	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	PAFAH1B1
Congenital secretory diarrhea, sodium type (disorder)	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	HGF
Scimitar Syndrome	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	SGCD
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	ATXN2
HEMIHYPERPLASIA, ISOLATED	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	CDKN1C
Hemiplegic migraine, familial type 1	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	CSAD
Sex hormone binding globulin measurement	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	OSBPL1A
Shield chest	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	BRAF
Hypocalciuric hypercalcemia, familial, type 1	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	ADH1B
MENTAL RETARDATION, X-LINKED, SNYDER-ROBINSON TYPE	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	CDKN1C
Spinal ataxia	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	PMP22
Stage 0 Skin Melanoma	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	BRAF
Pheochromocytoma, malignant	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	MAOB
Subacute progressive viral hepatitis	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	PDGFRL
Tubulovillous adenoma	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	BRAF
Abnormality of oral frenula	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	COL3A1
Abnormality of tibia morphology	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	HPGD
Vascular Endothelial Growth Factor Measurement	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	MEF2C
Adenosquamous cell lung cancer	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	BRAF
Adult attention deficit hyperactivity disorder	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	SYN3
Ambiguous genitalia due to virilization	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	TBX15
Amegakaryocytic thrombocytopenia	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	BRAF
Bardet-Biedl syndrome 1 (disorder)	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	BBS1
Branchio-Oto-Renal Syndrome	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	EYA2
Broad chest	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	BRAF
Bundle-Branch Block	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	BRAF
cervical cancer metastasis	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	XPNPEP2
Chronic skin ulcer	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	DCN
COLCHICINE RESISTANCE	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	FOXC1
Congenital ectopic pupil	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	FOXC1
cortex bone disorders	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	MAOA
Delinquent behavior	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	MAOA
Distemper	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	STAT2
Donohue Syndrome	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	INSR
Early-Onset Glaucoma	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	FOXC1
Epithelioid and spindle cell nevus	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	BRAF
Facial paralysis	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	HPGDS
Fasting hyperinsulinemia	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	INSR
Hemoptysis	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	COL3A1
Humoral immune defect	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	IDS
Increased size of penis	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	INSR
Insulin resistance in diabetes	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	PIK3R1
Laron Syndrome	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	GHR
Left ventricular dilatation	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	HGF
Loss of ability to walk	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	MECP2
Low-grade fibromyxoid sarcoma	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	CREB3L2
Macroorchidism	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	MECP2
Malignant melanoma of iris	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	BRAF
Melanosis	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	HGF
Melanosis coli	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	HGF
Myoclonic Absence Epilepsy	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	PMP22
Nodular thyroid disease	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	BRAF
Persistent Hyperplastic Primary Vitreous	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	FZD4
Poor wound healing	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	USP8
Primary acquired melanosis	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	BRAF
Radiohumeral synostosis of elbow	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	TBX15
Ramer Ladda syndrome	1/10	0.1253419862578444	0.37384264626547886	0	0	8.270440251572326	17.175300907975267	TBX15
Hepatomegaly	8/373	0.12592308618497347	0.3751017174000902	0	0	1.645449718594032	3.4095100108779444	CDKN1C;NSD1;NR1H2;PEX6;SAA1;IDS;BRAF;GNS
Cerebellar Hypoplasia	4/144	0.12596327913754024	0.3751017174000902	0	0	2.1367502726281353	4.426844107893419	CEP104;SON;ROGDI;PAFAH1B1
Liver Cirrhosis, Alcoholic	3/93	0.12706618098689	0.376599766937541	0	0	2.4897338403041824	5.136438473101973	COL3A1;ADH1B;MBOAT7
Small for gestational age (disorder)	3/93	0.12706618098689	0.376599766937541	0	0	2.4897338403041824	5.136438473101973	FZD4;INSR;PIK3R1
Muscular Dystrophies, Limb-Girdle	3/93	0.12706618098689	0.376599766937541	0	0	2.4897338403041824	5.136438473101973	SGCD;CALD1;SYVN1
Coughing	3/93	0.12706618098689	0.376599766937541	0	0	2.4897338403041824	5.136438473101973	FAM13A;ATP11A;PIK3R1
Intraepithelial Neoplasia	3/93	0.12706618098689	0.376599766937541	0	0	2.4897338403041824	5.136438473101973	IGFBP5;BRAF;ARHGAP24
Low Birth Weights	3/93	0.12706618098689	0.376599766937541	0	0	2.4897338403041824	5.136438473101973	FZD4;INSR;PIK3R1
Babinski Reflex	4/145	0.12827015319029714	0.3795708303753726	0	0	2.1214877375345136	4.356722577466667	MECP2;DSTYK;ATXN1;ATP13A2
Generalized osteopenia	4/145	0.12827015319029714	0.3795708303753726	0	0	2.1214877375345136	4.356722577466667	HPGD;NSD1;COG1;BRAF
Rhinovirus infection	2/47	0.12922945135798317	0.3812117018524061	0	0	3.3146464646464646	6.7823161088403605	AIMP2;EIF4G3
Colonic Polyps	2/47	0.12922945135798317	0.3812117018524061	0	0	3.3146464646464646	6.7823161088403605	BRAF;DCN
Failure to thrive in infancy	2/47	0.12922945135798317	0.3812117018524061	0	0	3.3146464646464646	6.7823161088403605	COG1;BRAF
Muscular Atrophy	2/47	0.12922945135798317	0.3812117018524061	0	0	3.3146464646464646	6.7823161088403605	GHR;MTOR
Long narrow head	3/94	0.13004149482686475	0.38300727991618416	0	0	2.4622487778381315	5.022745439372958	PEX6;NSD1;BRAF
Myelodysplasia	3/94	0.13004149482686475	0.38300727991618416	0	0	2.4622487778381315	5.022745439372958	HPGDS;FOXP1;PAFAH1B1
Cardiac Arrest	5/201	0.13083775954318877	0.38505143765561883	0	0	1.9096489170380797	3.883838620639708	HDAC4;HPGDS;ATXN2;ATXN1;SEMA3A
Agenesis	3/95	0.13304132477864147	0.385079437385579	0	0	2.435361216730038	4.912356118020232	CDKN1C;FOXC1;MTOR
Anorexia Nervosa	3/95	0.13304132477864147	0.385079437385579	0	0	2.435361216730038	4.912356118020232	MAOA;LMO3;EBF1
Congenital diaphragmatic hernia	3/95	0.13304132477864147	0.385079437385579	0	0	2.435361216730038	4.912356118020232	FOXC1;INSR;ARID1B
Fragile X Syndrome	3/95	0.13304132477864147	0.385079437385579	0	0	2.435361216730038	4.912356118020232	MECP2;MAOA;PKP4
Limb ischemia	3/95	0.13304132477864147	0.385079437385579	0	0	2.435361216730038	4.912356118020232	ATXN1;NPR1;HGF
Malignant neoplasm of lung	39/2449	0.13308920714195707	0.385079437385579	0	0	1.235008317034383	2.490685295092602	CDKN1C;HDAC4;ZNF197;HPGD;FAM13A;PRDM2;PIK3R1;WASL;LSP1;RCHY1;FSTL1;FHIT;MECP2;IL1RL1;HPGDS;NSD1;IDS;RBM5;SASH1;USP8;PRKCI;GSN;IGFBP5;INSR;NR1H2;LMO3;HGF;BRAF;IL16;ARHGAP24;MTOR;HIPK2;AIMP2;CEACAM1;DLC1;HOXD3;CD22;ANGPTL1;PAFAH1B1
Dupuytren Contracture	2/48	0.1337210291033632	0.385079437385579	0	0	3.242424242424242	6.5237560242669925	AIMP2;EBF2
Progressive cerebellar ataxia	2/48	0.1337210291033632	0.385079437385579	0	0	3.242424242424242	6.5237560242669925	ATXN2;ATXN1
Malignant Pleural Mesothelioma	6/260	0.13421695985480112	0.385079437385579	0	0	1.7698364627498486	3.5543584709195177	SLC25A16;BBS1;AIMP2;FZD4;HGF;MTOR
PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	3/96	0.13606517883762512	0.385079437385579	0	0	2.4090518827425487	4.805146082232649	ABCC9;ATP13A2;FHIT
Broad forehead	3/96	0.13606517883762512	0.385079437385579	0	0	2.4090518827425487	4.805146082232649	MEF2C;NFIA;NSD1
IMMUNE SUPPRESSION	3/96	0.13606517883762512	0.385079437385579	0	0	2.4090518827425487	4.805146082232649	PRKCI;HPGD;BRAF
Redundant neck skin	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	TBX15
Refractory Cytopenia of Childhood	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	MTOR
Arteriosclerotic cardiovascular disease, NOS	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	SORT1
Rotator cuff syndrome	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	SASH1
Sarcoglycanopathies	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	SGCD
Dendritic Cell Sarcoma, Follicular	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	BRAF
DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	INSR
Segmental peripheral demyelination/remyelination	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	PMP22
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, OF SORSBY	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	SYN3
Severe sensorineural hearing impairment	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	BRAF
Short Bowel Syndrome	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	INSR
SHORT syndrome	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	PIK3R1
INSULIN RESISTANCE, SUSCEPTIBILITY TO	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	INSR
Spontaneous pneumothorax	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	COL3A1
Nevus, Blue	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	BRAF
Parkinson Disease, Secondary Vascular	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	ATP13A2
Thin nails	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	NSD1
Abnormality of the ulna	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	BRAF
Alpers Syndrome (disorder)	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	RERE
Aplasia/Hypoplasia of the macula	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	FOXC1
Arterial aneurysm	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	COL3A1
Atherosclerotic Parkinsonism	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	ATP13A2
Communicable Diseases	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	HGF
Congenital Mesoblastic Nephroma	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	BRAF
Dimple chin	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	PIK3R1
Electrocardiogram	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	ARHGAP24
Elfin facies	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	INSR
Gastrooesophageal cancer	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	HGF
Hydranencephaly	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	TBX15
Increased circulating ACTH level	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	USP8
Isaacs syndrome	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	PMP22
Laryngeal Paralysis	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	PMP22
Lipoatrophic Diabetes Mellitus	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	INSR
Lipoblastoma	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	COL3A1
Malignant neoplasm of body of pancreas	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	MTOR
malignant neoplasm of head of pancreas	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	MTOR
Malignant neoplasm of other specified sites of pancreas	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	MTOR
Malignant neoplasm of tail of pancreas	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	MTOR
Microglossia	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	TBX15
MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	TTC19
Muscle fibrosis	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	DCN
Myoclonic Encephalopathy	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	PMP22
Myokymia	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	PMP22
Necrotizing fasciitis	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	AAK1
Obstruction of pelviureteric junction	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	DSTYK
Pili Torti	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	PEX6
Polyomavirus Infections	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	HGF
Pyogenic granuloma	1/11	0.13698073960623197	0.385079437385579	0	0	7.443018867924528	14.79608847958579	BRAF
Childhood Acute Lymphoblastic Leukemia	9/443	0.13802414736051827	0.3863340088915758	0	0	1.5573167888970576	3.08399590568761	CDKN1C;HDAC4;HPGDS;EBF1;BRAF;MAP4;FHIT;CD22;MTOR
Abnormality of vision	2/49	0.138247476502746	0.3863340088915758	0	0	3.1732753062540295	6.278991238178221	BRAF;ARID1B
Aortic coarctation	2/49	0.138247476502746	0.3863340088915758	0	0	3.1732753062540295	6.278991238178221	FOXC1;BRAF
Cardiovascular Abnormalities	2/49	0.138247476502746	0.3863340088915758	0	0	3.1732753062540295	6.278991238178221	ABCC9;PAFAH1B1
Dental Enamel Hypoplasia	2/49	0.138247476502746	0.3863340088915758	0	0	3.1732753062540295	6.278991238178221	PEX6;ROGDI
Gingival Overgrowth	2/49	0.138247476502746	0.3863340088915758	0	0	3.1732753062540295	6.278991238178221	INSR;ABCC9
Medullary carcinoma	2/49	0.138247476502746	0.3863340088915758	0	0	3.1732753062540295	6.278991238178221	HPGD;BRAF
Oral soft tissue hyperplasia	2/49	0.138247476502746	0.3863340088915758	0	0	3.1732753062540295	6.278991238178221	INSR;ABCC9
Squamous cell carcinoma of skin	5/205	0.13876787074537783	0.3872137548872876	0	0	1.871072796934866	3.6952803404681824	HPGDS;STAT2;DLC1;BRAF;ARHGAP24
Thymoma	5/205	0.13876787074537783	0.3872137548872876	0	0	1.871072796934866	3.6952803404681824	ATXN1;HGF;BRAF;FHIT;MTOR
Psychomotor regression, progressive	4/150	0.14006518169802618	0.38811130488346424	0	0	2.04831119941441	4.026257544941714	MECP2;SON;PEX6;ROGDI
Loss of developmental milestones	4/150	0.14006518169802618	0.38811130488346424	0	0	2.04831119941441	4.026257544941714	MECP2;SON;PEX6;ROGDI
Mental deterioration in childhood	4/150	0.14006518169802618	0.38811130488346424	0	0	2.04831119941441	4.026257544941714	MECP2;SON;PEX6;ROGDI
Neurodevelopmental regression	4/150	0.14006518169802618	0.38811130488346424	0	0	2.04831119941441	4.026257544941714	MECP2;SON;PEX6;ROGDI
Psychomotor regression	4/150	0.14006518169802618	0.38811130488346424	0	0	2.04831119941441	4.026257544941714	MECP2;SON;PEX6;ROGDI
Psychomotor regression beginning in infancy	4/150	0.14006518169802618	0.38811130488346424	0	0	2.04831119941441	4.026257544941714	MECP2;SON;PEX6;ROGDI
Single transverse palmar crease	2/50	0.1428070813555834	0.38811130488346424	0	0	3.1070075757575757	6.047046555927847	PEX6;ARID1B
Turcot syndrome (disorder)	2/50	0.1428070813555834	0.38811130488346424	0	0	3.1070075757575757	6.047046555927847	NR1H2;BRAF
Biparietal narrowing	2/50	0.1428070813555834	0.38811130488346424	0	0	3.1070075757575757	6.047046555927847	CEP104;BRAF
Cervical Squamous Intraepithelial Neoplasia	2/50	0.1428070813555834	0.38811130488346424	0	0	3.1070075757575757	6.047046555927847	FHIT;MAP2K5
Decreased width of the skull	2/50	0.1428070813555834	0.38811130488346424	0	0	3.1070075757575757	6.047046555927847	CEP104;BRAF
Dyspnea on exertion	2/50	0.1428070813555834	0.38811130488346424	0	0	3.1070075757575757	6.047046555927847	FAM13A;ATP11A
Erythroblastosis	2/50	0.1428070813555834	0.38811130488346424	0	0	3.1070075757575757	6.047046555927847	GSN;MTOR
Fibromyalgia	2/50	0.1428070813555834	0.38811130488346424	0	0	3.1070075757575757	6.047046555927847	MAOB;MAOA
Pointed chin	2/50	0.1428070813555834	0.38811130488346424	0	0	3.1070075757575757	6.047046555927847	RERE;NSD1
Myocardial Ischemia	9/448	0.14472056767337838	0.38811130488346424	0	0	1.53918084078601	2.975160399397801	GHR;ATXN1;ADH1B;NPR1;HGF;UTS2;ABCC9;ATP2B1;DCN
Adenoid Cystic Carcinoma	5/208	0.1448514971138736	0.38811130488346424	0	0	1.843138365135987	3.5610285098324983	SON;NSD1;ACACB;ARHGAP24;MTOR
Colorectal cancer metastatic	5/208	0.1448514971138736	0.38811130488346424	0	0	1.843138365135987	3.5610285098324983	HPGDS;EGFL7;INSR;HGF;BRAF
Leigh Disease	3/99	0.1452759623232247	0.38811130488346424	0	0	2.3334125475285172	4.501433179786766	GHR;OGDH;ATP11A
Malformations of Cortical Development	3/99	0.1452759623232247	0.38811130488346424	0	0	2.3334125475285172	4.501433179786766	PEX6;MTOR;PAFAH1B1
Palmoplantar Keratosis	3/99	0.1452759623232247	0.38811130488346424	0	0	2.3334125475285172	4.501433179786766	HPGD;BRAF;SASH1
Cerebrovascular accident	14/768	0.14594328014186153	0.38811130488346424	0	0	1.3984674329501916	2.6914026325725895	EGFL7;MAOA;ADH1B;SEMA3A;PIK3R1;ATP2B1;GHR;TGFBR3;CEACAM1;HPGDS;CALD1;GOLGB1;SIK3;IDS
Cervical Squamous Cell Carcinoma	4/153	0.14734316598131708	0.38811130488346424	0	0	2.0067626415287667	3.8429322980674576	HPGDS;HGF;FHIT;ARHGAP24
Primary Effusion Lymphoma	4/153	0.14734316598131708	0.38811130488346424	0	0	2.0067626415287667	3.8429322980674576	HGF;BRAF;IL16;FHIT
Psychomotor regression in infants	4/153	0.14734316598131708	0.38811130488346424	0	0	2.0067626415287667	3.8429322980674576	MECP2;SON;PEX6;ROGDI
Pain, Crushing	2/51	0.14739817049474432	0.38811130488346424	0	0	3.043444650587508	5.827033030901906	NPR1;HGF
Pain, Migratory	2/51	0.14739817049474432	0.38811130488346424	0	0	3.043444650587508	5.827033030901906	NPR1;HGF
Pain, Splitting	2/51	0.14739817049474432	0.38811130488346424	0	0	3.043444650587508	5.827033030901906	NPR1;HGF
Suffering, Physical	2/51	0.14739817049474432	0.38811130488346424	0	0	3.043444650587508	5.827033030901906	NPR1;HGF
Tumors of Adrenal Cortex	2/51	0.14739817049474432	0.38811130488346424	0	0	3.043444650587508	5.827033030901906	CDKN1C;GHR
Ache	2/51	0.14739817049474432	0.38811130488346424	0	0	3.043444650587508	5.827033030901906	NPR1;HGF
Adult Lymphoma	2/51	0.14739817049474432	0.38811130488346424	0	0	3.043444650587508	5.827033030901906	SYVN1;BRAF
Albinism	2/51	0.14739817049474432	0.38811130488346424	0	0	3.043444650587508	5.827033030901906	FZD4;IDS
Gingival Hyperplasia	2/51	0.14739817049474432	0.38811130488346424	0	0	3.043444650587508	5.827033030901906	INSR;ABCC9
Rabies (disorder)	2/51	0.14739817049474432	0.38811130488346424	0	0	3.043444650587508	5.827033030901906	MECP2;HDAC6
Radiating pain	2/51	0.14739817049474432	0.38811130488346424	0	0	3.043444650587508	5.827033030901906	NPR1;HGF
Childhood Neuroblastoma	3/100	0.1483909896361106	0.38811130488346424	0	0	2.3092391517384656	4.4058081544283505	ARID1B;ARHGAP24;HIPK2
Polymyositis	3/100	0.1483909896361106	0.38811130488346424	0	0	2.3092391517384656	4.4058081544283505	HPGDS;CALD1;HGF
recurrent muscle twitches (symptom)	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	PRKCI
Refractory anemia with excess blasts I	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	PAFAH1B1
Cerebral Infarction, Left Hemisphere	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	ADH1B
Cerebral Infarction, Right Hemisphere	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	ADH1B
Cirrhosis, Cryptogenic	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	HPGDS
CRANIOSYNOSTOSIS, TYPE 2	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	NR1H2
Sagittal craniosynostosis	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	IL11RA
Secondary Parkinson Disease	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	ATP13A2
Epilepsy, Myoclonic, Infantile	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	PMP22
Small adrenal gland	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	CDKN1C
Lymphoma, Lymphocytic, Intermediate	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	MTOR
Spinocerebellar Degeneration	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	ATXN1
Xeroderma pigmentosum, group G	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	NR1H2
Abdominal Neoplasms	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	FSTL1
Abdominal obesity metabolic syndrome	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	PRKCI
Abnormality of the nasolacrimal system	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	PEX6
Urologic Neoplasms	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	FHIT
Violence	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	MAOA
Vulvar Lichen Sclerosus	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	DCN
Adrenal hypoplasia	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	CDKN1C
Anterior chamber anomalies	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	FOXC1
Anterior Choroidal Artery Infarction	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	ADH1B
Aplasia/Hypoplasia of the earlobes	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	COL3A1
Bladder Diverticulum	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	COL3A1
Broad hallux phalanx	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	ABCC9
Carditis	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	DCN
Chronic Liver Failure	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	MAOA
Congenital blindness	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	FZD4
Congenital exomphalos	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	CDKN1C
Deficit in expressive language	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	NSD1
Dyssomnias	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	MAOA
Episodic ataxia type 2 (disorder)	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	ATXN1
Familial benign hypercalcemia	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	ADH1B
Female Pseudo-Turner Syndrome	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	BRAF
Flaccid Muscle Tone	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	MECP2
Generalized neonatal hypotonia	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	PEX6
Hypoglycemic seizures	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	INSR
Irido-corneal dysgenesis	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	FOXC1
Malignant neoplasm of anus	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	MTOR
MPS III B	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	GNS
Mucopolysaccharidosis II	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	IDS
Multiple lentigines	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	BRAF
Neuropil Threads	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	GSN
Nevus sebaceous	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	BRAF
Nicotine withdrawal	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	FKBP5
Onchocerciasis	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	HPGDS
Papillary Thyroid Microcarcinoma	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	BRAF
Placental dysfunction	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	CDKN1C
Poorly Differentiated Thyroid Carcinoma	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	BRAF
Posterior Choroidal Artery Infarction	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	ADH1B
Prenatal Exposure Delayed Effects	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	MAOA
Psychotic episodes	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	ATP13A2
PTEN Hamartoma Tumor Syndrome	1/12	0.1484651952049567	0.38811130488346424	0	0	6.766037735849056	12.905572339673263	MTOR
Primary malignant neoplasm of lung	36/2268	0.14968125578885896	0.39101892549003586	0	0	1.2273492286115006	2.331039594733194	CDKN1C;HDAC4;HPGD;FAM13A;PRDM2;PIK3R1;WASL;LSP1;FSTL1;FHIT;MECP2;IL1RL1;HPGDS;NSD1;RBM5;SASH1;USP8;PRKCI;GSN;IGFBP5;INSR;NR1H2;LMO3;HGF;BRAF;IL16;ATP11A;ARHGAP24;MTOR;HIPK2;AIMP2;DLC1;HOXD3;CD22;ANGPTL1;PAFAH1B1
Breast Cancer, Familial	4/154	0.14980137014324782	0.3910615116629345	0	0	1.9932824427480915	3.784137209524491	AKAP13;HPGDS;FHIT;FOXP1
Myopia	6/269	0.15018695638237037	0.3917965821969454	0	0	1.7084820122842936	3.2390672844683364	NSD1;HGF;BRAF;RSRC2;PIK3R1;ARID1B
Hypertension, Portal	3/101	0.15152758037713093	0.39189893984659974	0	0	2.2855590905563745	4.3128217130183435	PIK3R1;MTOR;CPEB4
Hemangioma	3/101	0.15152758037713093	0.39189893984659974	0	0	2.2855590905563745	4.3128217130183435	TBRG1;ARID1B;MTOR
Broad flat nasal bridge	7/330	0.15198886340015483	0.39189893984659974	0	0	1.624215546816166	3.059937676348257	RERE;SON;PEX6;BRAF;ABCC9;PIK3R1;ARID1B
X-linked agammaglobulinemia	2/52	0.15201910908012772	0.39189893984659974	0	0	2.9824242424242424	5.618138828607388	HPGDS;PIK3R1
Carcinomatosis of peritoneal cavity	2/52	0.15201910908012772	0.39189893984659974	0	0	2.9824242424242424	5.618138828607388	HGF;MTOR
Gingival Hypertrophy	2/52	0.15201910908012772	0.39189893984659974	0	0	2.9824242424242424	5.618138828607388	INSR;ABCC9
Hoarseness	2/52	0.15201910908012772	0.39189893984659974	0	0	2.9824242424242424	5.618138828607388	NSD1;IDS
Idiopathic crescentic glomerulonephritis	2/52	0.15201910908012772	0.39189893984659974	0	0	2.9824242424242424	5.618138828607388	DCN;MTOR
Progressive microcephaly	2/52	0.15201910908012772	0.39189893984659974	0	0	2.9824242424242424	5.618138828607388	MECP2;COG1
Progressive visual loss	2/52	0.15201910908012772	0.39189893984659974	0	0	2.9824242424242424	5.618138828607388	BRAF;DCN
Range of joint movement increased	2/52	0.15201910908012772	0.39189893984659974	0	0	2.9824242424242424	5.618138828607388	COL3A1;SON
Substance abuse problem	4/155	0.15227531573829123	0.39189893984659974	0	0	1.9799807896466306	3.726452760263425	MAOB;INSR;IL16;FHIT
Platelet hematocrit measurement	4/155	0.15227531573829123	0.39189893984659974	0	0	1.9799807896466306	3.726452760263425	ST7L;MEF2C;ATXN2;SMG6
Carcinoma breast stage IV	8/392	0.15323113562305735	0.39189893984659974	0	0	1.5625	2.930949698730717	AIMP2;AKAP13;HPGDS;HPGD;HGF;DCN;SASH1;MTOR
Hypertensive disease	22/1310	0.15436358717749554	0.39189893984659974	0	0	1.2912763466042154	2.4126781923734115	MEF2A;BBS1;USP8;NDFIP2;CALCRL;ADH1B;NPR1;INSR;HGF;IL16;ABCC9;PIK3R1;ATP2B1;ARID1B;DCN;HDAC6;MTOR;GHR;TGFBR3;COL3A1;HPGDS;UTS2
Adult Acute Myeloblastic Leukemia	3/102	0.15468524366588166	0.39189893984659974	0	0	2.2623574144486693	4.22237997366196	HPGDS;MTOR;PAFAH1B1
Childhood Acute Myeloid Leukemia	3/102	0.15468524366588166	0.39189893984659974	0	0	2.2623574144486693	4.22237997366196	HPGDS;MEF2C;NSD1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	3/102	0.15468524366588166	0.39189893984659974	0	0	2.2623574144486693	4.22237997366196	INSR;ARHGAP24;CD22
Mucocutaneous Lymph Node Syndrome	4/156	0.15476478280508826	0.39189893984659974	0	0	1.9668541582965047	3.6698525594779765	SGCD;HGF;INSR;EBF2
Osteosarcoma of bone	18/1042	0.1555377767403238	0.39189893984659974	0	0	1.3261561239919355	2.4677996900782966	GSN;URGCP;IGFBP5;IL11RA;HGF;EBF2;RAB27B;PRDM2;ARHGAP24;DCN;MTOR;FOXP1;MECP2;GHR;HPGDS;CCDC80;PMP22;SASH1
Lung Neoplasms	20/1177	0.15620775656560917	0.39189893984659974	0	0	1.3053804695350324	2.4235281100033985	CDKN1C;PRKCI;GSN;HPGD;HGF;SEMA3A;MGST1;PRRC2C;BRAF;PRDM2;RCHY1;FHIT;MTOR;MECP2;GHR;CEACAM1;DLC1;IDS;ANGPTL1;RBM5
Colonic Neoplasms	14/778	0.15645305136720927	0.39189893984659974	0	0	1.379435718440954	2.5588522993755562	EGFL7;MAOB;HPGD;HGF;BRAF;FHIT;DCN;FOXP1;CEACAM1;ATXN2;DLC1;SAA1;PMP22;SASH1
Pain, Burning	2/53	0.15666829993194012	0.39189893984659974	0	0	2.9237967914438503	5.41962121332065	NPR1;HGF
Thick vermilion border	2/53	0.15666829993194012	0.39189893984659974	0	0	2.9237967914438503	5.41962121332065	MECP2;ABCC9
Childhood Lymphoma	2/53	0.15666829993194012	0.39189893984659974	0	0	2.9237967914438503	5.41962121332065	SYVN1;BRAF
Nasal bridge wide	7/333	0.15695717640643414	0.39189893984659974	0	0	1.609020063007793	2.9795548289074674	RERE;SON;PEX6;BRAF;ABCC9;PIK3R1;ARID1B
Anxiety disease	4/157	0.1572695501230766	0.39189893984659974	0	0	1.953899116898668	3.6143109920453824	MECP2;USP8;ATXN2;TTC19
Cocaine Dependence	4/157	0.1572695501230766	0.39189893984659974	0	0	1.953899116898668	3.6143109920453824	MECP2;HDAC4;MAOA;LMO3
Inflammatory Bowel Diseases	16/911	0.15761397628429055	0.39189893984659974	0	0	1.3471463687150838	2.4889962842104	FZD4;HGF;IL16;SYN3;FHIT;TM9SF4;MTOR;FOXP1;AIMP2;IL1RL1;HPGDS;ATXN2;SAA1;PMP22;ULK1;CPEB4
Crohn Disease	16/912	0.158608964669992	0.39189893984659974	0	0	1.3455714285714286	2.477618766146158	IGFBP5;HPGD;NR1H2;HGF;IL16;FHIT;HDAC6;GHR;AIMP2;IL1RL1;ATXN2;SAA1;PMP22;ULK1;CPEB4;FKBP5
Anxiety Disorders	8/396	0.15931907339412496	0.39189893984659974	0	0	1.5460720850315672	2.839896845649439	MECP2;MAOA;ADH1B;NR1H2;PMP22;FHIT;MAP2K5;FKBP5
Adenocarcinoma, intestinal type	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	BRAF
Amyloid Neuropathies, Familial	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	GSN
refractory plasma cell neoplasm	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	HDAC6
Angina Pectoris, Variant	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	ABCC9
Cerebral Amyloid Angiopathy, Hereditary	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	GSN
Charcot-Marie-Tooth Disease, Type Ib	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	PMP22
Cystadenoma, Mucinous	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	BRAF
Scanning speech	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	ATXN1
Diabetes Mellitus, Transient Neonatal, 1	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	CDKN1C
Secondary malignant neoplasm of skin	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	BRAF
Eosinophilia, Tropical	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	HPGDS
EPILEPSY, PYRIDOXINE-DEPENDENT	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	AIMP2
Senile cardiac amyloidosis	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	GSN
Sotos' syndrome	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	NSD1
Sparse or absent eyelashes	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	BRAF
Sparse to absent eyelashes	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	BRAF
Stage III Cutaneous Melanoma AJCC v6	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	BRAF
Scleroderma, Limited	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	KIAA0319L
Tendinosis	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	DCN
Transformed migraine	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	MAOA
TUBEROUS SCLEROSIS 1 (disorder)	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	MTOR
Abnormality of aortic valve	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	BRAF
Ubiquinone dehydrogenase deficiency	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	TTC19
Abnormality of the abdominal wall	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	INSR
Abnormally low-pitched voice	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	NSD1
Absent earlobe	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	COL3A1
Axenfeld-Rieger syndrome	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	FOXC1
Behavioral tic	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	PRKCI
Benign symmetrical lipomatosis	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	MTOR
Broad face	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	NFIA
Calcium measurement	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	ARID1B
Cerebral Cavernous Malformations 3	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	AIMP2
Congenital hypogonadotropic hypogonadism	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	SEMA3A
Currarino triad	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	HPGD
Diarrheal disorder	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	SAA1
Dysthymic Disorder	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	MAOA
Explosive speech	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	ATXN1
Folliculitis	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	HPGDS
Hearing abnormality	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	INSR
Hypoglycemic coma	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	INSR
Insulin-dependent diabetes mellitus secretory diarrhea syndrome	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	HPGDS
Islets of Langerhans hyperplasia	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	INSR
Juvenile Spinal Muscular Atrophy	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	PMP22
Lysinuric Protein Intolerance	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	SLC7A6
Macrophage Activation Syndrome	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	FSTL1
Micropapillary carcinoma	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	BRAF
Mixed sensory-motor polyneuropathy	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	PMP22
Morphea	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	DCN
Myoclonic Astatic Epilepsy	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	PMP22
Nesidioblastosis	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	TGFBR3
Nicolaides Baraitser syndrome	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	ARID1B
Non-toxic nodular goiter	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	BRAF
Osteitis Fibrosa Disseminata	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	GHR
Paraparesis	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	ATP13A2
Partial to total absence of eyelashes	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	BRAF
Persistent cavum septum pellucidum	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	NSD1
Polymorphous light eruption	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	HPGDS
Prelingual sensorineural hearing impairment	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	HGF
Primary chondrosarcoma of bone	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	MTOR
Primary Cutaneous Follicle Center Lymphoma	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	FOXP1
Pulmonary Valve Stenosis	1/13	0.1597973909223194	0.39189893984659974	0	0	6.2018867924528305	11.373321243798689	BRAF
Neoplasm Metastasis	59/3920	0.1610341606154957	0.39440852449221153	0	0	1.1717659688674182	2.139807251954351	CDKN1C;PRDM2;MECP2;GHR;HPGDS;RBM5;PRKCI;EGFL7;IGFBP5;SCARA5;HGF;ATP11A;DCN;FOXP1;TGFBR3;CEACAM1;ULK1;ANGPTL1;PAFAH1B1;FKBP5;HDAC4;IGSF8;FOXC1;COL15A1;HPGD;MAOA;ADH1B;SEMA3A;LAMA4;PIK3R1;RCHY1;FSTL1;FHIT;HDAC6;CLEC3B;ATXN1;CALD1;CRNDE;RAI2;SASH1;GSN;URGCP;EYA2;INSR;RAB27B;BRAF;ARHGAP24;MTOR;HIPK2;AIMP2;COL3A1;DLC1;SAA1;PMP22;HOXD3;MPHOSPH8;OGT;CD22;CPEB4
Rotavirus Infections	2/54	0.16134418270307885	0.39440852449221153	0	0	2.867424242424242	5.230799504475622	AIMP2;ANGPTL1
Cognition	2/54	0.16134418270307885	0.39440852449221153	0	0	2.867424242424242	5.230799504475622	MEF2C;FOXP1
Hepatocellular Adenoma	2/54	0.16134418270307885	0.39440852449221153	0	0	2.867424242424242	5.230799504475622	SAA1;MTOR
Malignant neoplasm of nasopharynx	2/54	0.16134418270307885	0.39440852449221153	0	0	2.867424242424242	5.230799504475622	HGF;SAA1
Ulcerative Colitis	16/915	0.16161423429842345	0.3945681859018366	0	0	1.3408676307007787	2.443788985654009	HPGD;FZD4;INSR;NR1H2;HGF;BRAF;IL16;LSP1;TPD52L1;FHIT;AIMP2;IL1RL1;HPGDS;SAA1;PMP22;FKBP5
Dyslipidemias	5/216	0.16161898350053994	0.3945681859018366	0	0	1.7725300067185996	3.2304601635425017	HPGDS;SORT1;INSR;HGF;SIK3
Triglycerides measurement	7/336	0.16199945062705476	0.3952408876373803	0	0	1.5941017004846791	2.9015238732964166	MEF2A;MEF2C;NUMA1;INSR;SIK3;ATP2B1;ANGPTL1
Liver neoplasms	22/1321	0.16351975352068754	0.3980711776672895	0	0	1.2795782379888692	2.31708775779801	CDKN1C;CCDC134;FOXC1;URGCP;HPGD;ADH1B;INSR;STAT2;HGF;BRAF;PRDM2;FHIT;ARHGAP24;MTOR;GHR;AIMP2;HERC3;CEACAM1;CALD1;NSD1;DLC1;ANGPTL1
Severe Combined Immunodeficiency	5/217	0.16376842480857148	0.3980711776672895	0	0	1.7640786524976506	3.1917508451558474	GHR;HPGD;HGF;PIK3R1;MTOR
Dwarfism	6/277	0.165064368388476	0.3980711776672895	0	0	1.6573658813511212	2.985611664308637	CDKN1C;GHR;IDS;PIK3R1;MAP4;ARID1B
Invasive Ductal Breast Carcinoma	5/218	0.1659293407925463	0.3980711776672895	0	0	1.7557066537153958	3.1535884212813303	HPGDS;EGFL7;HGF;FMO2;FHIT
Russell-Silver syndrome	2/55	0.16604523332791188	0.3980711776672895	0	0	2.8131789594053744	5.051048862103685	CDKN1C;GHR
Decreased visual acuity, progressive	2/55	0.16604523332791188	0.3980711776672895	0	0	2.8131789594053744	5.051048862103685	BRAF;DCN
Hallucinations, Sensory	2/55	0.16604523332791188	0.3980711776672895	0	0	2.8131789594053744	5.051048862103685	ATP13A2;TTC19
Spastic Quadriplegia	2/55	0.16604523332791188	0.3980711776672895	0	0	2.8131789594053744	5.051048862103685	PMP22;ATP13A2
Systemic onset juvenile chronic arthritis	2/55	0.16604523332791188	0.3980711776672895	0	0	2.8131789594053744	5.051048862103685	ATXN2;FSTL1
Scoliosis, unspecified	2/55	0.16604523332791188	0.3980711776672895	0	0	2.8131789594053744	5.051048862103685	MECP2;COL3A1
Bone pain	2/55	0.16604523332791188	0.3980711776672895	0	0	2.8131789594053744	5.051048862103685	MEF2C;HPGD
Fetal Alcohol Syndrome	2/55	0.16604523332791188	0.3980711776672895	0	0	2.8131789594053744	5.051048862103685	MECP2;ADH1B
Primary central nervous system lymphoma	2/55	0.16604523332791188	0.3980711776672895	0	0	2.8131789594053744	5.051048862103685	EBF1;FOXP1
Familial multiple trichoepitheliomata	4/161	0.16743715859034866	0.3980711776672895	0	0	1.9037292750522683	3.4022443877013586	GHR;GSN;FHIT;MTOR
Nonorganic psychosis	5/220	0.17028508657610605	0.3980711776672895	0	0	1.739196293326205	3.0788666170730923	MEF2A;GHR;MAOA;PAFAH1B1;FKBP5
Claw hand	2/56	0.17076996325344773	0.3980711776672895	0	0	2.760942760942761	4.8797947988449035	PMP22;IDS
Congenital hypoplasia of kidney	2/56	0.17076996325344773	0.3980711776672895	0	0	2.760942760942761	4.8797947988449035	NFIA;ARID1B
Familial Mediterranean Fever	2/56	0.17076996325344773	0.3980711776672895	0	0	2.760942760942761	4.8797947988449035	SAA1;RNPC3
Glucocorticoid Receptor Deficiency	2/56	0.17076996325344773	0.3980711776672895	0	0	2.760942760942761	4.8797947988449035	CDKN1C;FKBP5
Paralysed	2/56	0.17076996325344773	0.3980711776672895	0	0	2.760942760942761	4.8797947988449035	ATXN2;PMP22
Parathyroid Neoplasms	2/56	0.17076996325344773	0.3980711776672895	0	0	2.760942760942761	4.8797947988449035	PRDM2;ARHGAP24
Dermatitis, Allergic Contact	3/107	0.17077253546979745	0.3980711776672895	0	0	2.153041825095057	3.8053352323727943	CALCRL;NUMA1;IL16
Alcohol abuse	3/107	0.17077253546979745	0.3980711776672895	0	0	2.153041825095057	3.8053352323727943	MAOA;ADH1B;FKBP5
Pleural effusion disorder	3/107	0.17077253546979745	0.3980711776672895	0	0	2.153041825095057	3.8053352323727943	HGF;FHIT;FSTL1
Cystadenoma, Serous	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	BRAF
Depressive Disorder, Treatment-Resistant	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	MAOA
Familial Partial Lipodystrophy, Type 2	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	INSR
Sex Cord-Stromal Tumor	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	TGFBR3
Hydatidiform Mole, Partial	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	CDKN1C
Subcortical Infarction	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	ADH1B
Pyloric Stenosis, Hypertrophic	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	SIK3
Syringomyelia	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	NFIA
Testicular embryonal carcinoma	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	ARHGAP24
Testicular Feminization	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	IGFBP5
Supratentorial Embryonal Tumor, Not Otherwise Specified	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	DLC1
Thyroid Lymphoma	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	BRAF
Transient neonatal diabetes mellitus	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	CDKN1C
Unilateral Cryptorchidism	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	HPGDS
Abnormality of the thyroid gland	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	INSR
Very long chain fatty acid accumulation	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	PEX6
Adenocarcinoma of small intestine	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	BRAF
Zellweger-Like Syndrome	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	PEX6
ALZHEIMER DISEASE 5	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	FHIT
Amelanotic Skin Melanoma	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	BRAF
Anal squamous cell carcinoma	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	BRAF
Angioedema	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	XPNPEP2
Atony of facial musculature	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	MECP2
Biconcave vertebral bodies	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	USP8
Cancer Relapse	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	ULK1
Cardio-facio-cutaneous syndrome	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	BRAF
Classical Lissencephaly	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	PAFAH1B1
Contralateral breast cancer	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	TMEM135
Copper-Overload Cirrhosis	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	HGF
Desmoplastic melanoma	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	BRAF
Exudative retinopathy	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	FZD4
Eye Neoplasms	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	BRAF
Facial hypotonia	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	MECP2
growth hormone treatment	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	GHR
Histiocytosis	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	BRAF
Hyperextensibility of the finger joints	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	BRAF
Hypoplastic ischia	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	TBX15
Hypotonic facies	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	MECP2
Inflammatory neuropathy	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	PMP22
Loeys-Dietz Syndrome	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	COL3A1
Low Grade Cervical Squamous Intraepithelial Neoplasia	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	FHIT
Manganese Poisoning	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	ATP13A2
Micronodular cirrhosis	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	PDGFRL
Mirror movements disorder	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	MEF2C
Nephrogenic rest	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	HGF
Neuroma	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	SEMA3A
Pachyonychia Congenita	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	MTOR
Pigmented lesions	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	BRAF
POEMS Syndrome	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	HGF
Poikiloderma with Neutropenia	1/14	0.17097933779285224	0.3980711776672895	0	0	5.724528301886792	10.110733794887718	MECP2
Waldenstrom Macroglobulinemia	3/108	0.17404638432504768	0.4049615378335112	0	0	2.132428028245519	3.7284084702313707	ARHGAP24;CD22;MTOR
Ataxia, Appendicular	2/57	0.17551691877090422	0.40618663963661733	0	0	2.7106060606060605	4.71650831702013	ATXN2;ATXN1
Ameloblastoma	2/57	0.17551691877090422	0.40618663963661733	0	0	2.7106060606060605	4.71650831702013	BRAF;MTOR
Atrophic	2/57	0.17551691877090422	0.40618663963661733	0	0	2.7106060606060605	4.71650831702013	ATXN1;MTOR
Broad nasal tip	2/57	0.17551691877090422	0.40618663963661733	0	0	2.7106060606060605	4.71650831702013	ARID1B;FOXP1
Hypertrophy of clitoris	2/57	0.17551691877090422	0.40618663963661733	0	0	2.7106060606060605	4.71650831702013	PEX6;INSR
Long eyelashes	2/57	0.17551691877090422	0.40618663963661733	0	0	2.7106060606060605	4.71650831702013	ABCC9;ARID1B
Obsessive compulsive behavior	2/57	0.17551691877090422	0.40618663963661733	0	0	2.7106060606060605	4.71650831702013	TTC19;FOXP1
Leukemogenesis	13/730	0.1764783182872916	0.40618663963661733	0	0	1.362842542213108	2.3639284159103893	RERE;GSN;EBF1;FHIT;ARHGAP24;MTOR;HIPK2;FOXP1;ARHGAP20;ATXN1;SON;DLC1;PAFAH1B1
Cerebral Infarction	6/283	0.17661877925883732	0.40618663963661733	0	0	1.6209663982227158	2.8103693911932344	CEACAM1;ADH1B;HGF;SEMA3A;IL16;ANGPTL1
Flexion contracture of proximal interphalangeal joint	3/109	0.17733790242352138	0.40618663963661733	0	0	2.1122031709591793	3.65347426172064	RERE;MECP2;NSD1
TARSAL-CARPAL COALITION SYNDROME	4/165	0.17783160208173818	0.40618663963661733	0	0	1.856052344601963	3.205250633817711	CDKN1C;MECP2;HPGDS;FHIT
Atrial Septal Defects	4/165	0.17783160208173818	0.40618663963661733	0	0	1.856052344601963	3.205250633817711	FOXC1;NSD1;BRAF;ARID1B
Curvature of spine	8/408	0.17824906107365449	0.40618663963661733	0	0	1.4987596899224807	2.5847212248803157	MECP2;COL3A1;SON;NSD1;PMP22;BRAF;ARID1B;SHROOM4
Severe mental retardation (I.Q. 20-34)	5/224	0.17912861229818305	0.40618663963661733	0	0	1.707080249829423	2.93558264566551	MECP2;MEF2C;MAOA;ROGDI;ARID1B
Severe Dengue	2/58	0.18028468044627666	0.40618663963661733	0	0	2.6620670995670994	4.560701590044581	IL1RL1;PMP22
Severe global developmental delay	2/58	0.18028468044627666	0.40618663963661733	0	0	2.6620670995670994	4.560701590044581	MECP2;PEX6
Tooth Crowding	2/58	0.18028468044627666	0.40618663963661733	0	0	2.6620670995670994	4.560701590044581	BBS1;PEX6
Tooth mass arch size discrepancy	2/58	0.18028468044627666	0.40618663963661733	0	0	2.6620670995670994	4.560701590044581	BBS1;PEX6
Tooth size discrepancy	2/58	0.18028468044627666	0.40618663963661733	0	0	2.6620670995670994	4.560701590044581	BBS1;PEX6
Wide anterior fontanel	2/58	0.18028468044627666	0.40618663963661733	0	0	2.6620670995670994	4.560701590044581	PEX6;MTOR
Cutis Laxa	2/58	0.18028468044627666	0.40618663963661733	0	0	2.6620670995670994	4.560701590044581	COL3A1;GSN
Inadequate arch length for tooth size	2/58	0.18028468044627666	0.40618663963661733	0	0	2.6620670995670994	4.560701590044581	BBS1;PEX6
Nausea	2/58	0.18028468044627666	0.40618663963661733	0	0	2.6620670995670994	4.560701590044581	ADH1B;SAA1
Contracture	4/166	0.18046394886238185	0.40618663963661733	0	0	1.8445009895391575	3.158199324271724	SON;IDS;GNS;DCN
polyps	6/285	0.18054225249372896	0.40618663963661733	0	0	1.6091811414392059	2.7545808985936002	CEACAM1;COL3A1;HPGD;SEMA3A;BRAF;MTOR
Lip and Oral Cavity Carcinoma	9/473	0.1805675105038319	0.40618663963661733	0	0	1.454364014490809	2.4893629678124913	CDKN1C;HPGDS;NR1H2;HGF;BRAF;FHIT;ARHGAP24;DCN;MTOR
Small testicle	3/110	0.18064661014001987	0.40618663963661733	0	0	2.0923563483884724	3.5804665185089184	CDKN1C;BBS1;SEMA3A
Borderline Personality Disorder	3/110	0.18064661014001987	0.40618663963661733	0	0	2.0923563483884724	3.5804665185089184	MAOB;MAOA;FKBP5
Hyperplastic Polyp	3/110	0.18064661014001987	0.40618663963661733	0	0	2.0923563483884724	3.5804665185089184	GSN;DLC1;BRAF
Polymicrogyria	3/110	0.18064661014001987	0.40618663963661733	0	0	2.0923563483884724	3.5804665185089184	MECP2;PEX6;MBOAT7
Atrophy, Muscular, Spinobulbar	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	ATXN1
Autosomal recessive, childhood type, muscular dystrophy resembling Duchenne or Becker muscular dystrophy	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	SGCD
Breast Fibrocystic Change, Proliferative Type	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	FHIT
Carcinoma of urinary bladder, invasive	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	INSR
Leukemia, Prolymphocytic, B-Cell	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	BRAF
Small wings of the pelvic girdle	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	TBX15
Reflex, Ankle, Absent	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	PMP22
Systemic amyloidosis	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	GSN
Tic disorder	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	PRKCI
Transient ischemia	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	PIK3R1
Urinary Stress Incontinence	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	DCN
X-Linked Lissencephaly	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	PAFAH1B1
Anovulation	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	INSR
Autonomic neuropathy	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	HPGDS
Benign scapuloperoneal muscular dystrophy with early contractures [Emery-Dreifuss]	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	SGCD
Clubbing	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	HPGD
Complex partial seizure with impairment of consciousness	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	MTOR
Congenital hypoplasia of femur	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	TBX15
Congenital muscular dystrophy with specific morphological abnormalities of the muscle fiber	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	SGCD
Curly eyelashes	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	ABCC9
Duchenne and Becker Muscular Dystrophy	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	SGCD
Epithelial cyst	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	MTOR
Granulocytosis	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	ADH1B
Hereditary liability to pressure palsies	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	PMP22
High anterior hairline	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	NSD1
Hypoplastic ilia	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	TBX15
Maternal hypertension	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	HPGDS
Mesomelia	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	TBX15
Metaphyseal chondrodysplasia	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	HDAC6
Mucosal Melanoma	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	BRAF
Nevi and Melanomas	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	BRAF
Nodular melanoma	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	BRAF
Oestrogen receptor positive breast cancer	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	MTOR
Periodic fever	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	AIMP2
Plasmacytosis	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	RCHY1
Pneumothorax	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	COL3A1
Primary congenital glaucoma	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	FOXC1
Progesterone Resistance	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	FKBP5
Progressive pseudorheumatoid dysplasia	1/15	0.18201302036278472	0.40618663963661733	0	0	5.315363881401617	9.055663478454154	HP1BP3
Hereditary hemochromatosis	4/167	0.1831093314414244	0.40839126793359726	0	0	1.8330913688943005	3.111987642883977	SLC25A16;HPGDS;FOXC1;MTOR
Acute Promyelocytic Leukemia	9/475	0.183597075891579	0.40923679578909944	0	0	1.4479718107580033	2.4543292002359425	RERE;ATXN1;NUMA1;STAT2;HGF;HOXD3;ARHGAP24;MTOR;PAFAH1B1
Urinary Incontinence	2/59	0.18507186233164408	0.41082245456882927	0	0	2.6152312599681022	4.411924123556102	COL3A1;DCN
Acne	2/59	0.18507186233164408	0.41082245456882927	0	0	2.6152312599681022	4.411924123556102	USP8;HPGD
Well Differentiated Pancreatic Endocrine Tumor	2/59	0.18507186233164408	0.41082245456882927	0	0	2.6152312599681022	4.411924123556102	FZD4;MTOR
Conn Syndrome	2/59	0.18507186233164408	0.41082245456882927	0	0	2.6152312599681022	4.411924123556102	CDKN1C;UTS2
Drug Resistant Epilepsy	2/59	0.18507186233164408	0.41082245456882927	0	0	2.6152312599681022	4.411924123556102	MECP2;MTOR
Moderate mental retardation (I.Q. 35-49)	2/59	0.18507186233164408	0.41082245456882927	0	0	2.6152312599681022	4.411924123556102	MECP2;ARID1B
Nephrocalcinosis	2/59	0.18507186233164408	0.41082245456882927	0	0	2.6152312599681022	4.411924123556102	CDKN1C;NSD1
Breast adenocarcinoma	4/168	0.18576751960955154	0.41212382000540676	0	0	1.8218208899646249	3.0665969224656724	AIMP2;HPGDS;BRAF;ARID1B
Aortic Aneurysm, Abdominal	6/288	0.18649262440977785	0.4124039706681266	0	0	1.5918166939443534	2.6732389947095303	COL3A1;PPP1R12A;HPGD;SORT1;UTS2;DCN
Renal Cell Carcinoma	22/1348	0.1872296998559238	0.4124039706681266	0	0	1.2516875602700097	2.097101213723399	COL15A1;IGFBP5;INSR;NR1H2;HGF;SYVN1;BRAF;PIK3R1;FHIT;ARHGAP24;DCN;MTOR;TGFBR3;ABR;AIMP2;AKAP13;CEACAM1;COL3A1;HPGDS;NFIA;DLC1;NFIC
Muscular Dystrophy, Facioscapulohumeral	3/112	0.18731368655250027	0.4124039706681266	0	0	2.0537551888931525	3.439979559577829	COL3A1;SGCD;DCN
Merkel cell carcinoma	3/112	0.18731368655250027	0.4124039706681266	0	0	2.0537551888931525	3.439979559577829	BRAF;FHIT;ARHGAP24
Pediatric failure to thrive	10/543	0.18873611207486796	0.4124039706681266	0	0	1.407202743902439	2.346377555355987	MECP2;RERE;USP8;SON;PEX6;STT3A;BRAF;PIK3R1;ARID1B;PAFAH1B1
Astrocytoma	13/741	0.18981763111858765	0.4124039706681266	0	0	1.3414737436476567	2.2291155226280233	GSN;ADH1B;EYA2;HGF;BRAF;PIK3R1;LSP1;ARHGAP24;MTOR;HIPK2;AIMP2;HPGDS;CPEB4
Angelman Syndrome	2/60	0.18987711141826477	0.4124039706681266	0	0	2.5700104493207943	4.269759329350917	MECP2;MEF2C
Bullous pemphigoid	2/60	0.18987711141826477	0.4124039706681266	0	0	2.5700104493207943	4.269759329350917	GYPC;CD22
Hypotrichosis	2/60	0.18987711141826477	0.4124039706681266	0	0	2.5700104493207943	4.269759329350917	PIK3R1;EDA2R
Oropharyngeal Carcinoma	2/60	0.18987711141826477	0.4124039706681266	0	0	2.5700104493207943	4.269759329350917	ADH1B;ARHGAP24
Adenocarcinoma, Clear Cell	3/113	0.19067110687790625	0.4124039706681266	0	0	2.034980988593156	3.372381256742085	BRAF;FSTL1;MTOR
Developmental Disabilities	4/170	0.1911213899411812	0.4124039706681266	0	0	1.7996872988135748	2.978206233621288	MECP2;FOXC1;DLG2;PMP22
Myeloid Leukemia, Chronic	15/876	0.1914547655019237	0.4124039706681266	0	0	1.3099518303094244	2.165486230267789	FOXC1;HGF;LAMA4;EBF2;BRAF;PRDM2;FHIT;ARHGAP24;MTOR;AIMP2;AKAP13;HPGDS;ATXN1;PMP22;PAFAH1B1
Adrenoleukodystrophy, Neonatal	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	PEX6
Replication Error Phenotype	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	BRAF
Depression, Postpartum	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	HP1BP3
Serous cystadenocarcinoma ovary	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	BRAF
Gaucher Disease, Type 3 (disorder)	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	AIMP2
Severe [Duchenne] muscular dystrophy	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	SGCD
Guillain-Barre Syndrome, Familial	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	PMP22
HYPERTRICHOSIS, CONGENITAL GENERALIZED	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	ABCC9
Malignant melanoma, metastatic	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	BRAF
Sore to touch	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	GHR
Polyneuropathy, Motor	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	PMP22
RETINOSCHISIS 1, X-LINKED, JUVENILE	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	PAFAH1B1
Abnormal platelet function	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	BRAF
Abnormality of the spleen	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	BRAF
Uterine Corpus Sarcoma	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	BRAF
Adenocarcinoma of salivary gland	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	ACACB
Adult Neuronal Ceroid Lipofuscinosis	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	ATP13A2
Arachnoid Cysts	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	SON
Autosomal dominant hypocalcemia	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	ADH1B
Basaloid squamous cell carcinoma	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	BRAF
Benign neoplasm of bladder	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	MTOR
Broad ribs	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	ABCC9
Cerebellar malformation	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	CDKN1C
Cerebellar Neoplasms	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	BRAF
Cervical Squamous Intraepithelial Neoplasia 1	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	FHIT
Congenital total cataract	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	LEMD2
cystic disease	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	HGF
Diffuse mesangial sclerosis (disorder)	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	DCN
Disproportionate tall stature	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	HPGD
Elevated levels of phytanic acid	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	PEX6
Familial Hemiplegic Migraine	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	CSAD
Focal Nodular Hyperplasia	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	FHIT
Growth hormone excess	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	INSR
Hereditary Sensory and Autonomic Neuropathies	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	NAA50
Infantile Neuroaxonal Dystrophy	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	ATP13A2
Large for gestational age	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	ABCC9
Lhermitte-Duclos disease	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	MTOR
Macroencephaly	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	MTOR
Malignant melanoma of choroid	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	BRAF
Microsatellite Instability	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	BRAF
Myelodysplastic-Myeloproliferative Diseases	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	PAFAH1B1
Neoplasm of uncertain or unknown behavior of bladder	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	MTOR
Non-small cell carcinoma	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	FHIT
Ocular muscular dystrophy	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	SGCD
Optic Nerve Glioma	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	MTOR
Ovarian Granulosa Cell Tumor	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	MTOR
Pleomorphic Xanthoastrocytoma	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	BRAF
premalignant lesion	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	BRAF
Primary Systemic Amyloidosis	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	GSN
Pyle metaphyseal dysplasia	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	CDKN1C
Quadriparesis	1/16	0.1929003972172124	0.4124039706681266	0	0	4.960754716981132	8.163325195582273	PMP22
Keloid	4/171	0.19381660982551663	0.413908873875067	0	0	1.7888193079489876	2.9351714200173156	COL3A1;IGFBP5;IL11RA;DCN
Intracranial Aneurysm	3/114	0.1940438203513056	0.413908873875067	0	0	2.0165450621724386	3.3064709977120934	TGFBR3;ADAMTS15;COL3A1
Lymphocyte Count measurement	3/114	0.1940438203513056	0.413908873875067	0	0	2.0165450621724386	3.3064709977120934	RERE;DIP2A;FOXP1
Posteriorly rotated ear	3/114	0.1940438203513056	0.413908873875067	0	0	2.0165450621724386	3.3064709977120934	RERE;BRAF;ARID1B
Bradykinesia	2/61	0.1946991070352869	0.4148613678801524	0	0	2.5263225475089883	4.133821465692842	ATXN2;TTC19
Acquired scoliosis	8/418	0.19474747604468054	0.4148613678801524	0	0	1.4614482889014937	2.391004744573543	MECP2;COL3A1;SON;NSD1;PMP22;BRAF;ARID1B;SHROOM4
Leukemia, Myelocytic, Acute	27/1703	0.19482074854791334	0.4148613678801524	0	0	1.2171987497628345	1.9909420292491211	CDKN1C;FOXC1;PRDM2;PIK3R1;FHIT;HDAC6;AKAP13;IL1RL1;HPGDS;ATXN1;NSD1;MEF2C;EGFL7;GSN;FZD4;INSR;HGF;BRAF;ARHGAP24;MTOR;HIPK2;FOXP1;SLC25A16;AIMP2;SON;ULK1;PAFAH1B1
Hypoglycemia	5/232	0.19731417610682472	0.4195599368723732	0	0	1.6462436916637129	2.6717843989981644	GHR;CALD1;INSR;NSD1;MTOR
Carcinoma, Cribriform	3/115	0.19743135894730693	0.4195599368723732	0	0	1.9984383487235198	3.242195042081115	CDKN1C;CEACAM1;MTOR
Carcinoma, Granular Cell	3/115	0.19743135894730693	0.4195599368723732	0	0	1.9984383487235198	3.242195042081115	CDKN1C;CEACAM1;MTOR
Malignant neoplasm of pancreas	29/1846	0.1974727284509471	0.4195599368723732	0	0	1.2065908241200662	1.9572770824647145	CDKN1C;RERE;FOXC1;CALCRL;HPGD;ADH1B;LSP1;FSTL1;FHIT;GHR;HPGDS;OSBP;PRKCI;GSN;PPP1R12A;SORT1;EYA2;INSR;HGF;BRAF;ARID1B;ARHGAP24;DCN;MTOR;FOXP1;AIMP2;CEACAM1;OGT;FKBP5
Pituitary Adenoma	6/294	0.19861927046790215	0.4217580562866896	0	0	1.5581730769230768	2.5185772053742674	GHR;USP8;EGFL7;BRAF;PRDM2;MTOR
Sparse scalp hair	2/62	0.19953656017821267	0.42176768278925597	0	0	2.484090909090909	4.003752899638559	HDAC4;ARID1B
Abnormality of the pinna	2/62	0.19953656017821267	0.42176768278925597	0	0	2.484090909090909	4.003752899638559	TBX15;ARID1B
Bardet-Biedl Syndrome	2/62	0.19953656017821267	0.42176768278925597	0	0	2.484090909090909	4.003752899638559	BBS1;INSR
Cancer of Nasopharynx	2/62	0.19953656017821267	0.42176768278925597	0	0	2.484090909090909	4.003752899638559	HGF;SAA1
Hemolytic-Uremic Syndrome	2/62	0.19953656017821267	0.42176768278925597	0	0	2.484090909090909	4.003752899638559	SAA1;CD22
Leber Congenital Amaurosis	2/62	0.19953656017821267	0.42176768278925597	0	0	2.484090909090909	4.003752899638559	MEF2A;MEF2C
Low grade glioma	2/62	0.19953656017821267	0.42176768278925597	0	0	2.484090909090909	4.003752899638559	HDAC4;BRAF
Osteomyelitis	2/62	0.19953656017821267	0.42176768278925597	0	0	2.484090909090909	4.003752899638559	HPGD;PIK3R1
Gallbladder Carcinoma	5/233	0.19963147820898416	0.42176768278925597	0	0	1.6389393022786851	2.640793759193025	DLC1;HGF;FHIT;ARHGAP24;CPEB4
Arteriosclerosis	18/1087	0.19994724927359256	0.4219607764742819	0	0	1.2672757174326323	2.039935877803858	CDKN1C;MEF2C;COL15A1;MAOA;SORT1;INSR;HGF;ARHGAP24;DCN;ABR;AIMP2;IL1RL1;HPGDS;OSBP;SAA1;UTS2;SASH1;SNTB2
Liver Cirrhosis	12/683	0.20058296593088354	0.4219607764742819	0	0	1.342196979475926	2.156276119917948	GHR;COL3A1;HPGDS;ADH1B;DGKB;HGF;MBOAT7;SYVN1;UTS2;FHIT;ARHGAP24;CPEB4
Ataxia, Spinocerebellar	3/116	0.20083325728314963	0.4219607764742819	0	0	1.9806521080790067	3.179501772538355	ATXN2;FOXC1;ATXN1
Increase in blood pressure	4/174	0.20197262944511254	0.4219607764742819	0	0	1.7569824876515492	2.8105097534395957	TGFBR3;USP8;BBS1;COL3A1
Affective Disorders, Psychotic	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	FKBP5
Relative short stature	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	IDS
Elliptocytosis, Hereditary	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	GYPC
Thick craniofacial bones	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	ABCC9
SYNOVITIS, GRANULOMATOUS, WITH UVEITIS AND CRANIAL NEUROPATHIES (disorder)	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	AIMP2
Tonic-Clonic Epilepsy	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	NR1H2
TUMOR PREDISPOSITION SYNDROME	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	BRAF
UV-Sensitive Syndrome	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	NR1H2
Vocal Cord Paralysis	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	PMP22
Adult Solid Neoplasm	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	BRAF
Alagille Syndrome	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	HGF
Anal carcinoma	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	MTOR
Atypical Endometrial Hyperplasia	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	CDKN1C
Brain Stem Glioma	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	BRAF
Carcinoma in situ of bladder	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	MTOR
Central nervous system lesion	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	BRAF
Childhood Myelodysplastic Syndrome	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	PAFAH1B1
Corneal diameter increased	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	PIK3R1
Craniofacial hyperostosis	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	ABCC9
Double ureter	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	FOXC1
Enlargement of craniofacial bones	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	ABCC9
Hypertrophy of craniofacial bones	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	ABCC9
Hypopharyngeal Carcinoma	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	HGF
McCune-Albright Syndrome	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	GHR
Mild short stature	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	IDS
Mucosal telangiectasiae	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	KIAA0319L
Mucosal ulcer	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	IL16
Neurofibrosarcoma	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	BRAF
Onychogryposis	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	INSR
Pancreatic Cyst	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	BRAF
Patella aplasia-hypoplasia	1/17	0.20364340101678907	0.4219607764742819	0	0	4.650471698113208	7.400690200913087	ARID1B
Adenocarcinoma, Basal Cell	3/117	0.2042490527256429	0.42225777711355145	0	0	1.9631779067440465	3.118341594141649	CDKN1C;CEACAM1;MTOR
Joint stiffness	3/117	0.2042490527256429	0.42225777711355145	0	0	1.9631779067440465	3.118341594141649	HPGD;NSD1;GNS
Simple ear	2/63	0.20438821292497403	0.42225777711355145	0	0	2.44324391455539	3.879221650937443	TBX15;ARID1B
Difficulty walking	2/63	0.20438821292497403	0.42225777711355145	0	0	2.44324391455539	3.879221650937443	SGCD;DHTKD1
Kidney Calculi	2/63	0.20438821292497403	0.42225777711355145	0	0	2.44324391455539	3.879221650937443	PDE1A;HIPK2
Squamous cell carcinoma of esophagus	17/1023	0.20445930062519718	0.42225777711355145	0	0	1.270992518782885	2.0175561654227976	PRKCI;EGFL7;ADH1B;NR1H2;HGF;BRAF;RSRC2;PRDM2;PIK3R1;FSTL1;FHIT;ARHGAP24;GHR;AIMP2;HPGDS;PEX6;ULK1
Multiple malignancy	4/176	0.20746629065959593	0.428201478823755	0	0	1.7363749334280134	2.7309468930308745	INSR;PRDM2;BRAF;MTOR
Red Blood Cell Count measurement	3/118	0.20767828558826662	0.428201478823755	0	0	1.9460076045627377	3.0586668382851965	MEF2C;MAST2;FOXP1
Mental Retardation, X-Linked	3/118	0.20767828558826662	0.428201478823755	0	0	1.9460076045627377	3.0586668382851965	MECP2;MAOA;SHROOM4
Smooth philtrum	2/64	0.20925283781041795	0.4297208540615325	0	0	2.4037145650048877	3.759919186112335	COG1;MTOR
Synophrys	2/64	0.20925283781041795	0.4297208540615325	0	0	2.4037145650048877	3.759919186112335	ABCC9;GNS
Cortical Dysplasia	2/64	0.20925283781041795	0.4297208540615325	0	0	2.4037145650048877	3.759919186112335	FOXC1;MTOR
High-Grade Squamous Intraepithelial Lesions	2/64	0.20925283781041795	0.4297208540615325	0	0	2.4037145650048877	3.759919186112335	FHIT;ARHGAP24
Mitral Valve Prolapse Syndrome	2/64	0.20925283781041795	0.4297208540615325	0	0	2.4037145650048877	3.759919186112335	COL3A1;BRAF
Malignant neoplasm of mouth	9/492	0.2102366416204187	0.4297208540615325	0	0	1.395775430794886	2.176741818398648	HPGDS;ADH1B;NR1H2;HGF;BRAF;FHIT;ARHGAP24;DCN;MTOR
Retrognathia	3/119	0.21112049901252194	0.4297208540615325	0	0	1.92913334207421	3.000431674873029	DSTYK;NSD1;FOXP1
Muscle Rigidity	3/119	0.21112049901252194	0.4297208540615325	0	0	1.92913334207421	3.000431674873029	MECP2;ATXN2;ATP13A2
Cerebrovascular Disorders	4/178	0.2130028391364595	0.4297208540615325	0	0	1.7162411160831799	2.6540807034001594	MEF2C;COL3A1;HGF;PAFAH1B1
Dyschezia	4/178	0.2130028391364595	0.4297208540615325	0	0	1.7162411160831799	2.6540807034001594	RERE;MECP2;BRAF;FOXP1
Cutaneous Melanoma	6/301	0.2131258541111698	0.4297208540615325	0	0	1.520651890482399	2.350733823076633	HGF;MIB2;BRAF;PRDM2;PIK3R1;MTOR
HEMOCHROMATOSIS, TYPE 1	2/65	0.21412923731791442	0.4297208540615325	0	0	2.3654401154401152	3.645558431974221	HPGDS;UBL3
Syndactyly of the toes	2/65	0.21412923731791442	0.4297208540615325	0	0	2.3654401154401152	3.645558431974221	HDAC4;TBX15
Adult Liver Carcinoma	2/65	0.21412923731791442	0.4297208540615325	0	0	2.3654401154401152	3.645558431974221	HPGDS;OGT
Mammary Ductal Carcinoma	2/65	0.21412923731791442	0.4297208540615325	0	0	2.3654401154401152	3.645558431974221	DLC1;FHIT
Open mouth (finding)	2/65	0.21412923731791442	0.4297208540615325	0	0	2.3654401154401152	3.645558431974221	BRAF;FOXP1
Recurrent Carcinoma	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	ARHGAP24
Adenoma, Villous	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	BRAF
Cafe au lait spots, multiple	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	BRAF
Decreased visual acuity, slowly progressive	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	BRAF
Hereditary motor and sensory neuropathy, types I-IV	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	PMP22
Infarction, Lacunar	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	FOXC1
Thymus Hyperplasia	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	MTOR
Acquired partial lipodystrophy	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	PIK3R1
Wolfram Syndrome	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	SYVN1
Adrenomyeloneuropathy	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	PMP22
Alexander Disease	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	MTOR
Alkalosis	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	USP8
Benign neoplasm of stomach	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	BRAF
Carcinoma in situ of stomach	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	BRAF
Congenital hernia of foramen of Bochdalek	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	INSR
Congenital hernia of foramen of Morgagni	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	INSR
Degeneration of lumbar intervertebral disc	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	CILP
Diminished ovarian reserve	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	FOXC1
Disease due to Papilloma virus	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	FHIT
Dysseborrheic dermatitis	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	HPGD
Ectopic kidney	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	ARID1B
Edema of eyelid	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	ABCC9
Heat Stroke	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	IL11RA
Hypertensive heart disease	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	NPR1
Hypertrophic neuropathy of infancy	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	PMP22
Hypoplastic scapulae	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	TBX15
Idiopathic scoliosis	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	GHR
Late-Infantile Neuronal Ceroid Lipfuscinosis	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	ATP13A2
Malignant neoplasm of other specified sites of female breast	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	HGF
Narrowing of ear canal	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	TBX15
Neoplasm of uncertain or unknown behavior of stomach	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	BRAF
Nongerminomatous Germ Cell Tumor	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	BRAF
Peroneal muscular atrophy (axonal type) (hypertrophic type)	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	PMP22
Proliferative Inflammatory Atrophy	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	HPGDS
Prostate specific antigen measurement	1/18	0.21424393910560827	0.4297208540615325	0	0	4.37669256381798	6.742907678758303	RAI2
Glioblastoma	30/1937	0.2144425371024735	0.4297208540615325	0	0	1.1883293486086053	1.8296867034227355	CDKN1C;PHF3;HDAC4;IGSF8;CALCRL;MAOB;HPGD;MAST2;PIK3R1;FSTL1;HDAC6;HPGDS;CREB3L2;LRIG3;USP8;PRKCI;GSN;IGFBP5;INSR;STAT2;HGF;BRAF;IL16;ARHGAP24;DCN;MTOR;FOXP1;SLC25A16;AIMP2;NFIA
Platelet distribution width measurement	3/120	0.2145752393123819	0.4297208540615325	0	0	1.9125475285171103	2.943592024923105	ST7L;MEF2C;ATXN2
Platelet distribution width result	3/120	0.2145752393123819	0.4297208540615325	0	0	1.9125475285171103	2.943592024923105	ST7L;MEF2C;ATXN2
Huntington Disease	11/627	0.21504827765207335	0.4304393527711798	0	0	1.3387955182072828	2.0575850973396754	MECP2;HDAC4;AIMP2;HPGDS;ATXN2;ATXN1;PPP1R12A;MAOB;MAOA;HDAC6;FOXP1
Pancreatic carcinoma	29/1869	0.21652082698864517	0.43315664113979097	0	0	1.1899789029535865	1.8207492798224085	CDKN1C;RERE;FOXC1;CALCRL;HPGD;ADH1B;LSP1;FSTL1;FHIT;GHR;HPGDS;OSBP;RBM5;PRKCI;GSN;PPP1R12A;EYA2;INSR;HGF;BRAF;ARID1B;ARHGAP24;DCN;MTOR;FOXP1;AIMP2;CEACAM1;OGT;FKBP5
Osteosarcoma	18/1103	0.21708939469416283	0.43406356147182135	0	0	1.2475174669243347	1.9055156310976884	GSN;URGCP;IGFBP5;IL11RA;HGF;EBF2;RAB27B;PRDM2;ARHGAP24;DCN;MTOR;FOXP1;MECP2;GHR;HPGDS;CCDC80;PMP22;SASH1
Adult Acute Lymphocytic Leukemia	3/121	0.21804205584213232	0.43491522844280417	0	0	1.896242830444029	2.8881054822156726	CDKN1C;PRDM2;FHIT
Hypodontia	3/121	0.21804205584213232	0.43491522844280417	0	0	1.896242830444029	2.8881054822156726	BBS1;FOXC1;PIK3R1
Juvenile Myelomonocytic Leukemia	3/121	0.21804205584213232	0.43491522844280417	0	0	1.896242830444029	2.8881054822156726	BRAF;PIK3R1;PAFAH1B1
Chondrosarcoma	5/241	0.21849465806491508	0.43491522844280417	0	0	1.5827326449769465	2.407326402307827	SLC25A16;AIMP2;HGF;DCN;MTOR
Severe psychomotor retardation	2/66	0.21901624325882652	0.43491522844280417	0	0	2.328361742424242	3.5358719862335053	MECP2;PEX6
Thyroid Nodule	2/66	0.21901624325882652	0.43491522844280417	0	0	2.328361742424242	3.5358719862335053	GHR;BRAF
Wide spaced nipples	2/66	0.21901624325882652	0.43491522844280417	0	0	2.328361742424242	3.5358719862335053	HDAC4;BRAF
Arachnodactyly	2/66	0.21901624325882652	0.43491522844280417	0	0	2.328361742424242	3.5358719862335053	HPGD;FZD4
Beckwith-Wiedemann Syndrome	2/66	0.21901624325882652	0.43491522844280417	0	0	2.328361742424242	3.5358719862335053	CDKN1C;NSD1
Dentatorubral-Pallidoluysian Atrophy	2/66	0.21901624325882652	0.43491522844280417	0	0	2.328361742424242	3.5358719862335053	ATXN2;ATXN1
Giant Cell Tumor of Bone	2/66	0.21901624325882652	0.43491522844280417	0	0	2.328361742424242	3.5358719862335053	HGF;DCN
Paroxysmal atrial fibrillation	2/66	0.21901624325882652	0.43491522844280417	0	0	2.328361742424242	3.5358719862335053	ABCC9;FKBP5
Proliferative vitreoretinopathy	2/66	0.21901624325882652	0.43491522844280417	0	0	2.328361742424242	3.5358719862335053	MECP2;HGF
Adenocarcinoma, Oxyphilic	3/122	0.22152050128590806	0.43564568582817065	0	0	1.8802121609099913	2.8339312353459825	CDKN1C;CEACAM1;MTOR
Congenital Disorders of Glycosylation	3/122	0.22152050128590806	0.43564568582817065	0	0	1.8802121609099913	2.8339312353459825	IGFBP5;STT3A;COG1
Nephroblastoma	7/370	0.22383049390903104	0.43564568582817065	0	0	1.4422604422604424	2.158870961279377	CDKN1C;HPGDS;DLG2;NSD1;HGF;PRDM2;ARHGAP24
Short distal phalanx of finger	2/67	0.22391271615625935	0.43564568582817065	0	0	2.2924242424242425	3.430610501729598	ABCC9;ARID1B
Abnormality of cardiovascular system morphology	2/67	0.22391271615625935	0.43564568582817065	0	0	2.2924242424242425	3.430610501729598	FOXC1;ARID1B
Wide nose	2/67	0.22391271615625935	0.43564568582817065	0	0	2.2924242424242425	3.430610501729598	MECP2;PAFAH1B1
Aplasia/Hypoplasia of the cerebellum	2/67	0.22391271615625935	0.43564568582817065	0	0	2.2924242424242425	3.430610501729598	MECP2;ARID1B
Arteriopathic disease	2/67	0.22391271615625935	0.43564568582817065	0	0	2.2924242424242425	3.430610501729598	HPGDS;FOXC1
Cervical Adenocarcinoma	2/67	0.22391271615625935	0.43564568582817065	0	0	2.2924242424242425	3.430610501729598	BRAF;MTOR
Cushing Syndrome	2/67	0.22391271615625935	0.43564568582817065	0	0	2.2924242424242425	3.430610501729598	USP8;UTS2
Flat face	2/67	0.22391271615625935	0.43564568582817065	0	0	2.2924242424242425	3.430610501729598	COL3A1;PEX6
Nail dysplasia	2/67	0.22391271615625935	0.43564568582817065	0	0	2.2924242424242425	3.430610501729598	INSR;ARID1B
Parasitemia	2/67	0.22391271615625935	0.43564568582817065	0	0	2.2924242424242425	3.430610501729598	MECP2;SYVN1
Adenocarcinoma of lung, stage IV	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	BRAF
Aneurysm, Dissecting	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	COL3A1
Short hallux	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	ABCC9
Slow decrease in visual acuity	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	BRAF
Smooth Muscle Tumor	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	CALD1
Melanoma, Amelanotic	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	BRAF
Somnolence	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	LMO3
Submucous clefting	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	BRAF
stage, cervical cancer	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	URGCP
Tuberculosis, Drug-Resistant	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	AIMP2
Agoraphobia	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	MAOA
Alcohol Withdrawal Delirium	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	LMO3
Aortopulmonary Septal Defect	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	FOXC1
Asymmetric Septal Hypertrophy	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	GNS
Bell-shaped thorax	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	TBX15
Bipolar II disorder	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	ADH1B
Borderline ovarian tumour	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	ARHGAP24
Cerebral Small Vessel Diseases	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	FOXC1
Chronic berylliosis	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	PMP22
Classical phenylketonuria	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	MAOB
Congenital Hydrocephalus	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	FOXC1
Congenital keratoglobus	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	PIK3R1
Decreased calcification of skull	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	HDAC6
Defect of skull ossification	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	HDAC6
Dent's disease	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	MAOB
Inflammatory disease of mucous membrane	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	ULK1
Intestinal Volvulus	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	HPGDS
Mixed Connective Tissue Disease	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	RNPC3
Polydactyly of toes	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	BBS1
Proximal amyotrophy	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	SGCD
Pseudolymphoma	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	TBRG1
Pulmonary Infiltrate	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	FOXP1
Pyoderma Gangrenosum	1/19	0.22470389369900068	0.43564568582817065	0	0	4.133333333333334	6.170949988897747	SYN3
Spasmodic movement	3/123	0.2250101315036008	0.4357908305265112	0	0	1.864448669201521	2.7810299977244943	MECP2;ATXN2;ATP13A2
Involuntary jerking movements	3/123	0.2250101315036008	0.4357908305265112	0	0	1.864448669201521	2.7810299977244943	MECP2;ATXN2;ATP13A2
Neoplasm Invasiveness	4/183	0.22701968267672967	0.43945690886086364	0	0	1.6678749626849758	2.472989158650282	TBX15;HGF;SEMA3A;FOXP1
Infection caused by Helicobacter pylori	6/308	0.22798859893682244	0.44090619287674476	0	0	1.4848700967906265	2.1953205324181946	CDKN1C;HPGD;HGF;FHIT;ARHGAP24;HDAC6
Upward slant of palpebral fissure	3/124	0.2285105058196103	0.44090619287674476	0	0	1.8489457310750086	2.7293639374765704	HDAC4;MEF2C;PEX6
CNS disorder	3/124	0.2285105058196103	0.44090619287674476	0	0	1.8489457310750086	2.7293639374765704	MEF2C;NR1H2;PMP22
Carcinoma, Large Cell	2/68	0.22881754482210578	0.44090619287674476	0	0	2.257575757575758	3.3295412232536212	MECP2;FHIT
Adenomatous polyp of colon	2/68	0.22881754482210578	0.44090619287674476	0	0	2.257575757575758	3.3295412232536212	HPGDS;FHIT
Angle class 2 malocclusion	2/68	0.22881754482210578	0.44090619287674476	0	0	2.257575757575758	3.3295412232536212	BRAF;PIK3R1
Angle class 3 malocclusion	2/68	0.22881754482210578	0.44090619287674476	0	0	2.257575757575758	3.3295412232536212	BRAF;PIK3R1
Precocious Puberty	2/68	0.22881754482210578	0.44090619287674476	0	0	2.257575757575758	3.3295412232536212	NSD1;INSR
Small head	10/570	0.22938648170326448	0.44090619287674476	0	0	1.3374720982142858	1.9692230380154636	MECP2;RERE;HDAC4;DSTYK;NSD1;PEX6;STT3A;ARID1B;SHROOM4;DHTKD1
Meningioma	8/438	0.22952263686096414	0.44090619287674476	0	0	1.3920317288624482	2.048727734418167	HPGDS;ZNF197;IGFBP5;DLC1;HGF;PRDM2;ARHGAP24;MTOR
Lupus Erythematosus, Discoid	6/309	0.23013902956280483	0.44090619287674476	0	0	1.47989337395278	2.174069439649396	MECP2;FOXC1;HPGDS;HGF;RNPC3;MTOR
Kidney Neoplasm	5/246	0.23055611460269396	0.44090619287674476	0	0	1.5494984181491551	2.2735185967667917	HPGDS;DLG2;BRAF;FHIT;MTOR
Adenocarcinoma, Tubular	3/125	0.23202118698674778	0.44090619287674476	0	0	1.8336969394751605	2.6788966137027153	CDKN1C;CEACAM1;MTOR
Non-Small Cell Lung Carcinoma	34/2243	0.23282771042392744	0.44090619287674476	0	0	1.1626613696320693	1.6945284160197571	CDKN1C;HDAC4;FOXC1;ZNF197;MAOB;HPGD;PIK3R1;FSTL1;FHIT;HDAC6;MECP2;HPGDS;NSD1;CRNDE;SLC16A7;RBM5;USP8;GSN;URGCP;INSR;NR1H2;LMO3;HGF;BRAF;FRS3;ARHGAP24;DCN;MTOR;TGFBR3;AIMP2;CEACAM1;DLC1;ULK1;PAFAH1B1
Adenocarcinoma of lung (disorder)	19/1187	0.23341514081423143	0.44090619287674476	0	0	1.2227344573234984	1.779001224777211	USP8;PRKCI;GSN;INSR;LMO3;HGF;FAM13A;BRAF;FSTL1;ARHGAP24;MTOR;FOXP1;AIMP2;HPGDS;ATXN1;NSD1;DIP2A;ULK1;PAFAH1B1
Calcification of coronary artery	7/375	0.23356352335197106	0.44090619287674476	0	0	1.4222972972972974	2.068448652356102	CLEC3B;ATXN1;SCARA5;DGKB;TSHZ2;PIP5K1B;ARID1B
Histiocytosis, Langerhans-Cell	2/69	0.2337296457096074	0.44090619287674476	0	0	2.223767526006332	3.232446664608192	GSN;BRAF
Thin lips	2/69	0.2337296457096074	0.44090619287674476	0	0	2.223767526006332	3.232446664608192	HDAC4;COL3A1
Bowed and upward slanting eyebrows	2/69	0.2337296457096074	0.44090619287674476	0	0	2.223767526006332	3.232446664608192	HDAC4;ABCC9
Highly arched eyebrow	2/69	0.2337296457096074	0.44090619287674476	0	0	2.223767526006332	3.232446664608192	HDAC4;ABCC9
Kallmann Syndrome	2/69	0.2337296457096074	0.44090619287674476	0	0	2.223767526006332	3.232446664608192	SEMA3A;EBF2
Malignant neoplasm of salivary gland	2/69	0.2337296457096074	0.44090619287674476	0	0	2.223767526006332	3.232446664608192	SON;ACACB
Progressive supranuclear palsy	2/69	0.2337296457096074	0.44090619287674476	0	0	2.223767526006332	3.232446664608192	ATXN2;MTOR
Arnold-Chiari Malformation, Type I	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	NFIA
Soft skin	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	COL3A1
Mental Disorders, Severe	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	MAOA
Psychosis, Involutional	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	FKBP5
Abnormal visual pursuit	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	STT3A
Abnormality of abdomen morphology	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	GSN
Velvety skin	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	COL3A1
Accessory nipple	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	HDAC4
Wolf-Hirschhorn Syndrome	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	IL1RL1
Zellweger Spectrum	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	PEX6
Adult Myelodysplastic Syndrome	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	PAFAH1B1
Aplasia/Hypoplasia of the iris	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	FOXC1
Arteriosclerosis Obliterans	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	HGF
Atrophy of testis	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	ADH1B
Autosomal dominant compelling helio ophthalmic outburst syndrome	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	FHIT
Calf muscle hypertrophy	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	SGCD
Constitutional Symptom	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	HGF
Coronal craniosynostosis	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	IL11RA
Destructive Arthritis	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	AIMP2
Fibrosis of pancreas	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	ADH1B
Fissured tongue	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	ABCC9
Glycogen Storage Disease Type I	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	HGF
Hereditary Motor and Sensory Neuropathy Type I	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	PMP22
Impaired smooth pursuit	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	STT3A
Impulsive Behavior	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	LMO3
Infantile neuronal ceroid lipofuscinosis	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	ATP13A2
Infantile Refsum Disease (disorder)	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	PEX6
Involutional Depression	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	FKBP5
Involutional paraphrenia	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	FKBP5
Morphologically abnormal structure (morphologic abnormality)	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	ZNF197
Multiple System Atrophy	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	ATXN2
Observation of Neuromuscular Block	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	PPP1R12A
Overnutrition	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	GHR
Panic Attacks	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	MAOA
Perineurioma	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	BRAF
Peroxisome biogenesis disorders	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	PEX6
PITUITARY DWARFISM I	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	RNPC3
Poikiloderma	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	MECP2
Pseudoachondroplasia	1/20	0.2350251221917981	0.44090619287674476	0	0	3.9155908639523336	5.6700217348339885	DCN
Respiratory Distress Syndrome, Adult	4/186	0.23554087911429325	0.4411252650925666	0	0	1.6401308615049073	2.3714173146622977	HPGDS;ACAA2;HGF;EBF1
Spastic Paraplegia, Hereditary	3/126	0.23554174122509733	0.4411252650925666	0	0	1.8186960957062042	2.629592915361422	USP8;ATXN2;DSTYK
Hypogonadotropic hypogonadism	3/126	0.23554174122509733	0.4411252650925666	0	0	1.8186960957062042	2.629592915361422	SEMA3A;PMP22;BRAF
Immunologic Deficiency Syndromes	11/641	0.23561030883096468	0.4411252650925666	0	0	1.3080859010270776	1.8909376793159591	MECP2;USP8;EGFL7;HGF;BRAF;IL16;PIK3R1;FHIT;VPS39;ANGPTL1;MTOR
Chronic Lymphocytic Leukemia	18/1120	0.23601276796961113	0.4416592632595753	0	0	1.2271529769919793	1.7718486005122545	IL11RA;INSR;HGF;LAMA4;EBF1;COG1;BRAF;IL16;PIK3R1;FAM126B;FHIT;ARHGAP24;MTOR;FOXP1;AIMP2;HPGDS;ARHGAP20;CD22
Secondary malignant neoplasm of liver	9/508	0.2366439323147602	0.4426205029938936	0	0	1.3498982400598862	1.945471538586039	CEACAM1;GSN;CALD1;HGF;ANKRD12;ULK1;BRAF;FSTL1;SASH1
Anemia, Diamond-Blackfan	2/70	0.23864796239288988	0.44482279779021083	0	0	2.1909536541889483	3.139123407315888	AIMP2;COL3A1
Chromosome 8, trisomy	2/70	0.23864796239288988	0.44482279779021083	0	0	2.1909536541889483	3.139123407315888	CD22;PAFAH1B1
Glaucoma, Open-Angle	2/70	0.23864796239288988	0.44482279779021083	0	0	2.1909536541889483	3.139123407315888	FOXC1;ATXN2
Squamous cell carcinoma of oropharynx	2/70	0.23864796239288988	0.44482279779021083	0	0	2.1909536541889483	3.139123407315888	NR1H2;ARHGAP24
Stromal Neoplasm	2/70	0.23864796239288988	0.44482279779021083	0	0	2.1909536541889483	3.139123407315888	ZNF407;HGF
alpha-Thalassemia	2/70	0.23864796239288988	0.44482279779021083	0	0	2.1909536541889483	3.139123407315888	TGFBR3;NSD1
Neck Neoplasms	2/70	0.23864796239288988	0.44482279779021083	0	0	2.1909536541889483	3.139123407315888	ADH1B;BRAF
Brain Diseases	5/250	0.24034151743386314	0.4460183616097401	0	0	1.5238877160059425	2.172598149142019	MECP2;LMO3;ABCC9;TTC19;MTOR
Ependymoma	3/128	0.24261075204955665	0.4460183616097401	0	0	1.7894144486692016	2.53434224988193	IGFBP5;LRIG3;ARHGAP24
Cholestasis	6/315	0.24317488656616712	0.4460183616097401	0	0	1.4507094846900672	2.0512660683968233	SLC10A7;MAOB;INSR;NR1H2;PEX6;SAA1
Splenic Marginal Zone B-Cell Lymphoma	2/71	0.24357146506553837	0.4460183616097401	0	0	2.159090909090909	3.0493810092411864	BRAF;CD22
Tracheal Diseases	2/71	0.24357146506553837	0.4460183616097401	0	0	2.159090909090909	3.0493810092411864	HGF;FHIT
Cakut	2/71	0.24357146506553837	0.4460183616097401	0	0	2.159090909090909	3.0493810092411864	DSTYK;FOXC1
Duodenal Ulcer	2/71	0.24357146506553837	0.4460183616097401	0	0	2.159090909090909	3.0493810092411864	ADH1B;ARID1B
Gout	2/71	0.24357146506553837	0.4460183616097401	0	0	2.159090909090909	3.0493810092411864	HGF;ABCC9
Malocclusion	2/71	0.24357146506553837	0.4460183616097401	0	0	2.159090909090909	3.0493810092411864	BRAF;PIK3R1
Neurofibromatoses	2/71	0.24357146506553837	0.4460183616097401	0	0	2.159090909090909	3.0493810092411864	HGF;BRAF
Pediatric Obesity	2/71	0.24357146506553837	0.4460183616097401	0	0	2.159090909090909	3.0493810092411864	GHR;SORT1
46, XY female	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	PMP22
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	MECP2
Disruptive, Impulse Control, and Conduct Disorders	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	LMO3
Shared Paranoid Disorder	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	HPGDS
Sinus Node Dysfunction (disorder)	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	NAA50
Lymphoma, Follicular, Grade 2	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	EBF1
Lymphoma, Mixed-Cell, Follicular	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	EBF1
Lymphoma, Small Cleaved-Cell, Follicular	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	EBF1
SMITH-MCCORT DYSPLASIA 1	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	COL15A1
Neoplasms, Neuroepithelial	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	BRAF
Neoplasms, Radiation-Induced	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	BRAF
Oncocytoma, renal	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	DLG2
Polyarticular Juvenile Idiopathic Arthritis, Rheumatoid Factor Negative	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	ATXN2
Abnormal development of end part of bone	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	CDKN1C
Absent eyelashes	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	BRAF
Aplasia of eyelashes	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	BRAF
Bilateral Cryptorchidism	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	ARID1B
Biliary tract abnormality	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	BBS1
Chediak-Higashi Syndrome	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	VPS39
Diabetic Ketoacidosis	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	INSR
Diabetic peripheral neuropathy	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	HGF
Duane Retraction Syndrome	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	HOXD3
Early tooth exfoliation	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	COL3A1
Epiphyseal dysplasia	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	CDKN1C
Erythema Chronicum Migrans	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	HPGDS
External exotoses	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	DCN
Failure of development of eyelashes	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	BRAF
Heparin-induced thrombocytopenia	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	SYVN1
Increased CSF protein	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	PMP22
Infantile nystagmus syndrome	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	MEF2A
Lumbar disc disease	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	CILP
Mental handicap	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	MECP2
Nodular Goiter	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	BRAF
pathologic fistula	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	UTS2
Pathological accumulation of air in tissues	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	HGF
Premature tooth loss	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	COL3A1
Progressive renal failure	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	SAA1
Prolonged QT interval	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	AKAP9
Raynaud Phenomenon	1/21	0.2452094576304146	0.4460183616097401	0	0	3.719622641509434	5.228459685894149	RNPC3
Chronic liver disease	3/129	0.246158359248098	0.44752825255192336	0	0	1.775122216186855	2.4883311989793815	ADH1B;HGF;CPEB4
Agenesis of corpus callosum	6/317	0.24756861170468641	0.44918248474525896	0	0	1.4412317585951027	2.0120568417536604	RERE;NFIA;NUMA1;ACACB;ARID1B;MTOR
Carcinoma of lung	37/2476	0.24775715512084084	0.44918248474525896	0	0	1.1457108020861868	1.5986174150965955	CDKN1C;HDAC4;HPGD;FAM13A;PRDM2;PIK3R1;WASL;LSP1;FSTL1;FHIT;MECP2;IL1RL1;HPGDS;NSD1;RBM5;SASH1;USP8;PRKCI;EGFL7;GSN;IGFBP5;INSR;NR1H2;LMO3;HGF;BRAF;IL16;ATP11A;ARHGAP24;MTOR;HIPK2;AIMP2;DLC1;HOXD3;CD22;ANGPTL1;PAFAH1B1
Glioblastoma Multiforme	14/854	0.2482085913965054	0.44918248474525896	0	0	1.2496031746031746	1.741304269445165	MEF2A;PHF3;USP8;GYPC;FZD4;HGF;BRAF;PIK3R1;FSTL1;HDAC6;MTOR;SLC25A16;HPGDS;TACC1
Varying degree of multiple fractures	2/72	0.2484991500422404	0.44918248474525896	0	0	2.1281385281385283	2.963041011819363	USP8;FZD4
alpha^+^ Thalassemia	2/72	0.2484991500422404	0.44918248474525896	0	0	2.1281385281385283	2.963041011819363	TGFBR3;NSD1
Benign melanocytic nevus	2/72	0.2484991500422404	0.44918248474525896	0	0	2.1281385281385283	2.963041011819363	CDKN1C;BRAF
Contact hypersensitivity	2/72	0.2484991500422404	0.44918248474525896	0	0	2.1281385281385283	2.963041011819363	HDAC4;SAA1
Frequent fractures	2/72	0.2484991500422404	0.44918248474525896	0	0	2.1281385281385283	2.963041011819363	USP8;FZD4
Hallucinations	2/72	0.2484991500422404	0.44918248474525896	0	0	2.1281385281385283	2.963041011819363	ATP13A2;TTC19
Increased fracture rate	2/72	0.2484991500422404	0.44918248474525896	0	0	2.1281385281385283	2.963041011819363	USP8;FZD4
Isolated somatotropin deficiency	2/72	0.2484991500422404	0.44918248474525896	0	0	2.1281385281385283	2.963041011819363	CDKN1C;RNPC3
Rectal Neoplasms	2/72	0.2484991500422404	0.44918248474525896	0	0	2.1281385281385283	2.963041011819363	CDKN1C;BRAF
Congenital pes cavus	3/130	0.24971414097910588	0.4501683315605776	0	0	1.7610550582317894	2.443355502867736	MECP2;PMP22;IDS
Delayed Puberty	3/130	0.24971414097910588	0.4501683315605776	0	0	1.7610550582317894	2.443355502867736	GHR;INSR;SEMA3A
Unipolar Depression	9/517	0.25200263993525884	0.4501683315605776	0	0	1.3253622966389902	1.8267676823106518	MECP2;RERE;DLG2;MAOB;MAOA;SEMA3A;FHIT;MTOR;FKBP5
Acute Coronary Syndrome	5/255	0.2527286686043604	0.4501683315605776	0	0	1.4930268199233716	2.0535670501954315	COL3A1;GSN;HGF;FSTL1;FHIT
Hematopoietic Neoplasms	4/192	0.2528043526364237	0.4501683315605776	0	0	1.5872990092577555	2.182757405862553	PMP22;FHIT;ARHGAP24;FOXP1
Fractures, Multiple	2/73	0.25343003916362444	0.4501683315605776	0	0	2.0980580452411437	2.87993603657619	USP8;FZD4
Withdrawal Symptoms	2/73	0.25343003916362444	0.4501683315605776	0	0	2.0980580452411437	2.87993603657619	ADH1B;LMO3
Attention Deficit Disorder	2/73	0.25343003916362444	0.4501683315605776	0	0	2.0980580452411437	2.87993603657619	MECP2;BTBD9
Chorea	2/73	0.25343003916362444	0.4501683315605776	0	0	2.0980580452411437	2.87993603657619	MECP2;ATXN1
Failure to Thrive	2/73	0.25343003916362444	0.4501683315605776	0	0	2.0980580452411437	2.87993603657619	GHR;PAFAH1B1
Infertility	2/73	0.25343003916362444	0.4501683315605776	0	0	2.0980580452411437	2.87993603657619	USP8;TTC19
Marfan Syndrome	2/73	0.25343003916362444	0.4501683315605776	0	0	2.0980580452411437	2.87993603657619	COL3A1;DCN
Invasive carcinoma of breast	7/385	0.25343892396527523	0.4501683315605776	0	0	1.383955383955384	1.8996620224296312	FOXC1;HPGDS;GSN;HGF;FHIT;HDAC6;MTOR
Skin Neoplasms	5/256	0.25522539825363394	0.4501683315605776	0	0	1.4870021828395232	2.0306623884689494	HPGDS;HGF;BRAF;HDAC6;MTOR
ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	ABCC9
Breast cancer, lobular	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	FHIT
Cockayne Syndrome, Type II	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	NR1H2
Rosacea	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	USP8
Roussy-Levy Syndrome (disorder)	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	PMP22
Severe depression	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	PAFAH1B1
Lymphoma, Follicular, Grade 3	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	EBF1
Spasm	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	SGCD
Submucous cleft of hard palate	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	BRAF
Psychoses, Drug	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	HPGDS
TDP-43 Proteinopathies	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	ATXN2
Absent eyebrow	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	BRAF
Agenesis of eyebrows	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	BRAF
AIDS with Kaposi's sarcoma	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	HGF
Anaplastic large B-cell lymphoma	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	INSR
Angiomyolipoma of kidney	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	MTOR
Aplasia of eyebrows	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	BRAF
Basal-Like Breast Carcinoma	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	HGF
Biliary Tract Diseases	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	BBS1
Collapse of vertebra	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	USP8
Compression fracture of vertebral column	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	USP8
Death in childhood	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	OGDH
Disorder of skeletal system	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	HPGD
Dystonia Musculorum Deformans	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	GSN
Dystrophic fingernails	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	BRAF
Epidermodysplasia Verruciformis	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	FOXK1
Familial generalized lipodystrophy	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	INSR
Fragile skin	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	COL3A1
Gallbladder adenocarcinoma	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	BRAF
Hypothalamic gonadotropin-releasing hormone deficiency	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	SEMA3A
Infantile muscular hypotonia	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	MECP2
Madarosis of eyebrow	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	BRAF
Mastitis	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	CRLS1
Nephrosclerosis	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	DCN
Neurodegeneration with brain iron accumulation (NBIA)	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	ATP13A2
Other specified manifestations of hyperkinetic syndrome	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	MECP2
Personality Traits	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	FHIT
Platelet Storage Pool Deficiency	1/22	0.25525870884348123	0.4501683315605776	0	0	3.542318059299191	4.836956329181093	RAB27B
Sleep Apnea, Obstructive	3/132	0.2568485709816249	0.4523368709152786	0	0	1.733575028738173	2.356394077542693	SGCD;GSN;IDS
Mouth Neoplasms	3/132	0.2568485709816249	0.4523368709152786	0	0	1.733575028738173	2.356394077542693	ADH1B;FHIT;DCN
Nausea and vomiting	3/132	0.2568485709816249	0.4523368709152786	0	0	1.733575028738173	2.356394077542693	BRAF;KIAA0319L;FOXP1
Erythrocyte Mean Corpuscular Hemoglobin Test	7/387	0.25747464533300585	0.4530158752776427	0	0	1.376529160739687	1.8677216064487774	CEP104;MEF2C;DSTYK;ATXN2;FRS3;CPEB4;FOXP1
Finding of Mean Corpuscular Hemoglobin	7/387	0.25747464533300585	0.4530158752776427	0	0	1.376529160739687	1.8677216064487774	CEP104;MEF2C;DSTYK;ATXN2;FRS3;CPEB4;FOXP1
Neuroendocrine Tumors	5/257	0.257728229868479	0.45325034636534095	0	0	1.481025360335705	2.0080476747616443	GSN;FZD4;BRAF;FHIT;MTOR
Acoustic Neuroma	2/74	0.2583631794194898	0.45384504659030184	0	0	2.0688131313131315	2.7999089592494055	HGF;BRAF
DiGeorge Syndrome	2/74	0.2583631794194898	0.45384504659030184	0	0	2.0688131313131315	2.7999089592494055	SYVN1;PKP4
Ovarian Carcinoma	33/2203	0.2591680969310731	0.45384504659030184	0	0	1.1463618203753883	1.5479076102627414	CDKN1C;HDAC4;CHIC1;ADH1B;PIK3R1;FSTL1;FHIT;HDAC6;AKAP13;HPGDS;ATXN2;CRNDE;PRKCI;PPP1R12A;IL11RA;EYA2;INSR;NR1H2;HGF;BRAF;IL16;ARHGAP24;DCN;MTOR;HIPK2;FOXP1;TGFBR3;AIMP2;CCDC80;DLC1;SIK3;OGT;FKBP5
Narcolepsy	5/258	0.2602370217197037	0.45384504659030184	0	0	1.475095785440613	1.985718543595583	NAA50;MAOA;CILP;ABCC9;FHIT
beta Thalassemia	3/133	0.26042640030919695	0.45384504659030184	0	0	1.7201520912547528	2.31435281188646	RERE;HPGDS;GSN
Gastrointestinal Stromal Tumors	6/323	0.26088415475927257	0.45384504659030184	0	0	1.4135161368599853	1.8993116972125972	SLC25A16;IGFBP5;INSR;BRAF;MTOR;HIPK2
Shy-Drager Syndrome	2/75	0.2632976423459775	0.45384504659030184	0	0	2.0403694479036947	2.7228121574163606	ATXN1;LMO3
Angiogenic Switch	2/75	0.2632976423459775	0.45384504659030184	0	0	2.0403694479036947	2.7228121574163606	AIMP2;SEMA3A
Apnea	2/75	0.2632976423459775	0.45384504659030184	0	0	2.0403694479036947	2.7228121574163606	MECP2;CEP104
Breast Fibrocystic Disease	2/75	0.2632976423459775	0.45384504659030184	0	0	2.0403694479036947	2.7228121574163606	HGF;FHIT
Central Nervous System Neoplasms	2/75	0.2632976423459775	0.45384504659030184	0	0	2.0403694479036947	2.7228121574163606	HGF;BRAF
Malignant Fibrous Histiocytoma	2/75	0.2632976423459775	0.45384504659030184	0	0	2.0403694479036947	2.7228121574163606	MTOR;FOXP1
Mitral Valve Stenosis	2/75	0.2632976423459775	0.45384504659030184	0	0	2.0403694479036947	2.7228121574163606	SYN3;ARHGAP24
Ovarian Cysts	2/75	0.2632976423459775	0.45384504659030184	0	0	2.0403694479036947	2.7228121574163606	INSR;PIK3R1
Polycythemia	2/75	0.2632976423459775	0.45384504659030184	0	0	2.0403694479036947	2.7228121574163606	ATXN1;PIK3R1
response to statin	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	EPB41L2
Bone Cysts, Aneurysmal	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	PAFAH1B1
Rubinstein-Taybi Syndrome	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	MECP2
Seborrheic dermatitis	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	HPGD
Lupus Erythematosus, Subacute Cutaneous	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	MECP2
Stage III Colon Cancer AJCC v7	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	BRAF
Stage IV Bladder Cancer AJCC v6	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	MTOR
Stomatitis	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	MTOR
Superficial spreading malignant melanoma of skin	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	BRAF
Psychomotor retardation, profound	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	PEX6
Taurodontism	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	PEX6
Varicocele	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	HPGDS
Acquired cubitus valgus	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	BRAF
Activated B-cell type diffuse large B-cell lymphoma	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	FOXP1
Akinesia	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	ATP13A2
Aniridia	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	FOXC1
Aplasia/Hypoplasia of the abdominal wall musculature	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	BRAF
Bullet vertebral body	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	ABCC9
Childhood Non-Hodgkin Lymphoma	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	HPGDS
Cholesteatoma	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	HGF
cocaine use	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	MAOA
Cryptogenic Chronic Hepatitis	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	HGF
Depletion of mitochondrial DNA	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	DGKB
Electrocardiogram: P-R interval	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	ARHGAP24
Enlarged thorax	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	BRAF
Episodic tachypnea	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	CEP104
External genital hypoplasia	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	PEX6
Ferritin measurement	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	SIK3
Gait imbalance	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	BBS1
Granulomatous Slack Skin	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	BRAF
Hemimegalencephaly	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	MTOR
Hunger	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	ARHGAP24
Increased gastric cancer	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	DLC1
Irido-corneo-trabecular dysgenesis (disorder)	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	FOXC1
Large elongated pulp chamber	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	PEX6
Macule	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	COL3A1
Menorrhagia	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	USP8
Multi-infarct dementia	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	MTOR
Neurocysticercosis	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	HPGDS
Ovoid vertebral bodies	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	ABCC9
Porphyria Cutanea Tarda	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	HPGDS
PR interval feature	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	ARHGAP24
Pre B-cell acute lymphoblastic leukemia	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	MTOR
Pseudoaphakia	1/23	0.2651746608827328	0.45384504659030184	0	0	3.3811320754716983	4.488001693967901	ATP2B1
Adenocarcinoma	26/1712	0.26721026624614985	0.4567724630673974	0	0	1.1596678529062872	1.5304361821455883	CDKN1C;HPGD;PRDM2;FHIT;MECP2;HPGDS;CLEC3B;MAP2K5;EGFL7;GSN;IGFBP5;IL11RA;EYA2;INSR;LMO3;HGF;BRAF;PDGFRL;ARHGAP24;MTOR;FOXP1;TGFBR3;AIMP2;CEACAM1;PMP22;CPEB4
Tuberous Sclerosis	4/197	0.26738671603283487	0.4567724630673974	0	0	1.545781750583396	2.038977784308842	GSN;HGF;BRAF;MTOR
Allergic asthma	4/197	0.26738671603283487	0.4567724630673974	0	0	1.545781750583396	2.038977784308842	TGFBR3;HPGDS;IL16;MTOR
Flexion contractures of joints	3/135	0.26760126995131933	0.4567724630673974	0	0	1.693916349809886	2.233017432858139	SON;IDS;GNS
Mycoses	3/135	0.26760126995131933	0.4567724630673974	0	0	1.693916349809886	2.233017432858139	MECP2;CEACAM1;MTOR
Impaired glucose tolerance	6/326	0.2676126429492291	0.4567724630673974	0	0	1.400048076923077	1.845563964309251	GHR;USP8;ADH1B;INSR;UTS2;PIK3R1
Machado-Joseph Disease	2/76	0.26823252369342243	0.4574159876655149	0	0	2.012694512694513	2.648506820408596	ATXN2;ATXN1
Platyspondyly	2/76	0.26823252369342243	0.4574159876655149	0	0	2.012694512694513	2.648506820408596	ABCC9;HDAC6
Melanoma, B16	3/136	0.27119751514459944	0.4585085599568786	0	0	1.6810943709082593	2.1936733007065303	HGF;MTOR;NSMAF
Flexion contracture	3/136	0.27119751514459944	0.4585085599568786	0	0	1.6810943709082593	2.1936733007065303	SON;IDS;GNS
Follicular adenoma	3/136	0.27119751514459944	0.4585085599568786	0	0	1.6810943709082593	2.1936733007065303	HGF;BRAF;HIPK2
Liver carcinoma	52/3593	0.27169701836863863	0.4585085599568786	0	0	1.1111967420365438	1.4479646235558672	CDKN1C;PRDM2;MECP2;GHR;HPGDS;MEF2A;MEF2C;EGFL7;IGFBP5;SCARA5;HGF;IL16;ARID1B;PDGFRL;DCN;FOXP1;ST7L;CEACAM1;ULK1;SRSF5;ANGPTL1;HDAC4;FOXC1;HPGD;MAOA;ADH1B;LAMA4;FOXK1;PIK3R1;RCHY1;FSTL1;FHIT;HDAC6;CLEC3B;CALD1;NSD1;GSN;URGCP;INSR;STAT2;NR1H2;RAB27B;BRAF;SORBS3;ARHGAP24;MTOR;HIPK2;AIMP2;GON4L;DLC1;SAA1;CD22
Pancreatic Neoplasm	11/665	0.27249349481636154	0.4585085599568786	0	0	1.2584997301672962	1.6362265154940911	CDKN1C;TGFBR3;AIMP2;GSN;HGF;SEMA3A;BRAF;FHIT;DCN;MTOR;FOXP1
Undergrowth	9/529	0.2729785835283308	0.4585085599568786	0	0	1.2939688715953308	1.680039928586518	MECP2;RERE;USP8;SON;PEX6;STT3A;BRAF;PIK3R1;ARID1B
Superficial ulcer	2/77	0.273166942681314	0.4585085599568786	0	0	1.9857575757575758	2.576862320665503	DCN;PAFAH1B1
High-Grade Prostatic Intraepithelial Neoplasia	2/77	0.273166942681314	0.4585085599568786	0	0	1.9857575757575758	2.576862320665503	HPGDS;DCN
Non-small cell lung cancer stage I	2/77	0.273166942681314	0.4585085599568786	0	0	1.9857575757575758	2.576862320665503	HPGDS;FHIT
PANIC DISORDER 1	2/77	0.273166942681314	0.4585085599568786	0	0	1.9857575757575758	2.576862320665503	MECP2;MAOA
Hepatitis, Drug-Induced	6/329	0.2743847286510626	0.4585085599568786	0	0	1.386830197666111	1.7934821486387533	COL3A1;HPGDS;CCDC80;SLC10A7;GSN;WASL
Diarrhea	6/329	0.2743847286510626	0.4585085599568786	0	0	1.386830197666111	1.7934821486387533	IL1RL1;SAA1;IDS;BRAF;PIK3R1;GNS
Lymphopenia	3/137	0.2747991106210673	0.4585085599568786	0	0	1.6684637648260598	2.155179597065231	ADH1B;BRAF;RNPC3
Periodontal Diseases	3/137	0.2747991106210673	0.4585085599568786	0	0	1.6684637648260598	2.155179597065231	COL3A1;HGF;IL16
Pruritus	3/137	0.2747991106210673	0.4585085599568786	0	0	1.6684637648260598	2.155179597065231	AIMP2;SEMA3A;MTOR
Anemia, Megaloblastic	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	MAOB
Asthma, Occupational	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	HPGDS
Secondary hypothyroidism	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	BRAF
Senile lentigo	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	BRAF
Glossitis, Benign Migratory	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	HPGDS
Skin tag on the posterior cheek	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	ARID1B
Stage III Colon Cancer	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	BRAF
Signs and Symptoms, Respiratory	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	HPGDS
Thickened calvaria	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	HPGD
Thickened helices	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	BRAF
Thymus Neoplasms	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	BRAF
Abnormality of immune system physiology	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	NSD1
Acute Lung Injury	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	IL1RL1
Adenoma of lung	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	BRAF
Alcohol or Other Drugs use	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	MAOA
Body Weight	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	MAP2K5
Carotid artery occlusion	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	HGF
Chronic thromboembolic pulmonary hypertension	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	MTOR
Cognitive changes	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	SORT1
Congenital hypoplasia of adrenal gland	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	PMP22
Dupuytren's Disease	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	AIMP2
Endemic Cretinism	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	GHR
Episodic Ataxia	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	ATXN1
Erectile abnormalities	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	SEMA3A
Etat Marbre	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	UTS2
Familial primary pulmonary hypertension	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	HDAC4
Fetal Alcohol Spectrum Disorders	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	MECP2
Healing ulcer	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	HGF
Increased thickness of cranium	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	HPGD
Infant Leukemia	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	CD22
Long nose	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	ABCC9
Lyme Arthritis	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	HPGDS
Pelger-Huet Anomaly	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	PAFAH1B1
Penis carcinoma	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	FHIT
Profound global developmental delay	1/24	0.2749590753763177	0.4585085599568786	0	0	3.2339622641509433	4.17547542976305	PEX6
Fatigue	6/330	0.2766513186536676	0.46112633511874596	0	0	1.3824786324786325	1.776481369688619	USP8;MEF2C;ATXN2;INSR;PIK3R1;FOXP1
Sudden infant death syndrome	2/78	0.2781000418771011	0.4627221103140635	0	0	1.9595295055821371	2.507755632936437	MAOA;IDS
Abnormal skeletal development	2/78	0.2781000418771011	0.4627221103140635	0	0	1.9595295055821371	2.507755632936437	PEX6;ABCC9
Giant Cell Glioblastoma	2/78	0.2781000418771011	0.4627221103140635	0	0	1.9595295055821371	2.507755632936437	BRAF;TACC1
Marinesco-Sjogren syndrome	2/78	0.2781000418771011	0.4627221103140635	0	0	1.9595295055821371	2.507755632936437	PRDM2;BRAF
Hamartoma Syndrome, Multiple	3/138	0.27840566894064367	0.46282178062639223	0	0	1.656020278833967	2.1175133664428007	MAOA;FSTL1;MTOR
Ureteral obstruction	3/138	0.27840566894064367	0.46282178062639223	0	0	1.656020278833967	2.1175133664428007	FOXC1;COL3A1;SYVN1
Distal sensory impairment	2/79	0.28303098647113906	0.46493485370780696	0	0	1.933982683982684	2.441070805708803	PMP22;ATP13A2
Apraxia, Developmental Verbal	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	FOXP1
Rhomboid shaped head	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	ARID1B
Hemangioma, Cavernous	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	BRAF
Small cheekbone	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	BRAF
Lymphoma, Follicular, Grade 1	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	EBF1
Lymphoma, Intermediate-Grade	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	BRAF
Spastic tetraparesis	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	PAFAH1B1
Specific language impairment	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	FOXP1
Spondyloepimetaphyseal disorder	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	DCN
Plagiocephaly, Nonsynostotic	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	ARID1B
Tooth Attrition	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	SAA1
Abnormality of nail of toe	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	PEX6
Abnormality of the liver	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	PEX6
Uterine Carcinosarcoma	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	PIK3R1
Adolescent idiopathic scoliosis	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	GHR
Aortic Diseases	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	COL3A1
Astrocytosis	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	MTOR
Asymmetry of the posterior cranium	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	ARID1B
Atrioventricular Septal Defect	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	FOXP1
CNS metastases	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	BRAF
Depressed cheekbone	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	BRAF
Dyspepsia	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	FHIT
Familial erythrocytosis	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	PIK3R1
Flat head	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	ARID1B
Flattening of cranial vault	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	ARID1B
Flattening of head	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	ARID1B
Flattening of the zygomatic bone	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	BRAF
Frontal lobe hypoplasia	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	BRAF
Hallervorden-Spatz Syndrome	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	ATP13A2
Hypokinesia	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	ATP13A2
Hypoplasia of the zygomatic bone	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	BRAF
Hypotrophic cheekbone	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	BRAF
Onion bulb formation	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	PMP22
Perianal Squamous Intraepithelial Neoplasia	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	FHIT
Plagiocephaly	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	ARID1B
Preauricular skin tag	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	ARID1B
Prematurely aged appearance	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	INSR
Pseudohypoparathyroidism	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	CDKN1C
Quadriplegia	1/25	0.2846136906424749	0.46493485370780696	0	0	3.099056603773585	3.894344224925176	PMP22
Left Ventricular Hypertrophy	4/203	0.28507934644027366	0.465493670585397	0	0	1.4987149487897502	1.880868869849521	BBS1;COL3A1;NPR1;MTOR
Thyroid Diseases	3/140	0.2856321452847524	0.46599233057066364	0	0	1.6316782770392162	2.0445752830570774	MECP2;INSR;BRAF
Contracture of joint	3/140	0.2856321452847524	0.46599233057066364	0	0	1.6316782770392162	2.0445752830570774	SON;IDS;GNS
Abnormality of the metaphysis	2/80	0.28795896399173315	0.46911709853441114	0	0	1.9090909090909092	2.376698472536413	NSD1;ABCC9
Dyslexia	2/80	0.28795896399173315	0.46911709853441114	0	0	1.9090909090909092	2.376698472536413	DIP2A;KIAA0319L
Extrahepatic Cholangiocarcinoma	2/80	0.28795896399173315	0.46911709853441114	0	0	1.9090909090909092	2.376698472536413	AIMP2;BRAF
Osteogenesis Imperfecta	4/204	0.2880456195673196	0.46911709853441114	0	0	1.491145038167939	1.8559334072660385	CDKN1C;COL3A1;INSR;DCN
Mood Disorders	6/336	0.29034085396493836	0.4723044402294305	0	0	1.356923076923077	1.6781063454567287	HDAC4;HPGDS;MAOB;MAOA;PIK3R1;FKBP5
Failure to gain weight	9/539	0.29084167760797125	0.4723044402294305	0	0	1.2688936201453638	1.5670534504842082	MECP2;RERE;USP8;SON;PEX6;STT3A;BRAF;PIK3R1;ARID1B
Cervical Intraepithelial Neoplasia	4/205	0.29101632083016515	0.4723044402294305	0	0	1.483650450039877	1.8313824011791795	HPGDS;IGFBP5;FHIT;MAP2K5
Colitis	10/608	0.29155296263535246	0.4723044402294305	0	0	1.25	1.5406669996175126	AIMP2;USP8;IL1RL1;HPGDS;GSN;HGF;PMP22;IL16;PIK3R1;FSTL1
Blepharoptosis	6/337	0.2926365237181606	0.4723044402294305	0	0	1.3527538926330467	1.6622964134435114	MECP2;HPGD;PEX6;IDS;BRAF;ARID1B
Neoplasms, Experimental	2/81	0.29288318369850536	0.4723044402294305	0	0	1.8848293057153818	2.3145354048207567	HGF;BRAF
Congenital ear anomaly NOS (disorder)	2/81	0.29288318369850536	0.4723044402294305	0	0	1.8848293057153818	2.3145354048207567	CDKN1C;PEX6
Granulocyte count	2/81	0.29288318369850536	0.4723044402294305	0	0	1.8848293057153818	2.3145354048207567	ATXN1;MAST2
Multicystic Dysplastic Kidney	2/81	0.29288318369850536	0.4723044402294305	0	0	1.8848293057153818	2.3145354048207567	BBS1;PEX6
Malignant neoplasm of ovary	30/2026	0.29403082714482937	0.4723044402294305	0	0	1.1296746034441765	1.3828015407061698	CDKN1C;HDAC4;ADH1B;POP4;PIK3R1;FSTL1;FHIT;HDAC6;HPGDS;ATXN2;CRNDE;PRKCI;IL11RA;EYA2;INSR;NR1H2;HGF;BRAF;IL16;ARHGAP24;DCN;MTOR;HIPK2;FOXP1;TGFBR3;AIMP2;DLC1;SIK3;OGT;FKBP5
Sacral dimples	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	ARID1B
Spasmodic torticollis	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	ATP13A2
Thin rib	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	HDAC6
AA amyloidosis	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	SAA1
Trichothiodystrophy Syndromes	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	NR1H2
Abnormality of the eyelashes	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	COL3A1
Abnormality of the palate	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	PEX6
Acute hepatitis	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	HGF
Anhidrosis	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	NAA50
ATRIOVENTRICULAR CANAL DEFECT	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	BRAF
Borna Disease	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	IL16
Carpal Tunnel Syndrome	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	PMP22
Choroideremia	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	RAB27B
Defect of vertebral segmentation	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	COG1
drug response	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	RCHY1
Generalized pustular psoriasis	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	STAT2
Hiatal Hernia	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	COL3A1
Klatskin Tumor	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	HGF
Menkes Kinky Hair Syndrome	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	AIMP2
Metastatic osteosarcoma	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	RAB27B
MUTYH-Associate Polyposis	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	BRAF
Pharyngeal Carcinoma	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	ADH1B
Plasmablastic lymphoma	1/26	0.29414022213385826	0.4723044402294305	0	0	2.974943396226415	3.640434304991801	MTOR
Thalassemia	2/82	0.2978028763874561	0.47777829444273734	0	0	1.8611742424242423	2.2544840974237617	HPGDS;ARID1B
Non-medullary thyroid carcinoma	2/82	0.2978028763874561	0.47777829444273734	0	0	1.8611742424242423	2.2544840974237617	BRAF;MTOR
Constipation	4/208	0.2999528798494917	0.48102277496510654	0	0	1.461607543780871	1.7599653218988422	MECP2;RERE;BRAF;FOXP1
Gait Ataxia	2/83	0.3027172937055778	0.4811857263873839	0	0	1.8381032547699214	2.1964523899095463	MECP2;PMP22
Myxoid cyst	4/209	0.30293918599521663	0.4811857263873839	0	0	1.454403276857196	1.7368821352383677	ATXN2;SIK3;IDS;BRAF
Nonalcoholic Steatohepatitis	4/209	0.30293918599521663	0.4811857263873839	0	0	1.454403276857196	1.7368821352383677	MAOA;INSR;PIK3R1;DCN
Recurrent skin infections	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	PIK3R1
Chronic Infantile Neurological, Cutaneous, and Articular Syndrome	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	AIMP2
Rothmund-Thomson syndrome	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	MECP2
Skin toxicity	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	HGF
Urogenital Abnormalities	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	BBS1
Achondroplasia	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	DCN
Cervical dysplasia	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	HPGDS
Conotruncal defect	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	HPGDS
Cutaneous lymphoma	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	CD22
Decreased number of peripheral myelinated nerve fibers	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	PMP22
Failure to thrive in infant	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	PAFAH1B1
Fluid overload	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	UTS2
Idiopathic Interstitial Pneumonias	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	FAM13A
Leg Ulcer	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	HGF
Localized scleroderma	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	DCN
Long palpebral fissure	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	BRAF
Loss of appetite (finding)	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	PIK3R1
Mucinous neoplasm	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	BRAF
Mucopolysaccharidoses	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	IDS
Pelizaeus-Merzbacher Disease	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	PMP22
Personality Disorders	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	MAOA
Primary Malignant Liver Neoplasm	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	HGF
Reactive systemic amyloidosis	1/27	0.30354036280548924	0.4811857263873839	0	0	2.860377358490566	3.410258264687014	SAA1
Abnormally small eyeball	3/145	0.3037588684229357	0.4811857263873839	0	0	1.5738231671397205	1.8752434929012507	RERE;TBX15;HDAC6
Decreased size of eyeball	3/145	0.3037588684229357	0.4811857263873839	0	0	1.5738231671397205	1.8752434929012507	RERE;TBX15;HDAC6
Frontotemporal dementia	3/145	0.3037588684229357	0.4811857263873839	0	0	1.5738231671397205	1.8752434929012507	ATXN2;MAOA;SORT1
Germ cell tumor	4/210	0.3059288725883359	0.48421599287405936	0	0	1.4472689542725858	1.7141491797397481	HPGDS;BRAF;PTPN23;FHIT
Neurofibromatosis 1	4/210	0.3059288725883359	0.48421599287405936	0	0	1.4472689542725858	1.7141491797397481	HGF;BRAF;MTOR;HIPK2
Rectal Carcinoma	5/276	0.30625408481115124	0.48452714720017087	0	0	1.3758465170858605	1.6280944638782298	CDKN1C;HPGDS;HGF;BRAF;ARHGAP24
Short philtrum	2/84	0.30762570792520594	0.4862887292296478	0	0	1.8155949741315596	2.140353114287536	MEF2C;SON
Kyphoscoliosis deformity of spine	2/84	0.30762570792520594	0.4862887292296478	0	0	1.8155949741315596	2.140353114287536	PMP22;BRAF
Congenital Heart Defects	5/277	0.30884948376405846	0.48774494502595184	0	0	1.3707178273608294	1.6104580590456754	MEF2C;FOXC1;HPGDS;ARID1B;FOXP1
Infant, Premature	5/278	0.3114480616594593	0.48774494502595184	0	0	1.3656267104542967	1.59303454504731	MECP2;FZD4;HGF;IDS;BRAF
Alzheimer's Disease, Focal Onset	2/85	0.3125274114312055	0.48774494502595184	0	0	1.7936290617013508	2.08610377150197	MAOB;INSR
Cicatrix, Hypertrophic	2/85	0.3125274114312055	0.48774494502595184	0	0	1.7936290617013508	2.08610377150197	COL3A1;DCN
Severe Acute Respiratory Syndrome	2/85	0.3125274114312055	0.48774494502595184	0	0	1.7936290617013508	2.08610377150197	AIMP2;NFIC
Syndactyly	2/85	0.3125274114312055	0.48774494502595184	0	0	1.7936290617013508	2.08610377150197	BBS1;FZD4
Acute Confusional Senile Dementia	2/85	0.3125274114312055	0.48774494502595184	0	0	1.7936290617013508	2.08610377150197	MAOB;INSR
Alcoholic Liver Diseases	2/85	0.3125274114312055	0.48774494502595184	0	0	1.7936290617013508	2.08610377150197	HPGDS;ADH1B
Increased tendency to bruise	2/85	0.3125274114312055	0.48774494502595184	0	0	1.7936290617013508	2.08610377150197	USP8;COL3A1
Primary physiologic amenorrhea	2/85	0.3125274114312055	0.48774494502595184	0	0	1.7936290617013508	2.08610377150197	TGFBR3;PEX6
AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	VPS54
Ataxia, Sensory	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	PMP22
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	GHR
Sarcopenia	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	MTOR
Liposarcoma, well differentiated	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	FOXP1
Spina Bifida Occulta	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	ARID1B
Parkinsonism, Experimental	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	ATP13A2
ADENOMAS AND ADENOCARCINOMAS	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	BRAF
Agammaglobulinemia	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	PIK3R1
Aortic valve disorder	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	FOXC1
Autosomal Dominant Juvenile Parkinson Disease	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	ATP13A2
Centronuclear myopathy	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	WASL
Condylomata Acuminata	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	STAT2
Double Outlet Right Ventricle	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	MEF2C
Familial Juvenile Parkinsonism	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	ATP13A2
Hyperemia	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	HGF
Odontogenic Tumors	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	BRAF
Oligomenorrhea	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	USP8
Paratuberculosis	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	GSN
Philadelphia chromosome positive chronic myelogenous leukemia	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	PAFAH1B1
Pulmonary artery stenosis	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	BRAF
Ramsay Hunt Paralysis Syndrome	1/28	0.3128157832521344	0.48774494502595184	0	0	2.7542976939203356	3.2008817629553445	ATP13A2
Coronary Arteriosclerosis	12/760	0.31281969396939197	0.48774494502595184	0	0	1.1991662806855026	1.3935850856195628	MEF2A;IL1RL1;COL3A1;HPGDS;ADH1B;SORT1;INSR;HGF;UTS2;IL16;ABCC9;ATP2B1
Recurrent respiratory infections	4/213	0.31491616407758044	0.4908105875383722	0	0	1.4262756126958618	1.6479884756311307	MECP2;INSR;PIK3R1;ARID1B
Epithelial ovarian cancer	20/1329	0.3157250002282301	0.4918676905954271	0	0	1.1443601830976293	1.3193141982768124	CDKN1C;PRKCI;COL15A1;GSN;CALCRL;PPP1R12A;GYPC;INSR;HGF;BRAF;FSTL1;FHIT;ARHGAP24;HDAC6;MTOR;FOXP1;AIMP2;HPGDS;DLC1;NFIC
Curvature of digit	2/86	0.31742171637705036	0.4929492747066443	0	0	1.772186147186147	2.033626231428861	BRAF;PIK3R1
Diabetic Neuropathies	2/86	0.31742171637705036	0.4929492747066443	0	0	1.772186147186147	2.033626231428861	HGF;INSR
Craniosynostosis	4/214	0.3179173282124256	0.4929492747066443	0	0	1.4194111232279172	1.6265939124049158	HPGDS;SON;IL11RA;IDS
Stomach Neoplasms	13/835	0.3200457705387438	0.4929492747066443	0	0	1.1821932431262803	1.3468624300958554	EGFL7;URGCP;HPGD;HGF;BRAF;PRDM2;FHIT;ARHGAP24;MTOR;FOXP1;CEACAM1;DLC1;TACC1
Charcot-Marie-Tooth Disease, Type Ia (disorder)	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	PMP22
Romano-Ward Syndrome	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	AKAP9
Scrub Typhus	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	AIMP2
Lymphangioma, Cystic	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	BRAF
Social disinhibition	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	MTOR
Stage IV Breast Cancer AJCC v6 and v7	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	MTOR
Stippled epiphyses	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	PEX6
Torticollis	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	ATP13A2
Upper Aerodigestive Tract Neoplasms	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	ADH1B
Alveolar Bone Loss	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	HGF
Angiofibroma	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	MTOR
Anterior hypopituitarism	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	SEMA3A
Asbestosis	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	AIMP2
Autoinflammatory disorder	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	SAA1
Breast cancer recurrent	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	CALD1
Cardiac Lymphoma	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	BRAF
Childhood Brain Neoplasm	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	BRAF
Cortical white matter abnormalities seen on MRI	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	PAFAH1B1
Costello syndrome (disorder)	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	BRAF
Diffusely thickened skin	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	ABCC9
Erythema Nodosum	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	BRAF
Exostoses	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	DCN
Head Neoplasms	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	ADH1B
HMN (Hereditary Motor Neuropathy) Proximal Type I	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	VPS54
Juvenile Neuronal Ceroid Lipofuscinosis	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	ATP13A2
Left ventricular noncompaction	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	MIB2
Malignant melanoma of eye	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	BRAF
Mask-like facies	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	ATP13A2
Microvascular Angina	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	NSD1
Muckle-Wells Syndrome	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	AIMP2
Open Bite	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	BRAF
Paget Disease Extramammary	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	DLC1
Phenylketonurias	1/29	0.32196813206215447	0.4929492747066443	0	0	2.6557951482479782	3.009819830976711	MAOB
Triangular face	2/87	0.3223079542347929	0.4929492747066443	0	0	1.751247771836007	1.9828464559455805	BRAF;PIK3R1
Actinic keratosis	2/87	0.3223079542347929	0.4929492747066443	0	0	1.751247771836007	1.9828464559455805	GHR;BRAF
Adrenal Gland Neoplasms	2/87	0.3223079542347929	0.4929492747066443	0	0	1.751247771836007	1.9828464559455805	CDKN1C;UTS2
Chronic active hepatitis	2/87	0.3223079542347929	0.4929492747066443	0	0	1.751247771836007	1.9828464559455805	HGF;FHIT
Contact Dermatitis	2/87	0.3223079542347929	0.4929492747066443	0	0	1.751247771836007	1.9828464559455805	HDAC4;SAA1
Gynecomastia	2/87	0.3223079542347929	0.4929492747066443	0	0	1.751247771836007	1.9828464559455805	MECP2;INSR
Malignant Childhood Neoplasm	2/87	0.3223079542347929	0.4929492747066443	0	0	1.751247771836007	1.9828464559455805	HPGDS;ARID1B
Nevus	2/87	0.3223079542347929	0.4929492747066443	0	0	1.751247771836007	1.9828464559455805	CDKN1C;BRAF
Hematologic Neoplasms	9/557	0.3237173261493059	0.4948221104034839	0	0	1.2260643585446902	1.3828591014419183	HDAC4;DLC1;COG1;BRAF;FHIT;CD22;ARHGAP24;MTOR;PAFAH1B1
Alopecia	4/216	0.32392655276214266	0.4948221104034839	0	0	1.4058764222958375	1.5847579983749458	COL3A1;PIK3R1;EDA2R;SASH1
Carcinoma	4/216	0.32392655276214266	0.4948221104034839	0	0	1.4058764222958375	1.5847579983749458	HPGD;BRAF;PIK3R1;FHIT
Squamous cell carcinoma of lung	5/283	0.3244839287767053	0.4954726224977093	0	0	1.3407205270266545	1.5090067890894228	PRKCI;HPGDS;LMO3;BRAF;FHIT
Lung Diseases, Interstitial	3/151	0.32557388659430697	0.49673423685733264	0	0	1.509557085602713	1.6939734085000064	AKAP13;HGF;FAM13A
Malignant Squamous Cell Neoplasm	3/151	0.32557388659430697	0.49673423685733264	0	0	1.509557085602713	1.6939734085000064	FHIT;ARHGAP24;MTOR
synovial sarcoma	4/217	0.3269342167683336	0.4979526234665659	0	0	1.399204386625094	1.5643053275893413	AIMP2;HGF;SYVN1;MTOR
Lupus Vulgaris	5/284	0.32709876381445324	0.4979526234665659	0	0	1.3358464137107073	1.4927991816051505	MECP2;HPGDS;HGF;RNPC3;MTOR
Abnormality of the skeletal system	2/88	0.327185475443544	0.4979526234665659	0	0	1.7307963354474982	1.933694241959757	FOXC1;MTOR
Diabetes	19/1268	0.3285728329070418	0.4979526234665659	0	0	1.1384492209151937	1.267090285268895	MEF2A;CDKN1C;IGFBP5;MAOA;ADH1B;SORT1;INSR;HGF;SEMA3A;EBF2;PIK3R1;ACACB;DCN;MTOR;GHR;HPGDS;UTS2;OGT;FKBP5
Congenital hypoplasia of penis	5/285	0.32971584399160553	0.4979526234665659	0	0	1.3310071154898742	1.4767844376689967	CDKN1C;GHR;BBS1;SEMA3A;STT3A
Respiratory Depression	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	MECP2
Hemorrhagic Fevers, Viral	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	ZNF197
Stomach Diseases	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	HGF
X-Linked Emery-Dreifuss Muscular Dystrophy	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	SGCD
Adult Learning Disorders	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	MECP2
African Burkitt's lymphoma	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	PIK3R1
Amyotrophic Lateral Sclerosis With Dementia	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	ATXN2
Bartter Disease	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	PPP1R12A
Cancer of Head	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	ADH1B
Cancer of Neck	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	ADH1B
Carney Complex	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	MTOR
Childhood Rhabdomyosarcoma	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	HPGDS
Christ-Siemens-Touraine syndrome	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	EDA2R
Developmental Academic Disorder	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	MECP2
Dilatation of ureter	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	FOXC1
Fasting Hypoglycemia	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	INSR
Generalized osteoarthritis	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	GHR
heart rate	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	ATP2B1
High pitched voice	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	GHR
Horseshoe Kidney	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	SON
Hypergammaglobulinemia	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	RNPC3
Hyperplasia of supraorbital margins	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	ABCC9
Hyperplasia of supraorbital ridge	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	ABCC9
Hypertrophy of supraorbital margins	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	ABCC9
Hypertrophy of supraorbital ridge	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	ABCC9
Learning Disturbance	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	MECP2
Narrow palate	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	NSD1
Nuclear non-senile cataract	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	HPGDS
Poorly differentiated carcinoma	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	BRAF
Prominent supraorbital ridges	1/30	0.33099903614554843	0.4979526234665659	0	0	2.5640858815875083	2.834955441188919	ABCC9
Wheezing	2/89	0.3320536489718623	0.4991405010682383	0	0	1.7108150470219436	1.8861029837167647	IL1RL1;HPGDS
Congenital clinodactyly	2/89	0.3320536489718623	0.4991405010682383	0	0	1.7108150470219436	1.8861029837167647	BRAF;PIK3R1
Squamous cell carcinoma of tongue	3/153	0.33284896492353055	0.49989646603517707	0	0	1.489277566539924	1.6383042866991182	CEACAM1;FOXC1;NR1H2
Familial lichen amyloidosis	3/153	0.33284896492353055	0.49989646603517707	0	0	1.489277566539924	1.6383042866991182	GHR;HPGDS;DLC1
Nasal Polyps	4/219	0.3329546677149613	0.49989646603517707	0	0	1.386046511627907	1.5243031698349148	HPGDS;BRAF;ARHGAP24;MTOR
Noninfiltrating Intraductal Carcinoma	5/287	0.33495621591388747	0.5027012212540295	0	0	1.3214314828401401	1.4453228920560797	FOXC1;HPGDS;GSN;HGF;FHIT
Myoclonus	3/154	0.3364856715677083	0.5047068783072064	0	0	1.47933925918465	1.6112958944379387	MECP2;ATXN2;ATP13A2
Short palm	2/90	0.3369118620398476	0.5047068783072064	0	0	1.691287878787879	1.8400094514973109	HDAC4;HDAC6
Adenovirus Infections	2/90	0.3369118620398476	0.5047068783072064	0	0	1.691287878787879	1.8400094514973109	CALD1;MAP4
Dehydration	2/90	0.3369118620398476	0.5047068783072064	0	0	1.691287878787879	1.8400094514973109	HPGDS;ADH1B
Cerebellar Ataxia	9/565	0.33856813165847904	0.5047068783072064	0	0	1.2079192676986816	1.3082127219625148	MECP2;BBS1;CEP104;ATXN2;ATXN1;PEX6;ROGDI;OGDH;ATP13A2
Recurrent upper respiratory tract infection	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	GNS
Alopecia, Male Pattern	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	EDA2R
Reduced number of teeth	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	GHR
Sebaceous Adenocarcinoma	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	FHIT
Lipomatosis, Multiple	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	DCN
Refractory anemia, without ringed sideroblasts, without excess blasts	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	PAFAH1B1
Thick skin	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	ABCC9
Abnormality of pulmonary valve	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	BRAF
Acute colitis	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	PMP22
AIDS-Associated Nephropathy	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	MTOR
Bulimia	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	LMO3
ESTROGEN RESISTANCE	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	INSR
Generalized elastolysis	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	GSN
Hanging skin	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	GSN
Histiocytic sarcoma	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	BRAF
Intervertebral disc disorder	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	CILP
Invasive Skin Melanoma	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	BRAF
Longevity	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	FAM13A
Myelomonocytic leukemia	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	MEF2C
Neoplastic disease	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	BRAF
Pericardial effusion	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	ABCC9
Progressive muscle weakness	1/31	0.339910100946478	0.5047068783072064	0	0	2.4784905660377357	2.6744749900790725	PEX6
Abnormality of metabolism/homeostasis	3/155	0.3401214017500587	0.5048216392405324	0	0	1.4695317190314188	1.5848203930092823	GHR;MECP2;PEX6
Microphthalmos	4/222	0.3419952544684119	0.5074029632069742	0	0	1.3667623783178093	1.466479199001963	RERE;TBX15;BRAF;HDAC6
Migraine Disorders	5/290	0.34283035381835586	0.5084417097770655	0	0	1.307320024198427	1.3995116432925823	MAOA;ADH1B;INSR;UTS2;CSAD
Premature aging syndrome	2/92	0.3465960444709364	0.5111143444369618	0	0	1.6535353535353536	1.7520783123716026	MECP2;SRSF5
Renal carcinoma	8/500	0.3482442642625233	0.5111143444369618	0	0	1.2127056154282474	1.2792238968321674	HGF;SYVN1;BRAF;PIK3R1;RCHY1;FHIT;ARHGAP24;MTOR
Squamous cell carcinoma of the hypopharynx	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	HGF
Adrenal hyperplasia	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	USP8
Zellweger Syndrome	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	PEX6
Aortic valve calcification	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	NPR1
Bowen's Disease	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	FHIT
Cannabis Dependence	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	FKBP5
Cardiovascular morbidity	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	HPGDS
Cervical high grade squamous intraepithelial lesion	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	FHIT
Chronic Persistent Hepatitis	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	HGF
Complete hydatidiform mole	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	CDKN1C
Congenital malrotation of intestine	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	ARID1B
Decrease in appetite	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	PIK3R1
Dermatofibrosarcoma Protuberans	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	INSR
Dysphonia	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	TTC19
Gastrinoma	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	HGF
Gastro-esophageal reflux disease with esophagitis	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	GHR
Giant Cell Fibroblastoma	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	INSR
Hallopeau-Siemens Disease	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	DCN
Hydrophthalmos	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	FOXC1
Hypereosinophilia	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	PAFAH1B1
Increased hepatocellular carcinoma risk	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	PDGFRL
Increased incidence of hepatocellular carcinoma	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	PDGFRL
Lipid Metabolism Disorders	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	SORT1
Lipomatosis	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	MTOR
Oropharyngeal disorders	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	BRAF
Papillary serous cystadenocarcinoma	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	BRAF
Periodic Fever Syndrome	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	GSN
Peritoneal Fibrosis	1/32	0.3487029108582405	0.5111143444369618	0	0	2.3984175289105294	2.5268167575761478	AIMP2
Myeloid Leukemia	8/501	0.3502451061199956	0.5131751515962751	0	0	1.2101828702611759	1.2696295535661182	IL1RL1;MEF2C;HPGDS;STAT2;FHIT;CD22;ARHGAP24;PAFAH1B1
Mucinous Adenocarcinoma	2/93	0.35142087588603493	0.5144976445638141	0	0	1.6352813852813852	1.7101293544628815	MECP2;BRAF
Panic Disorder	2/93	0.35142087588603493	0.5144976445638141	0	0	1.6352813852813852	1.7101293544628815	MECP2;MAOA
Tremor	4/226	0.3540599154321618	0.5165950895021568	0	0	1.3418609449143801	1.393239629770788	MECP2;ATP13A2;TTC19;MAP2K5
Ventricular Septal Defects	4/226	0.3540599154321618	0.5165950895021568	0	0	1.3418609449143801	1.393239629770788	RERE;NSD1;BRAF;ARID1B
Sporadic Breast Carcinoma	3/159	0.3546484074695021	0.5165950895021568	0	0	1.4315589353612168	1.48399462257576	HPGDS;FHIT;ARHGAP24
Colorectal Neoplasms	16/1073	0.3550527433467253	0.5165950895021568	0	0	1.130868495742668	1.1710018060657443	GSN;HPGD;ADH1B;NPR1;INSR;HGF;BRAF;PIK3R1;FHIT;ARHGAP24;MTOR;GHR;HPGDS;DLC1;SIK3;SLC16A7
Traditional Serrated Adenoma	2/94	0.3562334702885183	0.5165950895021568	0	0	1.6174242424242424	1.6694550782323077	NSD1;BRAF
AMYOTROPHIC LATERAL SCLEROSIS 1	2/94	0.3562334702885183	0.5165950895021568	0	0	1.6174242424242424	1.6694550782323077	HGF;VPS54
Albinism, Oculocutaneous	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	BRAF
Chromosome 5, trisomy 5q	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	ATXN1
Spastic	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	SGCD
Nephritis, Interstitial	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	DCN
Taste bitter	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	FZD4
Thalassemia Intermedia	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	HPGDS
Abnormal dermatoglyphic pattern	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	BRAF
Usher Syndrome	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	PEX6
X-Linked Combined Immunodeficiency Diseases	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	GHR
Albuminuria	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	DCN
Anemia of chronic disease	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	IL16
Central Diabetes Insipidus	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	BRAF
Chronic Airflow Obstruction	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	FAM13A
Corneal Ulcer	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	GSN
CREST Syndrome	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	KIAA0319L
Ectopic Tissue	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	PAFAH1B1
Fibrous Dysplasia	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	GHR
Hereditary Motor and Sensory Neuropathies	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	PMP22
Hypoplasia of scrotum	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	STT3A
Hypoplastic toenails	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	NSD1
Meckel syndrome type 1	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	MTOR
Metaphyseal widening	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	ABCC9
Nuclear cataract	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	HPGDS
Periapical Periodontitis	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	AIMP2
Pleural Tuberculosis	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	FHIT
Primary angle-closure glaucoma	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	HGF
Primary Lesion	1/33	0.3573790292653625	0.5165950895021568	0	0	2.3233490566037736	2.390629420559556	BRAF
Brain Neoplasms	10/646	0.35768899986823194	0.5168448264302377	0	0	1.1729805424528301	1.2059311911548607	HPGDS;ATXN1;HGF;LAMA4;BRAF;PIK3R1;FHIT;ARHGAP24;DCN;MTOR
Hypotrophic malar bone	3/160	0.35827468035800764	0.5172942586847892	0	0	1.422368070523843	1.4599972775500083	MECP2;FOXC1;ARID1B
Malar flattening	3/160	0.35827468035800764	0.5172942586847892	0	0	1.422368070523843	1.4599972775500083	MECP2;FOXC1;ARID1B
Pituitary Neoplasms	5/296	0.35861484783511033	0.5175870236761918	0	0	1.2799699806454161	1.3126172964501928	GHR;AIMP2;BRAF;LRIG3;MTOR
Gastric ulcer	2/95	0.36103330050042937	0.5208779942493748	0	0	1.5999511241446724	1.6300063336078876	HGF;ARID1B
Squamous cell carcinoma of the head and neck	14/934	0.36170225920231663	0.5215265617346175	0	0	1.136111111111111	1.1553498962126625	CDKN1C;IGFBP5;ADH1B;HGF;SEMA3A;BRAF;RCHY1;FHIT;ARHGAP24;MTOR;SLC25A16;HPGDS;DLC1;ULK1
Polycystic Kidney, Autosomal Dominant	3/161	0.36189817689787374	0.5215265617346175	0	0	1.4132935457477018	1.4364607990956701	AIMP2;CALD1;MTOR
Juvenile psoriatic arthritis	3/161	0.36189817689787374	0.5215265617346175	0	0	1.4132935457477018	1.4364607990956701	RERE;CALD1;FOXP1
Squamous cell carcinoma	27/1876	0.36213752167043256	0.5216719098021106	0	0	1.0927426563267264	1.109932858972756	CDKN1C;FOXC1;LDB1;ADH1B;MGST1;FHIT;HDAC6;SMG6;MECP2;HPGDS;PRKCI;GSN;IGFBP5;FZD4;INSR;STAT2;NR1H2;HGF;SYVN1;BRAF;PDGFRL;ARHGAP24;DCN;MTOR;FOXP1;TGFBR3;AIMP2
Epithelioma	5/298	0.36388338769298606	0.5223554287937535	0	0	1.2711022190838597	1.2849849765440806	EGFL7;HPGD;HGF;BRAF;FHIT
Fibrosarcoma	5/298	0.36388338769298606	0.5223554287937535	0	0	1.2711022190838597	1.2849849765440806	STAT2;HGF;CREB3L2;BRAF;ANGPTL1
Steroid Sulfatase Deficiency Disease	2/96	0.3658198553570497	0.5223554287937535	0	0	1.582849774339136	1.591736312788687	HPGDS;BRAF
Telecanthus	2/96	0.3658198553570497	0.5223554287937535	0	0	1.582849774339136	1.591736312788687	COL3A1;PIK3R1
Idiopathic pulmonary hypertension	2/96	0.3658198553570497	0.5223554287937535	0	0	1.582849774339136	1.591736312788687	TGFBR3;DCN
MAJOR AFFECTIVE DISORDER 2	2/96	0.3658198553570497	0.5223554287937535	0	0	1.582849774339136	1.591736312788687	MAOA;FZD4
Amyotrophic Lateral Sclerosis, Guam Form	1/34	0.36593999909389846	0.5223554287937535	0	0	2.2528301886792454	2.264738414586116	ATXN2
Renal interstitial fibrosis	1/34	0.36593999909389846	0.5223554287937535	0	0	2.2528301886792454	2.264738414586116	HGF
Secondary malignant neoplasm of pancreas	1/34	0.36593999909389846	0.5223554287937535	0	0	2.2528301886792454	2.264738414586116	GSN
Short long bone	1/34	0.36593999909389846	0.5223554287937535	0	0	2.2528301886792454	2.264738414586116	GHR
Parkinson Disease, Familial, Type 1	1/34	0.36593999909389846	0.5223554287937535	0	0	2.2528301886792454	2.264738414586116	AIMP2
Abnormality of the urinary system	1/34	0.36593999909389846	0.5223554287937535	0	0	2.2528301886792454	2.264738414586116	COL3A1
Autosomal Recessive Parkinsonism	1/34	0.36593999909389846	0.5223554287937535	0	0	2.2528301886792454	2.264738414586116	ATP13A2
Cancer of Urinary Tract	1/34	0.36593999909389846	0.5223554287937535	0	0	2.2528301886792454	2.264738414586116	FHIT
Cholangitis	1/34	0.36593999909389846	0.5223554287937535	0	0	2.2528301886792454	2.264738414586116	HGF
Chorioretinal abnormality	1/34	0.36593999909389846	0.5223554287937535	0	0	2.2528301886792454	2.264738414586116	PEX6
Dysautonomia	1/34	0.36593999909389846	0.5223554287937535	0	0	2.2528301886792454	2.264738414586116	PMP22
Gestational trophoblastic disease	1/34	0.36593999909389846	0.5223554287937535	0	0	2.2528301886792454	2.264738414586116	CDKN1C
Idiopathic osteoarthritis	1/34	0.36593999909389846	0.5223554287937535	0	0	2.2528301886792454	2.264738414586116	GHR
Infant Acute Lymphoblastic Leukemia	1/34	0.36593999909389846	0.5223554287937535	0	0	2.2528301886792454	2.264738414586116	FHIT
Monocytosis	1/34	0.36593999909389846	0.5223554287937535	0	0	2.2528301886792454	2.264738414586116	ADH1B
Myelodysplastic Syndrome with Isolated del(5q)	1/34	0.36593999909389846	0.5223554287937535	0	0	2.2528301886792454	2.264738414586116	ATXN1
Neuroectodermal Tumors	1/34	0.36593999909389846	0.5223554287937535	0	0	2.2528301886792454	2.264738414586116	HGF
Poor suck	1/34	0.36593999909389846	0.5223554287937535	0	0	2.2528301886792454	2.264738414586116	BRAF
Ductal Carcinoma	4/230	0.3661258122423789	0.5224227025443339	0	0	1.3178409781800986	1.3241379588883675	HPGDS;FHIT;CRLS1;OGT
androgen independent prostate cancer	3/163	0.36913570532810785	0.5261454306102027	0	0	1.3954847908745247	1.3907274959122549	MEF2C;MAP2K5;ARHGAP24
Metastatic malignant neoplasm to brain	3/163	0.36913570532810785	0.5261454306102027	0	0	1.3954847908745247	1.3907274959122549	FOXC1;BRAF;MTOR
Choriocarcinoma	5/300	0.3691538022571717	0.5261454306102027	0	0	1.2623546983570362	1.2579893666126936	CDKN1C;CALCRL;INSR;BRAF;ANGPTL1
Sweating	2/97	0.37059263949968546	0.5271988191069922	0	0	1.5661084529505582	1.5546004161072196	HPGD;FOXP1
Ductal Breast Carcinoma	2/97	0.37059263949968546	0.5271988191069922	0	0	1.5661084529505582	1.5546004161072196	FHIT;CRLS1
Hyperhidrosis disorder	2/97	0.37059263949968546	0.5271988191069922	0	0	1.5661084529505582	1.5546004161072196	HPGD;FOXP1
Increased sweating	2/97	0.37059263949968546	0.5271988191069922	0	0	1.5661084529505582	1.5546004161072196	HPGD;FOXP1
Ovarian Serous Adenocarcinoma	2/97	0.37059263949968546	0.5271988191069922	0	0	1.5661084529505582	1.5546004161072196	GSN;BRAF
Motor delay	4/232	0.37215563977721783	0.5288028198712361	0	0	1.3061470470068302	1.2910520697807344	MECP2;GHR;MEF2C;PMP22
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	1/35	0.37438734287140607	0.5288028198712361	0	0	2.1864594894561598	2.148118482269945	PMP22
Therapy-related myelodysplastic syndrome	1/35	0.37438734287140607	0.5288028198712361	0	0	2.1864594894561598	2.148118482269945	PAFAH1B1
Acanthosis Nigricans	1/35	0.37438734287140607	0.5288028198712361	0	0	2.1864594894561598	2.148118482269945	INSR
Ventricular Fibrillation	1/35	0.37438734287140607	0.5288028198712361	0	0	2.1864594894561598	2.148118482269945	SEMA3A
Acinar Cell Carcinoma	1/35	0.37438734287140607	0.5288028198712361	0	0	2.1864594894561598	2.148118482269945	MTOR
Cervical Dystonia	1/35	0.37438734287140607	0.5288028198712361	0	0	2.1864594894561598	2.148118482269945	ATP13A2
Coagulation factor measurement	1/35	0.37438734287140607	0.5288028198712361	0	0	2.1864594894561598	2.148118482269945	NSD1
Complete trisomy 18 syndrome	1/35	0.37438734287140607	0.5288028198712361	0	0	2.1864594894561598	2.148118482269945	GHR
Congenital hemivertebra	1/35	0.37438734287140607	0.5288028198712361	0	0	2.1864594894561598	2.148118482269945	SON
Deficiency of glucose-6-phosphate dehydrogenase	1/35	0.37438734287140607	0.5288028198712361	0	0	2.1864594894561598	2.148118482269945	GOLGB1
Follicular neoplasm	1/35	0.37438734287140607	0.5288028198712361	0	0	2.1864594894561598	2.148118482269945	BRAF
Hereditary Melanoma	1/35	0.37438734287140607	0.5288028198712361	0	0	2.1864594894561598	2.148118482269945	BRAF
Leiomyosarcoma of uterus	1/35	0.37438734287140607	0.5288028198712361	0	0	2.1864594894561598	2.148118482269945	DLC1
Low Grade Squamous Intraepithelial Neoplasia	1/35	0.37438734287140607	0.5288028198712361	0	0	2.1864594894561598	2.148118482269945	FHIT
Multinodular goiter	1/35	0.37438734287140607	0.5288028198712361	0	0	2.1864594894561598	2.148118482269945	IL16
Nephrogenic Diabetes Insipidus	1/35	0.37438734287140607	0.5288028198712361	0	0	2.1864594894561598	2.148118482269945	BBS1
PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	1/35	0.37438734287140607	0.5288028198712361	0	0	2.1864594894561598	2.148118482269945	BRAF
Pre-renal acute kidney injury	1/35	0.37438734287140607	0.5288028198712361	0	0	2.1864594894561598	2.148118482269945	HGF
Thrombosis	2/98	0.3753511728132095	0.5295684898829064	0	0	1.5497159090909092	1.5185561283340812	HGF;DCN
Frontotemporal Lobar Degeneration	2/98	0.3753511728132095	0.5295684898829064	0	0	1.5497159090909092	1.5185561283340812	ATXN2;DCN
Myelofibrosis	2/98	0.3753511728132095	0.5295684898829064	0	0	1.5497159090909092	1.5185561283340812	HPGD;PAFAH1B1
Fatty Liver	7/443	0.3759917502883826	0.5302736515673296	0	0	1.1962558889164394	1.1701632470471588	COL3A1;SORT1;INSR;HGF;SAA1;ACACB;OGT
Tumor Initiation	4/234	0.37818152673494065	0.5331623544949556	0	0	1.2946564885496183	1.2588993310888483	AIMP2;HGF;BRAF;DCN
Lupus Erythematosus	5/304	0.3796963875891193	0.5337711570650412	0	0	1.2452107279693487	1.2058413058797879	MECP2;HPGDS;HGF;RNPC3;MTOR
Classical Hodgkin's Lymphoma	3/166	0.3799641892347652	0.5337711570650412	0	0	1.369591079801255	1.3253235261046257	HGF;EBF1;FHIT
invasive cancer	3/166	0.3799641892347652	0.5337711570650412	0	0	1.369591079801255	1.3253235261046257	PUM1;FHIT;MTOR
Keratoconus	3/166	0.3799641892347652	0.5337711570650412	0	0	1.369591079801255	1.3253235261046257	COL3A1;GSN;HGF
Reduced tensile strength of hair	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	BRAF
Astrocytoma, low grade	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	BRAF
DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	HGF
Scaphycephaly	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	IDS
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	PAFAH1B1
Squamous intraepithelial lesion	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	FHIT
Stage IV Skin Melanoma	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	BRAF
5q-syndrome	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	ATXN1
Ulnohumeral dislocation	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	ARID1B
Adrenal gland hypofunction	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	CDKN1C
Autoimmune state	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	KIAA0319L
Avellino corneal dystrophy	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	IL16
Dislocation of elbow joint	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	ARID1B
Fatigable weakness of respiratory muscles	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	ATXN2
Fractured hair	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	BRAF
Fragile hair	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	BRAF
Hammer Toe	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	PMP22
Hepatitis E	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	HPGDS
High-grade hypermetropia	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	RERE
Inflammatory Myofibroblastic Tumor	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	BRAF
Large cell neuroendocrine carcinoma	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	MTOR
Paranoid Schizophrenia	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	MAOA
Radiohumeral dislocation	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	ARID1B
Rapidly progressive	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	ATP13A2
Rapidly progressive disorder	1/36	0.3827225631092849	0.5337711570650412	0	0	2.1238814016172505	2.039871125368213	ATP13A2
Ataxias, Hereditary	3/167	0.3835651918961051	0.5345505282547643	0	0	1.3611703607530372	1.3043356189094362	ATXN2;ATXN1;TTC19
Infratentorial atrophy	3/167	0.3835651918961051	0.5345505282547643	0	0	1.3611703607530372	1.3043356189094362	STT3A;ATP13A2;TTC19
Uveal melanoma	4/236	0.38420211103130186	0.5352401450646872	0	0	1.283364043169255	1.2276487619760872	FZD4;ADH1B;HGF;BRAF
Rhinitis	2/100	0.38482364253272927	0.5353141290327884	0	0	1.517934446505875	1.4495820420264696	HPGDS;NFIA
Abnormal heart beat	2/100	0.38482364253272927	0.5353141290327884	0	0	1.517934446505875	1.4495820420264696	PEX6;BRAF
ECG abnormality	2/100	0.38482364253272927	0.5353141290327884	0	0	1.517934446505875	1.4495820420264696	PEX6;BRAF
Mood swings	2/100	0.38482364253272927	0.5353141290327884	0	0	1.517934446505875	1.4495820420264696	USP8;ATXN2
Colorectal Cancer	46/3298	0.38633639668111364	0.5368841041398041	0	0	1.0597282791009728	1.0078511834683253	CDKN1C;LDB1;HPGD;ADH1B;ANKRD12;PRDM2;FOXK1;FSTL1;FHIT;EDA2R;MECP2;GHR;ADAMTS15;HPGDS;CALD1;CRNDE;OSBP;SLC16A7;MAP2K5;GSN;PPP1R12A;SCARA5;FZD4;SORT1;INSR;NR1H2;HGF;RAB27B;BRAF;IL16;BTBD9;CRLS1;PDGFRL;ARHGAP24;DCN;MTOR;HIPK2;AIMP2;CEACAM1;COL3A1;DLC1;AKAP9;PMP22;ANGPTL1;CPEB4;GLYR1
HIV Infections	12/806	0.3863494912792349	0.5368841041398041	0	0	1.1269561078164978	1.0717497977761878	GHR;AIMP2;GOLGB1;STT3A;ULK1;BRAF;IL16;PIK3R1;FHIT;HDAC6;HIPK2;FKBP5
Drug-Induced Liver Disease	6/377	0.3865223494630074	0.5368841041398041	0	0	1.2044163383786026	1.1448767241245827	COL3A1;HPGDS;CCDC80;SLC10A7;GSN;WASL
Hyperinsulinism	6/377	0.3865223494630074	0.5368841041398041	0	0	1.2044163383786026	1.1448767241245827	CDKN1C;GHR;COL3A1;HPGDS;MAOA;INSR
Juvenile-Onset Still Disease	3/168	0.3871615123169001	0.5374429093405027	0	0	1.352851711026616	1.2837390201153762	RERE;CALD1;FOXP1
Periodontitis	4/237	0.3872099962702745	0.5374429093405027	0	0	1.277790518625299	1.2123524474358507	COL3A1;IGFBP5;STAT2;IL16
Serum total cholesterol measurement	5/307	0.3876011230598569	0.5377876355677647	0	0	1.2326507827763822	1.1682799117707188	SGCD;SORT1;TSHZ2;SIK3;ATP2B1
Hematocrit procedure	2/101	0.3895366931578598	0.5378735886032242	0	0	1.5025252525252526	1.4165766195085994	SIK3;ATP2B1
Mean corpuscular hemoglobin concentration determination	2/101	0.3895366931578598	0.5378735886032242	0	0	1.5025252525252526	1.4165766195085994	ATXN2;FRS3
Hepatitis B, Chronic	4/238	0.39021605708064994	0.5378735886032242	0	0	1.272264631043257	1.1972706116299743	FOXC1;GSN;ADH1B;IL16
Overweight	4/238	0.39021605708064994	0.5378735886032242	0	0	1.272264631043257	1.1972706116299743	MAOA;INSR;BRAF;CRLS1
Papillary Renal Cell Carcinoma	3/169	0.390752895055425	0.5378735886032242	0	0	1.3446332859956938	1.263524872712073	AKAP13;BRAF;MTOR
Renal tubular acidosis	1/37	0.3909471424464103	0.5378735886032242	0	0	2.0647798742138366	1.9392059784013267	ATP11A
Rubella	1/37	0.3909471424464103	0.5378735886032242	0	0	2.0647798742138366	1.9392059784013267	HPGDS
Sessile Serrated Adenoma/Polyp	1/37	0.3909471424464103	0.5378735886032242	0	0	2.0647798742138366	1.9392059784013267	BRAF
Simple syndactyly of toes, first web space	1/37	0.3909471424464103	0.5378735886032242	0	0	2.0647798742138366	1.9392059784013267	TBX15
ACTH-Secreting Pituitary Adenoma	1/37	0.3909471424464103	0.5378735886032242	0	0	2.0647798742138366	1.9392059784013267	USP8
Atypical Lipoma	1/37	0.3909471424464103	0.5378735886032242	0	0	2.0647798742138366	1.9392059784013267	FOXP1
Carcinoma testes	1/37	0.3909471424464103	0.5378735886032242	0	0	2.0647798742138366	1.9392059784013267	HPGDS
Cervical intraepithelial neoplasia grade 1	1/37	0.3909471424464103	0.5378735886032242	0	0	2.0647798742138366	1.9392059784013267	FHIT
Chronic leukemia (category)	1/37	0.3909471424464103	0.5378735886032242	0	0	2.0647798742138366	1.9392059784013267	PAFAH1B1
Congenital hypoplasia of breast	1/37	0.3909471424464103	0.5378735886032242	0	0	2.0647798742138366	1.9392059784013267	SEMA3A
Fatigable weakness of swallowing muscles	1/37	0.3909471424464103	0.5378735886032242	0	0	2.0647798742138366	1.9392059784013267	ATXN2
Flat back of the head	1/37	0.3909471424464103	0.5378735886032242	0	0	2.0647798742138366	1.9392059784013267	PEX6
Gowers sign	1/37	0.3909471424464103	0.5378735886032242	0	0	2.0647798742138366	1.9392059784013267	SGCD
Hereditary pyropoikilocytosis	1/37	0.3909471424464103	0.5378735886032242	0	0	2.0647798742138366	1.9392059784013267	BRAF
Immunoblastic Large-Cell Lymphoma	1/37	0.3909471424464103	0.5378735886032242	0	0	2.0647798742138366	1.9392059784013267	MTOR
Leukoaraiosis	1/37	0.3909471424464103	0.5378735886032242	0	0	2.0647798742138366	1.9392059784013267	PAFAH1B1
Malignant neoplasm of pharynx	1/37	0.3909471424464103	0.5378735886032242	0	0	2.0647798742138366	1.9392059784013267	ADH1B
QRS complex feature	1/37	0.3909471424464103	0.5378735886032242	0	0	2.0647798742138366	1.9392059784013267	NFIA
Medullary carcinoma of thyroid	4/239	0.3932201306828354	0.540803297656897	0	0	1.2667857722917004	1.1823997184392123	SLC25A16;CEACAM1;BRAF;MTOR
Cardiac conduction abnormality	2/102	0.39423372098122694	0.5411567751020416	0	0	1.4874242424242423	1.3845113598224021	PEX6;BRAF
Hypertrophy of lower jaw	2/102	0.39423372098122694	0.5411567751020416	0	0	1.4874242424242423	1.3845113598224021	INSR;NSD1
Intervertebral Disc Degeneration	2/102	0.39423372098122694	0.5411567751020416	0	0	1.4874242424242423	1.3845113598224021	AIMP2;CILP
mandibular excess (physical finding)	2/102	0.39423372098122694	0.5411567751020416	0	0	1.4874242424242423	1.3845113598224021	INSR;NSD1
Mandibular hyperplasia	2/102	0.39423372098122694	0.5411567751020416	0	0	1.4874242424242423	1.3845113598224021	INSR;NSD1
Respiratory function loss	3/170	0.394339088838626	0.5411567751020416	0	0	1.336513285216639	1.2436845631496292	MECP2;COL3A1;PEX6
Glaucoma	6/381	0.3960088705054577	0.5426962468154511	0	0	1.191323076923077	1.1035448054302208	TGFBR3;FOXC1;COL3A1;HPGDS;SAA1;PIK3R1
Hypercholesterolemia	4/240	0.3962220560784262	0.5426962468154511	0	0	1.261353344546513	1.1677363012511215	COL3A1;COL15A1;SORT1;ACACB
Chronic Obstructive Airway Disease	10/669	0.3987463147384072	0.5426962468154511	0	0	1.1306785849772383	1.0395796609614243	CDKN1C;TGFBR3;IL1RL1;HPGDS;DLG2;SGCD;HGF;FAM13A;IL16;BTBD9
Ichthyosis, X-Linked	2/103	0.39891431841909136	0.5426962468154511	0	0	1.4726222622262226	1.3533525617617146	HPGDS;BRAF
Specific learning disability	2/103	0.39891431841909136	0.5426962468154511	0	0	1.4726222622262226	1.3533525617617146	BBS1;NSD1
Death in infancy	2/103	0.39891431841909136	0.5426962468154511	0	0	1.4726222622262226	1.3533525617617146	PEX6;HDAC6
Electrocardiogram abnormal	2/103	0.39891431841909136	0.5426962468154511	0	0	1.4726222622262226	1.3533525617617146	PEX6;BRAF
Eczema, Infantile	1/38	0.3990625441143615	0.5426962468154511	0	0	2.0088730239673636	1.845425333623264	CCDC80
Sensorimotor neuropathy	1/38	0.3990625441143615	0.5426962468154511	0	0	2.0088730239673636	1.845425333623264	HGF
Septic Shock	1/38	0.3990625441143615	0.5426962468154511	0	0	2.0088730239673636	1.845425333623264	SAA1
Shprintzen syndrome	1/38	0.3990625441143615	0.5426962468154511	0	0	2.0088730239673636	1.845425333623264	PKP4
Nephritis, Tubulointerstitial	1/38	0.3990625441143615	0.5426962468154511	0	0	2.0088730239673636	1.845425333623264	DCN
Subfertility	1/38	0.3990625441143615	0.5426962468154511	0	0	2.0088730239673636	1.845425333623264	TTC19
Tented mouth	1/38	0.3990625441143615	0.5426962468154511	0	0	2.0088730239673636	1.845425333623264	MECP2
Tented upper lip	1/38	0.3990625441143615	0.5426962468154511	0	0	2.0088730239673636	1.845425333623264	MECP2
Tented upper lip vermilion	1/38	0.3990625441143615	0.5426962468154511	0	0	2.0088730239673636	1.845425333623264	MECP2
Autosomal Recessive Polycystic Kidney Disease	1/38	0.3990625441143615	0.5426962468154511	0	0	2.0088730239673636	1.845425333623264	MTOR
Coffin-Siris syndrome	1/38	0.3990625441143615	0.5426962468154511	0	0	2.0088730239673636	1.845425333623264	ARID1B
Growth abnormality	1/38	0.3990625441143615	0.5426962468154511	0	0	2.0088730239673636	1.845425333623264	GNS
Hypoplasia of the brainstem	1/38	0.3990625441143615	0.5426962468154511	0	0	2.0088730239673636	1.845425333623264	PAFAH1B1
Idiopathic Membranous Glomerulonephritis	1/38	0.3990625441143615	0.5426962468154511	0	0	2.0088730239673636	1.845425333623264	HPGDS
Milroy Disease	1/38	0.3990625441143615	0.5426962468154511	0	0	2.0088730239673636	1.845425333623264	BRAF
Monoparesis - leg	1/38	0.3990625441143615	0.5426962468154511	0	0	2.0088730239673636	1.845425333623264	DSTYK
Neurobehavioral Manifestations	1/38	0.3990625441143615	0.5426962468154511	0	0	2.0088730239673636	1.845425333623264	FKBP5
Papillary adenoma	1/38	0.3990625441143615	0.5426962468154511	0	0	2.0088730239673636	1.845425333623264	TBRG1
Meningioma, benign, no ICD-O subtype	4/241	0.3992216738201899	0.5427167251103051	0	0	1.255966760073437	1.1532769620812562	HPGDS;DLC1;ARHGAP24;MTOR
Polycystic Ovary Syndrome	8/526	0.4006086503434419	0.5444022887540612	0	0	1.1502798479542666	1.0522417984790142	MEF2A;INSR;NFIC;USP34;PIK3R1;HOOK3;ARID1B;PAFAH1B1
Gastric Adenocarcinoma	6/383	0.4007506096933931	0.5444022887540612	0	0	1.1848806366047746	1.0834737720492316	HPGDS;HPGD;INSR;BRAF;ARHGAP24;MTOR
Acquired flat foot	2/104	0.4035780914531771	0.5472565408582138	0	0	1.4581105169340463	1.3230680120936322	PEX6;NSD1
Xerosis	2/104	0.4035780914531771	0.5472565408582138	0	0	1.4581105169340463	1.3230680120936322	INSR;BRAF
Death in early childhood	2/104	0.4035780914531771	0.5472565408582138	0	0	1.4581105169340463	1.3230680120936322	PEX6;HDAC6
Electrocardiographic changes	2/104	0.4035780914531771	0.5472565408582138	0	0	1.4581105169340463	1.3230680120936322	PEX6;BRAF
Increased size of the mandible	2/104	0.4035780914531771	0.5472565408582138	0	0	1.4581105169340463	1.3230680120936322	INSR;NSD1
Short toe	1/39	0.40707021195870524	0.548830883481905	0	0	1.9559086395233367	1.7579112206183944	GHR
Static Tremor	1/39	0.40707021195870524	0.548830883481905	0	0	1.9559086395233367	1.7579112206183944	ATXN2
Abnormal cortical bone morphology	1/39	0.40707021195870524	0.548830883481905	0	0	1.9559086395233367	1.7579112206183944	HPGD
Abnormality of coagulation	1/39	0.40707021195870524	0.548830883481905	0	0	1.9559086395233367	1.7579112206183944	BRAF
Broad hallux	1/39	0.40707021195870524	0.548830883481905	0	0	1.9559086395233367	1.7579112206183944	ABCC9
Dislocations	1/39	0.40707021195870524	0.548830883481905	0	0	1.9559086395233367	1.7579112206183944	COL3A1
Disorder of macula of retina	1/39	0.40707021195870524	0.548830883481905	0	0	1.9559086395233367	1.7579112206183944	BBS1
Flat occiput	1/39	0.40707021195870524	0.548830883481905	0	0	1.9559086395233367	1.7579112206183944	PEX6
Gowers sign present	1/39	0.40707021195870524	0.548830883481905	0	0	1.9559086395233367	1.7579112206183944	SGCD
Growth Disorders	1/39	0.40707021195870524	0.548830883481905	0	0	1.9559086395233367	1.7579112206183944	TBX15
heavy drinking	1/39	0.40707021195870524	0.548830883481905	0	0	1.9559086395233367	1.7579112206183944	ADH1B
Klinefelter's syndrome - male with more than two X chromosomes	1/39	0.40707021195870524	0.548830883481905	0	0	1.9559086395233367	1.7579112206183944	BBS1
Low Grade Lymphoma (neoplasm)	1/39	0.40707021195870524	0.548830883481905	0	0	1.9559086395233367	1.7579112206183944	CDKN1C
Myofibrillar Myopathy	1/39	0.40707021195870524	0.548830883481905	0	0	1.9559086395233367	1.7579112206183944	GSN
Orbital separation diminished	1/39	0.40707021195870524	0.548830883481905	0	0	1.9559086395233367	1.7579112206183944	ARID1B
Ovarian failure	1/39	0.40707021195870524	0.548830883481905	0	0	1.9559086395233367	1.7579112206183944	TGFBR3
Leukoencephalopathy, Progressive Multifocal	2/105	0.40822465945255776	0.5497970297310637	0	0	1.443880553103854	1.2936269066141672	MTOR;HIPK2
Ehlers-Danlos Syndrome	2/105	0.40822465945255776	0.5497970297310637	0	0	1.443880553103854	1.2936269066141672	COL3A1;DCN
Pick Disease of the Brain	2/105	0.40822465945255776	0.5497970297310637	0	0	1.443880553103854	1.2936269066141672	HPGDS;MAOA
Atrial Premature Complexes	2/106	0.41285365470880203	0.5549158350594322	0	0	1.4299242424242424	1.264999777093749	BRAF;PAFAH1B1
Hepatitis	5/317	0.41389427638618603	0.5549158350594322	0	0	1.1925287356321839	1.05198291425066	CEACAM1;HPGDS;SON;HGF;ARHGAP24
Anemia, severe	1/40	0.414971570842161	0.5549158350594322	0	0	1.9056603773584906	1.6761145617804996	HPGD
Anxiety States, Neurotic	1/40	0.414971570842161	0.5549158350594322	0	0	1.9056603773584906	1.6761145617804996	MECP2
Muscular Dystrophy, Oculopharyngeal	1/40	0.414971570842161	0.5549158350594322	0	0	1.9056603773584906	1.6761145617804996	SGCD
Neoplasm Recurrence, Local	1/40	0.414971570842161	0.5549158350594322	0	0	1.9056603773584906	1.6761145617804996	ITSN2
Syncope	1/40	0.414971570842161	0.5549158350594322	0	0	1.9056603773584906	1.6761145617804996	AKAP9
Xeroderma pigmentosum, group A	1/40	0.414971570842161	0.5549158350594322	0	0	1.9056603773584906	1.6761145617804996	NR1H2
Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome	1/40	0.414971570842161	0.5549158350594322	0	0	1.9056603773584906	1.6761145617804996	PAFAH1B1
X-Linked Lymphoproliferative Disorder	1/40	0.414971570842161	0.5549158350594322	0	0	1.9056603773584906	1.6761145617804996	HPGDS
Anthrax disease	1/40	0.414971570842161	0.5549158350594322	0	0	1.9056603773584906	1.6761145617804996	BRAF
Aspirin exacerbated respiratory disease	1/40	0.414971570842161	0.5549158350594322	0	0	1.9056603773584906	1.6761145617804996	HPGDS
Chemical Carcinogenesis	1/40	0.414971570842161	0.5549158350594322	0	0	1.9056603773584906	1.6761145617804996	GSN
Chronic rejection of renal transplant	1/40	0.414971570842161	0.5549158350594322	0	0	1.9056603773584906	1.6761145617804996	HGF
Contracture of joint of hand	1/40	0.414971570842161	0.5549158350594322	0	0	1.9056603773584906	1.6761145617804996	TBX15
Decreased motor nerve conduction velocity	1/40	0.414971570842161	0.5549158350594322	0	0	1.9056603773584906	1.6761145617804996	PMP22
Fibrodysplasia Ossificans Progressiva	1/40	0.414971570842161	0.5549158350594322	0	0	1.9056603773584906	1.6761145617804996	AIMP2
Hereditary Nonpolyposis Colorectal Neoplasms	1/40	0.414971570842161	0.5549158350594322	0	0	1.9056603773584906	1.6761145617804996	BRAF
Malignant neoplasm of stomach stage IV	1/40	0.414971570842161	0.5549158350594322	0	0	1.9056603773584906	1.6761145617804996	MTOR
Osteoarthritis of the hand	1/40	0.414971570842161	0.5549158350594322	0	0	1.9056603773584906	1.6761145617804996	CILP
Anaplastic thyroid carcinoma	3/176	0.41573372693558164	0.5551467385205019	0	0	1.2897646102112135	1.132039687008987	CCDC80;HGF;BRAF
Carcinomatosis	3/176	0.41573372693558164	0.5551467385205019	0	0	1.2897646102112135	1.132039687008987	PIK3R1;FHIT;MAP2K5
Liver Failure	3/176	0.41573372693558164	0.5551467385205019	0	0	1.2897646102112135	1.132039687008987	HPGDS;PEX6;PAFAH1B1
Mucosa-Associated Lymphoid Tissue Lymphoma	3/176	0.41573372693558164	0.5551467385205019	0	0	1.2897646102112135	1.132039687008987	CDKN1C;HPGDS;FOXP1
Liver diseases	9/606	0.4159423761627422	0.555228536855085	0	0	1.1225583168762099	0.9847177502438054	RERE;GHR;COL3A1;HPGDS;ADH1B;HGF;PEX6;SRSF5;CPEB4
Hairy Cell Leukemia	2/107	0.4174647222239921	0.5570632690817493	0	0	1.4162337662337663	1.2371584217921618	BRAF;CD22
Intrahepatic Cholangiocarcinoma	3/177	0.4192769053048872	0.5587954937249243	0	0	1.2822866133473187	1.114593921554316	HGF;BRAF;FHIT
Platelet mean volume determination (procedure)	3/177	0.4192769053048872	0.5587954937249243	0	0	1.2822866133473187	1.114593921554316	ST7L;MEF2C;DCAF5
Red cell distribution width determination	2/108	0.4220575196559471	0.5587954937249243	0	0	1.4028016009148085	1.2100758396769635	ATP11A;CPEB4
Severe myopia	2/108	0.4220575196559471	0.5587954937249243	0	0	1.4028016009148085	1.2100758396769635	HGF;DCN
Leukemia, Myelomonocytic, Chronic	2/108	0.4220575196559471	0.5587954937249243	0	0	1.4028016009148085	1.2100758396769635	BRAF;PAFAH1B1
Class III malocclusion	2/108	0.4220575196559471	0.5587954937249243	0	0	1.4028016009148085	1.2100758396769635	INSR;NSD1
Flatfoot	2/108	0.4220575196559471	0.5587954937249243	0	0	1.4028016009148085	1.2100758396769635	PEX6;NSD1
Long face	2/108	0.4220575196559471	0.5587954937249243	0	0	1.4028016009148085	1.2100758396769635	CEP104;BRAF
Malabsorption	2/108	0.4220575196559471	0.5587954937249243	0	0	1.4028016009148085	1.2100758396769635	PEX6;SAA1
RDW - Red blood cell distribution width result	2/108	0.4220575196559471	0.5587954937249243	0	0	1.4028016009148085	1.2100758396769635	ATP11A;CPEB4
Recurrent pneumonia	1/41	0.42276802684258935	0.5587954937249243	0	0	1.8579245283018868	1.5995460302120732	MECP2
Conjunctivitis, recurrent	1/41	0.42276802684258935	0.5587954937249243	0	0	1.8579245283018868	1.5995460302120732	PIK3R1
Pancreatitis, Alcoholic	1/41	0.42276802684258935	0.5587954937249243	0	0	1.8579245283018868	1.5995460302120732	ADH1B
TNF receptor-associated periodic fever syndrome (TRAPS)	1/41	0.42276802684258935	0.5587954937249243	0	0	1.8579245283018868	1.5995460302120732	HGF
Unilateral agenesis of kidney	1/41	0.42276802684258935	0.5587954937249243	0	0	1.8579245283018868	1.5995460302120732	DSTYK
AIDS related complex	1/41	0.42276802684258935	0.5587954937249243	0	0	1.8579245283018868	1.5995460302120732	HPGDS
Alcoholic Intoxication	1/41	0.42276802684258935	0.5587954937249243	0	0	1.8579245283018868	1.5995460302120732	ADH1B
Dysphasia	1/41	0.42276802684258935	0.5587954937249243	0	0	1.8579245283018868	1.5995460302120732	MECP2
Freckles	1/41	0.42276802684258935	0.5587954937249243	0	0	1.8579245283018868	1.5995460302120732	BRAF
Genitourinary Cancer	1/41	0.42276802684258935	0.5587954937249243	0	0	1.8579245283018868	1.5995460302120732	FZD4
Gestational Trophoblastic Neoplasms	1/41	0.42276802684258935	0.5587954937249243	0	0	1.8579245283018868	1.5995460302120732	CDKN1C
Hypoplastic Left Heart Syndrome	1/41	0.42276802684258935	0.5587954937249243	0	0	1.8579245283018868	1.5995460302120732	FOXP1
Intestinal Polyps	1/41	0.42276802684258935	0.5587954937249243	0	0	1.8579245283018868	1.5995460302120732	ATXN1
Irregular hyperpigmentation	1/41	0.42276802684258935	0.5587954937249243	0	0	1.8579245283018868	1.5995460302120732	COL3A1
Microcalcification	1/41	0.42276802684258935	0.5587954937249243	0	0	1.8579245283018868	1.5995460302120732	LSP1
Micronychia (disorder)	1/41	0.42276802684258935	0.5587954937249243	0	0	1.8579245283018868	1.5995460302120732	NSD1
Prolymphocytic Leukemia	1/41	0.42276802684258935	0.5587954937249243	0	0	1.8579245283018868	1.5995460302120732	BRAF
Stomach Carcinoma	33/2378	0.4249284645656688	0.5614540603363292	0	0	1.0502429605497954	0.8988340990453867	HDAC4;HPGD;ADH1B;PRDM2;FOXK1;FHIT;HDAC6;MECP2;GHR;HPGDS;CALD1;CRNDE;MEF2A;CCDC134;EGFL7;GSN;INSR;NR1H2;HGF;BRAF;IL16;ARHGAP24;MTOR;ST7L;SLC25A16;AIMP2;NFIA;DLC1;NFIC;PMP22;ULK1;TACC1;FKBP5
Immune System Diseases	4/250	0.42608893403040615	0.5627899770310448	0	0	1.2094582014522435	1.031797486661491	ATXN2;PMP22;PAFAH1B1;FOXP1
Oligospermia	2/109	0.42663171664380267	0.5632451480586813	0	0	1.3896205041064855	1.1837261706552535	HPGDS;SLC16A7
melanoma	34/2454	0.4268001295068555	0.5632451480586813	0	0	1.048510971786834	0.8927436115516401	CDKN1C;IGSF8;RAB5B;NPR1;SEMA3A;PRDM2;LSP1;CSAD;TM9SF4;HDAC6;GHR;HPGDS;PRKCI;GSN;FZD4;STAT2;NR1H2;HGF;EBF1;VWA5A;MIB2;BRAF;ARHGAP24;DCN;MTOR;SLC25A16;AIMP2;CEACAM1;DLG2;AKAP9;HOXD3;ANGPTL1;FKBP5;NSMAF
Retinoblastoma	8/539	0.42688210716950764	0.5632451480586813	0	0	1.1213594359041739	0.9545543037145006	ITSN2;CDKN1C;HPGDS;BRAF;PRDM2;ARHGAP24;DCN;MTOR
Barrett Esophagus	5/323	0.42959537910146617	0.5642124094692984	0	0	1.1696667389575652	0.9882648697037653	GHR;HPGDS;HGF;FHIT;FOXP1
Reduced bone mineral density	1/42	0.43046096756431207	0.5642124094692984	0	0	1.8125172572480441	1.5277683073735129	SEMA3A
Parkinsonism, Juvenile	1/42	0.43046096756431207	0.5642124094692984	0	0	1.8125172572480441	1.5277683073735129	ATP13A2
Vascular Neoplasms	1/42	0.43046096756431207	0.5642124094692984	0	0	1.8125172572480441	1.5277683073735129	MTOR
Bulimia Nervosa	1/42	0.43046096756431207	0.5642124094692984	0	0	1.8125172572480441	1.5277683073735129	LMO3
Cervical intraepithelial neoplasia grade 2	1/42	0.43046096756431207	0.5642124094692984	0	0	1.8125172572480441	1.5277683073735129	FHIT
Choanal Atresia	1/42	0.43046096756431207	0.5642124094692984	0	0	1.8125172572480441	1.5277683073735129	ARID1B
Chronic diarrhea	1/42	0.43046096756431207	0.5642124094692984	0	0	1.8125172572480441	1.5277683073735129	SAA1
Clear Cell Sarcoma of Soft Tissue	1/42	0.43046096756431207	0.5642124094692984	0	0	1.8125172572480441	1.5277683073735129	BRAF
Disease due to Parvoviridae	1/42	0.43046096756431207	0.5642124094692984	0	0	1.8125172572480441	1.5277683073735129	AIMP2
Dyskeratosis Congenita	1/42	0.43046096756431207	0.5642124094692984	0	0	1.8125172572480441	1.5277683073735129	RNPC3
exudative macular degeneration	1/42	0.43046096756431207	0.5642124094692984	0	0	1.8125172572480441	1.5277683073735129	SYN3
Ganglioneuroblastoma	1/42	0.43046096756431207	0.5642124094692984	0	0	1.8125172572480441	1.5277683073735129	UTS2
Isochromosomes	1/42	0.43046096756431207	0.5642124094692984	0	0	1.8125172572480441	1.5277683073735129	PAFAH1B1
Late fontanel closure	1/42	0.43046096756431207	0.5642124094692984	0	0	1.8125172572480441	1.5277683073735129	RERE
Oligoarticular Juvenile Idiopathic Arthritis	1/42	0.43046096756431207	0.5642124094692984	0	0	1.8125172572480441	1.5277683073735129	ATXN2
Other ureteric obstruction	1/42	0.43046096756431207	0.5642124094692984	0	0	1.8125172572480441	1.5277683073735129	MTOR
PITUITARY ADENOMA PREDISPOSITION (disorder)	1/42	0.43046096756431207	0.5642124094692984	0	0	1.8125172572480441	1.5277683073735129	SLC7A6
Rat Adrenal Gland Pheochromocytoma	1/42	0.43046096756431207	0.5642124094692984	0	0	1.8125172572480441	1.5277683073735129	UTS2
Dry skin	2/110	0.4311869948748532	0.5647710047613255	0	0	1.3766835016835017	1.1580846369165825	INSR;BRAF
Neutrophil count (procedure)	2/110	0.4311869948748532	0.5647710047613255	0	0	1.3766835016835017	1.1580846369165825	ATXN1;MAST2
Ataxia Telangiectasia	6/396	0.4314960855110964	0.5649794070630171	0	0	1.1446153846153846	0.9620456141468837	HDAC4;AIMP2;HGF;BRAF;FSTL1;MTOR
Gastritis	3/181	0.4333769629750093	0.5672449685638846	0	0	1.2532148502584697	1.0478722703602465	HPGDS;HGF;ARHGAP24
Malignant Head and Neck Neoplasm	7/470	0.43466066392300134	0.5681356616399105	0	0	1.1249197361508376	0.9372714646514078	HPGDS;IGFBP5;ADH1B;NR1H2;FHIT;ARHGAP24;MTOR
Hepatitis, Toxic	5/325	0.43481155097102786	0.5681356616399105	0	0	1.1622365900383143	0.9679600945525202	COL3A1;CCDC80;SLC10A7;GSN;WASL
Chemical and Drug Induced Liver Injury	5/325	0.43481155097102786	0.5681356616399105	0	0	1.1622365900383143	0.9679600945525202	COL3A1;CCDC80;SLC10A7;GSN;WASL
Chemically-Induced Liver Toxicity	5/325	0.43481155097102786	0.5681356616399105	0	0	1.1622365900383143	0.9679600945525202	COL3A1;CCDC80;SLC10A7;GSN;WASL
Drug-Induced Acute Liver Injury	5/325	0.43481155097102786	0.5681356616399105	0	0	1.1622365900383143	0.9679600945525202	COL3A1;CCDC80;SLC10A7;GSN;WASL
Sensorineural Hearing Loss (disorder)	7/471	0.4368259725956628	0.5686219808592358	0	0	1.1224370922646785	0.9296252921970566	FOXC1;PEX6;OGDH;PMP22;BRAF;PIK3R1;ARID1B
Respiratory Insufficiency	3/182	0.43688276812305016	0.5686219808592358	0	0	1.2461499245916265	1.031924770873554	MECP2;COL3A1;PEX6
Bipolar Disorder	12/837	0.43689196191960544	0.5686219808592358	0	0	1.0828346456692914	0.8966621716470113	RERE;PRKCI;HPGDS;DLG2;MAOB;NFIA;MAOA;FZD4;DGKB;LMO3;SYN3;FKBP5
Thin dental enamel	1/43	0.4380517622653311	0.5686219808592358	0	0	1.7692722371967655	1.4603894998526634	ROGDI
Triploidy syndrome	1/43	0.4380517622653311	0.5686219808592358	0	0	1.7692722371967655	1.4603894998526634	CDKN1C
Becker Muscular Dystrophy	1/43	0.4380517622653311	0.5686219808592358	0	0	1.7692722371967655	1.4603894998526634	SGCD
Broad thumbs	1/43	0.4380517622653311	0.5686219808592358	0	0	1.7692722371967655	1.4603894998526634	NSD1
Defective enamel matrix	1/43	0.4380517622653311	0.5686219808592358	0	0	1.7692722371967655	1.4603894998526634	ROGDI
Dissection of aorta	1/43	0.4380517622653311	0.5686219808592358	0	0	1.7692722371967655	1.4603894998526634	COL3A1
Dysplasia of tooth enamel	1/43	0.4380517622653311	0.5686219808592358	0	0	1.7692722371967655	1.4603894998526634	ROGDI
Erythrokeratoderma	1/43	0.4380517622653311	0.5686219808592358	0	0	1.7692722371967655	1.4603894998526634	SASH1
High Grade Lymphoma (neoplasm)	1/43	0.4380517622653311	0.5686219808592358	0	0	1.7692722371967655	1.4603894998526634	CD22
intracranial glioma	1/43	0.4380517622653311	0.5686219808592358	0	0	1.7692722371967655	1.4603894998526634	HGF
Macrocephaly	1/43	0.4380517622653311	0.5686219808592358	0	0	1.7692722371967655	1.4603894998526634	MTOR
Myoclonic Epilepsy	1/43	0.4380517622653311	0.5686219808592358	0	0	1.7692722371967655	1.4603894998526634	PMP22
Peroxisomal Disorders	1/43	0.4380517622653311	0.5686219808592358	0	0	1.7692722371967655	1.4603894998526634	PEX6
Primary Carcinoma	1/43	0.4380517622653311	0.5686219808592358	0	0	1.7692722371967655	1.4603894998526634	BRAF
Proliferative retinopathy	1/43	0.4380517622653311	0.5686219808592358	0	0	1.7692722371967655	1.4603894998526634	ADH1B
Pyruvate Carboxylase Deficiency Disease	1/43	0.4380517622653311	0.5686219808592358	0	0	1.7692722371967655	1.4603894998526634	OGDH
Uric acid measurement (procedure)	2/112	0.4402395799932324	0.5704790154229468	0	0	1.3515151515151516	1.1088319555185038	ATXN2;INSR
Bilateral cataracts (disorder)	2/112	0.4402395799932324	0.5704790154229468	0	0	1.3515151515151516	1.1088319555185038	HPGDS;MGST1
Bronchiectasis	2/112	0.4402395799932324	0.5704790154229468	0	0	1.3515151515151516	1.1088319555185038	FAM13A;ATP11A
Cholera	2/112	0.4402395799932324	0.5704790154229468	0	0	1.3515151515151516	1.1088319555185038	HGF;VPS54
Glomerulosclerosis (disorder)	2/112	0.4402395799932324	0.5704790154229468	0	0	1.3515151515151516	1.1088319555185038	CDKN1C;HGF
Obesity, Morbid	2/113	0.4447363076537254	0.5730132529896597	0	0	1.3392710892710893	1.0851761937393045	INSR;ACACB
Cocaine-Related Disorders	2/113	0.4447363076537254	0.5730132529896597	0	0	1.3392710892710893	1.0851761937393045	MECP2;HDAC4
Erythema	2/113	0.4447363076537254	0.5730132529896597	0	0	1.3392710892710893	1.0851761937393045	HPGD;ADH1B
Paresis	2/113	0.4447363076537254	0.5730132529896597	0	0	1.3392710892710893	1.0851761937393045	HGF;PMP22
Malignant neoplasm of stomach	33/2398	0.4449660823400787	0.5730132529896597	0	0	1.0401636889909172	0.8422800562905903	HDAC4;HPGD;ADH1B;PRDM2;FOXK1;FHIT;HDAC6;MECP2;GHR;HPGDS;CALD1;CRNDE;MEF2A;CCDC134;EGFL7;GSN;URGCP;INSR;NR1H2;HGF;BRAF;IL16;ARHGAP24;MTOR;ST7L;AIMP2;NFIA;DLC1;NFIC;PMP22;ULK1;TACC1;FKBP5
Metabolic Syndrome X	8/548	0.44502359718387	0.5730132529896597	0	0	1.1021533161068044	0.8923341528766812	IGFBP5;INSR;HGF;OSBP;UTS2;PIK3R1;ACACB;MTOR
Osteopenia	5/329	0.4452127729158239	0.5730132529896597	0	0	1.147651482900525	0.92868298814967	GHR;IL1RL1;HPGD;COG1;BRAF
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	1/44	0.445541762146725	0.5730132529896597	0	0	1.7280386134269416	1.3970575180796234	GSN
Intellectual disability, progressive	1/44	0.445541762146725	0.5730132529896597	0	0	1.7280386134269416	1.3970575180796234	MECP2
Split hand foot deformity 1	1/44	0.445541762146725	0.5730132529896597	0	0	1.7280386134269416	1.3970575180796234	BRAF
Strawberry nevus of skin	1/44	0.445541762146725	0.5730132529896597	0	0	1.7280386134269416	1.3970575180796234	MTOR
Thyroiditis	1/44	0.445541762146725	0.5730132529896597	0	0	1.7280386134269416	1.3970575180796234	BRAF
Tumoral calcinosis	1/44	0.445541762146725	0.5730132529896597	0	0	1.7280386134269416	1.3970575180796234	LSP1
Acquired aplastic anemia	1/44	0.445541762146725	0.5730132529896597	0	0	1.7280386134269416	1.3970575180796234	HPGDS
Autonomic nervous system disorders	1/44	0.445541762146725	0.5730132529896597	0	0	1.7280386134269416	1.3970575180796234	SGCD
Behavior Disorders	1/44	0.445541762146725	0.5730132529896597	0	0	1.7280386134269416	1.3970575180796234	MAOA
Birth Weight	1/44	0.445541762146725	0.5730132529896597	0	0	1.7280386134269416	1.3970575180796234	ABCC9
Birthmark	1/44	0.445541762146725	0.5730132529896597	0	0	1.7280386134269416	1.3970575180796234	MTOR
Conjunctivitis	1/44	0.445541762146725	0.5730132529896597	0	0	1.7280386134269416	1.3970575180796234	PIK3R1
Endometriosis of uterus	1/44	0.445541762146725	0.5730132529896597	0	0	1.7280386134269416	1.3970575180796234	HGF
Paranasal Sinus Diseases	1/44	0.445541762146725	0.5730132529896597	0	0	1.7280386134269416	1.3970575180796234	PIK3R1
Peripheral motor neuropathy	1/44	0.445541762146725	0.5730132529896597	0	0	1.7280386134269416	1.3970575180796234	EBF2
Respiratory Failure	3/185	0.4473508754309707	0.5751435999141524	0	0	1.2254209668658338	0.9857433749922672	MECP2;ATXN2;PEX6
Secondary malignant neoplasm of bone	5/330	0.4478060251869327	0.5755323428451639	0	0	1.1440613026819924	0.9191332673533913	DLC1;HGF;MAP2K5;RAI2;DCN
Testicular Germ Cell Tumor	2/114	0.4492129575784697	0.5765537346501176	0	0	1.327245670995671	1.062139245742004	HPGDS;FHIT
Gingival Diseases	2/114	0.4492129575784697	0.5765537346501176	0	0	1.327245670995671	1.062139245742004	COL3A1;IL16
Head and Neck Carcinoma	2/114	0.4492129575784697	0.5765537346501176	0	0	1.327245670995671	1.062139245742004	MGST1;FHIT
leiomyosarcoma	2/114	0.4492129575784697	0.5765537346501176	0	0	1.327245670995671	1.062139245742004	PPP1R12A;CALD1
HYDATIDIFORM MOLE, RECURRENT, 1	1/45	0.4529323006942458	0.5781755258269142	0	0	1.6886792452830188	1.3374552586345125	CDKN1C
Leukemia, Plasma Cell	1/45	0.4529323006942458	0.5781755258269142	0	0	1.6886792452830188	1.3374552586345125	BRAF
Tall stature	1/45	0.4529323006942458	0.5781755258269142	0	0	1.6886792452830188	1.3374552586345125	NSD1
Skin Diseases, Genetic	1/45	0.4529323006942458	0.5781755258269142	0	0	1.6886792452830188	1.3374552586345125	SASH1
Widely spaced teeth	1/45	0.4529323006942458	0.5781755258269142	0	0	1.6886792452830188	1.3374552586345125	IDS
Age-related cataract	1/45	0.4529323006942458	0.5781755258269142	0	0	1.6886792452830188	1.3374552586345125	HPGDS
Cafe-au-Lait Spots	1/45	0.4529323006942458	0.5781755258269142	0	0	1.6886792452830188	1.3374552586345125	MTOR
Cerebral Amyloid Angiopathy	1/45	0.4529323006942458	0.5781755258269142	0	0	1.6886792452830188	1.3374552586345125	GSN
Chondrodysplasia	1/45	0.4529323006942458	0.5781755258269142	0	0	1.6886792452830188	1.3374552586345125	HDAC6
Congenital hypoplasia of ovary	1/45	0.4529323006942458	0.5781755258269142	0	0	1.6886792452830188	1.3374552586345125	BBS1
Delirium	1/45	0.4529323006942458	0.5781755258269142	0	0	1.6886792452830188	1.3374552586345125	LMO3
Distal Muscular Dystrophies	1/45	0.4529323006942458	0.5781755258269142	0	0	1.6886792452830188	1.3374552586345125	SGCD
Hypoplastic ovary	1/45	0.4529323006942458	0.5781755258269142	0	0	1.6886792452830188	1.3374552586345125	BBS1
LATERAL MENINGOCELE SYNDROME	1/45	0.4529323006942458	0.5781755258269142	0	0	1.6886792452830188	1.3374552586345125	CALD1
Myxoid/Round Cell Liposarcoma	1/45	0.4529323006942458	0.5781755258269142	0	0	1.6886792452830188	1.3374552586345125	MTOR
Purpura	1/45	0.4529323006942458	0.5781755258269142	0	0	1.6886792452830188	1.3374552586345125	USP8
Spastic Paraplegia	2/115	0.4536692674275698	0.578920098373867	0	0	1.3154330919817645	1.0397009946186753	DSTYK;ATP13A2
Craniofacial Abnormalities	3/187	0.45428661502204504	0.579511574259412	0	0	1.211977186311787	0.95628268643359	MECP2;TBX15;FZD4
Colorectal Carcinoma	40/2931	0.4561171565662036	0.5816497389251486	0	0	1.0311525240064527	0.8094604853538432	CDKN1C;HPGD;ADH1B;ANKRD12;PRDM2;FOXK1;FSTL1;FHIT;EDA2R;MECP2;GHR;ADAMTS15;HPGDS;CALD1;CRNDE;SLC16A7;MAP2K5;GSN;PPP1R12A;SCARA5;SORT1;INSR;NR1H2;HGF;RAB27B;BRAF;IL16;CRLS1;ARHGAP24;DCN;MTOR;HIPK2;AIMP2;CEACAM1;COL3A1;DLC1;AKAP9;PMP22;ANGPTL1;CPEB4
Carcinoma, Spindle-Cell	3/188	0.457741032304458	0.5825492006360216	0	0	1.2053642996608775	0.9419339647377718	HGF;PIK3R1;FHIT
Alzheimer Disease, Early Onset	2/116	0.4581049851908896	0.5825492006360216	0	0	1.3038277511961722	1.0178421249437788	MAOB;INSR
Organic Mental Disorders, Substance-Induced	2/116	0.4581049851908896	0.5825492006360216	0	0	1.3038277511961722	1.0178421249437788	INSR;FHIT
Complex partial seizures	2/116	0.4581049851908896	0.5825492006360216	0	0	1.3038277511961722	1.0178421249437788	MECP2;MTOR
Familial (FPAH)	2/116	0.4581049851908896	0.5825492006360216	0	0	1.3038277511961722	1.0178421249437788	INSR;ATP13A2
Prescription Drug Abuse	2/116	0.4581049851908896	0.5825492006360216	0	0	1.3038277511961722	1.0178421249437788	INSR;FHIT
Hepatitis A	4/261	0.4584990862953329	0.5825492006360216	0	0	1.1570380491282264	0.9022547765714486	HPGDS;SON;HGF;ARHGAP24
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	6/408	0.45965344318598406	0.5825492006360216	0	0	1.1097588978185993	0.8625961236773084	HDAC4;MEF2C;BRAF;FHIT;CD22;MTOR
Refractive Errors	1/46	0.4602246936800637	0.5825492006360216	0	0	1.651069182389937	1.2812964617680371	HGF
Thrombus	1/46	0.4602246936800637	0.5825492006360216	0	0	1.651069182389937	1.2812964617680371	HGF
Adult Diffuse Large B-Cell Lymphoma	1/46	0.4602246936800637	0.5825492006360216	0	0	1.651069182389937	1.2812964617680371	FOXP1
Basal Cell Nevus Syndrome	1/46	0.4602246936800637	0.5825492006360216	0	0	1.651069182389937	1.2812964617680371	HPGDS
Childhood Diffuse Large B-Cell Lymphoma	1/46	0.4602246936800637	0.5825492006360216	0	0	1.651069182389937	1.2812964617680371	FOXP1
Choreoathetoid movements	1/46	0.4602246936800637	0.5825492006360216	0	0	1.651069182389937	1.2812964617680371	MECP2
Cortical visual impairment	1/46	0.4602246936800637	0.5825492006360216	0	0	1.651069182389937	1.2812964617680371	SON
Facial asymmetry	1/46	0.4602246936800637	0.5825492006360216	0	0	1.651069182389937	1.2812964617680371	SON
Foot-drop	1/46	0.4602246936800637	0.5825492006360216	0	0	1.651069182389937	1.2812964617680371	PMP22
Hypoalbuminemia	1/46	0.4602246936800637	0.5825492006360216	0	0	1.651069182389937	1.2812964617680371	FHIT
Moyamoya disease 1	1/46	0.4602246936800637	0.5825492006360216	0	0	1.651069182389937	1.2812964617680371	ATP11A
Obstructive nephropathy	1/46	0.4602246936800637	0.5825492006360216	0	0	1.651069182389937	1.2812964617680371	HGF
Peptic Esophagitis	1/46	0.4602246936800637	0.5825492006360216	0	0	1.651069182389937	1.2812964617680371	GHR
Pyloric Stenosis	1/46	0.4602246936800637	0.5825492006360216	0	0	1.651069182389937	1.2812964617680371	PEX6
Malignant mesothelioma	5/335	0.4607252239989755	0.5829868722889286	0	0	1.1264367816091954	0.8729360780857607	HDAC4;HGF;SEMA3A;FHIT;MTOR
Arthritis	9/630	0.46136108410618176	0.5835954344620506	0	0	1.0778210116731517	0.8337746129364237	AIMP2;HPGD;HGF;SYVN1;SAA1;BRAF;PIK3R1;RNPC3;FSTL1
Carcinoma, Small Cell	2/117	0.46251986921719707	0.5842764410936222	0	0	1.2924242424242425	0.9965440839361249	FHIT;MTOR
Hypogonadism, Isolated Hypogonadotropic	2/117	0.46251986921719707	0.5842764410936222	0	0	1.2924242424242425	0.9965440839361249	SEMA3A;BRAF
Leukemia, B-Cell	2/117	0.46251986921719707	0.5842764410936222	0	0	1.2924242424242425	0.9965440839361249	LAMA4;COG1
Muscle Hypertonia	2/117	0.46251986921719707	0.5842764410936222	0	0	1.2924242424242425	0.9965440839361249	OGDH;BRAF
Malignant neoplasm of gastrointestinal tract	4/263	0.4643284351909456	0.5863644704540033	0	0	1.1479854991305374	0.8806921632747255	GHR;CEACAM1;HPGDS;HPGD
Myeloproliferative disease	4/264	0.46723491736548767	0.5877076244324025	0	0	1.1435114503816795	0.8701242922886455	NUMA1;GOLGB1;ULK1;PAFAH1B1
Blindness, Cortical	1/47	0.46742023966006846	0.5877076244324025	0	0	1.6150943396226416	1.2283221343745168	SON
Abnormality of the outer ear	1/47	0.46742023966006846	0.5877076244324025	0	0	1.6150943396226416	1.2283221343745168	PEX6
Antiphospholipid Syndrome	1/47	0.46742023966006846	0.5877076244324025	0	0	1.6150943396226416	1.2283221343745168	ATXN2
Foot dorsiflexor weakness	1/47	0.46742023966006846	0.5877076244324025	0	0	1.6150943396226416	1.2283221343745168	PMP22
FRAGILE X TREMOR/ATAXIA SYNDROME	1/47	0.46742023966006846	0.5877076244324025	0	0	1.6150943396226416	1.2283221343745168	MTOR
Hand deformities	1/47	0.46742023966006846	0.5877076244324025	0	0	1.6150943396226416	1.2283221343745168	ABCC9
Kidney damage	1/47	0.46742023966006846	0.5877076244324025	0	0	1.6150943396226416	1.2283221343745168	SAA1
LIMB-MAMMARY SYNDROME	1/47	0.46742023966006846	0.5877076244324025	0	0	1.6150943396226416	1.2283221343745168	CALD1
Lower limb muscle weakness	1/47	0.46742023966006846	0.5877076244324025	0	0	1.6150943396226416	1.2283221343745168	DSTYK
Peripheral demyelinating neuropathy	1/47	0.46742023966006846	0.5877076244324025	0	0	1.6150943396226416	1.2283221343745168	PMP22
Phospholipid measurement	1/47	0.46742023966006846	0.5877076244324025	0	0	1.6150943396226416	1.2283221343745168	DLG2
Post MI	1/47	0.46742023966006846	0.5877076244324025	0	0	1.6150943396226416	1.2283221343745168	DCN
Platelet Count measurement	3/191	0.4680483618346359	0.5883010273710622	0	0	1.1859477388560795	0.9003521344577515	MEF2C;ATXN2;SMG6
Infarction, Middle Cerebral Artery	2/119	0.47128621919322167	0.5917783959002887	0	0	1.27020202020202	0.9555598782597002	HDAC4;MTOR
Von Hippel-Lindau Syndrome	2/119	0.47128621919322167	0.5917783959002887	0	0	1.27020202020202	0.9555598782597002	SYVN1;FHIT
Drug Use Disorders	2/119	0.47128621919322167	0.5917783959002887	0	0	1.27020202020202	0.9555598782597002	INSR;FHIT
Inflammatory disorder	3/192	0.4714649320618148	0.5918055311818915	0	0	1.1796125294224153	0.8869631116135618	AIMP2;HGF;SAA1
Refractory anemias	4/266	0.47303090543480986	0.5934653615354677	0	0	1.1346658120156168	0.8494046468484118	HPGDS;URGCP;IGFBP5;PAFAH1B1
Hyperglycemia	7/488	0.4734126928690609	0.5934653615354677	0	0	1.0818115412710008	0.8089654401344172	AIMP2;COL3A1;INSR;HGF;ULK1;PIK3R1;MTOR
Mental Retardation, X-Linked 1	1/48	0.4745202200543745	0.5934653615354677	0	0	1.5806503412284223	1.178297454098973	MECP2
Abnormal urinary amino-acid findings	1/48	0.4745202200543745	0.5934653615354677	0	0	1.5806503412284223	1.178297454098973	DHTKD1
Agyria	1/48	0.4745202200543745	0.5934653615354677	0	0	1.5806503412284223	1.178297454098973	PAFAH1B1
Barrett Epithelium	1/48	0.4745202200543745	0.5934653615354677	0	0	1.5806503412284223	1.178297454098973	HGF
contracture of elbow	1/48	0.4745202200543745	0.5934653615354677	0	0	1.5806503412284223	1.178297454098973	TBX15
Fabry Disease	1/48	0.4745202200543745	0.5934653615354677	0	0	1.5806503412284223	1.178297454098973	IDS
Foot Deformities	1/48	0.4745202200543745	0.5934653615354677	0	0	1.5806503412284223	1.178297454098973	PMP22
keratoacanthoma	1/48	0.4745202200543745	0.5934653615354677	0	0	1.5806503412284223	1.178297454098973	BRAF
Paresthesia	1/48	0.4745202200543745	0.5934653615354677	0	0	1.5806503412284223	1.178297454098973	PMP22
Neurologic Symptoms	2/120	0.47563725094973164	0.5946649599494321	0	0	1.2593733949666153	0.9358401092559183	MECP2;IDS
Adenocarcinoma of colon	4/267	0.4759201796041073	0.5948212729159497	0	0	1.1302934432415175	0.8392486785649392	GSN;PMP22;BRAF;FHIT
Hypothyroidism	4/268	0.47880348882992646	0.5982264485646213	0	0	1.1259541984732824	0.829225879848219	ATXN2;GSN;INSR;BRAF
Wide skull shape	2/121	0.47996658005629994	0.5988097147835714	0	0	1.2487267634326458	0.916613897938486	RERE;MECP2
Broad cranium shape	2/121	0.47996658005629994	0.5988097147835714	0	0	1.2487267634326458	0.916613897938486	RERE;MECP2
Polyhydramnios	2/121	0.47996658005629994	0.5988097147835714	0	0	1.2487267634326458	0.916613897938486	BRAF;PAFAH1B1
Sparse body hair	1/49	0.4815258992613444	0.5988097147835714	0	0	1.5476415094339622	1.131009080025355	EDA2R
Thromboangiitis Obliterans	1/49	0.4815258992613444	0.5988097147835714	0	0	1.5476415094339622	1.131009080025355	FOXP1
Airway Obstruction	1/49	0.4815258992613444	0.5988097147835714	0	0	1.5476415094339622	1.131009080025355	ADAMTS15
Astigmatism	1/49	0.4815258992613444	0.5988097147835714	0	0	1.5476415094339622	1.131009080025355	ARID1B
cardiac event	1/49	0.4815258992613444	0.5988097147835714	0	0	1.5476415094339622	1.131009080025355	MAOA
Dryness of eye	1/49	0.4815258992613444	0.5988097147835714	0	0	1.5476415094339622	1.131009080025355	HPGDS
Female Breast Carcinoma	1/49	0.4815258992613444	0.5988097147835714	0	0	1.5476415094339622	1.131009080025355	ADH1B
Hypermelanotic macule	1/49	0.4815258992613444	0.5988097147835714	0	0	1.5476415094339622	1.131009080025355	INSR
Low anterior hairline	1/49	0.4815258992613444	0.5988097147835714	0	0	1.5476415094339622	1.131009080025355	ABCC9
Neck webbing	1/49	0.4815258992613444	0.5988097147835714	0	0	1.5476415094339622	1.131009080025355	BRAF
Nervous System Neoplasms	1/49	0.4815258992613444	0.5988097147835714	0	0	1.5476415094339622	1.131009080025355	BRAF
Decreased tendon reflex	3/195	0.48165474802076486	0.5988097147835714	0	0	1.1610028517110267	0.8481447568899191	ATXN2;ATXN1;PMP22
Gastrointestinal Neoplasms	2/122	0.48427401285142524	0.601668933512968	0	0	1.2382575757575758	0.8978660043908274	FHIT;ARHGAP24
Hyperammonemia	2/122	0.48427401285142524	0.601668933512968	0	0	1.2382575757575758	0.8978660043908274	OGDH;IDS
Cytomegalovirus Infections	4/270	0.484551767797641	0.601815532243229	0	0	1.1173735866383516	0.8095718082234277	AIMP2;STAT2;WASL;MTOR
Cardiomyopathy, Dilated	6/419	0.48516433619072225	0.602377737122759	0	0	1.0795865151797355	0.7808299563880434	MEF2A;SGCD;HGF;LAMA4;ABCC9;MAP2K5
Small Lymphocytic Lymphoma	1/50	0.4884385252284191	0.6040049640351937	0	0	1.5159799768964188	1.086262808220724	CD22
Calcinosis	1/50	0.4884385252284191	0.6040049640351937	0	0	1.5159799768964188	1.086262808220724	LSP1
Childhood onset	1/50	0.4884385252284191	0.6040049640351937	0	0	1.5159799768964188	1.086262808220724	PMP22
Endocardial Cushion Defects	1/50	0.4884385252284191	0.6040049640351937	0	0	1.5159799768964188	1.086262808220724	BRAF
Giant Cell Tumors	1/50	0.4884385252284191	0.6040049640351937	0	0	1.5159799768964188	1.086262808220724	BRAF
Hypercalciuria	1/50	0.4884385252284191	0.6040049640351937	0	0	1.5159799768964188	1.086262808220724	CDKN1C
Li-Fraumeni Syndrome	1/50	0.4884385252284191	0.6040049640351937	0	0	1.5159799768964188	1.086262808220724	DCN
Microscopic Polyarteritis	1/50	0.4884385252284191	0.6040049640351937	0	0	1.5159799768964188	1.086262808220724	FKBP5
Moyamoya Disease	1/50	0.4884385252284191	0.6040049640351937	0	0	1.5159799768964188	1.086262808220724	HGF
Muscular fasciculation	1/50	0.4884385252284191	0.6040049640351937	0	0	1.5159799768964188	1.086262808220724	ATXN2
Opiate Addiction	1/50	0.4884385252284191	0.6040049640351937	0	0	1.5159799768964188	1.086262808220724	FKBP5
Substance-Related Disorders	2/123	0.48855936432578584	0.6040049640351937	0	0	1.227961432506887	0.8795817639014041	INSR;FHIT
Hyperplasia	2/123	0.48855936432578584	0.6040049640351937	0	0	1.227961432506887	0.8795817639014041	HGF;SAA1
Recurrent tumor	5/347	0.49135635398128613	0.6072635779027248	0	0	1.0862405054782551	0.7718669075780697	URGCP;HGF;BRAF;PRDM2;MTOR
Pneumonia	7/497	0.49255187455132055	0.6078989550460424	0	0	1.0614451185879756	0.7516681932400284	AIMP2;HPGDS;HGF;IL16;LSP1;CRLS1;MTOR
Nicotine Dependence	2/124	0.49282245838525296	0.6078989550460424	0	0	1.2178340784898163	0.8617470599360478	MAOA;ADH1B
Polycystic Kidney Diseases	2/124	0.49282245838525296	0.6078989550460424	0	0	1.2178340784898163	0.8617470599360478	HGF;MTOR
Encephalomyelitis	5/348	0.49388172805619257	0.6078989550460424	0	0	1.0830177719692147	0.7640248589586202	AIMP2;HPGDS;SORT1;IL11RA;SYVN1
Aplasia Cutis Congenita	3/199	0.495095705031431	0.6078989550460424	0	0	1.1370761232249553	0.7993692808000287	NUMA1;ACACB;MTOR
Amaurosis congenita of Leber, type 1	1/51	0.49525932918404675	0.6078989550460424	0	0	1.4855849056603774	1.0438815259009178	MEF2C
Lymphohistiocytosis, Hemophagocytic	1/51	0.49525932918404675	0.6078989550460424	0	0	1.4855849056603774	1.0438815259009178	IL16
Tachycardia, Ventricular	1/51	0.49525932918404675	0.6078989550460424	0	0	1.4855849056603774	1.0438815259009178	MECP2
Abnormality of the ribs	1/51	0.49525932918404675	0.6078989550460424	0	0	1.4855849056603774	1.0438815259009178	SON
Adrenal Cushing's syndrome	1/51	0.49525932918404675	0.6078989550460424	0	0	1.4855849056603774	1.0438815259009178	UTS2
Angioimmunoblastic Lymphadenopathy	1/51	0.49525932918404675	0.6078989550460424	0	0	1.4855849056603774	1.0438815259009178	HGF
Autosomal recessive retinitis pigmentosa	1/51	0.49525932918404675	0.6078989550460424	0	0	1.4855849056603774	1.0438815259009178	BBS1
Bicuspid aortic valve	1/51	0.49525932918404675	0.6078989550460424	0	0	1.4855849056603774	1.0438815259009178	ABCC9
Convex nasal ridge	1/51	0.49525932918404675	0.6078989550460424	0	0	1.4855849056603774	1.0438815259009178	COL3A1
Cystadenoma	1/51	0.49525932918404675	0.6078989550460424	0	0	1.4855849056603774	1.0438815259009178	BRAF
Hematuria	1/51	0.49525932918404675	0.6078989550460424	0	0	1.4855849056603774	1.0438815259009178	IL16
Hermanski-Pudlak Syndrome	1/51	0.49525932918404675	0.6078989550460424	0	0	1.4855849056603774	1.0438815259009178	VPS39
Hypsarrhythmia	1/51	0.49525932918404675	0.6078989550460424	0	0	1.4855849056603774	1.0438815259009178	ROGDI
Lafora Disease	1/51	0.49525932918404675	0.6078989550460424	0	0	1.4855849056603774	1.0438815259009178	ATP13A2
Malignant neoplasm of female breast	1/51	0.49525932918404675	0.6078989550460424	0	0	1.4855849056603774	1.0438815259009178	ADH1B
NONAKA MYOPATHY	1/51	0.49525932918404675	0.6078989550460424	0	0	1.4855849056603774	1.0438815259009178	GSN
Uranostaphyloschisis	4/274	0.49597194594336347	0.6085753486542834	0	0	1.100593723494487	0.7717758461379557	CDKN1C;TBX15;SON;ARID1B
Congenital hypoplasia of lung	2/125	0.49706312748463205	0.6097156630526241	0	0	1.207871396895787	0.844348300118671	NFIA;FHIT
Cerebral Ischemia	4/275	0.49881046787044286	0.6116598412981635	0	0	1.0964761556012508	0.7626310509675894	CEACAM1;SEMA3A;IL16;ANGPTL1
Nodule	2/126	0.5012812123374016	0.6131629527047002	0	0	1.198069403714565	0.8273723932653829	BRAF;ANGPTL1
Arthritis, Psoriatic	3/201	0.5017512418301515	0.6131629527047002	0	0	1.1254752851711027	0.7761849491560407	AKAP13;BRAF;MTOR
Gait, Unsteady	1/52	0.5019895264511004	0.6131629527047002	0	0	1.4563817980022198	1.003703415737085	TTC19
Allergic sensitization	1/52	0.5019895264511004	0.6131629527047002	0	0	1.4563817980022198	1.003703415737085	HPGDS
Aminoaciduria	1/52	0.5019895264511004	0.6131629527047002	0	0	1.4563817980022198	1.003703415737085	DHTKD1
Central visual impairment	1/52	0.5019895264511004	0.6131629527047002	0	0	1.4563817980022198	1.003703415737085	SON
Coronary Stenosis	1/52	0.5019895264511004	0.6131629527047002	0	0	1.4563817980022198	1.003703415737085	COL3A1
Decreased antibody level in blood	1/52	0.5019895264511004	0.6131629527047002	0	0	1.4563817980022198	1.003703415737085	PIK3R1
Decreased nerve conduction velocity	1/52	0.5019895264511004	0.6131629527047002	0	0	1.4563817980022198	1.003703415737085	PEX6
Flexion contracture - elbow	1/52	0.5019895264511004	0.6131629527047002	0	0	1.4563817980022198	1.003703415737085	TBX15
Hippocampal sclerosis	1/52	0.5019895264511004	0.6131629527047002	0	0	1.4563817980022198	1.003703415737085	ABCC9
Lymphocytic infiltration	1/52	0.5019895264511004	0.6131629527047002	0	0	1.4563817980022198	1.003703415737085	BRAF
Herpes Simplex Infections	7/503	0.5051972460309629	0.6168810456397528	0	0	1.0482781168265038	0.7157709440068739	HDAC4;AIMP2;NFIA;NUMA1;NFIC;MTOR;HIPK2
Hyperkeratosis	2/127	0.5054765619198782	0.617022102641666	0	0	1.1884242424242424	0.8108067269069428	INSR;BRAF
Malignant neoplasm of gallbladder	3/203	0.5083620412079927	0.618267312266812	0	0	1.114106463878327	0.7537614352963348	DLC1;HGF;ARHGAP24
Muscular Dystrophy	3/203	0.5083620412079927	0.618267312266812	0	0	1.114106463878327	0.7537614352963348	HPGDS;SGCD;BRAF
RESTING HEART RATE	1/53	0.5086303160910142	0.618267312266812	0	0	1.4283018867924528	0.9655803818240372	CALCRL
Other specified types of schizophrenia, unspecified	1/53	0.5086303160910142	0.618267312266812	0	0	1.4283018867924528	0.9655803818240372	MTOR
Turner Syndrome, Male	1/53	0.5086303160910142	0.618267312266812	0	0	1.4283018867924528	0.9655803818240372	BRAF
Visual field constriction	1/53	0.5086303160910142	0.618267312266812	0	0	1.4283018867924528	0.9655803818240372	PEX6
Anxiety neurosis (finding)	1/53	0.5086303160910142	0.618267312266812	0	0	1.4283018867924528	0.9655803818240372	MECP2
Bradycardia	1/53	0.5086303160910142	0.618267312266812	0	0	1.4283018867924528	0.9655803818240372	UTS2
Choreoathetosis	1/53	0.5086303160910142	0.618267312266812	0	0	1.4283018867924528	0.9655803818240372	MECP2
Language Disorders	1/53	0.5086303160910142	0.618267312266812	0	0	1.4283018867924528	0.9655803818240372	FOXP1
Myeloid neoplasm	1/53	0.5086303160910142	0.618267312266812	0	0	1.4283018867924528	0.9655803818240372	NUMA1
NEUROTICISM	1/53	0.5086303160910142	0.618267312266812	0	0	1.4283018867924528	0.9655803818240372	MAOA
Nodular glomerulosclerosis	1/53	0.5086303160910142	0.618267312266812	0	0	1.4283018867924528	0.9655803818240372	SEMA3A
Sarcomatoid Renal Cell Carcinoma	2/128	0.5096490330747304	0.6185077021883085	0	0	1.178932178932179	0.7946391469163203	AKAP13;MTOR
Arthralgia	2/128	0.5096490330747304	0.6185077021883085	0	0	1.178932178932179	0.7946391469163203	HPGD;BRAF
beta^+^ Thalassemia	2/128	0.5096490330747304	0.6185077021883085	0	0	1.178932178932179	0.7946391469163203	RERE;HPGDS
Biliary Tract Cancer	2/128	0.5096490330747304	0.6185077021883085	0	0	1.178932178932179	0.7946391469163203	BRAF;MTOR
Cocaine Abuse	2/128	0.5096490330747304	0.6185077021883085	0	0	1.178932178932179	0.7946391469163203	MECP2;HDAC4
Anaplastic carcinoma	3/204	0.5116503444208134	0.620536654035159	0	0	1.1085068951818853	0.7428257770488639	BRAF;PIK3R1;FHIT
Papilloma	3/204	0.5116503444208134	0.620536654035159	0	0	1.1085068951818853	0.7428257770488639	FHIT;ARHGAP24;DCN
Rett Syndrome	2/129	0.5137984904000338	0.6219405248511977	0	0	1.169589596754951	0.7788579375051156	MECP2;HDAC6
Cleft palate, isolated	2/129	0.5137984904000338	0.6219405248511977	0	0	1.169589596754951	0.7788579375051156	CDKN1C;FZD4
Hepatitis, Autoimmune	2/129	0.5137984904000338	0.6219405248511977	0	0	1.169589596754951	0.7788579375051156	HPGDS;RNPC3
Seizures, Focal	2/129	0.5137984904000338	0.6219405248511977	0	0	1.169589596754951	0.7788579375051156	MECP2;MBOAT7
tumor vasculature	2/129	0.5137984904000338	0.6219405248511977	0	0	1.169589596754951	0.7788579375051156	CALD1;SEMA3A
early pregnancy	2/129	0.5137984904000338	0.6219405248511977	0	0	1.169589596754951	0.7788579375051156	HPGDS;CALCRL
Hypogonadism	3/205	0.5149270856988812	0.6222167085925058	0	0	1.1029627677596656	0.7320694442148852	CDKN1C;BBS1;PEX6
Reduced tendon reflexes	1/54	0.5151828813644878	0.6222167085925058	0	0	1.4012815948736206	0.9293766611111113	PEX6
Severe muscular hypotonia	1/54	0.5151828813644878	0.6222167085925058	0	0	1.4012815948736206	0.9293766611111113	PEX6
Xeroderma Pigmentosum, Complementation Group D	1/54	0.5151828813644878	0.6222167085925058	0	0	1.4012815948736206	0.9293766611111113	HPGDS
Action Tremor	1/54	0.5151828813644878	0.6222167085925058	0	0	1.4012815948736206	0.9293766611111113	ATXN2
Cerebral Aneurysm	1/54	0.5151828813644878	0.6222167085925058	0	0	1.4012815948736206	0.9293766611111113	COL3A1
Diabetic Cardiomyopathies	1/54	0.5151828813644878	0.6222167085925058	0	0	1.4012815948736206	0.9293766611111113	MAOA
Brachycephaly	2/130	0.51792480620605	0.625327802877625	0	0	1.1603929924242424	0.7634518020907335	RERE;MECP2
Lymphoma, Follicular	5/359	0.5213430152776417	0.6288158352895633	0	0	1.0487694006104293	0.6831128816605057	CDKN1C;HPGDS;EBF1;MTOR;FOXP1
Liver Dysfunction	3/207	0.521445408736676	0.6288158352895633	0	0	1.0920375754864684	0.7110810221537665	COL3A1;HPGDS;SRSF5
Ganglioneuroma	1/55	0.521648390039789	0.6288158352895633	0	0	1.3752620545073375	0.8949675979755651	PRDM2
Hypocholesterolemia	1/55	0.521648390039789	0.6288158352895633	0	0	1.3752620545073375	0.8949675979755651	BRAF
Immunoglobulin A deficiency (disorder)	1/55	0.521648390039789	0.6288158352895633	0	0	1.3752620545073375	0.8949675979755651	MTOR
Ataxia	3/208	0.5246867611501592	0.6322760810149232	0	0	1.086654919781137	0.7008422631400497	MECP2;ATXN2;ATXN1
Cardiac Arrhythmia	2/132	0.5261075394937854	0.6335828328878164	0	0	1.1424242424242423	0.7337215577778532	PEX6;BRAF
precancerous lesions	2/132	0.5261075394937854	0.6335828328878164	0	0	1.1424242424242423	0.7337215577778532	BRAF;FHIT
Treatment related acute myeloid leukaemia	1/56	0.5280279944523304	0.6344757432542038	0	0	1.350188679245283	0.8622385604889001	PAFAH1B1
Adenoviral infections	1/56	0.5280279944523304	0.6344757432542038	0	0	1.350188679245283	0.8622385604889001	HGF
Adult Cholangiocarcinoma	1/56	0.5280279944523304	0.6344757432542038	0	0	1.350188679245283	0.8622385604889001	HGF
Autoimmune arthritis	1/56	0.5280279944523304	0.6344757432542038	0	0	1.350188679245283	0.8622385604889001	AIMP2
Hyperandrogenism	1/56	0.5280279944523304	0.6344757432542038	0	0	1.350188679245283	0.8622385604889001	INSR
Laryngeal Diseases	1/56	0.5280279944523304	0.6344757432542038	0	0	1.350188679245283	0.8622385604889001	ADH1B
Pituitary-dependent Cushing's disease	1/56	0.5280279944523304	0.6344757432542038	0	0	1.350188679245283	0.8622385604889001	USP8
Glomerulonephritis	3/210	0.5311332975110554	0.6378001695008434	0	0	1.0760456273764258	0.6808595401374794	HGF;RNPC3;DCN
Lupus Nephritis	3/210	0.5311332975110554	0.6378001695008434	0	0	1.0760456273764258	0.6808595401374794	MECP2;HGF;MTOR
Malignant neoplasm of large intestine	7/516	0.5322263428273876	0.6383742805720679	0	0	1.0208145276907556	0.6438138637088137	CDKN1C;AIMP2;CRNDE;BRAF;FOXK1;FSTL1;ANGPTL1
Leukemia, T-Cell	5/364	0.5336165446428619	0.6383742805720679	0	0	1.033895772633646	0.6493669607574897	CDKN1C;MEF2C;LDB1;HGF;MIB2
Skin Carcinogenesis	2/134	0.5341963564584095	0.6383742805720679	0	0	1.125	0.7053657737474405	NSD1;STAT2
Absent tendon reflex	2/134	0.5341963564584095	0.6383742805720679	0	0	1.125	0.7053657737474405	ATXN1;PMP22
Sentinel node (disorder)	1/57	0.5343228316017335	0.6383742805720679	0	0	1.326010781671159	0.8310839791328084	BRAF
Respiratory Distress Syndrome, Newborn	1/57	0.5343228316017335	0.6383742805720679	0	0	1.326010781671159	0.8310839791328084	HPGDS
Abnormality of epiphysis morphology	1/57	0.5343228316017335	0.6383742805720679	0	0	1.326010781671159	0.8310839791328084	HPGD
Abnormality of the voice	1/57	0.5343228316017335	0.6383742805720679	0	0	1.326010781671159	0.8310839791328084	SEMA3A
Bleeding tendency	1/57	0.5343228316017335	0.6383742805720679	0	0	1.326010781671159	0.8310839791328084	BRAF
Carotid Artery Diseases	1/57	0.5343228316017335	0.6383742805720679	0	0	1.326010781671159	0.8310839791328084	HGF
Ectodermal Dysplasia	1/57	0.5343228316017335	0.6383742805720679	0	0	1.326010781671159	0.8310839791328084	EDA2R
Geographic Atrophy	1/57	0.5343228316017335	0.6383742805720679	0	0	1.326010781671159	0.8310839791328084	SYN3
Hyperaldosteronism	1/57	0.5343228316017335	0.6383742805720679	0	0	1.326010781671159	0.8310839791328084	INSR
Malignant neoplasm of colon stage IV	1/57	0.5343228316017335	0.6383742805720679	0	0	1.326010781671159	0.8310839791328084	BRAF
Peutz-Jeghers Syndrome	1/57	0.5343228316017335	0.6383742805720679	0	0	1.326010781671159	0.8310839791328084	MTOR
Pneumocystis jiroveci pneumonia	1/57	0.5343228316017335	0.6383742805720679	0	0	1.326010781671159	0.8310839791328084	BRAF
Anoxia	4/288	0.5350571539259423	0.6390489216357086	0	0	1.0455864960756909	0.6538906688025481	CALCRL;HGF;MTOR;FOXP1
Growth failure	3/212	0.5375309102677285	0.641724446152725	0	0	1.065639383630178	0.6615159085594354	GHR;BRAF;PAFAH1B1
Middle Cerebral Artery Occlusion	2/135	0.538205302879228	0.641724446152725	0	0	1.1164843928001822	0.6916790382231531	EGFL7;HGF
Cataract	7/519	0.5383840694769223	0.641724446152725	0	0	1.0146748310810811	0.6282694969780959	FOXC1;HPGDS;FZD4;PEX6;MGST1;PIK3R1;ATP2B1
Recurrent bacterial infection	1/58	0.5405340237968134	0.641724446152725	0	0	1.3026812313803375	0.8014064910457609	PIK3R1
Carcinoma, Lobular	1/58	0.5405340237968134	0.641724446152725	0	0	1.3026812313803375	0.8014064910457609	EGFL7
SCHIZOPHRENIA 1 (disorder)	1/58	0.5405340237968134	0.641724446152725	0	0	1.3026812313803375	0.8014064910457609	MTOR
Silicosis	1/58	0.5405340237968134	0.641724446152725	0	0	1.3026812313803375	0.8014064910457609	FAM13A
Sparse and thin eyebrow	1/58	0.5405340237968134	0.641724446152725	0	0	1.3026812313803375	0.8014064910457609	HDAC4
Ambiguous Genitalia	1/58	0.5405340237968134	0.641724446152725	0	0	1.3026812313803375	0.8014064910457609	PMP22
Amnesia	1/58	0.5405340237968134	0.641724446152725	0	0	1.3026812313803375	0.8014064910457609	MTOR
Congenital aneurysm of ascending aorta	1/58	0.5405340237968134	0.641724446152725	0	0	1.3026812313803375	0.8014064910457609	COL3A1
Congenital defects	1/58	0.5405340237968134	0.641724446152725	0	0	1.3026812313803375	0.8014064910457609	ADH1B
Extrapyramidal Disorders	1/58	0.5405340237968134	0.641724446152725	0	0	1.3026812313803375	0.8014064910457609	ATXN1
Inclusion Body Myositis (disorder)	1/58	0.5405340237968134	0.641724446152725	0	0	1.3026812313803375	0.8014064910457609	PMP22
Increased susceptibility to bacterial infections	1/58	0.5405340237968134	0.641724446152725	0	0	1.3026812313803375	0.8014064910457609	PIK3R1
Large cell carcinoma of lung	1/58	0.5405340237968134	0.641724446152725	0	0	1.3026812313803375	0.8014064910457609	MTOR
Nerve Sheath Tumors	1/58	0.5405340237968134	0.641724446152725	0	0	1.3026812313803375	0.8014064910457609	HGF
Oncocytic Neoplasm	1/58	0.5405340237968134	0.641724446152725	0	0	1.3026812313803375	0.8014064910457609	BRAF
Prone to bacterial infection	1/58	0.5405340237968134	0.641724446152725	0	0	1.3026812313803375	0.8014064910457609	PIK3R1
Carcinoid Tumor	3/213	0.5407111191434781	0.6417324466961192	0	0	1.0605105920695275	0.6520762733703431	CEACAM1;BRAF;FHIT
Precursor B-cell lymphoblastic leukemia	5/367	0.540912903586611	0.6417697347435476	0	0	1.025168815224064	0.6299631661831328	INSR;FHIT;CD22;ARHGAP24;FOXP1
Vasculitis	2/136	0.5421904914890168	0.6428805733204678	0	0	1.1080958842152873	0.678307464268196	PMP22;CD22
Cholelithiasis	2/136	0.5421904914890168	0.6428805733204678	0	0	1.1080958842152873	0.678307464268196	MECP2;ATP11A
Reflex, Deep Tendon, Absent	2/137	0.5461518430165452	0.6461494536497634	0	0	1.0998316498316498	0.6652422372641724	ATXN1;PMP22
Absent reflex	2/137	0.5461518430165452	0.6461494536497634	0	0	1.0998316498316498	0.6652422372641724	ATXN1;PMP22
Paraparesis, Spastic	1/59	0.5466626782006361	0.6461494536497634	0	0	1.2801561483409238	0.7731161804543513	TTC19
Waddling gait	1/59	0.5466626782006361	0.6461494536497634	0	0	1.2801561483409238	0.7731161804543513	TTC19
Alopecia Areata	1/59	0.5466626782006361	0.6461494536497634	0	0	1.2801561483409238	0.7731161804543513	ATXN2
Body fluid retention	1/59	0.5466626782006361	0.6461494536497634	0	0	1.2801561483409238	0.7731161804543513	USP8
Generalized myoclonic seizures	1/59	0.5466626782006361	0.6461494536497634	0	0	1.2801561483409238	0.7731161804543513	MBOAT7
Hemorrhagic Disorders	1/59	0.5466626782006361	0.6461494536497634	0	0	1.2801561483409238	0.7731161804543513	BRAF
Leukocyte adhesion deficiency type 1	1/59	0.5466626782006361	0.6461494536497634	0	0	1.2801561483409238	0.7731161804543513	HGF
Progeria	1/59	0.5466626782006361	0.6461494536497634	0	0	1.2801561483409238	0.7731161804543513	SRSF5
Restenosis	3/215	0.547033865148751	0.646182681096063	0	0	1.0503981634263577	0.6336469860973758	FZD4;INSR;UTS2
Lymphoproliferative Disorders	3/215	0.547033865148751	0.646182681096063	0	0	1.0503981634263577	0.6336469860973758	BRAF;ARHGAP24;MTOR
Collecting Duct Carcinoma of the Kidney	2/138	0.550089284427599	0.648877213593448	0	0	1.0916889483065955	0.6524748413186854	AKAP13;MTOR
Drug habituation	2/138	0.550089284427599	0.648877213593448	0	0	1.0916889483065955	0.6524748413186854	INSR;FHIT
Psoriasis vulgaris	2/138	0.550089284427599	0.648877213593448	0	0	1.0916889483065955	0.6524748413186854	STAT2;SYVN1
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site	3/216	0.5501762198612883	0.648877213593448	0	0	1.0454131633909924	0.6246517736857295	AIMP2;STAT2;MTOR
Adenocarcinoma of prostate	3/216	0.5501762198612883	0.648877213593448	0	0	1.0454131633909924	0.6246517736857295	HPGDS;GSN;BRAF
AURAL ATRESIA, CONGENITAL	1/60	0.5527098876063448	0.6496281268683621	0	0	1.2583946274384394	0.7461298978708554	GSN
Fatty Liver, Alcoholic	1/60	0.5527098876063448	0.6496281268683621	0	0	1.2583946274384394	0.7461298978708554	ACACB
Absence Epilepsy	1/60	0.5527098876063448	0.6496281268683621	0	0	1.2583946274384394	0.7461298978708554	MEF2C
Autoimmune thyroiditis	1/60	0.5527098876063448	0.6496281268683621	0	0	1.2583946274384394	0.7461298978708554	BRAF
Cavernous Hemangioma of Brain	1/60	0.5527098876063448	0.6496281268683621	0	0	1.2583946274384394	0.7461298978708554	ULK1
Cerebral calcification	1/60	0.5527098876063448	0.6496281268683621	0	0	1.2583946274384394	0.7461298978708554	BRAF
Dry Eye Syndromes	1/60	0.5527098876063448	0.6496281268683621	0	0	1.2583946274384394	0.7461298978708554	HPGDS
Gastrointestinal Stromal Sarcoma	1/60	0.5527098876063448	0.6496281268683621	0	0	1.2583946274384394	0.7461298978708554	HIPK2
MAJOR AFFECTIVE DISORDER 8	1/60	0.5527098876063448	0.6496281268683621	0	0	1.2583946274384394	0.7461298978708554	MAOA
MAJOR AFFECTIVE DISORDER 9	1/60	0.5527098876063448	0.6496281268683621	0	0	1.2583946274384394	0.7461298978708554	MAOA
Post-Traumatic Osteoporosis	1/60	0.5527098876063448	0.6496281268683621	0	0	1.2583946274384394	0.7461298978708554	GSN
Differentiated Thyroid Gland Carcinoma	2/139	0.5540027489152267	0.6509445898826135	0	0	1.0836651183366512	0.6399970469538253	BRAF;ARHGAP24
Cholestasis, Extrahepatic	1/61	0.5586767302959683	0.6545988314229899	0	0	1.2373584905660377	0.7203706534118656	COL3A1
Depression, Bipolar	1/61	0.5586767302959683	0.6545988314229899	0	0	1.2373584905660377	0.7203706534118656	MAOA
Sinusitis	1/61	0.5586767302959683	0.6545988314229899	0	0	1.2373584905660377	0.7203706534118656	PIK3R1
Aura	1/61	0.5586767302959683	0.6545988314229899	0	0	1.2373584905660377	0.7203706534118656	MEF2C
Awakening Epilepsy	1/61	0.5586767302959683	0.6545988314229899	0	0	1.2373584905660377	0.7203706534118656	MEF2C
Brain Infarction	1/61	0.5586767302959683	0.6545988314229899	0	0	1.2373584905660377	0.7203706534118656	HGF
Disorders of Sex Development	1/61	0.5586767302959683	0.6545988314229899	0	0	1.2373584905660377	0.7203706534118656	CDKN1C
MAJOR AFFECTIVE DISORDER 7	1/61	0.5586767302959683	0.6545988314229899	0	0	1.2373584905660377	0.7203706534118656	MAOA
Noonan Syndrome	1/61	0.5586767302959683	0.6545988314229899	0	0	1.2373584905660377	0.7203706534118656	BRAF
Kidney Failure	4/297	0.5593742859371196	0.6552123554493562	0	0	1.0130005471172134	0.5884889583955464	GSN;LDB1;SEMA3A;UTS2
Neoplasm, Residual	3/220	0.5626168524916705	0.6584252651861431	0	0	1.0259326102573987	0.5900717362179991	CDKN1C;BRAF;CD22
Eczema	6/454	0.5634378941512063	0.6584252651861431	0	0	0.993440934065934	0.5699352419401099	HDAC4;IL1RL1;HPGDS;MAOB;HPGD;IL16
Arsenic Poisoning, Inorganic	1/62	0.564564270387906	0.6584252651861431	0	0	1.2170120630992887	0.6957670721688616	AKAP9
Reticulosarcoma	1/62	0.564564270387906	0.6584252651861431	0	0	1.2170120630992887	0.6957670721688616	BRAF
Nervous System, Organic Arsenic Poisoning	1/62	0.564564270387906	0.6584252651861431	0	0	1.2170120630992887	0.6957670721688616	AKAP9
Xerostomia	1/62	0.564564270387906	0.6584252651861431	0	0	1.2170120630992887	0.6957670721688616	ATXN2
Arsenic Encephalopathy	1/62	0.564564270387906	0.6584252651861431	0	0	1.2170120630992887	0.6957670721688616	AKAP9
Arsenic Induced Polyneuropathy	1/62	0.564564270387906	0.6584252651861431	0	0	1.2170120630992887	0.6957670721688616	AKAP9
Arsenic Poisoning	1/62	0.564564270387906	0.6584252651861431	0	0	1.2170120630992887	0.6957670721688616	AKAP9
Hereditary Malignant Neoplasm	1/62	0.564564270387906	0.6584252651861431	0	0	1.2170120630992887	0.6957670721688616	BRAF
Marijuana Abuse	1/62	0.564564270387906	0.6584252651861431	0	0	1.2170120630992887	0.6957670721688616	HIPK2
Narrow forehead	1/62	0.564564270387906	0.6584252651861431	0	0	1.2170120630992887	0.6957670721688616	BRAF
Nijmegen Breakage Syndrome	1/62	0.564564270387906	0.6584252651861431	0	0	1.2170120630992887	0.6957670721688616	BBS1
Pemphigus Vulgaris	1/62	0.564564270387906	0.6584252651861431	0	0	1.2170120630992887	0.6957670721688616	AIMP2
Lymphatic Metastasis	2/142	0.565598701086973	0.6591311022139705	0	0	1.0602813852813853	0.6042230417402207	HGF;FOXP1
Mycosis Fungoides	2/142	0.565598701086973	0.6591311022139705	0	0	1.0602813852813853	0.6042230417402207	MEF2C;IL16
Status Epilepticus	3/221	0.5656944129168481	0.6591311022139705	0	0	1.0211741723933443	0.5817642056338858	MEF2C;STAT2;MTOR
Supratentorial atrophy	2/143	0.5694157066731765	0.660700243783819	0	0	1.0527079303675049	0.5928267020577819	ROGDI;TTC19
Myositis	2/143	0.5694157066731765	0.660700243783819	0	0	1.0527079303675049	0.5928267020577819	GSN;SRSF5
Senile Plaques	4/301	0.5699609018491213	0.660700243783819	0	0	0.9991518235793045	0.5617106795601462	HPGDS;MAOB;HOOK3;DCN
Epilepsy, Cryptogenic	1/63	0.5703735579466364	0.660700243783819	0	0	1.1973219720024346	0.6722529059008445	MEF2C
Inclusion Body Myopathy, Sporadic	1/63	0.5703735579466364	0.660700243783819	0	0	1.1973219720024346	0.6722529059008445	PHF1
Lichen Planus, Oral	1/63	0.5703735579466364	0.660700243783819	0	0	1.1973219720024346	0.6722529059008445	CEACAM1
Thin face	1/63	0.5703735579466364	0.660700243783819	0	0	1.1973219720024346	0.6722529059008445	DSTYK
Abdomen distended	1/63	0.5703735579466364	0.660700243783819	0	0	1.1973219720024346	0.6722529059008445	INSR
Viral hepatitis	1/63	0.5703735579466364	0.660700243783819	0	0	1.1973219720024346	0.6722529059008445	ADH1B
Chronic ear infection	1/63	0.5703735579466364	0.660700243783819	0	0	1.1973219720024346	0.6722529059008445	PIK3R1
Dystrophia myotonica 2	1/63	0.5703735579466364	0.660700243783819	0	0	1.1973219720024346	0.6722529059008445	INSR
Familial aplasia of the vermis	1/63	0.5703735579466364	0.660700243783819	0	0	1.1973219720024346	0.6722529059008445	CEP104
Idiopathic hypogonadotropic hypogonadism	1/63	0.5703735579466364	0.660700243783819	0	0	1.1973219720024346	0.6722529059008445	SEMA3A
Iron deficiency	1/63	0.5703735579466364	0.660700243783819	0	0	1.1973219720024346	0.6722529059008445	AIMP2
Lymphangioleiomyomatosis	1/63	0.5703735579466364	0.660700243783819	0	0	1.1973219720024346	0.6722529059008445	MTOR
Narrow face	1/63	0.5703735579466364	0.660700243783819	0	0	1.1973219720024346	0.6722529059008445	DSTYK
Necrotizing Enterocolitis	1/63	0.5703735579466364	0.660700243783819	0	0	1.1973219720024346	0.6722529059008445	HGF
Pallor of optic disc	1/63	0.5703735579466364	0.660700243783819	0	0	1.1973219720024346	0.6722529059008445	ATXN1
Papule	1/63	0.5703735579466364	0.660700243783819	0	0	1.1973219720024346	0.6722529059008445	BRAF
Pancreatitis, Chronic	4/302	0.5725855416089664	0.6630586336430914	0	0	0.9957477329781239	0.55522210214953	IL1RL1;CEACAM1;ADH1B;DCN
Encephalitis	2/144	0.5732084879383823	0.6635760215316183	0	0	1.0452411438326932	0.5816827329676507	GSN;IL16
Adenocarcinoma, Endometrioid	1/64	0.5761056291171133	0.6640727983121681	0	0	1.1782569631626236	0.6497665939294983	BRAF
Short metacarpal	1/64	0.5761056291171133	0.6640727983121681	0	0	1.1782569631626236	0.6497665939294983	HDAC4
Osteoporosis, Senile	1/64	0.5761056291171133	0.6640727983121681	0	0	1.1782569631626236	0.6497665939294983	GSN
Uterine Cancer	1/64	0.5761056291171133	0.6640727983121681	0	0	1.1782569631626236	0.6497665939294983	BRAF
Allergic Reaction	1/64	0.5761056291171133	0.6640727983121681	0	0	1.1782569631626236	0.6497665939294983	IL16
Bronchiolitis Obliterans	1/64	0.5761056291171133	0.6640727983121681	0	0	1.1782569631626236	0.6497665939294983	HGF
Congenital Camptodactyly	1/64	0.5761056291171133	0.6640727983121681	0	0	1.1782569631626236	0.6497665939294983	TBX15
Diaphragmatic Hernia	1/64	0.5761056291171133	0.6640727983121681	0	0	1.1782569631626236	0.6497665939294983	MEF2A
Febrile Convulsions	1/64	0.5761056291171133	0.6640727983121681	0	0	1.1782569631626236	0.6497665939294983	MBOAT7
Lissencephaly	1/64	0.5761056291171133	0.6640727983121681	0	0	1.1782569631626236	0.6497665939294983	PAFAH1B1
Mastocytosis	1/64	0.5761056291171133	0.6640727983121681	0	0	1.1782569631626236	0.6497665939294983	CEACAM1
Muscle biopsy shows dystrophic changes	1/64	0.5761056291171133	0.6640727983121681	0	0	1.1782569631626236	0.6497665939294983	SGCD
Osteopetrosis	1/64	0.5761056291171133	0.6640727983121681	0	0	1.1782569631626236	0.6497665939294983	GHR
Polyp of large intestine	1/64	0.5761056291171133	0.6640727983121681	0	0	1.1782569631626236	0.6497665939294983	BRAF
Age related macular degeneration	5/382	0.5765710348219396	0.6644059615094055	0	0	0.9836173867089444	0.5416355332243704	HPGDS;SGCD;FZD4;MGST1;SYN3
Gastrointestinal Carcinoid Tumor	3/225	0.5778720540652809	0.6657015375119001	0	0	1.0025691090329873	0.549811701135319	BRAF;FHIT;MTOR
Mitochondrial Diseases	5/384	0.5812156423539216	0.6685465512154243	0	0	0.9783257008259283	0.5308722343712793	STAT2;OGDH;TTC19;MTOR;DHTKD1
Multiple, subcutaneous nodules	1/65	0.5817615064730981	0.6685465512154243	0	0	1.1597877358490567	0.628250867230011	INSR
Subcutaneous nodule	1/65	0.5817615064730981	0.6685465512154243	0	0	1.1597877358490567	0.628250867230011	INSR
Systemic Inflammatory Response Syndrome	1/65	0.5817615064730981	0.6685465512154243	0	0	1.1597877358490567	0.628250867230011	HGF
Familial Nonmedullary Thyroid Cancer	1/65	0.5817615064730981	0.6685465512154243	0	0	1.1597877358490567	0.628250867230011	BRAF
Hepatic methionine adenosyltransferase deficiency	1/65	0.5817615064730981	0.6685465512154243	0	0	1.1597877358490567	0.628250867230011	HGF
Limitation of joint mobility	1/65	0.5817615064730981	0.6685465512154243	0	0	1.1597877358490567	0.628250867230011	HPGD
Paroxysmal nocturnal hemoglobinuria	1/65	0.5817615064730981	0.6685465512154243	0	0	1.1597877358490567	0.628250867230011	CRLS1
Ki-1+ Anaplastic Large Cell Lymphoma	3/228	0.5868642050440653	0.6731116713166154	0	0	0.9890494296577946	0.5271255872157916	COL15A1;INSR;MTOR
Bronchitis, Chronic	1/66	0.5873421989959424	0.6731116713166154	0	0	1.1418867924528302	0.6076523920067124	FAM13A
Shigella Infections	1/66	0.5873421989959424	0.6731116713166154	0	0	1.1418867924528302	0.6076523920067124	WASL
Addison Disease	1/66	0.5873421989959424	0.6731116713166154	0	0	1.1418867924528302	0.6076523920067124	PEX6
Bronchiolitis	1/66	0.5873421989959424	0.6731116713166154	0	0	1.1418867924528302	0.6076523920067124	IL1RL1
Cleft palate with cleft lip	1/66	0.5873421989959424	0.6731116713166154	0	0	1.1418867924528302	0.6076523920067124	DCN
GRN-related frontotemporal dementia	1/66	0.5873421989959424	0.6731116713166154	0	0	1.1418867924528302	0.6076523920067124	ATXN2
Hip Dislocation	1/66	0.5873421989959424	0.6731116713166154	0	0	1.1418867924528302	0.6076523920067124	SHROOM4
Pulmonary Stenosis	1/66	0.5873421989959424	0.6731116713166154	0	0	1.1418867924528302	0.6076523920067124	BRAF
Dystonic disease	2/148	0.5881367827684941	0.6738172933968727	0	0	1.0163968451639684	0.5394991098506068	MECP2;TTC19
Seminoma	3/229	0.5898343935885496	0.6753514166103545	0	0	0.9846226319862714	0.5197955506033711	HPGDS;BRAF;FHIT
No development of motor milestones	3/229	0.5898343935885496	0.6753514166103545	0	0	0.9846226319862714	0.5197955506033711	GHR;MEF2C;PMP22
Fibrosis, Liver	7/545	0.59028439587013	0.6754097967033708	0	0	0.9643323621018788	0.5083486063522239	MECP2;BBS1;AIMP2;COL3A1;INSR;HGF;DCN
Cardiomyopathy, Familial Idiopathic	5/388	0.5904232706514999	0.6754097967033708	0	0	0.9679081260066225	0.5100058826477428	SGCD;MAOA;HGF;ABCC9;FOXP1
Chronic kidney disease stage 5	5/388	0.5904232706514999	0.6754097967033708	0	0	0.9679081260066225	0.5100058826477428	DSTYK;UTS2;BTBD9;MAP2K5;MTOR
Adrenoleukodystrophy	2/149	0.5918080461379449	0.675517562649921	0	0	1.0094310451453308	0.5295202141740384	ACAA2;PMP22
Chromophobe Renal Cell Carcinoma	2/149	0.5918080461379449	0.675517562649921	0	0	1.0094310451453308	0.5295202141740384	AKAP13;MTOR
Mastocytosis, Systemic	1/67	0.5928487024477406	0.675517562649921	0	0	1.1245283018867924	0.5879214468726711	MTOR
Bipolar I disorder	1/67	0.5928487024477406	0.675517562649921	0	0	1.1245283018867924	0.5879214468726711	ADH1B
Congenital Hypothyroidism	1/67	0.5928487024477406	0.675517562649921	0	0	1.1245283018867924	0.5879214468726711	GHR
Congenital muscular dystrophy (disorder)	1/67	0.5928487024477406	0.675517562649921	0	0	1.1245283018867924	0.5879214468726711	SGCD
Gestational Diabetes	1/67	0.5928487024477406	0.675517562649921	0	0	1.1245283018867924	0.5879214468726711	INSR
Idiopathic Inflammatory Myopathies	1/67	0.5928487024477406	0.675517562649921	0	0	1.1245283018867924	0.5879214468726711	RNPC3
Joint swelling	1/67	0.5928487024477406	0.675517562649921	0	0	1.1245283018867924	0.5879214468726711	HPGD
Meningococcal Infections	1/67	0.5928487024477406	0.675517562649921	0	0	1.1245283018867924	0.5879214468726711	CEACAM1
Multiple Chronic Conditions	1/67	0.5928487024477406	0.675517562649921	0	0	1.1245283018867924	0.5879214468726711	MTOR
Oxyphilic Adenoma	1/67	0.5928487024477406	0.675517562649921	0	0	1.1245283018867924	0.5879214468726711	BRAF
Pyramidal sign	1/67	0.5928487024477406	0.675517562649921	0	0	1.1245283018867924	0.5879214468726711	ATXN2
Fibroid Tumor	4/310	0.5932566441029336	0.675777979539084	0	0	0.9693159706630744	0.5061071877071817	GHR;COL3A1;HPGDS;MTOR
Monoclonal Gammopathy of Undetermined Significance	2/150	0.5954549610098576	0.6780770369178155	0	0	1.0025593775593775	0.519756382165404	HGF;SEMA3A
Hepatitis C	10/783	0.5971627124354396	0.6798162398743732	0	0	0.9581682567917206	0.4939986425956663	IGSF8;AIMP2;STAT2;SAA1;AAK1;IL16;FHIT;ARHGAP24;MTOR;FKBP5
Recurrent infections	1/68	0.5982819993894647	0.6800628520519353	0	0	1.1076879752182485	0.5690116313866093	INSR
Short palpebral fissure	1/68	0.5982819993894647	0.6800628520519353	0	0	1.1076879752182485	0.5690116313866093	TBX15
Wiskott-Aldrich Syndrome	1/68	0.5982819993894647	0.6800628520519353	0	0	1.1076879752182485	0.5690116313866093	WASL
Human papilloma virus infection	1/68	0.5982819993894647	0.6800628520519353	0	0	1.1076879752182485	0.5690116313866093	BRAF
Primary hypogonadism	1/68	0.5982819993894647	0.6800628520519353	0	0	1.1076879752182485	0.5690116313866093	SLC10A7
Pulmonary Hypertension	2/151	0.5990775232067553	0.680761698316696	0	0	0.995779947122229	0.5102020638900713	UTS2;MTOR
Aneurysm	2/152	0.602675732966486	0.6836811199667874	0	0	0.9890909090909091	0.5008518815375927	COL3A1;DCN
Osteochondrodysplasias	2/152	0.602675732966486	0.6836811199667874	0	0	0.9890909090909091	0.5008518815375927	PEX6;ABCC9
Pre-Eclampsia	2/152	0.602675732966486	0.6836811199667874	0	0	0.9890909090909091	0.5008518815375927	NSD1;IL16
Simple Partial Status Epilepticus	1/69	0.6036430594662954	0.6836811199667874	0	0	1.0913429522752498	0.5508796013987478	MEF2C
Status Epilepticus, Subclinical	1/69	0.6036430594662954	0.6836811199667874	0	0	1.0913429522752498	0.5508796013987478	MEF2C
Williams Syndrome	1/69	0.6036430594662954	0.6836811199667874	0	0	1.0913429522752498	0.5508796013987478	CDKN1C
Chronic otitis media	1/69	0.6036430594662954	0.6836811199667874	0	0	1.0913429522752498	0.5508796013987478	PIK3R1
Complex Partial Status Epilepticus	1/69	0.6036430594662954	0.6836811199667874	0	0	1.0913429522752498	0.5508796013987478	MEF2C
Grand Mal Status Epilepticus	1/69	0.6036430594662954	0.6836811199667874	0	0	1.0913429522752498	0.5508796013987478	MEF2C
Hepatolenticular Degeneration	1/69	0.6036430594662954	0.6836811199667874	0	0	1.0913429522752498	0.5508796013987478	BRAF
Non-Convulsive Status Epilepticus	1/69	0.6036430594662954	0.6836811199667874	0	0	1.0913429522752498	0.5508796013987478	MEF2C
Encephalopathies	3/234	0.6044789960235941	0.6844221154255722	0	0	0.9630635524171646	0.4847949779539851	MECP2;TTC19;MTOR
Cachexia	2/153	0.6062495948040374	0.6860144859197383	0	0	0.9824904675898053	0.4917006231325588	MECP2;INSR
Hyperlipoproteinemia Type IIa	2/153	0.6062495948040374	0.6860144859197383	0	0	0.9824904675898053	0.4917006231325588	GHR;SORT1
Respiratory Tract Infections	1/70	0.6089328395434153	0.6871929318634048	0	0	1.0754716981132075	0.5334848291172628	IDS
Benign Neoplasm	1/70	0.6089328395434153	0.6871929318634048	0	0	1.0754716981132075	0.5334848291172628	DLC1
Cooley's anemia	1/70	0.6089328395434153	0.6871929318634048	0	0	1.0754716981132075	0.5334848291172628	HPGDS
Hereditary pancreatitis	1/70	0.6089328395434153	0.6871929318634048	0	0	1.0754716981132075	0.5334848291172628	DLC1
Knee joint valgus deformity	1/70	0.6089328395434153	0.6871929318634048	0	0	1.0754716981132075	0.5334848291172628	NSD1
Metabolic acidosis	1/70	0.6089328395434153	0.6871929318634048	0	0	1.0754716981132075	0.5334848291172628	OGDH
Neurofibromatosis 2	1/70	0.6089328395434153	0.6871929318634048	0	0	1.0754716981132075	0.5334848291172628	SRSF5
Ovarian adenocarcinoma	1/70	0.6089328395434153	0.6871929318634048	0	0	1.0754716981132075	0.5334848291172628	ARHGAP24
Philadelphia chromosome-positive acute lymphoblastic leukemia	1/70	0.6089328395434153	0.6871929318634048	0	0	1.0754716981132075	0.5334848291172628	MTOR
Sarcoidosis	3/236	0.6102396754034708	0.6884614726699235	0	0	0.9546989996573051	0.4715291663852227	COL3A1;ATXN2;HGF
Undifferentiated carcinoma	3/237	0.6130990282353096	0.6903944055177829	0	0	0.9505703422053232	0.4650463965938142	BRAF;PIK3R1;FHIT
IGA Glomerulonephritis	3/237	0.6130990282353096	0.6903944055177829	0	0	0.9505703422053232	0.4650463965938142	CDKN1C;HGF;DCN
Aplastic Anemia	2/155	0.6133243137694332	0.6903944055177829	0	0	0.9695484254307783	0.47397482289058707	HPGDS;PAFAH1B1
Focal glomerulosclerosis	2/155	0.6133243137694332	0.6903944055177829	0	0	0.9695484254307783	0.47397482289058707	ARHGAP24;PAFAH1B1
Monocyte count procedure	2/155	0.6133243137694332	0.6903944055177829	0	0	0.9695484254307783	0.47397482289058707	ATXN2;SMG6
Monocyte count result	2/155	0.6133243137694332	0.6903944055177829	0	0	0.9695484254307783	0.47397482289058707	ATXN2;SMG6
Rhabdoid Tumor	1/71	0.6141522837510195	0.6903944055177829	0	0	1.0600539083557952	0.5167893851849691	CDKN1C
Leukemia, Myeloid, Chronic-Phase	1/71	0.6141522837510195	0.6903944055177829	0	0	1.0600539083557952	0.5167893851849691	ARHGAP24
Abnormality of the skull	1/71	0.6141522837510195	0.6903944055177829	0	0	1.0600539083557952	0.5167893851849691	SON
Proximal muscle weakness	1/71	0.6141522837510195	0.6903944055177829	0	0	1.0600539083557952	0.5167893851849691	SGCD
Proximal neurogenic muscle weakness	1/71	0.6141522837510195	0.6903944055177829	0	0	1.0600539083557952	0.5167893851849691	SGCD
Pterygium	1/71	0.6141522837510195	0.6903944055177829	0	0	1.0600539083557952	0.5167893851849691	AIMP2
Myoclonic Seizures	2/156	0.6168252003386013	0.6931922821227658	0	0	0.9632034632034632	0.46539063298582595	MECP2;MBOAT7
Feeding difficulties	3/239	0.6187755785386717	0.6947325354201116	0	0	0.9424179931687826	0.4523725365399736	RERE;SON;STT3A
Cockayne Syndrome	1/72	0.619302323849412	0.6947325354201116	0	0	1.0450704225352112	0.5007577397872922	NR1H2
Learning Disabilities	1/72	0.619302323849412	0.6947325354201116	0	0	1.0450704225352112	0.5007577397872922	MECP2
MAJOR AFFECTIVE DISORDER 4	1/72	0.619302323849412	0.6947325354201116	0	0	1.0450704225352112	0.5007577397872922	MAOA
MAJOR AFFECTIVE DISORDER 6	1/72	0.619302323849412	0.6947325354201116	0	0	1.0450704225352112	0.5007577397872922	MAOA
Neutrophil count decreased	1/72	0.619302323849412	0.6947325354201116	0	0	1.0450704225352112	0.5007577397872922	PIK3R1
Allergic disposition	3/240	0.6215927096872154	0.6970942951449063	0	0	0.9383934157963132	0.44617811287592496	AIMP2;HPGDS;IL16
Intestinal Neoplasms	2/158	0.6237541302954144	0.6971246640267268	0	0	0.9507575757575758	0.4487566347188692	HPGDS;DCN
Lupus Erythematosus, Systemic	14/1113	0.6239624211287189	0.6971246640267268	0	0	0.9420179961581235	0.4443170453080155	CDKN1C;FOXC1;EGFL7;STAT2;HGF;IL16;RNPC3;MTOR;MECP2;HPGDS;ATXN2;ATXN1;KIAA0319L;CD22
Hepatitis, Alcoholic	1/73	0.6243838793079437	0.6971246640267268	0	0	1.030503144654088	0.48535658187823755	HGF
Syndactyly of fingers	1/73	0.6243838793079437	0.6971246640267268	0	0	1.030503144654088	0.48535658187823755	HDAC4
Urinary tract infection	1/73	0.6243838793079437	0.6971246640267268	0	0	1.030503144654088	0.48535658187823755	AIMP2
Bone neoplasms	1/73	0.6243838793079437	0.6971246640267268	0	0	1.030503144654088	0.48535658187823755	IL11RA
Cystic Kidney Diseases	1/73	0.6243838793079437	0.6971246640267268	0	0	1.030503144654088	0.48535658187823755	BBS1
Difficulty speaking	1/73	0.6243838793079437	0.6971246640267268	0	0	1.030503144654088	0.48535658187823755	RERE
Dysplastic Nevus	1/73	0.6243838793079437	0.6971246640267268	0	0	1.030503144654088	0.48535658187823755	BRAF
Guillain-Barre Syndrome	1/73	0.6243838793079437	0.6971246640267268	0	0	1.030503144654088	0.48535658187823755	PMP22
hypopigmented skin patch	1/73	0.6243838793079437	0.6971246640267268	0	0	1.030503144654088	0.48535658187823755	KIAA0319L
Long QT Syndrome	1/73	0.6243838793079437	0.6971246640267268	0	0	1.030503144654088	0.48535658187823755	AKAP9
mixed gliomas	1/73	0.6243838793079437	0.6971246640267268	0	0	1.030503144654088	0.48535658187823755	BRAF
Problems speaking	1/73	0.6243838793079437	0.6971246640267268	0	0	1.030503144654088	0.48535658187823755	RERE
Metastatic Prostate Carcinoma	3/241	0.6243957038561657	0.6971246640267268	0	0	0.9344026584017637	0.44007652714547024	DLC1;HGF;MAP2K5
Dermatitis, Atopic	6/484	0.6257739253357031	0.6983666123093816	0	0	0.9296427421950435	0.43578501636025413	IL1RL1;HPGDS;CCDC80;MAOB;BRAF;IL16
Liver Cirrhosis, Experimental	10/801	0.6258788646552886	0.6983666123093816	0	0	0.9354752686472819	0.438362245510408	GHR;COL3A1;HPGDS;GSN;XPNPEP2;EPB41L2;HGF;CSAD;FSTL1;DHTKD1
T-Cell Lymphoma	4/324	0.6279788606827209	0.7005023299353893	0	0	0.9262404580152672	0.43093223790402496	SAA1;IL16;ARHGAP24;MTOR
Chronic heart failure	1/74	0.6293978573658381	0.7008400025708283	0	0	1.0163349702765572	0.4705546542414007	MECP2
Decreased corneal diameter	1/74	0.6293978573658381	0.7008400025708283	0	0	1.0163349702765572	0.4705546542414007	TBX15
Hereditary gingival fibromatosis	1/74	0.6293978573658381	0.7008400025708283	0	0	1.0163349702765572	0.4705546542414007	HGF
MAJOR AFFECTIVE DISORDER 1	1/74	0.6293978573658381	0.7008400025708283	0	0	1.0163349702765572	0.4705546542414007	MAOA
Marginal Zone B-Cell Lymphoma	1/74	0.6293978573658381	0.7008400025708283	0	0	1.0163349702765572	0.4705546542414007	FOXP1
Necrotizing enterocolitis in fetus OR newborn	1/74	0.6293978573658381	0.7008400025708283	0	0	1.0163349702765572	0.4705546542414007	HGF
Turner Syndrome	2/160	0.6305861162228735	0.7019556441523537	0	0	0.9386267740698121	0.43280601385718	GHR;MAOB
Juvenile arthritis	4/326	0.6327830697194389	0.7041931532151038	0	0	0.920392584514722	0.42119706555971037	RERE;ATXN2;CALD1;FOXP1
Weight decreased	2/161	0.6339658360111528	0.7048903224208896	0	0	0.9326758147512865	0.4250765274449845	PIK3R1;FOXP1
Clouding of corneal stroma	1/75	0.6343451534395581	0.7048903224208896	0	0	1.0025497195308517	0.4563226022350155	PEX6
Congenital Bilateral Cataracts	1/75	0.6343451534395581	0.7048903224208896	0	0	1.0025497195308517	0.4563226022350155	LEMD2
Endometrial Hyperplasia	1/75	0.6343451534395581	0.7048903224208896	0	0	1.0025497195308517	0.4563226022350155	CDKN1C
Proliferative diabetic retinopathy	1/75	0.6343451534395581	0.7048903224208896	0	0	1.0025497195308517	0.4563226022350155	HGF
Steatohepatitis	7/569	0.6355014942766595	0.7059670094191024	0	0	0.9219967298259113	0.4179787692246037	COL3A1;SORT1;INSR;HGF;OGT;DCN;MTOR
Retinitis Pigmentosa	5/410	0.6390152370888397	0.7078091695049444	0	0	0.914289768695899	0.40944362566690096	HDAC4;BBS1;ATXN2;GSN;PEX6
Papillary thyroid carcinoma	7/571	0.6391403400303375	0.7078091695049444	0	0	0.9186313973548016	0.4112080970396766	HDAC4;IL11RA;INSR;HGF;BRAF;HOOK3;MTOR
Respiration Disorders	1/76	0.6392266510899446	0.7078091695049444	0	0	0.9891320754716981	0.44263283612318377	HPGDS
Stable angina	1/76	0.6392266510899446	0.7078091695049444	0	0	0.9891320754716981	0.44263283612318377	COL3A1
Acute Undifferentiated Leukemia	1/76	0.6392266510899446	0.7078091695049444	0	0	0.9891320754716981	0.44263283612318377	SYVN1
Axonal neuropathy	1/76	0.6392266510899446	0.7078091695049444	0	0	0.9891320754716981	0.44263283612318377	PMP22
Congenital pectus carinatum	1/76	0.6392266510899446	0.7078091695049444	0	0	0.9891320754716981	0.44263283612318377	BRAF
Microcornea	1/76	0.6392266510899446	0.7078091695049444	0	0	0.9891320754716981	0.44263283612318377	TBX15
Petit mal status	1/76	0.6392266510899446	0.7078091695049444	0	0	0.9891320754716981	0.44263283612318377	MEF2C
Poor speech	1/76	0.6392266510899446	0.7078091695049444	0	0	0.9891320754716981	0.44263283612318377	RERE
Primary infection NOS	1/76	0.6392266510899446	0.7078091695049444	0	0	0.9891320754716981	0.44263283612318377	AIMP2
Primary biliary cirrhosis	4/329	0.6399146544653862	0.7083627691363826	0	0	0.9117557251908397	0.40702641382002036	HPGDS;HGF;OGDH;IL16
Inflammatory dermatosis	2/163	0.640652920357661	0.7088456007971982	0	0	0.920995670995671	0.4100893797090866	HPGDS;IL16
Splenomegaly	3/247	0.640915348105988	0.7088456007971982	0	0	0.9111450476843483	0.40533006614810235	IDS;BRAF;GNS
Acute myocardial infarction	3/247	0.640915348105988	0.7088456007971982	0	0	0.9111450476843483	0.40533006614810235	HPGDS;HGF;ABCC9
Infection	6/492	0.6415141973108565	0.7092996716378034	0	0	0.913960113960114	0.40572879649278354	IL1RL1;CEACAM1;SAA1;IL16;FHIT;HDAC6
Recurrent otitis media	1/77	0.6440432220121077	0.7108440718779987	0	0	0.9760675273088382	0.4294594049421682	IDS
Neoplastic Syndromes, Hereditary	1/77	0.6440432220121077	0.7108440718779987	0	0	0.9760675273088382	0.4294594049421682	BRAF
Niemann-Pick Disease, Type C	1/77	0.6440432220121077	0.7108440718779987	0	0	0.9760675273088382	0.4294594049421682	ULK1
Ulnar polydactyly of fingers	1/77	0.6440432220121077	0.7108440718779987	0	0	0.9760675273088382	0.4294594049421682	BBS1
aggressive cancer	1/77	0.6440432220121077	0.7108440718779987	0	0	0.9760675273088382	0.4294594049421682	BRAF
Parathyroid Adenoma	1/77	0.6440432220121077	0.7108440718779987	0	0	0.9760675273088382	0.4294594049421682	ARHGAP24
Sicca Syndrome	1/78	0.6487957266987797	0.7137889902086166	0	0	0.9633423180592992	0.4167778798353423	ITSN2
Pleural Effusion, Malignant	1/78	0.6487957266987797	0.7137889902086166	0	0	0.9633423180592992	0.4167778798353423	FSTL1
Abnormal vision	1/78	0.6487957266987797	0.7137889902086166	0	0	0.9633423180592992	0.4167778798353423	FOXC1
Bronchial Hyperreactivity	1/78	0.6487957266987797	0.7137889902086166	0	0	0.9633423180592992	0.4167778798353423	HPGDS
Cardiac Hypertrophy	1/78	0.6487957266987797	0.7137889902086166	0	0	0.9633423180592992	0.4167778798353423	NPR1
Cerebral arterial aneurysm	1/78	0.6487957266987797	0.7137889902086166	0	0	0.9633423180592992	0.4167778798353423	COL3A1
Narrow thorax	1/78	0.6487957266987797	0.7137889902086166	0	0	0.9633423180592992	0.4167778798353423	ABCC9
Peripheral Vascular Diseases	1/78	0.6487957266987797	0.7137889902086166	0	0	0.9633423180592992	0.4167778798353423	HGF
Protruding ear	1/78	0.6487957266987797	0.7137889902086166	0	0	0.9633423180592992	0.4167778798353423	COL3A1
Pulmonary Edema	1/78	0.6487957266987797	0.7137889902086166	0	0	0.9633423180592992	0.4167778798353423	HPGDS
Pulmonary Embolism	1/78	0.6487957266987797	0.7137889902086166	0	0	0.9633423180592992	0.4167778798353423	HGF
Malignant neoplasm of brain	2/166	0.6505033286305486	0.7154586975040222	0	0	0.904009608277901	0.3887321447085972	INSR;BRAF
Glioblastoma, IDH-Wildtype	1/79	0.6534850140317341	0.7169241879310999	0	0	0.9509433962264151	0.40456524854874	IL16
Polyendocrinopathies, Autoimmune	1/79	0.6534850140317341	0.7169241879310999	0	0	0.9509433962264151	0.40456524854874	MTOR
Chronic granulomatous disease	1/79	0.6534850140317341	0.7169241879310999	0	0	0.9509433962264151	0.40456524854874	AKAP13
Gliosis	1/79	0.6534850140317341	0.7169241879310999	0	0	0.9509433962264151	0.40456524854874	HGF
Lysosomal Storage Diseases	1/79	0.6534850140317341	0.7169241879310999	0	0	0.9509433962264151	0.40456524854874	IDS
Malignancy	1/79	0.6534850140317341	0.7169241879310999	0	0	0.9509433962264151	0.40456524854874	MTOR
Osteitis Deformans	1/79	0.6534850140317341	0.7169241879310999	0	0	0.9509433962264151	0.40456524854874	FKBP5
Retinal pigment epithelial abnormality	2/167	0.6537389396186165	0.7169241879310999	0	0	0.8984848484848484	0.3818984530183867	PEX6;IDS
Abnormality of retinal pigmentation	2/167	0.6537389396186165	0.7169241879310999	0	0	0.8984848484848484	0.3818984530183867	PEX6;IDS
Degenerative brain disorder	2/167	0.6537389396186165	0.7169241879310999	0	0	0.8984848484848484	0.3818984530183867	ROGDI;TTC19
Growth retardation	2/168	0.6569507130051292	0.7200271562089967	0	0	0.8930266520627966	0.3752018272058131	BRAF;PAFAH1B1
Poor growth	2/168	0.6569507130051292	0.7200271562089967	0	0	0.8930266520627966	0.3752018272058131	BRAF;PAFAH1B1
Dementia, Vascular	1/80	0.6581119218548439	0.7200428723866388	0	0	0.9388583711487939	0.39279981704497463	MTOR
Corneal Opacity	1/80	0.6581119218548439	0.7200428723866388	0	0	0.9388583711487939	0.39279981704497463	PEX6
Eosinophilic esophagitis	1/80	0.6581119218548439	0.7200428723866388	0	0	0.9388583711487939	0.39279981704497463	FKBP5
Intestinal Diseases	1/80	0.6581119218548439	0.7200428723866388	0	0	0.9388583711487939	0.39279981704497463	HGF
Prion Diseases	1/80	0.6581119218548439	0.7200428723866388	0	0	0.9388583711487939	0.39279981704497463	GSN
Prominent ear	1/80	0.6581119218548439	0.7200428723866388	0	0	0.9388583711487939	0.39279981704497463	COL3A1
Benign Prostatic Hyperplasia	5/420	0.6598940971500895	0.7214222549561827	0	0	0.8917970733508748	0.3706985650837649	RERE;HPGDS;IGFBP5;DLC1;HOXD3
Tuberculosis, Pulmonary	2/169	0.6601387079463663	0.7214222549561827	0	0	0.8876338232625658	0.36863903346849036	AIMP2;FHIT
Cyst	2/169	0.6601387079463663	0.7214222549561827	0	0	0.8876338232625658	0.36863903346849036	PRKCI;HGF
Growth delay	2/169	0.6601387079463663	0.7214222549561827	0	0	0.8876338232625658	0.36863903346849036	BRAF;PAFAH1B1
Sensory neuropathy	1/81	0.6626772767859395	0.7229052602494851	0	0	0.9270754716981132	0.38146112008147176	PMP22
Vascular lesions	1/81	0.6626772767859395	0.7229052602494851	0	0	0.9270754716981132	0.38146112008147176	MTOR
Acute myelomonocytic leukemia	1/81	0.6626772767859395	0.7229052602494851	0	0	0.9270754716981132	0.38146112008147176	NSD1
Peptic Ulcer	1/81	0.6626772767859395	0.7229052602494851	0	0	0.9270754716981132	0.38146112008147176	HPGD
Primary immune deficiency disorder	1/81	0.6626772767859395	0.7229052602494851	0	0	0.9270754716981132	0.38146112008147176	PIK3R1
Lens Opacities	4/339	0.6630309727002843	0.7229052602494851	0	0	0.8840833997949186	0.3632995511025661	FOXC1;PEX6;PIK3R1;ATP2B1
Muscle Weakness	4/339	0.6630309727002843	0.7229052602494851	0	0	0.8840833997949186	0.3632995511025661	ATXN1;PMP22;BRAF;TTC19
Pneumonitis	4/339	0.6630309727002843	0.7229052602494851	0	0	0.8840833997949186	0.3632995511025661	AIMP2;HPGDS;LSP1;MTOR
Blood Coagulation Disorders	2/171	0.666443612271864	0.7263798259077922	0	0	0.877039627039627	0.3559024576085911	GSN;BRAF
Hyperlipidemia, Familial Combined	1/82	0.6671818947812478	0.7263798259077922	0	0	0.9155835080363383	0.3705298378124854	OSBP
Osteoporosis, Age-Related	1/82	0.6671818947812478	0.7263798259077922	0	0	0.9155835080363383	0.3705298378124854	GSN
Cholecystolithiasis	1/82	0.6671818947812478	0.7263798259077922	0	0	0.9155835080363383	0.3705298378124854	ATP11A
Malignant neoplasm of tongue	1/82	0.6671818947812478	0.7263798259077922	0	0	0.9155835080363383	0.3705298378124854	FHIT
Thrombocytopenia	4/341	0.6675319919527555	0.7265510007760849	0	0	0.8787460076562393	0.35516098288694076	CDKN1C;HGF;MTOR;PAFAH1B1
Behcet Syndrome	3/258	0.6698635420923605	0.7280625408853122	0	0	0.8713486915678819	0.34913308802872406	TGFBR3;UTS2;PDGFRL
Lymphoma	16/1307	0.6708208179697083	0.7280625408853122	0	0	0.9142927962819519	0.3650343383433506	HGF;EBF1;SYVN1;BRAF;IL16;FHIT;ARHGAP24;HDAC6;MTOR;FOXP1;AIMP2;SLC7A6;HPGDS;DLC1;CD22;PAFAH1B1
Carcinoma, Neuroendocrine	1/83	0.6716265807211201	0.7280625408853122	0	0	0.9043718361711919	0.35998772024880205	BRAF
Testicular Neoplasms	1/83	0.6716265807211201	0.7280625408853122	0	0	0.9043718361711919	0.35998772024880205	BRAF
Van der Woude syndrome	1/83	0.6716265807211201	0.7280625408853122	0	0	0.9043718361711919	0.35998772024880205	AIMP2
Chubby cheeks	1/83	0.6716265807211201	0.7280625408853122	0	0	0.9043718361711919	0.35998772024880205	BRAF
Full cheeks	1/83	0.6716265807211201	0.7280625408853122	0	0	0.9043718361711919	0.35998772024880205	BRAF
Hay fever	1/83	0.6716265807211201	0.7280625408853122	0	0	0.9043718361711919	0.35998772024880205	IL1RL1
Hydatidiform Mole	1/83	0.6716265807211201	0.7280625408853122	0	0	0.9043718361711919	0.35998772024880205	CDKN1C
Hyperplasia of cheeks	1/83	0.6716265807211201	0.7280625408853122	0	0	0.9043718361711919	0.35998772024880205	BRAF
Hypertrophy of cheeks	1/83	0.6716265807211201	0.7280625408853122	0	0	0.9043718361711919	0.35998772024880205	BRAF
Maturity onset diabetes mellitus in young	1/83	0.6716265807211201	0.7280625408853122	0	0	0.9043718361711919	0.35998772024880205	INSR
Paraganglioma	1/83	0.6716265807211201	0.7280625408853122	0	0	0.9043718361711919	0.35998772024880205	PRDM2
Puffy cheeks	1/83	0.6716265807211201	0.7280625408853122	0	0	0.9043718361711919	0.35998772024880205	BRAF
Tonic - clonic seizures	2/173	0.6726541769539287	0.7287570562512078	0	0	0.8666932482721956	0.34366461669768966	MECP2;NR1H2
Fever	2/173	0.6726541769539287	0.7287570562512078	0	0	0.8666932482721956	0.34366461669768966	PIK3R1;FOXP1
Sjogren's Syndrome	3/260	0.6749401433848052	0.7290402777894441	0	0	0.8644789986832566	0.3398537253513522	ITSN2;GSN;EDA2R
Very poor growth	2/174	0.6757242564032812	0.7290402777894441	0	0	0.8616102889358703	0.33772554942164873	BRAF;PAFAH1B1
Prostatic Intraepithelial Neoplasias	2/174	0.6757242564032812	0.7290402777894441	0	0	0.8616102889358703	0.33772554942164873	HPGDS;IGFBP5
Retrusion of upper jaw bones	1/84	0.676012129099689	0.7290402777894441	0	0	0.8934303250738804	0.34981751606885275	IL11RA
Hyperalgesia, Secondary	1/84	0.676012129099689	0.7290402777894441	0	0	0.8934303250738804	0.34981751606885275	INSR
Sloping forehead	1/84	0.676012129099689	0.7290402777894441	0	0	0.8934303250738804	0.34981751606885275	ABCC9
Venous Thromboembolism	1/84	0.676012129099689	0.7290402777894441	0	0	0.8934303250738804	0.34981751606885275	DLC1
Allodynia	1/84	0.676012129099689	0.7290402777894441	0	0	0.8934303250738804	0.34981751606885275	INSR
Chronic sinusitis	1/84	0.676012129099689	0.7290402777894441	0	0	0.8934303250738804	0.34981751606885275	HPGDS
Decreased projection of maxilla	1/84	0.676012129099689	0.7290402777894441	0	0	0.8934303250738804	0.34981751606885275	IL11RA
Deficiency of upper jaw bones	1/84	0.676012129099689	0.7290402777894441	0	0	0.8934303250738804	0.34981751606885275	IL11RA
Distal muscle weakness	1/84	0.676012129099689	0.7290402777894441	0	0	0.8934303250738804	0.34981751606885275	PMP22
Hemochromatosis	1/84	0.676012129099689	0.7290402777894441	0	0	0.8934303250738804	0.34981751606885275	UBL3
Hypoplasia of the maxilla	1/84	0.676012129099689	0.7290402777894441	0	0	0.8934303250738804	0.34981751606885275	IL11RA
Hypotrophic maxilla	1/84	0.676012129099689	0.7290402777894441	0	0	0.8934303250738804	0.34981751606885275	IL11RA
Maxillary retrognathia	1/84	0.676012129099689	0.7290402777894441	0	0	0.8934303250738804	0.34981751606885275	IL11RA
Low Vision	3/261	0.6774568976343391	0.7303892768713668	0	0	0.8610840923158546	0.33531419494467957	PEX6;SYN3;ARID1B
Ovarian Failure, Premature	2/175	0.678770964946336	0.7315966308877961	0	0	0.8565860921352251	0.3319027156692237	TGFBR3;XPNPEP2
Hip Dislocation, Congenital	1/85	0.6803393237835119	0.7320303435282746	0	0	0.8827493261455526	0.34000290809968303	TBX15
Hyperalgesia, Primary	1/85	0.6803393237835119	0.7320303435282746	0	0	0.8827493261455526	0.34000290809968303	INSR
Demyelinating Diseases	1/85	0.6803393237835119	0.7320303435282746	0	0	0.8827493261455526	0.34000290809968303	PMP22
Hurthle Cell Tumor	1/85	0.6803393237835119	0.7320303435282746	0	0	0.8827493261455526	0.34000290809968303	BRAF
Hypogammaglobulinemia	1/85	0.6803393237835119	0.7320303435282746	0	0	0.8827493261455526	0.34000290809968303	PIK3R1
Lesion of brain	1/85	0.6803393237835119	0.7320303435282746	0	0	0.8827493261455526	0.34000290809968303	MAOA
Major Depressive Disorder	6/513	0.6809127852344495	0.7324381673267194	0	0	0.8751479289940829	0.33633777071903576	MECP2;DLG2;MAOB;MAOA;MTOR;FKBP5
Well Differentiated Oligodendroglioma	2/176	0.6817943785449978	0.7329678721401275	0	0	0.851619644723093	0.32619345760844554	BRAF;ARHGAP24
Mammary Tumorigenesis	2/176	0.6817943785449978	0.7329678721401275	0	0	0.851619644723093	0.32619345760844554	TSHZ2;MTOR
Renal Insufficiency	3/263	0.6824473403681461	0.7332513209260715	0	0	0.8543726235741445	0.32643007299270704	GSN;SEMA3A;UTS2
Male infertility	3/263	0.6824473403681461	0.7332513209260715	0	0	0.8543726235741445	0.32643007299270704	HPGDS;SLC16A7;BRAF
Leishmaniasis, Visceral	1/86	0.6846089383468777	0.7344521848883162	0	0	0.8723196448390677	0.33052845291818894	FAM120B
Distal limb muscle weakness due to peripheral neuropathy	1/86	0.6846089383468777	0.7344521848883162	0	0	0.8723196448390677	0.33052845291818894	PMP22
Headache	1/86	0.6846089383468777	0.7344521848883162	0	0	0.8723196448390677	0.33052845291818894	BRAF
Muscle Cramp	1/86	0.6846089383468777	0.7344521848883162	0	0	0.8723196448390677	0.33052845291818894	ATXN2
Refractory cancer	2/177	0.6847945752758016	0.7344521848883162	0	0	0.8467099567099567	0.320595189366041	PIK3R1;MTOR
Dengue Fever	2/177	0.6847945752758016	0.7344521848883162	0	0	0.8467099567099567	0.320595189366041	IL1RL1;PMP22
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	4/349	0.6851247617991886	0.7344521848883162	0	0	0.8580152671755725	0.3244621827320252	HPGDS;CD22;HDAC6;MTOR
Uterine Fibroids	4/349	0.6851247617991886	0.7344521848883162	0	0	0.8580152671755725	0.3244621827320252	GHR;HPGDS;INSR;MTOR
Retinal Dystrophies	2/178	0.6877716353690091	0.737079872101012	0	0	0.8418560606060606	0.31510539460153925	BBS1;FZD4
Adult type dermatomyositis	1/87	0.6888217361476333	0.7371566704739019	0	0	0.8621325142606406	0.3213795252948286	HGF
DOSAGE-SENSITIVE SEX REVERSAL	1/87	0.6888217361476333	0.7371566704739019	0	0	0.8621325142606406	0.3213795252948286	PMP22
Generalized muscle weakness	1/87	0.6888217361476333	0.7371566704739019	0	0	0.8621325142606406	0.3213795252948286	ATXN2
Lipoma	1/87	0.6888217361476333	0.7371566704739019	0	0	0.8621325142606406	0.3213795252948286	DCN
Multiple tumors	1/87	0.6888217361476333	0.7371566704739019	0	0	0.8621325142606406	0.3213795252948286	BRAF
Myasthenia Gravis	2/179	0.690725640799271	0.7389842342774365	0	0	0.8370570107858244	0.30972162471917425	AIMP2;PMP22
Ewings sarcoma	4/352	0.6915517469203469	0.7396579871234944	0	0	0.8504869702553304	0.3136743062011583	FOXC1;INSR;MGST1;MTOR
Memory impairment	3/267	0.6922562036562668	0.7402012827627469	0	0	0.841254752851711	0.30941278756465684	HDAC4;AIMP2;PHF1
Brain Tumor, Primary	1/88	0.6929784704075806	0.7405531625603848	0	0	0.8521795705920625	0.31254226673107505	FHIT
Myoclonic Epilepsies, Progressive	1/88	0.6929784704075806	0.7405531625603848	0	0	0.8521795705920625	0.31254226673107505	MBOAT7
Kidney Failure, Chronic	5/437	0.6935709658712848	0.7409761283145574	0	0	0.8559493401447424	0.31319333103200203	INSR;HGF;UTS2;BTBD9;MTOR
Ciliopathies	2/181	0.6965648259160264	0.7430390278827266	0	0	0.8276197731504994	0.2992626887681876	CEP104;BBS1
insulinoma	2/181	0.6965648259160264	0.7430390278827266	0	0	0.8276197731504994	0.2992626887681876	CDKN1C;INSR
Pancreatitis	3/269	0.6970748093173489	0.7430390278827266	0	0	0.8348437634008977	0.3012638439194818	ADH1B;HGF;BRAF
Retinal Degeneration	1/89	0.6970798844007315	0.7430390278827266	0	0	0.8424528301886792	0.30400353762244614	BBS1
Malaria, Falciparum	1/89	0.6970798844007315	0.7430390278827266	0	0	0.8424528301886792	0.30400353762244614	MECP2
Tactile Allodynia	1/89	0.6970798844007315	0.7430390278827266	0	0	0.8424528301886792	0.30400353762244614	INSR
Acute Kidney Insufficiency	1/89	0.6970798844007315	0.7430390278827266	0	0	0.8424528301886792	0.30400353762244614	FSTL1
Osteoarthrosis Deformans	1/89	0.6970798844007315	0.7430390278827266	0	0	0.8424528301886792	0.30400353762244614	ACAA2
Periodontitis, Juvenile	1/90	0.7011267116608145	0.7456646874156658	0	0	0.8329446682213271	0.2957508728561069	PAFAH1B1
Venous Thrombosis	1/90	0.7011267116608145	0.7456646874156658	0	0	0.8329446682213271	0.2957508728561069	SAA1
Age at menarche	1/90	0.7011267116608145	0.7456646874156658	0	0	0.8329446682213271	0.2957508728561069	MAP2K5
Cystic kidney	1/90	0.7011267116608145	0.7456646874156658	0	0	0.8329446682213271	0.2957508728561069	PEX6
Degenerative disorder	1/90	0.7011267116608145	0.7456646874156658	0	0	0.8329446682213271	0.2957508728561069	FZD4
Gaucher Disease	1/90	0.7011267116608145	0.7456646874156658	0	0	0.8329446682213271	0.2957508728561069	AIMP2
Micromelia	1/90	0.7011267116608145	0.7456646874156658	0	0	0.8329446682213271	0.2957508728561069	CDKN1C
Motor neuron atrophy	1/90	0.7011267116608145	0.7456646874156658	0	0	0.8329446682213271	0.2957508728561069	VPS54
oligodendroglioma	2/183	0.7023128246171562	0.7467153289113259	0	0	0.8183910932529717	0.28920006158190364	BRAF;ARHGAP24
Ichthyoses	1/91	0.7051196760674764	0.7491006202230767	0	0	0.8236477987421383	0.28777244072568575	BRAF
Prolactinoma	1/91	0.7051196760674764	0.7491006202230767	0	0	0.8236477987421383	0.28777244072568575	PRDM2
Proteinuria	2/184	0.7051528535468623	0.7491006202230767	0	0	0.8138528138528138	0.2843119003992607	INSR;SAA1
MIXED LINEAGE LEUKEMIA	2/185	0.7079703584435678	0.7517667057585077	0	0	0.809364133134625	0.27951637418056985	MEF2C;HGF
Sepsis	6/529	0.7089937793151548	0.7517667057585077	0	0	0.8476687748198265	0.2915205192015715	AIMP2;IL1RL1;GSN;SAA1;AAK1;MTOR
Thyroid associated opthalmopathies	1/92	0.7090594917865617	0.7517667057585077	0	0	0.81455525606469	0.2800570049168634	IGFBP5
Acute kidney injury	1/92	0.7090594917865617	0.7517667057585077	0	0	0.81455525606469	0.2800570049168634	FSTL1
Bell Palsy	1/92	0.7090594917865617	0.7517667057585077	0	0	0.81455525606469	0.2800570049168634	HPGDS
Cholestasis in newborn	1/92	0.7090594917865617	0.7517667057585077	0	0	0.81455525606469	0.2800570049168634	PEX6
Dejerine-Sottas Disease (disorder)	1/92	0.7090594917865617	0.7517667057585077	0	0	0.81455525606469	0.2800570049168634	PMP22
Osteoarthritis, Knee	1/93	0.7129468635701431	0.7550381880991648	0	0	0.8056603773584906	0.27259388873981516	IL16
Childhood Medulloblastoma	1/93	0.7129468635701431	0.7550381880991648	0	0	0.8056603773584906	0.27259388873981516	HGF
Edema	1/93	0.7129468635701431	0.7550381880991648	0	0	0.8056603773584906	0.27259388873981516	USP8
Manic	1/93	0.7129468635701431	0.7550381880991648	0	0	0.8056603773584906	0.27259388873981516	MAOA
Bacterial Infections	3/276	0.7134915654144076	0.7552397592913301	0	0	0.8131450298750679	0.27450529133465307	CEACAM1;HGF;SAA1
Vomiting	2/187	0.7135381744937203	0.7552397592913301	0	0	0.8005323505323505	0.2701951508819714	SAA1;BRAF
Optic Atrophy	4/363	0.714320490352107	0.7558554177405582	0	0	0.8239596844500202	0.27719944318175416	RERE;ATXN1;SON;PEX6
Multiple Sclerosis	13/1106	0.7160119485692196	0.7572998740608546	0	0	0.8763384672132036	0.29274824743614036	CDKN1C;SORT1;STAT2;SEMA3A;EBF1;SYN3;ARHGAP24;DCN;FOXP1;MECP2;AIMP2;HPGDS;ATXN2
Acquired Immunodeficiency Syndrome	2/188	0.716288678332579	0.7572998740608546	0	0	0.7961876832844574	0.26566554561303474	AIMP2;IL16
Dyspnea	2/188	0.716288678332579	0.7572998740608546	0	0	0.7961876832844574	0.26566554561303474	ATXN2;PMP22
Renal cyst	1/95	0.7205670482719222	0.7611822969266212	0	0	0.788438378161381	0.2583845100905354	PEX6
Rotting teeth	1/95	0.7205670482719222	0.7611822969266212	0	0	0.788438378161381	0.2583845100905354	COL3A1
Pachygyria	1/95	0.7205670482719222	0.7611822969266212	0	0	0.788438378161381	0.2583845100905354	PAFAH1B1
Dermatitis	2/190	0.721723369866814	0.7621900572717376	0	0	0.7876370083816893	0.25685894948096655	HPGDS;IL16
Renal failure in adulthood	1/96	0.7243012246951659	0.7638417450802604	0	0	0.7800993048659385	0.2516194057713582	GSN
Retinal Detachment	1/96	0.7243012246951659	0.7638417450802604	0	0	0.7800993048659385	0.2516194057713582	FZD4
Sparse hair	1/96	0.7243012246951659	0.7638417450802604	0	0	0.7800993048659385	0.2516194057713582	BRAF
Thin, sparse hair	1/96	0.7243012246951659	0.7638417450802604	0	0	0.7800993048659385	0.2516194057713582	BRAF
Aortic Aneurysm	1/96	0.7243012246951659	0.7638417450802604	0	0	0.7800993048659385	0.2516194057713582	COL3A1
Neoplasms, Intracranial	1/97	0.7279856846819742	0.7675124752860334	0	0	0.7719339622641509	0.24506888158797033	HGF
Low density lipoprotein cholesterol measurement	3/283	0.7292166293404388	0.7685951434598303	0	0	0.7925312330255296	0.25026902488880737	TGFBR3;SORT1;PDE1A
Hypercalcemia	1/98	0.7316210874080097	0.7709137444100622	0	0	0.7639369772417818	0.23872460580379787	CDKN1C
Disseminated Malignant Neoplasm	2/195	0.7349279966771696	0.7740438379105824	0	0	0.767035641387973	0.23623374485769572	HGF;ARHGAP24
Aortic Aneurysm, Thoracic	1/99	0.7352080838980791	0.7740438379105824	0	0	0.7561031959953792	0.23257863790907765	COL3A1
Ischemia of kidney	1/99	0.7352080838980791	0.7740438379105824	0	0	0.7561031959953792	0.23257863790907765	AIMP2
Conventional (Clear Cell) Renal Cell Carcinoma	7/631	0.7381312755004453	0.7769043070159758	0	0	0.8277027027027027	0.2513183431724454	TGFBR3;AKAP13;SLC7A6;HGF;RCHY1;FHIT;MTOR
Neuralgia	1/100	0.738747316125365	0.7771184417325468	0	0	0.7484276729559748	0.22662340785081836	HGF
Rash and Dermatitis Adverse Event Associated with Chemoradiation	1/100	0.738747316125365	0.7771184417325468	0	0	0.7484276729559748	0.22662340785081836	HPGDS
Atrial Fibrillation	3/288	0.7400305649220632	0.7773188453537745	0	0	0.7784270562337402	0.2343561995455377	SIK3;ABCC9;ATP2B1
Single Seizure	1/101	0.7422394177694523	0.7773188453537745	0	0	0.7409056603773585	0.22085169492272455	MECP2
Seizures, Auditory	1/101	0.7422394177694523	0.7773188453537745	0	0	0.7409056603773585	0.22085169492272455	MECP2
Seizures, Clonic	1/101	0.7422394177694523	0.7773188453537745	0	0	0.7409056603773585	0.22085169492272455	MECP2
Seizures, Sensory	1/101	0.7422394177694523	0.7773188453537745	0	0	0.7409056603773585	0.22085169492272455	MECP2
Seizures, Somatosensory	1/101	0.7422394177694523	0.7773188453537745	0	0	0.7409056603773585	0.22085169492272455	MECP2
Vertiginous seizure	1/101	0.7422394177694523	0.7773188453537745	0	0	0.7409056603773585	0.22085169492272455	MECP2
Atonic Absence Seizures	1/101	0.7422394177694523	0.7773188453537745	0	0	0.7409056603773585	0.22085169492272455	MECP2
Forced expiratory volume function	1/101	0.7422394177694523	0.7773188453537745	0	0	0.7409056603773585	0.22085169492272455	FAM13A
Generalized Absence Seizures	1/101	0.7422394177694523	0.7773188453537745	0	0	0.7409056603773585	0.22085169492272455	MECP2
Gustatory seizure	1/101	0.7422394177694523	0.7773188453537745	0	0	0.7409056603773585	0.22085169492272455	MECP2
Jacksonian Seizure	1/101	0.7422394177694523	0.7773188453537745	0	0	0.7409056603773585	0.22085169492272455	MECP2
Non-epileptic convulsion	1/101	0.7422394177694523	0.7773188453537745	0	0	0.7409056603773585	0.22085169492272455	MECP2
Nonepileptic Seizures	1/101	0.7422394177694523	0.7773188453537745	0	0	0.7409056603773585	0.22085169492272455	MECP2
Olfactory seizure	1/101	0.7422394177694523	0.7773188453537745	0	0	0.7409056603773585	0.22085169492272455	MECP2
Otitis Media	1/101	0.7422394177694523	0.7773188453537745	0	0	0.7409056603773585	0.22085169492272455	NSD1
Heart Decompensation	1/102	0.7456850141924881	0.7807102413738474	0	0	0.7335325985428731	0.21525660878961556	NPR1
Epileptic Seizures	1/103	0.7490847222946424	0.7840517223906412	0	0	0.7263041065482797	0.20983157182751097	MECP2
Malaria	5/469	0.7506092117573504	0.7854291390805386	0	0	0.7955971726780288	0.22823305626367682	MECP2;AIMP2;GSN;GYPC;ADH1B
Tonic Seizures	1/104	0.7524391509973292	0.7864701114891618	0	0	0.7192159736215424	0.20457030196622059	MECP2
Acute pancreatitis	1/104	0.7524391509973292	0.7864701114891618	0	0	0.7192159736215424	0.20457030196622059	ADH1B
Enterovirus Infections	1/104	0.7524391509973292	0.7864701114891618	0	0	0.7192159736215424	0.20457030196622059	COG1
Ischemia	1/104	0.7524391509973292	0.7864701114891618	0	0	0.7192159736215424	0.20457030196622059	ARID1B
Biliary Atresia	1/105	0.7557489011659257	0.7890538000809431	0	0	0.7122641509433962	0.19946679713484772	GHR
Carotid Atherosclerosis	1/105	0.7557489011659257	0.7890538000809431	0	0	0.7122641509433962	0.19946679713484772	HGF
Mixed Salivary Gland Tumor	1/105	0.7557489011659257	0.7890538000809431	0	0	0.7122641509433962	0.19946679713484772	ARHGAP24
Premature Obstetric Labor	1/105	0.7557489011659257	0.7890538000809431	0	0	0.7122641509433962	0.19946679713484772	HPGD
Heart Failure, Right-Sided	1/106	0.7590145655866741	0.7918050037565776	0	0	0.70544474393531	0.1945153206111238	NPR1
Chronic graft-versus-host disease	1/106	0.7590145655866741	0.7918050037565776	0	0	0.70544474393531	0.1945153206111238	HGF
Malignant Testicular Germ Cell Tumor	1/106	0.7590145655866741	0.7918050037565776	0	0	0.70544474393531	0.1945153206111238	HPGDS
Embryonal Carcinoma	2/205	0.7597449092791523	0.79234747321555	0	0	0.7288774443946858	0.20027551237831667	BRAF;ARHGAP24
Basal cell carcinoma	1/107	0.7622367292241287	0.794506297450828	0	0	0.6987540049839801	0.1897103870052932	FOXP1
Head and Neck Neoplasms	1/107	0.7622367292241287	0.794506297450828	0	0	0.6987540049839801	0.1897103870052932	ADH1B
Visual seizure	2/207	0.7644610443917165	0.796277812065695	0	0	0.7216925351071692	0.1938352198228279	MECP2;PAFAH1B1
Polycythemia Vera	2/207	0.7644610443917165	0.796277812065695	0	0	0.7216925351071692	0.1938352198228279	HPGDS;HGF
Reduced visual acuity	1/108	0.7654159696017737	0.796277812065695	0	0	0.6921883265737965	0.18504674898344167	FZD4
Secondary Neoplasm	1/108	0.7654159696017737	0.796277812065695	0	0	0.6921883265737965	0.18504674898344167	BRAF
Congenital ocular coloboma (disorder)	1/108	0.7654159696017737	0.796277812065695	0	0	0.6921883265737965	0.18504674898344167	RERE
Mechanical Allodynia	1/108	0.7654159696017737	0.796277812065695	0	0	0.6921883265737965	0.18504674898344167	INSR
Myocardial Failure	1/108	0.7654159696017737	0.796277812065695	0	0	0.6921883265737965	0.18504674898344167	NPR1
Hyperalgesia, Thermal	1/109	0.7685528561833253	0.7990998093410396	0	0	0.6857442348008386	0.18051938568343848	INSR
Convulsive Seizures	1/109	0.7685528561833253	0.7990998093410396	0	0	0.6857442348008386	0.18051938568343848	MECP2
Reperfusion Injury	1/110	0.771647951135041	0.8018752639795034	0	0	0.6794183832438982	0.17612349059027677	HGF
Post-Traumatic Stress Disorder	1/110	0.771647951135041	0.8018752639795034	0	0	0.6794183832438982	0.17612349059027677	FKBP5
Congenital cataract	1/111	0.7747018092249109	0.8043830527426239	0	0	0.6732075471698113	0.17185446088727038	LEMD2
Multiple Endocrine Neoplasia Type 1	1/111	0.7747018092249109	0.8043830527426239	0	0	0.6732075471698113	0.17185446088727038	MTOR
Plasmacytoma	1/111	0.7747018092249109	0.8043830527426239	0	0	0.6732075471698113	0.17185446088727038	EBF1
Congenital contractural arachnodactyly	2/212	0.7759021708714444	0.8054074063578758	0	0	0.7043290043290044	0.17870857787361502	ARHGAP24;PAFAH1B1
Skin Erosion	1/112	0.777714977780079	0.8066223351590192	0	0	0.6671086180520143	0.1677078873755735	PAFAH1B1
Synovitis	1/112	0.777714977780079	0.8066223351590192	0	0	0.6671086180520143	0.1677078873755735	BRAF
Infectious disease of lung	1/112	0.777714977780079	0.8066223351590192	0	0	0.6671086180520143	0.1677078873755735	DCN
Arthrogryposis	3/307	0.7780294533520603	0.8067263833683489	0	0	0.7290624374624775	0.1829880356881933	SGCD;PEX6;VPS39
Diabetes Mellitus, Experimental	1/113	0.7806879969718009	0.8088150947724901	0	0	0.6611185983827493	0.16367954469759385	INSR
Streptozotocin Diabetes	1/113	0.7806879969718009	0.8088150947724901	0	0	0.6611185983827493	0.16367954469759385	INSR
Alloxan Diabetes	1/113	0.7806879969718009	0.8088150947724901	0	0	0.6611185983827493	0.16367954469759385	INSR
Kidney Failure, Acute	3/310	0.7835939716215677	0.810962036442899	0	0	0.721826581290794	0.17602772395227034	HGF;FSTL1;MTOR
Carcinoma, Endometrioid	1/114	0.7836213996952885	0.810962036442899	0	0	0.655234596760728	0.15976538246326627	BRAF
Neuroectodermal Tumor, Primitive	1/114	0.7836213996952885	0.810962036442899	0	0	0.655234596760728	0.15976538246326627	ABR
Dermatomyositis	1/114	0.7836213996952885	0.810962036442899	0	0	0.655234596760728	0.15976538246326627	HGF
Epileptic drop attack	1/115	0.786515712055291	0.8135103479715216	0	0	0.6494538232373386	0.15596151637786473	MECP2
Pancreatic intraepithelial neoplasia	1/115	0.786515712055291	0.8135103479715216	0	0	0.6494538232373386	0.15596151637786473	BRAF
Hepatitis B	9/839	0.7893272587536979	0.8151212343020618	0	0	0.7975997374712859	0.18869157365975403	MECP2;HPGDS;URGCP;ADH1B;CALD1;INSR;DLC1;IL16;MTOR
Acute Myeloid Leukemia, M1	1/116	0.789371452809642	0.8151212343020618	0	0	0.6437735849056604	0.15226422072611198	HGF
Respiratory Syncytial Virus Infections	1/116	0.789371452809642	0.8151212343020618	0	0	0.6437735849056604	0.15226422072611198	MTOR
Condition, Preneoplastic	1/116	0.789371452809642	0.8151212343020618	0	0	0.6437735849056604	0.15226422072611198	CCDC134
Liver Neoplasms, Experimental	1/116	0.789371452809642	0.8151212343020618	0	0	0.6437735849056604	0.15226422072611198	HGF
Experimental Hepatoma	1/116	0.789371452809642	0.8151212343020618	0	0	0.6437735849056604	0.15226422072611198	HGF
Teratoma	1/117	0.792189134108629	0.817582594023892	0	0	0.6381912817176317	0.14866992022370448	FHIT
Hyperhomocysteinemia	1/117	0.792189134108629	0.817582594023892	0	0	0.6381912817176317	0.14866992022370448	MEF2C
Anemia, Hemolytic	1/118	0.7949692614538862	0.8197780476038296	0	0	0.6327044025157232	0.1451751829513631	HPGDS
Convulsions	1/118	0.7949692614538862	0.8197780476038296	0	0	0.6327044025157232	0.1451751829513631	MECP2
Erectile dysfunction	1/118	0.7949692614538862	0.8197780476038296	0	0	0.6327044025157232	0.1451751829513631	NPR1
Small cell carcinoma of lung	7/673	0.7951913551047111	0.8197826586424319	0	0	0.7738008278548819	0.17733386638821055	HPGDS;HGF;BRAF;FSTL1;FHIT;RBM5;MTOR
Hepatoma, Novikoff	1/119	0.7977123333241792	0.8214823290410561	0	0	0.6273105212663895	0.1417767139379347	HGF
Giant Cell Arteritis	1/119	0.7977123333241792	0.8214823290410561	0	0	0.6273105212663895	0.1417767139379347	IL1RL1
Hyperalgesia	1/119	0.7977123333241792	0.8214823290410561	0	0	0.6273105212663895	0.1417767139379347	INSR
Increased serum lactate	1/119	0.7977123333241792	0.8214823290410561	0	0	0.6273105212663895	0.1417767139379347	OGDH
Adult T-Cell Lymphoma/Leukemia	5/500	0.7980073164839576	0.8215615089355202	0	0	0.7445721583652618	0.16800341009839098	CDKN1C;GSN;HGF;IL16;TM9SF3
Liver Failure, Acute	1/120	0.8004188419730033	0.8238190649487167	0	0	0.6220072934834311	0.1384713481772926	HGF
Acute Erythroblastic Leukemia	2/224	0.8014016012145813	0.8246052531481365	0	0	0.6658476658476659	0.14741406739083165	HGF;HOXD3
Hepatoma, Morris	1/121	0.8030892726743466	0.8258906061054502	0	0	0.6167924528301887	0.13525604522433604	HGF
Acute Myeloid Leukemia (AML-M2)	1/121	0.8030892726743466	0.8258906061054502	0	0	0.6167924528301887	0.13525604522433604	HGF
Myopathy	4/415	0.8053408048205865	0.8279800250434358	0	0	0.7177801303839082	0.15539202743696046	GSN;MAOA;CALD1;INSR
Acute Megakaryocytic Leukemias	1/122	0.8057241048592496	0.8281480772182246	0	0	0.611663807890223	0.13212788263570005	DLC1
Kaposi Sarcoma	3/323	0.8063931453239517	0.8286096504188014	0	0	0.6920389733840304	0.14891563281816214	INSR;HGF;SEMA3A
Absence Seizures	1/123	0.8083238110833306	0.8301406205973028	0	0	0.6066192390968141	0.12908405140042875	MECP2
Peripheral T-Cell Lymphoma	1/123	0.8083238110833306	0.8301406205973028	0	0	0.6066192390968141	0.12908405140042875	FOXP1
Encephalitis, St. Louis	1/124	0.810888857950349	0.832547922567175	0	0	0.6016566958122411	0.12612185014813185	RNPC3
Familial M??ni??re disease	1/125	0.8134197058676056	0.8349188098101554	0	0	0.5967741935483871	0.12323868052762584	NPR1
Difficulties with night vision	1/126	0.8159168090347322	0.8363424815330166	0	0	0.5919698113207548	0.12043204265331851	PEX6
Generalized seizures	1/126	0.8159168090347322	0.8363424815330166	0	0	0.5919698113207548	0.12043204265331851	MECP2
Left-Sided Heart Failure	1/126	0.8159168090347322	0.8363424815330166	0	0	0.5919698113207548	0.12043204265331851	NPR1
Memory Loss	1/126	0.8159168090347322	0.8363424815330166	0	0	0.5919698113207548	0.12043204265331851	MTOR
Myocarditis	1/126	0.8159168090347322	0.8363424815330166	0	0	0.5919698113207548	0.12043204265331851	IDS
Metastasis from malignant tumor of prostate	2/232	0.816944159022629	0.837167749466334	0	0	0.6424242424242425	0.12988824689914188	HGF;MAP2K5
Childhood asthma	1/127	0.8183806157955057	0.8384116887956676	0	0	0.5872416891284816	0.11769953052551217	HPGDS
Chronic myeloproliferative disorder	2/233	0.8188087998534265	0.8386222808721745	0	0	0.6396103896103896	0.12786110897827635	NUMA1;PAFAH1B1
Hereditary Nonpolyposis Colorectal Cancer	1/128	0.8208115684493065	0.8404450063464358	0	0	0.5825880255534096	0.11503882807189869	BRAF
Endometrial adenocarcinoma	1/129	0.8232101033160992	0.8424429391990617	0	0	0.5780070754716982	0.1124477052099022	CEACAM1
liposarcoma	1/129	0.8232101033160992	0.8424429391990617	0	0	0.5780070754716982	0.1124477052099022	FOXP1
Non-alcoholic Fatty Liver Disease	3/334	0.8240800809464257	0.843104200142636	0	0	0.6686616199326847	0.12937771077626645	HPGDS;INSR;MTOR
Aortic Valve Stenosis	1/130	0.8255766511832872	0.8439897497821252	0	0	0.5734971478718737	0.10992401384263009	OGT
Lyme Disease	1/130	0.8255766511832872	0.8439897497821252	0	0	0.5734971478718737	0.10992401384263009	DCN
Graves Disease	3/335	0.8256177934555697	0.8439897497821252	0	0	0.666613220944615	0.12773864677693558	ATXN2;IL16;MTOR
Disorder of eye	1/131	0.8279116371522002	0.8458755457424296	0	0	0.5690566037735849	0.10746568447170564	IL16
Neoplastic Cell Transformation	1/131	0.8279116371522002	0.8458755457424296	0	0	0.5690566037735849	0.10746568447170564	EBF1
Autoimmune thyroid disease	1/132	0.830215480476466	0.8477695079845072	0	0	0.5646838542416822	0.1050707229821175	ARHGAP24
Night Blindness	1/132	0.830215480476466	0.8477695079845072	0	0	0.5646838542416822	0.1050707229821175	PEX6
Vesicular Stomatitis	1/133	0.832488594959156	0.8493999288220857	0	0	0.560377358490566	0.10273720720779667	STAT2
Lewy Body Disease	1/133	0.832488594959156	0.8493999288220857	0	0	0.560377358490566	0.10273720720779667	INSR
PACHYONYCHIA CONGENITA 3	1/133	0.832488594959156	0.8493999288220857	0	0	0.560377358490566	0.10273720720779667	HGF
Diabetic Retinopathy	2/247	0.8431856652348533	0.8598417987820357	0	0	0.6026283240568955	0.10278916930878607	HGF;SEMA3A
Abdominal discomfort	1/138	0.8434073391291802	0.8598417987820357	0	0	0.5397879080016527	0.0919287069923791	SAA1
Measles	1/138	0.8434073391291802	0.8598417987820357	0	0	0.5397879080016527	0.0919287069923791	STAT2
Cholangitis, Sclerosing	1/140	0.8475736174767071	0.8636218060683678	0	0	0.5319668793267273	0.08797539472865201	FOXP1
Gastrointestinal pain	1/140	0.8475736174767071	0.8636218060683678	0	0	0.5319668793267273	0.08797539472865201	SAA1
Triple Negative Breast Neoplasms	6/632	0.8491751824328996	0.8650000793882464	0	0	0.704399115261735	0.11516205231730102	TGFBR3;SLC25A16;FOXC1;HGF;ARHGAP24;MTOR
Visual Impairment	2/251	0.8495848667114837	0.8650000793882464	0	0	0.5928258488499453	0.09663502452287852	PEX6;ARID1B
Electroretinogram abnormal	1/141	0.8496151562878981	0.8650000793882464	0	0	0.5281401617250674	0.0860719471742505	BBS1
Rheumatoid Arthritis	20/1833	0.8526279980147142	0.8677915725447352	0	0	0.8036358907439047	0.12812522654024597	FOXC1;GSN;CALCRL;URGCP;IGFBP5;HGF;SYVN1;BRAF;IL16;LSP1;RCHY1;FSTL1;MECP2;AIMP2;HPGDS;CILP;CALD1;SAA1;PAFAH1B1;FKBP5
Metastatic Neoplasm	5/544	0.8528177333582717	0.8677915725447352	0	0	0.6822269137540073	0.1086169591003532	HGF;CRNDE;BRAF;PIK3R1;FSTL1
Leprosy	1/143	0.8536168685202893	0.8683701711358168	0	0	0.5206484188147754	0.08240449220821383	IL1RL1
Disease Exacerbation	1/144	0.8555777615384874	0.8698951221904135	0	0	0.5169811320754717	0.08063783489159945	RCHY1
Ophthalmoplegia	1/144	0.8555777615384874	0.8698951221904135	0	0	0.5169811320754717	0.08063783489159945	ATXN2
Mammary Carcinoma, Animal	1/145	0.8575124841572376	0.8711568305880028	0	0	0.5133647798742138	0.07891419846339422	PIK3R1
Thrombocythemia, Essential	1/145	0.8575124841572376	0.8711568305880028	0	0	0.5133647798742138	0.07891419846339422	HDAC6
Animal Mammary Neoplasms	1/145	0.8575124841572376	0.8711568305880028	0	0	0.5133647798742138	0.07891419846339422	PIK3R1
Hematological Disease	1/147	0.8613048057189515	0.8745377906046605	0	0	0.5062806926854484	0.0755911620706083	PAFAH1B1
Polydactyly	1/147	0.8613048057189515	0.8745377906046605	0	0	0.5062806926854484	0.0755911620706083	BBS1
Chronic Periodontitis	1/148	0.8631630867471848	0.8761884526479777	0	0	0.5028109356950328	0.07398944837738046	IL16
Decreased platelet count	1/152	0.870351429525651	0.8832472615902822	0	0	0.48939147819567663	0.06795602314055849	MTOR
Sezary Syndrome	1/153	0.8720889367856378	0.8845339323832788	0	0	0.4861469712015889	0.0665359551612077	BRAF
Abdominal Pain	1/153	0.8720889367856378	0.8845339323832788	0	0	0.4861469712015889	0.0665359551612077	SAA1
Septicemia	4/468	0.8724418526113632	0.8846536901176326	0	0	0.634048433798368	0.08652178749732355	AIMP2;SAA1;AAK1;MTOR
Icterus	1/154	0.8738032445108063	0.8855573909260713	0	0	0.482944876063633	0.06514928762256596	PEX6
Premature Menopause	1/154	0.8738032445108063	0.8855573909260713	0	0	0.482944876063633	0.06514928762256596	TGFBR3
Biliary cirrhosis	1/155	0.8754946613809488	0.8867944042543787	0	0	0.4797843665768194	0.06379511607097715	HGF
Other specified transient cerebral ischemias	1/155	0.8754946613809488	0.8867944042543787	0	0	0.4797843665768194	0.06379511607097715	MECP2
Elevated creatine kinase	1/156	0.8771634918272615	0.8882459337938963	0	0	0.4766646378575776	0.06247256465796501	SGCD
Hypertriglyceridemia	1/157	0.8788100363877829	0.8896741217610261	0	0	0.47358490566037736	0.06118078492886692	IL16
Blindness, Legal	1/158	0.8804345914652631	0.8910283972808617	0	0	0.4705444057204663	0.05991895498274346	FZD4
Mammary Neoplasms, Human	4/476	0.880620844989819	0.8910283972808617	0	0	0.6230430844869971	0.0792062926402734	ITSN2;IGFBP5;LSP1;VPS39
Creatine phosphokinase serum increased	1/159	0.8820374497319677	0.8922220926800006	0	0	0.46754239312156676	0.05868627832303721	SGCD
Mammary Neoplasms, Experimental	1/160	0.8836188998689316	0.8935818512231586	0	0	0.4645781416874333	0.05748198310701314	PIK3R1
Nephritis	1/162	0.8867187114008517	0.8964759489659174	0	0	0.4587601078167116	0.05515556734217499	RNPC3
Blindness	1/164	0.8897362599587404	0.8992853478037498	0	0	0.45308484778330826	0.052933992159024605	FZD4
Hepatitis C, Chronic	3/386	0.8901381704728659	0.8994502382433707	0	0	0.5763285647628786	0.06707230031672054	AIMP2;HPGDS;MTOR
Bone Diseases	1/165	0.8912148675588619	0.9002967031628406	0	0	0.45029912563276575	0.05186082751128376	HGF
Sclerocystic Ovaries	1/166	0.8926737206493993	0.901287029130605	0	0	0.44754716981132076	0.05081188271347325	HOOK3
Acute GVH disease	1/166	0.8926737206493993	0.901287029130605	0	0	0.44754716981132076	0.05081188271347325	HGF
Anemia	4/490	0.8938459317977872	0.9022287312653441	0	0	0.6046555461313731	0.06785556669445265	HGF;FHIT;PAFAH1B1;FOXP1
Childhood Leukemia	1/168	0.895533211254929	0.9036896884000315	0	0	0.4421421308326743	0.048784181476008916	PAFAH1B1
Ischemic stroke	3/394	0.8980586046363206	0.9057707070429165	0	0	0.564303287855066	0.0606738621537129	CEACAM1;SAA1;IL16
Complete atrioventricular block	1/170	0.8983167936056109	0.9057707070429165	0	0	0.43686502177068215	0.04684612672026884	GSN
Dental caries	1/170	0.8983167936056109	0.9057707070429165	0	0	0.43686502177068215	0.04684612672026884	COL3A1
Cystic Fibrosis	5/594	0.8995549590283762	0.9067764331442048	0	0	0.6226866759037006	0.06591457773608816	AIMP2;HPGDS;FZD4;HGF;HDAC6
Virus Diseases	8/875	0.9001432186377397	0.9071266732499641	0	0	0.674767307743891	0.07098646308601532	AIMP2;FOXC1;ADH1B;STAT2;HGF;HDAC6;MTOR;FKBP5
Hemoglobin low	1/177	0.90749006737581	0.9142859277359392	0	0	0.4193396226415094	0.04070641175081817	FOXP1
Idiopathic pulmonary arterial hypertension	2/297	0.9078454827011528	0.9143994474158403	0	0	0.4992039034411916	0.04826357656774673	TGFBR3;HDAC4
Neutropenia	1/178	0.9087314097903872	0.9150471052339986	0	0	0.41694915254237286	0.039904413529506945	STAT2
Dermatologic disorders	3/406	0.9089810700950479	0.9150538992645766	0	0	0.5471605543971544	0.05221608433797735	AIMP2;AKAP9;BRAF
Hereditary Diffuse Gastric Cancer	2/300	0.9107995542225781	0.9166395727374971	0	0	0.4941020947732357	0.04616516147166841	DLC1;FHIT
Epilepsy, Temporal Lobe	1/181	0.9123567446709051	0.9177163837584245	0	0	0.409937106918239	0.03760115235903966	MTOR
Conductive hearing loss	1/181	0.9123567446709051	0.9177163837584245	0	0	0.409937106918239	0.03760115235903966	NSD1
Hepatitis, Chronic	1/183	0.914693565121707	0.9198213186901949	0	0	0.40539083557951483	0.03614714869075211	HGF
Malignant neoplasm of testis	1/185	0.9169683056014174	0.9218627187618199	0	0	0.4009433962264151	0.03475472400603936	HPGDS
Hashimoto Disease	1/186	0.9180829110302965	0.9227370133007275	0	0	0.39875573686894444	0.034080686012419016	BRAF
Metabolic Diseases	3/421	0.921143004983796	0.9255656707852652	0	0	0.5271162697618571	0.043297321623704386	ADH1B;INSR;MTOR
Celiac Disease	2/312	0.9217530668212851	0.9259316807242082	0	0	0.47468230694037145	0.038676124514905534	ATXN2;NFIA
Transient Ischemic Attack	1/191	0.9234362630867609	0.9273752074241077	0	0	0.38816285998013905	0.03091852975204621	MECP2
Inflammation	3/429	0.92700666657536	0.9307127166816048	0	0	0.5170031596422643	0.039186007297065506	CEACAM1;HGF;SAA1
Hypertrophic Cardiomyopathy	2/328	0.9344025729643999	0.937888220718597	0	0	0.45101319947945717	0.030600304460564214	SGCD;BRAF
Leukodystrophy	1/204	0.9357793210853299	0.939019899448172	0	0	0.36306348173622083	0.02409855584778425	PEX6
Cytopenia	1/206	0.9374935874849226	0.9404895723184297	0	0	0.35948458352508056	0.023203062281206548	BRAF
Congenital anemia	1/208	0.9391622600604834	0.9419127352630035	0	0	0.3559748427672956	0.022343477863390623	BRAF
Diabetes Mellitus, Insulin-Dependent	8/956	0.9429568615968013	0.9454667281435055	0	0	0.6144637425179079	0.03609037019361425	IL1RL1;HPGDS;ATXN2;GSN;CALD1;INSR;HGF;DCN
Graft-vs-Host Disease	1/226	0.9523177928935129	0.9545984901090643	0	0	0.32719496855345914	0.015985595690501835	ARHGAP24
Anemia, Sickle Cell	1/231	0.9554399333838537	0.9574733251016168	0	0	0.32	0.01458668203039084	HPGDS
Influenza	4/589	0.955848686431734	0.9575646671511907	0	0	0.4997455470737914	0.022566338135662754	ITSN2;CLK1;AIMP2;SFSWAP
Hyperlipidemia	1/232	0.9560394778751335	0.9575646671511907	0	0	0.31859838274932617	0.01432293181321466	SAA1
Pituitary Diseases	1/240	0.9605553315109737	0.9618319866565226	0	0	0.30780768927133495	0.01238731767167594	GHR
Tuberculosis	4/602	0.9608673841917807	0.9618887686022956	0	0	0.48854961832061067	0.01950235224607106	AIMP2;HPGDS;FHIT;MTOR
Leukopenia	1/246	0.9636361352757856	0.9644041768288748	0	0	0.3001771274547555	0.0111190136656496	STAT2
Brain Ischemia	1/264	0.9715126757602861	0.9720287515508627	0	0	0.279374417103092	0.008074189589139467	HGF
Psoriasis	5/818	0.9856059833613349	0.9858676949872939	0	0	0.4458441136135499	0.006464122349797637	AIMP2;HPGDS;STAT2;SEMA3A;SAA1
Ankylosing spondylitis	1/348	0.990908100509077	0.990908100509077	0	0	0.21083138491653527	0.001925624880548392	SAA1
